Onsite Program Book - ASHP MediaWelcome to Las Vegas! It is great to be back in this city of boundless energy and excitement for the largest gathering of pharmacists in the world

4 GeneralInformation11 ConventionCenterMap16 EducationInformation19 Schedule-at-a-Glance30 SpecialEvents&Activities36 ASHPBoardReviewandRecertificationEvents—Live43 Pre-MeetingWorkshops44 ResidentandNewPractitionerProgramming49 ASHPStudentForumProgramming54 ProgrammingforSmall&RuralHospitalPractitioners55 PharmacyResidency&TechnicianTrainingActivities57 PharmacyPracticeSectionsNetworkingSessions62 EducationalSessions107 Industry-supportedSymposia110 Posters127 Acknowledgments132 ASHPStaffinAttendance134 PresenterDisclosures135 PresenterIndex138 ShuttleSchedule&HotelMap140 ColorCards

51st ASHP Midyear Clinical Meeting & ExhibitionLasVegas,NevadaDecember4-8,2016

with ASHPASHP’s Midyear Clinical Meeting is the largest gathering of pharmacists and the longest-running clinical meeting in the world!

We invite you to join us as we celebrate more than five decades of excellence in clinical pharmacy with a focus on improving patient care and medication safety. The Midyear meeting provides pharmacy practitioners with a value-packed event for updating knowledge, networking with colleagues, enhancing skills, and learning about the latest products and innovations.

Always one of our most popular destinations, Las Vegas offers our Midyear meeting attendees and exhibitors the best of both worlds — world-class hotels, where you can find pharmacy’s best educational and networking opportunities, and one of the most exciting cities in the world, with seemingly endless entertainment and dining options.

All of the Midyear meeting’s official sessions and events will take place at the newly expanded and updated Mandalay Bay Convention Center. So much has changed since the last time ASHP visited Mandalay Bay that it would be difficult to com-pile a complete list. However, you can count on a resort-wide remodel of guest rooms and suites, more conference space, and new entertainment and dining options just steps away from the meeting.

AllroomsarelocatedintheMandalay Bay South Convention Center

unlessotherwisenoted.

2

X

51st ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION

Ambulatory Care Pharmacy* I Critical Care Pharmacy Pediatric Pharmacy I Pharmacotherapy

The first program of its kind, the RRRP was developed to ease the financial burden on residents and new practitioners preparing for board certification during this unique time in their pharmacy careers.

You can choose between the live review course or the online, home-study course. You will also have access to the Practice Exam and Core Therapeutic Modules for free.

ASHP’s 2017 Review and Recertification Reward Program (RRRP)

$0ASHP Live or OnlinePharmacotherapy

Review Course

$0ASHP Live or

Online Review Course

$0Practice Exam & Core Therapeutic Module Package

$10/moAll Your

Recertification Needs

HOW DOES THE RECERTIFICATION PORTION WORK?

For just $10 per month during the initial 7-year recertification cycle, you will have access to the entire online catalog of recertification activities for your specialty. This price will never increase.

Monthly billing for the recertification plan will begin on January 1 of the year following your exam. If you do not pass the exam, contact the ASHP Customer Relations department.

*Ambulatory Care Pharmacy programs are developed in partnership with the American Pharmacists Association (APhA).

To reserve your spot in the RRRP program, visit www.ashp.org/rrrp

Visit Booth 1665 in the Exhibit Hall

RRRP_FPAD_Booth.indd 1 11/3/16 3:27 PM



3

X


Welcome!

Welcome to Las Vegas! It is great to be back in this city of boundless energy and excitement for the largest gathering of pharmacists in the world. I’m looking forward to joining you this week as we take advantage of all the exceptional opportunities for continuous professional development and networking that the Midyear Clinical Meeting and Exhibition offers.

We’re kicking off our award-winning meeting with an inspiring keynote address and Q&A with Super Bowl MVP Peyton Manning. And that’s just the beginning.

The ASHP LIVE app, along with this program book, is your day-by-day guide for everything happening this week, including educational programming targeting students, new practitioners, federal pharmacists, and practitioners in settings across the entire spectrum of care. I encourage you to meet with your colleagues during one of the many networking sessions, check out the latest technological advances in our expansive exhibit program, and take in the first-rate science and research presented in the poster sessions.

We’re striving to exceed your expectations. Please let us know how we are doing by sharing your thoughts with the ASHP Board and staff members here in Las Vegas. Or send me an e-mail at [email protected].

Sincerely,

Lisa M. Gersema, Pharm.D., M.H.A., BCPS, FASHP

ASHP President

A MESSAGE FROM THE PRESIDENT

4 51st ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION

TheMandalayBayConventionCenterincludestheSouthConventionCenter,NorthConventionCenter,andtheEventsCenter.All ASHP sessions, events, and exhibits will take place in the South Convention Centerunlessotherwisenoted.

GENERAL INFORMATION

RegistrationPreregistered? Just Scan & Go at our new satellite regis-tration kiosks located at the MGM Grand, Conference Center, Level 1, and Mandalay Bay, South Pacific Registration Desk, Lower Level*.Preregisteredattendees:Bringyourregistrationconfirma-tionbarcodewithyou.Scanitatournewsatelliteregistra-tionkiosksandbeonyourway.

Hours:

Saturday–Sunday* 7:00a.m.–5:30p.m.

Monday 7:00a.m.–12:00p.m.

Mandalay Bay Convention Bayside A, Level 1 Center Registration Preregistered? Just Scan & Go!Preregisteredattendees:Besuretobringyourregistrationconfirmationbarcodewithyou—it’llgetyouthroughthefastlaneofScan&Go registration.Simplyscanyourregis-trationbarcodeattheScan&Goself-registrationkiosks.Self-registrationkioskscanalsobeusedforonsiteregistration.

NOTE: Registrationordersmustbepaidinfull,andyoumustpresentphotoidentificationpriortobadgepickup.

Hours:

Saturday–Monday 7:00a.m.–5:30p.m.

Tuesday–Wednesday 7:30a.m.–5:00p.m.

Thursday 9:00a.m.–12:00p.m.

Attendee Onsite RegistrationAssistancewillbeavailableifyouchoosetoregisteronsiteandnotuseself-registrationkiosks.

Customer RelationsIfyouwouldliketorenewyourmembership,checkonarecentorder,orupdateyourprofile,visitCustomerRelations,locatednexttoAttendeeRegistration.

Hours:


Tuesday–Wednesday 7:30a.m.–5:00p.m.


Name BadgesBadgesshouldbewornatalltimes.Yourbadgeisyouradmissionpassforallmeetingsessions,posters,ResidencyShowcaseandexhibits.TheQRcodeonyourbadgecon-tainsyourregistrationinformation.UseitintheExhibitHalltorequestinformationfromexhibitorsandtosavetimeincompletingsurveysandformsbyallowingexhibitorstoscanthecodeonyourbadge.Ifyouloseyourbadge,checkwithMeetingInfoorgotoLostandFoundlocatedintheASHPHeadquartersOffice(SurfF,Level2)toseeifithasbeenturnedin.LostbadgescanbereplacedatAttendeeRegistrationfora$40 fee.BadgeribbonsareavailablefromtheMembershipInformationCenter,Level2.

Theletteronyourbadgerepresentsyourprimarypositionasfollows:A=Director,AssociateorAssistantDirector,ClinicalCoordinator,OtherSupervisoryPositionB=StaffPharmacist,ClinicalPharmacist–General,ClinicalPharmacist–Specialist,FacultyC=ResidentD=StudentE=Technician,Physician,Nurse,Medication/PatientSafetyOfficer,Informatics/TechnologySpecialist,Other

“PPS”or@=PPSParticipant

Badges are color-coded as follows:l FullRegistration:Yellowl PartTimeandBusinessClients:Redl Exhibitor:Greenl ExhibitPassGuests:Blue

Emergency Contact Information CardAnEmergencyContactinformationCardisincludedwithyourbadge.Pleasefillitoutwithyouremergencycontact’sinformationandplaceitbehindyournamebadgeinthebadgeholder.ThiswillhelpASHPstafftocontactsomeoneonyourbehalfintheeventofanemergency.

Certificate of Attendance:Internationalattendeesmaypickupacertificateofattendanceattheattendeeregistra-

tiondeskoratmeetinginformation.

ASHP would like to thank Sagent Pharmaceuticals for their sponsorship of the meeting lanyards.


Hours:

Sunday 7:00a.m.–5:30p.m.


Tuesday 7:30a.m.–6:00p.m.

Wednesday 7:30a.m.–5:30p.m.


Code of ConductASHPiscommittedtoprovidingacollegial,safe,andwel-comingenvironmentinwhichallindividualsaretreatedwithrespectanddignity.TheASHPEventCodeofConductoutlinesASHP’sexpectationsforallwhoparticipateinASHPmeetingsandevents,aswellasthepotentialconsequencesforbehaviorwhichviolatesthisCodeofConduct.Tolearnmore,visithttp://www.ashp.org/DocLibrary/Meetings/ASHP-Event-Code-of-Conduct.pdf.

Concierge MandalayBay’sconciergeisavailabletoassistyouwithworld-classdining,shopping,andentertainmentarrange-ments.TheConciergeDeskislocatedintheMandalayBayHotelLobbyandcanbereachedbydialing74760fromanyMandalayBayhousephoneorat702-632-4760.

Consent to Use of Photographic ImagesRegistrationandattendanceat,orparticipationin,ASHPmeetingsandotheractivitiesconstitutesanagreementbytheregistranttoASHPuseanddistribution(bothnowandinthefuture)oftheregistrantorattendee’simageorvoiceinphotographs,videotapes,electronicreproductions,andaudiotapesofsucheventsandactivities.

Consumption of Alcoholic Beverages PolicyAttendeesofthemeetingshouldtakenoteofthepolicyapprovedbytheASHPHouseofDelegatesregardingtheconsumptionofalcoholicbeverages:

“That alcohol is a drug and should be used with the respect and concern afforded to any drug; that pharmacists should extend their professional obligations and responsibilities to alcohol use by individuals and themselves; that pharmacists have an obligation to ensure that, if consumed, alcohol is used only responsibly; that pharmacists, by example in their personal conduct, should foster awareness of the nature of alcohol and responsible use of alcohol by those who choose to use alcohol; and that ASHP and its members continue to support and foster impaired-pharmacists programs as a means of providing opportunities for such individuals to rehabilitate themselves.”

Exhibit Program Bayside CD, Level 1Featuringsomeofthemostinnovativetechnologiesandproducts,theExhibitProgramisamust-attendcomponentoftheMidyearmeeting.Perusethehall,participateinahands-ondemonstration,andlearnforyourselfhowexhibi-torcompaniesandtheirproductsarehelpingtodefinewhatisimportanttopatientcare,yourpractice,andyourcareer.

FindacurrentlistofexhibitorsontheASHPLIVEapporintheExhibitorYellowPages.

continues >

ASHP Headquarters Office Surf F, Level 2RegistrantsmaycontactASHPstaffandmakegeneralmeet-inginquiries.

ASHP Store Mandalay Bay Foyer, Level 2See What’s New at the ASHP Store!ExplorethelatestproductsfromASHP,alldevelopedtomeetyourpracticeneeds.AttheASHPStore,youcannotonlybrowseprintpublications,butyoucanalsolearnmoreaboutebooks,apps,andonlinesubscriptions,aswellascontinuingeducationprogramsavailablethroughASHP’seLearningplatform.

Takeadvantageofextrasavingswhileatthestore.Priortothemeeting,we’llprovideaspecialcodethatwillallowyoutosave10%onallproducts.ThisdiscountcanbeusedatanytimefromSaturday,December3,throughThursday,December8.IfyouhavelimitedtimetopurchasewhileattheMidyearClinicalMeeting,youcanbrowsethelatestprod-uctofferingsandthenplaceyourorderfromyoursmart-phone,tablet,orPC,regardlessofyourlocation.

Doyouneedtorenewyourmembership?Youcanrenewwithinsecondsatcheckout,andyoucanmakeadonationtotheASHPResearchandEducationFoundationatthesametime.Everypurchaseinthestorecomeswithaspe-cialgiftfromASHP.

Onceagain,ASHPthank-youcardswillbeforsale—aper-fectitemtopickupandhand-deliverafterinterviewsatPPSandtheResidencyShowcase.Hours:





Business and Social FunctionsAlistingofbusinessandsocialfunctionsscheduledatoffi-cialmeetinghotelsisavailableontheMidyearmeetingwebsite,ASHPLIVEapp,andinthemeetingregistrationbags.

Business Center – FedEx Office Bayside Foyer Email:[email protected] (Near Bayside A), Level 1Phone:702-262-5320Hours:

Opensevendaysaweek 7:00a.m.to6:00p.m.

CE Info Center Bayside Foyer, Level 1NeedhelpprocessingCE?VisittheCEInfoCenteroremaileducserv@ashp.org.Hours:

Sunday 12:00p.m.–6:30p.m.



Wednesday 7:30p.m.–5:15p.m.


Coat & Baggage Check Bayside A, Level 1 Coats,bags,andposterscanbecheckedduringthemeeting.


Hours:

Monday–Tuesday 11:00a.m.–3:00p.m.


You must be 16 years or older to enter the Exhibit Hall.

First Aid Station Bayside A Foyer, Level 1 (behind FedEx Office)FirstaidisaccessiblebycallingMandalayBaySecurity.

l Dispatchfromanyin-housephonelocatedthroughouttheConventionCenter.

l Pickupanyin-housephoneanddial77911.Fromacellphone,call702-632-7911.

l Requestfirstaidserviceandstateyourlocation.

Food and BeverageFoodandbeverageoutletsandconcessionstandsareavail-ableintheSouthConventionCenter,includingtheExhibitHallduringopenhours.TherearealsoavarietyofrestaurantslocatedwithintheMandalayBayHotel,theShoppesatMandalayBayPlace,andtheLuxorHotel,juststepsawayfromtheConventionCenter.ChecktheASHPLIVEappformoreinformationondiningoptionsandhoursofoperation.

Future Meetings Mandalay Bay Foyer, Level 2StopbytheASHPFutureMeetingsareaandpickupinfor-mationonupcomingASHPmeetingsandconferences.

Remember to mark your calendars for:

2017 ASHP Summer Meetings & ExhibitionMinneapolis,MinnesotaJune3-7,2017

52nd Midyear Clinical Meeting & ExhibitionOrlando,FloridaDecember3-7,2017

Aspecialthankyoutoourfuturemeetingcitypartners!(Seeoppositepage.)

Housing (Orchid Event Solutions) Bayside A Foyer, Level 1ArepresentativefromOrchidEventSolutions,ASHP’sofficialhousingcompany,willbeavailabletoassistregistrantswithhotelrelatedmatters.RegistrantsmayalsocallOrchidEventSolutionsdirectlyat877-505-0675.AgentswillbeavailabletoassistMondaythroughFridayfrom9:00a.m.to8:00p.m.ET.Hours:

SaturdayandSunday 7:00a.m.–5:30p.m.

Lost and Found Surf F, Level 2LocatedintheASHPHeadquartersOfficeduringmeetingdaysandhours.Afterwards,attendeesmaycalltheConventionCenter’sBuildingSecuritynon-emergencylinebydialing702-632-7995.

Meeting Information Center Bayside Foyer, Level 1DoyouhaveaquestionabouttheMidyearmeeting?StopbytheMeetingInformationCenterfortheanswers.Hours:

Saturday 7:00a.m.–5:30p.m.






Membership Information Center Mandalay Bay Foyer, Level 2Discoveruniqueopportunitiesfornetworking,careergrowth,andcontinuingeducation,allofwhichwillhelpyouadvanceprofessionally.GettoknowmembersoftheASHPSectionandForumExecutiveCommittees,learnhowtomakethemostoutofyourmembership,andbecomeanactivemem-berthroughsomeofthehundredsofASHPleadershipopportunities.VolunteerswillbeavailabletohelpsetupASHPConnectprofilesandexplainhowtofindamentorormenteethroughASHPConnect’sMentorMatch.Member ribbons will be available for pickup at this location.Hours:





Mother’s Room Bayside A Foyer, Level 1 (behind FedEx Office)LocatedinFirstAid,anursingmother’sroomwillbeavailableforuseduringthemeeting.Seatingwillbeprovided,aswellaspoweroutlets.

Personnel Placement Service (PPS) Shoreline Exhibit Hall, Level 2PPSistheindustry’slargestandmost

widelyattendednationalpharmacyrecruitmentevent.Hostingmorethan3,000pharmacycandidatesandnearly400employers,PPSiswherepharmacyresidency,fellow-ship,andemploymentconnectionsaremade.Hours:

Sunday–Wednesday 7:30a.m.–5:00p.m.

Press Office Surf A, Level 2

Hours:

Saturday Byappointment


Monday–Wednesday 8:00a.m.–5:00p.m.


Promotional TheatersPromotionalTheaterstakingplaceduringthemeetingareinformationalorpromotionalinnature.Theircontentandtheopinionsexpressedbypresentersarethoseofthesponsorsor

General Information

continues >


ORLANDO WELCOMES BACK ASHP IN 2017!

We look forward to hosting the 52nd ASHPMidyear Clinical Meeting & ExhibitionDecember 3-7, 2017.

Visit Orlando®

Orange County Convention Center occc.net

Enjoy the Anaheim Convention Center campus environment under sunny skies and palm trees.After hours, experience world class dining, entertainment and nightlife, all within walking distance at The Anaheim GardenWalk and Downtown Disney® District.

Find helpful tips, discounts, maps and more to help you experience the best of Anaheim.visitanaheim.org/ASHP

53rd ASHP Midyear Clinical Meeting and ExhibitionDecember 2-6, 2018

16390 ASHP HalfPageAds_4.indd 1 10/12/16 1:49 PM


presentersandnotthoseofASHP.CEcreditisnotofferedforattendance.PromotionaltheaterswillbeheldattheMandalayBayConventionCenter.Alistingofpromotionaltheaterssched-uledandtheirlocationsareavailableontheASHPLIVEapp,registrationbags,andASHPwebsite.

Recharging StationsLocatedthroughouttheSouthConventionCenter.Network,relax,andrechargemobilephones,laptops,oranyofyourportablemobiledevices.

Residency Showcase Bayside B, Level 1Foranup-to-datelistofprograms,gotowww.ashp.org/showcase16.PrintedlistingswillbeavailableattheShow-casewhilesupplieslast.Wi-FiisnotavailableintheResidencyShowcase.YoucanalsoviewthelistingontheASHPLIVEapp.

Hours:

Monday 1:00p.m.–4:00p.m.

Tuesday 8:00a.m.–11:00a.m. 1:00p.m.–4:00p.m.

Rules for Academic Titles and CredentialsDisclaimer:Inanefforttostandardizethenamingandplacementofacademicdegreesandcredentials,ASHPnowliststheseacademicabbreviationsandcredentialsasfollows.Eachperson’snameisfollowedfirstbyanypharmacy-relatedacademicdegreesinrankedorder(Pharm.D.,M.S.Pharm.,B.S.Pharm.,R.Ph.),thenbyotheracademicdegreesinthefollowingorder(Ph.D.,J.D.,M.P.H.,M.P.A.,M.H.A.,M.S.,M.A.,MBA,B.S.,B.A.),andthenbycredentialsinalphabeticalorder(AAHIVP,ASH-CHC,BCACP,BC-ADM,BCCCP,BCNSP,BCOP,BCPP,BCPPS,BCPS,BCPS-AQCardiology,BCPS-AQID,CACP,CAHIMS,CDE,CGP,CHHIMS,CJCP,CLS,CMQ,CPE,CPFT,CPHIMS,CPHQ,CPP,CPPS,DABAT,FAACT,FACC,FACHE,FAPhA,FASCP,FASHP,FASPEN,FAST,FCCM,FCCP,FCSHP,FFIP,FHFSA,FIDSA,FISMP,FKSHP,FMSHP,FNLA,FPPAG,FTSHP,LSSYB,MCCM,MSCR,MSPH,NREMT,RRT).

EXAMPLES:l JonathanDoe,Pharm.D.,M.P.H.,M.S.,MBA,BCPS-AQID,FASHP,FCCP

l JaneP.Doe,B.S.Pharm.,Ph.D.,M.A.,MBA,AAHIVP,CACP,FASHP,RRT

l DonaldDoe,R.Ph.,Ph.D.,M.S.,BCOP,BCPS,FCCP

Forallabbreviatedacademicdegrees,ASHPfollowsAssociatedPress(AP)style.

Safety and SecurityAsamatterofbasicsecuritysense,remembertokeepyourpersonalbelongingsunderyourcontrolatalltimes.ReportanysuspiciouspersonsoractivitiestotheConventionCentersecurity.RememberthatallattendeesarerequiredtowearaMidyear2016badgewhentheyattendanyASHPmeetingactivityorsessionincludingtheExhibitHall,Posters,andtheResidencyShowcase.

Also,pleasebesuretofillouttheEmergencyContactInformationCardthatyouwillreceivewithyourbadgeandplaceitinthebadgeholder.ThiswillhelpASHPstaffcontactsomeoneonyourbehalfintheeventofanemergency.

Shuttle Bus ServiceComplimentaryshuttlebusservicewillbeprovidedSaturday,December3,throughThursday,December8,fromofficialMidyearClinicalMeetinghotelstotheMandalayBay

ConventionCenter,exceptfortheDelano,FourSeasons,andLuxor,whicharewithinwalkingdistanceoftheConventionCenter.Nonstop shuttle service will be pro-vided from the MGM Grand and The Signature at MGM Grand. Foracompleteshuttleschedule,seepage138.

Theshuttlescheduleissubjecttochangebasedonusage,traffic,andweather.ChecktheASHPLIVEappandtheMidyear News & Viewsforchangesandupdatestotheschedule.

NOTE:ASHPdoesnotprovideshuttlebusserviceformorningoreveningsymposia,socialevents,ormeetingssupportedbythepharmaceuticalindustry,universities,andotherorganizations.

Sorry, No ChildrenForhealthandsafetyconsiderations,childrenundertheageof16arenotpermittedintheExhibitHall,PosterSessions,ResidencyShowcase,PersonnelPlacementService(PPS),orsessions.

Speaker Preview Room Surf D, Level 2TheSpeakerPreviewRoomhascomputersavailableforpresenterswhowanttopreviewtheirslidespriortotheirpresentation.

Hours:

Saturday–Tuesday 7:00a.m.–5:30p.m.



Stay ConnectedTaketimetomeetnewpeers,catchupwithyourcolleagues,andshareyourMidyearmeetingstorywithASHPandothermeetingattendees.Here’show:

l Follow #ASHP16 StayconnectedtoeverythinghappeningattheMidyearClinicalMeetingwith#ASHP16,theofficialhashtagfortheMidyearmeeting.Don’tforgettotagyourtweets,photos,andvideoswiththehashtagsootherscanfollowalongwithyourexperiencesonTwitter,Facebook,andInstagram.

l Like Us on FacebookLikeusonFacebook(facebook.com/ASHPOfficial).We’llbepostingphotosandupdateshere.Also,jointhe2016MidyearClinicalMeetingevent(you’llfinditontheEventstabonourFacebookpage)toconnectwithothermeetingattendeesandpostyourphotosonthewall,tagged#ASHP16.

l Win Daily PrizesWanttowinsomecoolprizes?Tapintoyourcompetitivesideandfollow@ASHPOfficialonTwitterformoreinfoonhowyoucantakethe#ASHP16Challenge.Andwatchfor@ASHPOfficial’scluesforourscavengerhunt.Youcan’twinifyoudon’tplay!

l Post Your Midyear Meeting BadgeSpreadtheword!TheI’m AttendingbadgescanbedisplayedonTwitter,Facebook,LinkedIn,blogs,andmore.Whenyoupost,tweetitoutusing#ASHP16orshareitonFacebook.Leteveryoneknowyou’reattheMidyearmeeting.Getyourbadgeathttp://www.ashp.org/get-social.

Wi-Fi AccessComplimentaryWi-Fiaccessisavailableintheconventioncentermeetingspaceandlobbies.Toensurefastspeedsforallattendees,pleaselimityourusageto20minutes.Onceintheconventioncenter,openInternetsettingsandselectSSIDashp2016andenterpasswordvegas2016.

General Information


© 2016 American Society of Health-System Pharmacists® All rights reserved. HPCP1216

Designed for participants who are proficient in the

fundamental skills required for safe and compliant

sterile product preparation, and who are now responsible

for managing and developing the personnel and

facilities associated with these compounding activities.

Highlights of the Advanced Sterile Product Preparation

Training Certificate include the following:

n Reflects all pending changes associated

with USP <797> and <800>

n Includes 9 modules, plus activities for

23 hours of CE

n Learn in manageable segments

n Upload practice-based components to

earn an ASHP Professional Certificate

www.ashp.org/certificate-programs

The Advanced Sterile Product Preparation Training and Certificate Program includes 9 modules and activities and is intended for pharmacists, pharmacy technicians, or other pharmacy professionals who have responsibility for managing the personnel and facilities involved in low, medium, and high risk compounding.


SterilePrep2_FP_Ad_R.indd 1 11/1/16 11:43 AM


HALFPAGE AD

Explore the schedule, session, detailed presenter information.

Access the app’s Activity Feed, which highlightsuseful comments, photos, ratings and more!

Receive announcements and updates.

Earn points and badges—top the leaderboard!

Expand your professional network and have fun!

Download:

Apple App Store or Google Play store; search “ASHP LIVE”.

www.ashp.org/ASHPLive

ASHP LIVEMobile App!

Available foriPhone®, iPad®,

Android™,or your mobile

browser.

COMING SOON, THE NEW AHFS CLINICAL

DRUG INFORMATION. YOUR COMPREHENSIVE, INTERACTIVE TREATMENT

AND DRUG THERAPY SOLUTION.

HELP FASTER. HEAL SMARTER. AHFS. REAL-TIME DRUG INFORMATION TO ADVANCE CARE.

REGISTER TO WIN A FREE SUBSCRIPTIONStop by booth #1765, grab a cup of espresso, and see how this exciting new product will mean more real time information, access, and agility for you!AHFSCDI2017.COM/PA

Quick care counts! For 59 years, you’ve counted on AHFS to make expert treatment, safety and drug therapy recommendations. Now, make them…FAST.

The new AHFS Clinical Drug Information™ is your solution to optimize time and advance care.

ASHP_AD_CDI_HalfH.indd 1 10/31/16 2:00 PM


General Information

CITIZENSKITCHENKUMI

LUPO

LIG

HT

NIG

HTC

LUB

HOUSEOF BLUES

FOUR

SEAS

ONS

M A N D A L A Y B A Y H O T E L

WAVEPOOL

POOL POOL

BIKINIBAR

BEACHSIDECASINO

BEACH BAR& GRILL

VILLAS SOLEIL(3rd Level)

MANDALAYBAY BEACHENTRANCE

LAS

VE

GA

S B

OU

LEV

AR

D

HACIENDA AVENUE < M A N D A L A Y B A Y R D

R U S S E L L R O A D

MANDALAY BAY DRIVE

CONVENTION CENTER PARKING

SHU

TTLE

BU

SPA

RKIN

G AR

EASHARK REEFAQUARIUM

CASINO

TRAM

D E L A N OM A N D A L A Y B A Y

H O T E L

O.N.E. OASIS BAR

BORD

ERGR

ILL

HOTEL ENTRANCECHECK-IN

SELF-PARKGARAGE

PARKING GARAGEELEVATORS

PARKING GARAGEESCALATORS

FR

AN

K S

INA

TR

A D

RIV

E

CAR RENTAL

THE

WED

DIN

GCH

APEL

CHARLIE PALMERSTEAK

ADNAREV

FOUR

SEAS

ONS

ELEVATORS

THE SHOPPES AT MANDALAY PLACE

MIZUYA

STRIPSTEAK BAYSIDEBUFFET

SEABREEZECAFÉ

Cirque du SoleilMichael Jackson ONE™

HOTEL ENTRANCECHECK-IN

EVENTS CENTER

SOUTH CONVENTION

CENTER

NORTH CONVENTION

CENTER

MANDALAY BAY CONVENTION CENTER OVERVIEW

to Luxor

Shuttle Buses


FedExCenter

ELEVATORS

ESSENTIALS

FOODCOURT

ESCALATOR TO LEVEL 2

BAYSIDE C

BAYSIDE BBA

YSID

E FO

YER

BAYSIDE A

BAYSIDE D

General Information

1LEV

EL

WiFi inmeetingrooms,publicareasandPPS

Recharging Stations

Escalators

Entrance

SOUTH CONVENTION CENTER

Escalator down to North Convention Center

Escalator up to Levels 2 and 3

REGISTRATION

POSTERS

RESIDENCY SHOWCASE

E X H I B I T H A L L

to Shuttle

Buses

to Events Center

Meeting Info & CE Info

Free Wi-FiComplimentaryWi-Fiaccessisavailableintheconvention

centermeetingrooms&publicareasaswellasPPS.Selectthenetworkashp2016onyourdevice

Andusepasswordvegas2016


2SOUTH CONVENTION CENTER

LEV

EL

ESCALATOR TO LEVEL 1

ESCALATOR TO LEVELS 1 & 3

MAN

DALA

Y BA

Y FO

YER

SERVICE CORRIDOR

C EF

G H F

B

D H

J

L

ELEVATORS

B A L L R O O M

SHORELINE EXHIBIT HALL

M A N D A L A Y B A Y

R E E F

L A G O O N

B R E A K E R S

O C E A N S I D EB A L L R O O M

F

DC

A

B

OCE

AN

SID

E PR

EFU

NCT

ION


Recharging Stations

Escalators

Entrance

Educational Sessions

Escalator to Levels 1 & 3

Escalator to Level 1

Membership InfoSpotlight

on ScienceandWednesday Evening Event

P E R S O N N E LP L A C E M E N T

S E R V I C E ( P P S )

ASHPStore,Lounge


General Information


Recharging Stations

Escalators

Entrance

Educational Sessions

J

H B

C

F

JASMINE FOYER NORTH

JASMINE FOYER SOUTHSOUTH SEAS FOYER WEST

SOU

TH SEAS FOYER NO

RTH

OPEN TO MANDALAY BAY

BALLROOM

SOUTH SEAS

BALLROOM PALM FOYER

BANYAN

JASMINEDF

ELEVATORS

3SOUTH CONVENTION CENTER

LEV

EL

Escalator to Level 2


centermeetingrooms&publicareasaswellasPPS.

Selectthenetworkashp2016onyourdevice



NORTH CONVENTION CENTER

F GI

H

SOUTH PACIFICBALLROOM

B D

FE

H J

BORDERGRILLISLANDER

BALLROOM

ELEVATOR

STAIRS TO HOTEL


Recharging Stations

Escalators

Entrance

Session Locations

Escalator up to hoteland Events Center

Escalator up to South Convention Center

to Events Center

Promotional Theater(Sun)

South Pacific Registration Desk

(Satellite Scan&Go Registration

Sun Only)

Review & Recertification(Sat-Sun)

M I D D AY S Y M P O S I A( M O N – W E D )

M I D D AY S Y M P O S I A( M O N – W E D )

LowerLevel


EDUCATION INFORMATION

Florida Department of Health Continuing Education CreditsFlorida-licensedpharmacistsmustself-

reporttheirmeetingCEcreditstoCEBroker.ASHPisnotofferingFloridaConsultant

PharmacyCEatthismeeting.

Audio-Synced PresentationsWithsomanyeducationsessionstochoosefrom,itused

tobeimpossibletocatchthemall—butnotanylonger.Thefullmeetingregistrationfeeincludesaccesstoallavailableaudio-syncededucationalsessionpresentations.Downloadthesessionsyou’vemissedonlineandattendatyourleisure.

NOTE:CEcreditisnotavailableforaudio-syncedrecordings.

CE ProcessingAfterparticipatingintheactivitiesofthismeeting,attend-eescanprocesstheirCEonlinethroughtheASHPeLearn-ingPortalatelearning.ashp.org.RegistrantsrecordingtheirCEonlinewillbeabletoviewtheirCEstatementsimmedi-ately.All attendees must record their CE online within 60 days of the sessions they attend.

NABP’s CPE MonitorToprocessCE,pharmacistsandpharmacytech-niciansmustenteranNABPe-ProfileID,birthmonth,anddateintheeLearningPortal.Afteryouhaveenteredthisinformation,itissavedforfutureCEpro-cessing.Youmayobtainyoure-ProfileIDatwww.nabp.net.

Continuing EducationInaccordancewithACPE’sAccreditationStandardsforContinuingPharmacyEducation,ASHPfullysupportsthefollowing:

Active LearningAbasicprincipleandbestpracticeinadultlearning,activelearningmeansinteractionwithfacultyandotherparticipantstoimprovelearning,retention,andapplicationofnewknowledgeandskills.Eveninlargesessions,facultyuseparticipatoryinstructionaltechniquesintendedtoengageyoumorefullyasalearner.

Learning Assessments and FeedbackTheStandardscallforlearningassessmentstobepartofeveryactivity;assessmentsandmechanismsforfeedbacktoparticipantsarepartofeveryCEsession.

Activity CategoriesCElearningactivitiesatthe2016MidyearClinicalMeetingsessionsareknowledge-basedandapplication-based.Knowledge-basedsessionsaredesignedprimarilyforacquiringfactualknowledge;application-basedsessionsprimarilyapplytheinformationlearnedinthetimeallotted.

EvaluationsACPEStandardsrequireustodevelopandconductevalu-ationsofeachCEactivity.Beyondthisrequirement,your

Educational ObjectivesThe2016MidyearClinicalMeetingeduca-tionalsessionsaredevelopedtomaintainandenhancetheknowledge,skills,andabilitiesofpharmacistsandassociatedpersonnelinacuteandambulatorysettingsthroughskill-buildingandactiveparticipationinsessionsonimportantissuesrel-evanttocontemporarypractice.Theeducationalgoalofthismeetingistoprovideinformationandinstructiononavarietyoftopicstoenablepharmacypractitionerstoprovidequalitypatientcare.

Target AudienceActivitiesareplannedandstructuredtomeeteithertheknowledge-orapplication-basededucationalneedsofpharmacistsandpharmacytechniciansinavarietyofset-tings.Thisincludesthosepracticinginlargeandsmallhos-pitals,managedcarefacilities,ambulatorycaresettings,inpatientfacilities,outpatientclinics,andhomecaresettings,aswellasinacademiaandthepharmaceuticalindustry.

Levels of ContentEducationalsessioncontentiscategorizedintothefollowinglevels:l General Interest: Nopriorknowledgeofthespecificcon-tentisrequired.l Intermediate: Basicknowledgeofthespecificcontentareaissuggested,butextensiveexperienceisnotnecessary.l Advanced: Generalworkingknowledgeofthespecificcontentareaissuggested;informationwillbeprovidedtoexpandcurrentexpertise.

ACPE AccreditationThe American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a pro-vider of continuing pharmacy education.

Somestateshavespecialcriteriaforprogramcontenttomeettheirrequirementsforcontinuingeducation.Pleasecheckwithyourstatetodetermineifsuchrequirementsexistandtodetermineiftheseprogramsmeetthoserequirements.

PharmacistsASHPdeterminesthenumberofcontacthoursforeachsession.Registrantsmayearnupto30contacthours(3.0CEUs)atASHP’s51stMidyearClinicalMeeting.

Pharmacy TechniciansEducationalsessionsatASHP’s51stMidyearClinicalMeetingsatisfytherequirementpertainingtopharmacy-relatedsub-jectmatterandareacceptableforcertifiedpharmacytech-nicians.Sessionsfortechniciansaredesignatedwitha“T”followingtheACPEnumber.Forfurtherinformation,[email protected].

CE PROCESSING REMINDER

All attendees must claim their CE credits online within 60 days of the

sessions they attended.


feedbackisimportanttousforevaluatingachievementofthelearningobjectives,qual-ityoffaculty,effectivenessofteachingmethodsandmate-rials,andperceptionsofcom-mercialbias.

Noncommercialism and the ACCMEStandardsforCommercialSupportACPEhasadoptedtheACCMEStandardsforCommercialSupport.Thesestandardsrequirecompleteseparationofcontinuingeducationfromcom-mercialsupport.InstructionalmaterialsforCEactivities,includingpresentationslides,undergoanintensivereviewprocessatASHPtoensurecompliancewiththeStandardsforCommercialSupport.Disclosuresofrelevantfinancialinter-estbyeveryoneinvolvedintheplanningordeliveryofASHP’sCEcontenthavebeenincludedintheonsiteprogramandareannouncedinthesessions.Inaccordancewiththesestandards,anyactualconflictsofinteresthavebeenresolvedpriortotheCEactivitytakingplace.

Continuing Professional Development (CPD)Anapproachtolifelonglearning,continuingprofessionaldevelopment(CPD)isaprocessofactiveparticipationinlearningactivitiesgearedtohelpingindividualsdevelopandmaintaincontinuingcompetence,enhancetheirpro-fessionalpractice,andsupportachievementoftheircareergoals.CPDemphasizesself-reflectionaswellaseducationalplandevelopment,implementation,documentation,andevaluation.CEsessionsorotheractivitiesyouparticipateinatthemeetingmayformpartofyourownCPDplan.Formoreinformation,visitwww.ashp.org/midyear.

Educational Session MaterialsMaterialsareavailableonlineforallregisteredattendees.Printthematerialsforthesessionsyouplantoattendandbringthemwithyou.Handoutswillnotbeprovidedinthesessionrooms.

NOTE:Paperhandoutswillnotbeprintableonsite.

Featured Programming: Antimicrobial StewardshipTheMidyearmeetingistherightplacetostaycurrentwithimportanttrendsandinformation.Over10hoursofeduca-tionalprogrammingonantimicrobialstewardshipwillbeoffered,includingprogramsincommunityhospitals,ambu-latorycare,informatics,pediatrics,andotherspecialtyareas.ManysessionsarealsoeligibleforBoardofPharmacySpecialties(BPS)andCommissionforCertificationinGeriatricPharmacy(CCGP)board-recertificationcredit.

Pharmaceutical Industry-Supported SymposiaASHPAdvantage,adivisionofASHP,specializesindevelopingcustomized,needs-basededucationalactivitiesforpharma-cists,physicians,andotherhealthcareprofessionals.YoumayprocesscontinuingeducationcreditonlineforASHPAdvantagesymposiapresentedattheASHPMidyearClinicalMeeting.

Otherindustry-supportedsymposiahavebeenscheduledinconjunctionwiththe2016Midyearmeetingandwillbeheldthroughouttheweekatofficialmeetinghotels.Theprogramorganizerisrespon-sibleforcontinuingeducationcreditsandcontent.Seepage107forthelisting,orvisitwww.ashp.org/midyearforthemostup-to-dateinformation.

Management Case StudiesFindouthowyourpeersaremeetingtoday’sadministrativechallengesbydiscussingactualcasesinpharmacymanage-ment.Eachpresentationfocusesononepharmacydepart-ment’sadministrativestepsanddecision-makingprocessesonplanningandimplementinganewprogram,orresolvinganadministrativeproblem.Casesmaybepresentedbyanindividualorateamandwillconsistofa20-minutecasesummary,followedbyabriefperiodofquestions,answers,anddiscussion.

Pearl SessionsTheobjectofeachpearlpresentationistoconveyoneidea,concept,orfactthathasbeenusefulinday-to-daypracticeandmaynotbewidelyknown,understood,pub-lished,ortaught.AmongthecategoriesofpearlsthisyearareSafetyandQuality,Management,Clinical,Informatics,EmergencyMedicine,Pediatric,and,forstudents,CareerPearlsandClinicalPearlsforStudents.

PostersPostersessionsencourageregistrantstoinformallydiscusscurrentprojectsinpharmacypracticewithcolleagues.Thisisyouropportunitytopickupideasfromhundredsofsuc-cessfulprogramsthathaveworkedinotherhealthcaresystems.

Foralistingofprofessionalpostersandscheduledtimesforotherposterpresentations,seepage110.

NOTE:CEisNOTofferedforpostersessions.

Poster MentorsPostermentorsvolunteerjustafewmomentsoftheirtimetoprovideone-on-onefeedbackandguidancetoresidentsandstudentsontheirprojects.Theinsightfulfeedbackofpracticingprofessionalshelpsthestudentsandresidentsbecometherisingstarsofourprofession.

Postermentorsarewelcometovolunteeronsite.Pleasevisittheposterhallonthedaythatyouplantovolunteer.

Presenter Disclosure StatementsASHPmaintainsdisclosureinformationforallpresentersofASHP-sponsorededucationalprograms,includingspeakersandposterabstractauthors.Presenterdisclosurescanbefoundintheonsiteprogram.Posterdisclosuresaredis-playedinthelower-rightcorneroftheposterboards.

Intensive Studies and BCOP Clinical SessionsTheIntensiveStudiesandBCOPClinicalSessionsareadvanced-level,thought-provokingsessionsthatareopenforallMidyearmeetingregistrants.Theseses-sionsareapprovedbyBPSorCCGPtoproviderecerti-ficationcredit.Ifyouareboard-certified,besuretopurchasethepackageforyourspecialtytoreceivetherecertificationassessmentandclaimrecertificationcredit.Formoreinformation,seepage36.


NEED HELP PROCESSING CE? Visit the CE Info Center in Bayside Foyer, Level 1, or email [email protected].

Education Information

All continuing pharmacy education credits must be claimed within 60 days of the live session you attend. Learn more at www.ashp.org/ProcessCE.Claiming CE Credit

1LogintotheASHP eLearning Portalatelearning.ashp.orgwiththeemailaddressandpasswordthatyouusedwhenregisteringfortheMidyear.The system validates your meeting registration to grant you access to claim credit.

2ClickonProcess CE for the Midyear Clinical Meeting and Exhibition. Itisalsoavailableunder the Conference tab under My Learning Activities menuitem.

3EntertheAttendanceCodesthatwereannouncedduringthesessionsandclickSubmit.

4ClickClaim foranysession.

5CompletetheEvaluation.

6Onceallrequirementsarecomplete,clickClaim Creditfortheappropriateprofession.l Pharmacists and Pharmacy Technicians:BepreparedtoprovideyourNABPeProfileID,birthmonthanddate(requiredinorderforASHPtosubmityourcreditstoCPEMonitor).l Others (International, students, etc.).SelectASHP Statement of Completion.

NOTE: PrintingisoptionalforACPEcredit–yourcreditswillbesubmittedelectronicallytoCPEMonitor.ThiswillonlyhappenwhenyouclickthecheckboxtoverifythesessiondetailsonthescreenwithyourNABPeProfileID.

ExhibitorsExhibitorsshouldcompletethestepsbelowfirst.Ifyouencounteranyissueswiththeprocess,[email protected].

1 Logintowww.ashp.org/ExhibitorCEwithyourASHPuser-nameandpassword.

2 ClickontheGet Startedbutton.

3 Selectthe2016 Midyear Clinical Meeting and Exhibitionfromthedropdownmenu.

4 Selectyourexhibitingcompanyfromthelistofexhibitors.YourscreenwillchangeandyouwillbethenbeloggedintotheASHP eLearning Portal.

5 Followtheinstructionsinthesectionabove,startingwithStep 2.

ForsymposiaofferedbyotherCEproviders,SpecialtyReviewandRecertificationCourses,ortheIntensiveStudiesforRecertification,followthedirectionsgivenwiththeprogrammaterials.Ifyouhaveanyquestions,contacttheprogramcoordinator.

Like us!facebook.com/ASHPOfficialWe’ll be posting photos and updates here. Also, join the 2016 Midyear Clinical Meeting event (you’ll find it on the Events tab on our Facebook page) to connect with other meeting attendees and post your photos on the wall, tagged #ASHP16.


XSU

NDAY

TIME SESSION/EVENT ROOM ATTENDANCE CODE

— — S A M P L E — — — — — — — 7:00a.m.–6:00p.m. ClinicalSkillsCompetitionSemi-FinalRound BanyanB,Level3 (closedsession)

a 7:30a.m.–6:00p.m. Live Pharmacotherapy Specialty Review and IslanderBallroomF, — — — — — — Recertification Course(separatefeerequired) LowerLevel,MandalayBay NorthConventionCenter

a 7:30a.m.–6:00p.m. Live Geriatric Pharmacy Specialty Review IslanderBallroomG, — — — — — — and Recertification Course(separatefeerequired) LowerLevel,MandalayBay NorthConventionCenter

8:00a.m.–5:00p.m. Pre-MeetingWorkshops(separatefeerequired) Seepage43

Saturday 31 2 3 4 5

DEC

All rooms are located in the Mandalay Bay South Convention Center unless otherwise noted.

SCHEDULE-AT-A-GLANCESU

NDAY


a 7:00a.m.–11:30a.m. Satellite Symposia Seepage107 — — — — — — 7:30a.m.–5:00p.m. PersonnelPlacementService(PPS) ShorelineExhibitHall,Level2

a 7:30a.m.–6:00p.m. Live Pharmacotherapy Specialty Review IslanderBallroomF, — — — — — — and Recertification Course(separatefeerequired) LowerLevel, MandalayBay NorthConventionCenter

a 7:30a.m.–6:00p.m. Live Geriatric Pharmacy Specialty Review IslanderBallroomG, — — — — — — and Recertification Course(separatefeerequired) LowerLevel, MandalayBay NorthConventionCenter

a 8:00a.m.–8:30a.m. (Management Case Study) Development of MandalayBayJ, — — — — — — ACPE-accredited Comprehensive Professional Level2 Education in a Large Health System

a 8:00a.m.–5:00p.m. Pre-Meeting Workshops(separatefeerequired) Seepage43 — — — — — —a 8:30a.m.–9:30a.m. First-Time Attendee Welcome Event BreakersC,Level2

8:30a.m.–6:30p.m. StudentProgramming Seepage49

a 8:45a.m.–9:15a.m. (Management Case Study) Implementation of MandalayBayJ, — — — — — — Medication Reconciliation Order Pending Across Level2 a Multi-Hospital Health System

a 9:00a.m.–11:00a.m. Innovations in Drug Information Practice OceansideC, — — — — — — and Research 2016 Level2

a 9:00a.m.–5:15p.m. Resident and New Practitioner Programming Seepage44 — — — — — —a 9:30a.m.–10:00a.m. (Management Case Study) Clinical Decision MandalayBayJ, — — — — — —

Support System Enhancements to Reduce Level2 Order Entry Errors for Pediatric Infusion Orders

a 9:30a.m.–11:00a.m. Professional and Academic Book Publishing: MandalayBayL, — — — — — — Putting Your Ideas into Practice 2016 Level2

continues >

Sunday 4DEC

a Continuing Educationa Special Eventa Intensive Studies for Recertification


4DEC

SUN

DAY

Schedule-at-a-glance TIME SESSION/EVENT ROOM ATTENDANCE CODE

a 10:00a.m.–11:00a.m. Antibiotic Stewardship — OceansideD,Level2 — — — — — — CDC Update on National Activities

a 10:10a.m.–11:20a.m. First-Time Attendee Welcome Keynote MandalayBayH,Level2

a 10:15a.m.–10:45a.m. (Management Case Study) Effects of Inventory MandalayBayJ, — — — — — — Optimization on Pharmacy Metrics Pre- and Level2 Post-Electronic Health Record (EHR) Implementation

a 11:00a.m.–11:30a.m. (Management Case Study) Standardizing MandalayBayJ, — — — — — — Systemwide Primary National Drug Code for Level2 Improved Inventory Management and Cost Savings

11:15a.m.–12:15p.m. Networking Session: Investigational Drug Services LagoonG,Level2

11:15a.m.–12:15p.m. Networking Session: Optimizing the Pharmacy LagoonH,Level2 Revenue Cycle

11:15a.m.–12:15p.m. Networking Session: Preceptor Skills Development LagoonL,Level2

11:15a.m.–1:30p.m. Networking and Poster Session: Emergency Care BaysideB,Level1

a 11:30a.m.–12:30p.m. Creating a Values-based Culture MandalayBayL, — — — — — — in Health-System Pharmacy Level2

a 11:30a.m.–12:30p.m. Contemporary Considerations: Update on the OceansideC, — — — — — — ASHP Standardize 4 Safety Project Level2

a 11:45a.m.–12:15p.m. (Management Case Study) Evaluation and MandalayBayJ, — — — — — — Implementation of a Time and Materials Level2 Maintenance Arrangement for Pharmacy Automation Equipment

12:00p.m.–1:00p.m. PhORCAS:HowProgramsCanOptimizethe SouthSeasJ, WebAdMITPortalWithinPhORCAS Level3

a 12:00p.m.–4:30p.m. Programming for Small & Rural Hospital Practitioners Seepage54 — — — — — —a 12:30p.m.–1:00p.m. (Management Case Study) Optimization of MandalayBayJ, — — — — — — Automated Dispensing Cabinets in Level2 a Multisite Health System

12:30p.m.–1:30p.m. Networking Session: Advancing Pharmacy LagoonH,Level2 Practice with Technicians

12:30p.m.–1:30p.m. Networking Session: Clinical Leadership LagoonL,Level2

12:30p.m.–1:30p.m. Networking Session: OR/Anesthesiology LagoonG,Level2

12:30p.m.–1:30p.m. Networking Session: Pain Management and LagoonF,Level2 Palliative Care

1:00p.m.–2:00p.m. NewandProspectivePharmacyTechnician PalmB,Level3 TrainingProgramDirectorsandInstructorsMeeting

1:00p.m.–2:00p.m. GettingStartedandApplyingforAccreditation— PalmC,Level3 FindingthePathwayandTakingtheRightSteps

a 1:00p.m.–2:15p.m. Practical Guide to Resourcing a OceansideC, — — — — — — Pharmacy Transitions-of-Care Program Level2

a 1:00p.m.–2:30p.m. On the Record: A Guide to Working Effectively MandalayBayL, — — — — — — with the Media Level2

a 1:00p.m.–2:30p.m. The ASHP Federal Forum: OceansideD,Level2 — — — — — — Welcome Event & Keynote

a 1:15p.m.–1:45p.m. (Management Case Study) Evaluation of a MandalayBayJ, — — — — — — Pharmacy Workplace Safety Training Program Level2 to Ensure Regulatory Compliance

a 2:00p.m.–3:00p.m. Continuing Professional Development (CPD): MandalayBayJ, — — — — — — A Cascade of Benefits for Employers Level2

2:00p.m.–3:00p.m. PharmacyTechnicianTraining:What’sNewfor2017! PalmB,Level3

SundayC

ON

TIN

UE

D



a 6:30a.m.–8:30a.m. Satellite Symposia Seepage107 — — — — — — 6:30a.m.–9:00a.m. VeteransAffairsResidencyOpenForum MandalayBayL,Level2

7:30a.m.–5:00p.m. PersonnelPlacementService(PPS) ShorelineExhibitHall,Level2

a 9:00a.m.–10:30a.m. Opening Session and Keynote MandalayBayEventsCenter (featuring Peyton Manning)

10:45a.m.–11:45a.m. StudentPosters BaysideB,Level1

11:00a.m.–12:00p.m. PharmacyTechnicianMeet-and-Greet BanyanD,Level3 NetworkingSession

a 11:00a.m.–3:00p.m. Exhibit Program BaysideCD,Level1

11:15a.m.–12:15p.m. ACPEUpdate2016 PalmB,Level3

11:15a.m.–12:15p.m. Networking Session: Ambulatory Care Informatics LagoonH,Level2

11:15a.m.–12:15p.m. Networking Session: Home Infusion SouthSeasD,Level3

11:15a.m.–12:15p.m. Networking Session: Pediatrics/Neonatal/OB BanyanB,Level3

11:15a.m.–12:15p.m. Networking Session: Reducing Readmissions LagoonG,Level2

11:15a.m.–12:15p.m. Networking Session: Pharmacy Practice Experiences LagoonF,Level2

continues >


2:00p.m.–3:00p.m. UsingPharmAcademictoSupportResidentLearning PalmC,Level3

a 2:00p.m.–5:00p.m. State Affiliate Volunteer Conference LagoonL,Level2

a 2:30p.m.–3:30p.m. The ASHP Federal Forum OceansideD,Level2 — — — — — —

2:30p.m.–3:30p.m. Networking Session: Anticoagulation LagoonF,Level2

2:30p.m.–3:30p.m. Networking Session: Hematology/Oncology LagoonG,Level2

a 2:45p.m.–4:15p.m. Advocacy, Healthcare, and You: Not a House of Cards MandalayBayL,Level2 — — — — — —a 3:00p.m.–4:30p.m. The 2016 ISMP Medication Safety Assessment and OceansideC, — — — — — —

Strategies for Antithrombotic Therapy in Hospitals Level2

3:00p.m.–5:00p.m. ResidencyProgramDirectorsandPreceptorsTownHall: BreakersC,Level2 UpdatesfromtheCommissiononCredentialing

a 3:15p.m.–3:45p.m. (Management Case Study) Small Intradepartmental MandalayBayJ, — — — — — — Groups Drive Pharmacy Improvement Process in Level2 a Large Community Hospital

a 3:45p.m.–5:15p.m. Federal Forum: Meet the Researchers BaysideB, — — — — — — Poster Presentations Level1

a 4:00p.m.–4:30p.m. (Management Case Study) Implementation of a MandalayBayJ, — — — — — — Pharmacy Technician Residency Program in Level2 a Teaching Hospital

a 4:45p.m.–5:15p.m. (Management Case Study) Transformation from MandalayBayJ, — — — — — — a Dispensing Model to Patient-centered Clinical Level2 Practice in a Small Urban Hospital

5:00p.m.–6:30p.m. LGBTQ Networking Reception JasmineF,Level3

5:00p.m.–7:00p.m. ASHP Foundation Donor Match Reception: BreakersF,Level2 Match for Med Safety!

5:30p.m.–7:00p.m. ASHP Best Practices Award Poster Reception ReefE,Level2

4

5

DEC

DEC

Monday

SUN

DAYM

ON

DAYa Continuing Educationa Special Eventa Intensive Studies for Recertification

All rooms are located in the Mandalay Bay South Convention Center

unless otherwise noted.



11:15a.m.–12:15p.m. Networking Session: SouthSeasF,Level3 Women in Pharmacy Leadership

11:15a.m.–12:15p.m. Networking Session: Pharmacogenetics SouthSeasJ, and Biomarkers Level3

a 11:30a.m.–1:00p.m. Midday Symposia Seepage107 — — — — — — (MandalayBay NorthConventionCenter)

11:30a.m.–5:30p.m. StudentProgramming Seepage49

12:00p.m.–1:00p.m. StudentPosters BaysideB,Level1

12:30p.m.–1:30p.m. Networking Session: Advice from the Trenches: SouthSeasD,Level3 Building and Sustaining Successful Ambulatory Care Services

12:30p.m.–1:30p.m. Networking Session: Clinical Information Systems LagoonH,Level2

12:30p.m.–1:30p.m. Networking Session: Critical Care SouthSeasF,Level3

12:30p.m.–1:30p.m. Networking Session: Geriatrics SouthSeasJ,Level3

12:30p.m.–1:30p.m. Networking Session: Infectious Diseases BanyanB,Level3

12:30p.m.–1:30p.m. Networking Session: Nutrition Support LagoonG,Level2

a 12:30p.m.–1:30p.m. ASHP-PAC Donors Luncheon JasmineF,Level3

1:00p.m.–4:00p.m. ResidencyShowcase BaysideB,Level1

a 2:00p.m.–2:30p.m. Donald E. Francke Medal Lecture SouthSeasJ,Level3

a 2:00p.m.–2:30p.m. (Management Case Study) Using Data Analytics SouthSeasD,Level3 — — — — — — to Decrease Renal Failure Cost Per Case

a 2:00p.m.–3:00p.m. Brain Matters and Blood Splatters: OceansideC,Level2 — — — — — — Drug Therapy in the Emergency Trauma Patient

a 2:00p.m.–3:30p.m. Interprofessional Education: LagoonF,Level2 — — — — — — Preparing Students for Team-based Care

a 2:00p.m.–3:30p.m. Beyond the Pillbox: Improving Medication MandalayBayL, — — — — — — Adherence and Health Outcomes Level2

a 2:00p.m.–3:30p.m. All In for Specialty Pharmacy LagoonL,Level2 — — — — — —a 2:00p.m.–3:30p.m. CDC Opioid Prescribing Guidelines: Controversy, BreakersC,Level2 — — — — — —

Opiophobia, and the Role of the Pharmacist

a 2:00p.m.–3:30p.m. Beyond the Numbers: An Innovative, SouthsSeasB,Level3 — — — — — — Patient-centered Approach to Diabetes Care

a 2:00p.m.–3:30p.m. Antimicrobial Stewardship for All: MandalayBayH, — — — — — — What You Need to Know (CEcreditavailable; Level2 allattendeeswelcome)

a 2:00p.m.–3:45p.m. Trends in 340B: Central Distribution and MandalayBayD,Level2 — — — — — — Medicaid Reimbursement

a 2:00p.m.–4:00p.m. Safety & Quality Pearls 2016 OceansideD,Level2 — — — — — —a 2:00p.m.–4:00p.m. Debates in Therapeutics 2016 MandalayBayJ,Level2 — — — — — —a 2:00p.m.–4:00p.m. Joint Commission: Don’t Roll the Dice; Be Prepared! OceansideA,Level2 — — — — — —a 2:00p.m.–4:00p.m. Balancing Act: Managing Bleeding and Thrombosis MandalayBayF,Level2 — — — — — —

with Direct Oral Anticoagulants

a 2:00p.m.–4:30p.m. Overcoming the Headwinds of Change: SouthSeasF,Level3 — — — — — — Proactive Focus on Career Inflection Points in Women’s Leadership Advancement

2:30p.m.–4:00p.m. ProfessionalPosters BaysideB,Level1

a 2:30p.m.–4:30p.m. Pharmacy Practice Pearls from SouthSeasJ,Level3 — — — — — — Around the Globe 2016

5DEC

MO

NDAY

Schedule-at-a-glance MondayC

ON

TIN

UE

D

23

DEC



a 2:45p.m.–3:15p.m. (Management Case Study) Pharmacist Population SouthSeasD,Level3 — — — — — — Health Interventions Based on Data-generated Risk and Care Gaps

a 3:30p.m.–4:00p.m. (Management Case Study) Business Intelligence SouthSeasD,Level3 — — — — — — Strategies: Improving Access and Analysis of Ad Hoc Reports Across the Pharmacy Enterprise

3:30p.m.–4:30p.m. Networking Session: Expanding Pharmacy Services LagoonH,Level2 Across Care Transitions

a 3:30p.m.–5:00p.m. Chronic Opioid Therapy for Patients with Substance BreakersC,Level2 — — — — — — Use Disorder: Between the Devil and the Deep Blue Sea

a 3:45p.m.–5:15p.m. Antimicrobial Stewardship: Considerations and OceansideC,Level2 — — — — — — Limitations in Geriatric Care Settings (CEcreditavailable;allattendeeswelcome)

a 3:45p.m.–4:45p.m. Improving Antimicrobial Dosing for Critically Ill MandalayBayH,Level2 — — — — — — Patients: How to Translate Current Evidence into Practice (CEcreditavailable;allattendeeswelcome)

a 4:00p.m.–5:00p.m. Combating Illegal Internet Pharmacy Websites: LagoonF,Level2 — — — — — — National Association of Boards of Pharmacy’s View from the Top

a 4:00p.m.–5:15p.m. What Happens in the Cath Lab Stays in the Cath Lab: MandalayBayL,Level2 — — — — — — An Update of Old, New, and Controversial Topics in Interventional Cardiology

a 4:00p.m.–5:15p.m. Biosimilar Therapeutics in Hematology LagoonL,Level2 — — — — — — Malignancies — A Contemporary Review

a 4:00p.m.–5:15p.m. What’s New in Diabetes? Insulin Products, SouthSeasB,Level3 — — — — — — Concentrations, and Multimodal Therapy

a 4:15p.m.–4:45p.m. (Management Case Study) Ace the MACE SouthSeasD,Level3 — — — — — — (Medication-related Acute Care Episode): Assessment of the Impact of Pharmacists’ Post-Discharge Follow-up on High-Risk Patients

a 4:15p.m.–5:15p.m. Preparing for Change: Antimicrobial Stewardship MandalayBayB,Level2 — — — — — — in Ambulatory Care (CEcreditavailable;allattendeeswelcome)

a 4:30p.m.–5:15p.m. Data Science Principles of Predictive and Prescriptive MandalayBayD,Level2 — — — — — — Analytics: Streamlining Your Pharmacy Practice

a 4:30p.m.–5:15p.m. Pediatric Clinical Pearls 2016 OceansideD,Level2 — — — — — — 4:30p.m.–5:30p.m. CommunityPharmacyResidencyOpenForum PalmB,Level3

4:30p.m.–5:30p.m. RegionalResidencyConferencePlannersMeeting PalmD,Level3

a 4:45p.m.–5:45p.m. International Registrants Gathering and Reception SouthSeasFoyer,Level3

5DEC

MO

NDAY






a 5:45a.m.–7:45a.m. Satellite Symposia Seepage107 — — — — — — 7:30a.m.–5:00p.m. PersonnelPlacementService(PPS) ShorelineExhibitHall,Level2

a 8:00a.m.–8:30a.m. (Management Case Study) Exploring the Use of SouthSeasD,Level3 — — — — — — Rapid Diagnostic Tests to Ensure Timely Treatment of Infections

a 8:00a.m.–9:00a.m. When Patients Outweigh the Mold: OceansideC,Level2 — — — — — — Pharmacotherapy in Pediatric Obesity

a 8:00a.m.–9:00a.m. Doing the Right Things and Doing Things Right: MandalayBayD,Level2 — — — — — — Tips and Tricks for Relevant and Efficient Inpatient Drug Surveillance

a 8:00a.m.–9:00a.m. Combat the Opioid Crisis: Fuel the Battle with MandalayBayJ,Level2 — — — — — — Nonpharmacologic Alternatives

a 8:00a.m.–9:30a.m. Washington State Pharmacist Billing for Care LagoonF,Level2 — — — — — — Services: Successful Collaboration Among Provider Associations, Health Systems, and Health Plans

a 8:00a.m.–9:30a.m. Transitioning Your Antibiotic Patients Through the SouthSeasJ,Level3 — — — — — — Healthcare System: Practical Approaches for Seamless Care

a 8:00a.m.–9:30a.m. Pharmacy Technicians: Essential Pieces LagoonL,Level2 — — — — — — of the Specialty Pharmacy Puzzle

a 8:00a.m.–9:30a.m. Welcome to Your Future: Credentialing and SouthSeasF,Level3 — — — — — — Privileging Processes for Pharmacists

a 8:00a.m.–9:30a.m. Help After a Tragic Medication Error: OceansideB,Level2 — — — — — — The Implementation of a Second Victim Program

a 8:00a.m.–9:30a.m. Dazed and Confused in the Intensive Care Unit: OceansideA,Level2 — — — — — — Managing Delirium Is More Than Just a State of Mind

a 8:00a.m.–10:00a.m. BCOP Clinical Sessions: Lung Cancer Therapy MandalayBayB,Level2 — — — — — — and Molecular Targets (CEcreditavailable;allattendeeswelcome)

a 8:00a.m.–10:00a.m. Pharmacy Forecast 2017: BreakersC,Level2 — — — — — — Trends That Will Shape Your Future

a 8:00a.m.–10:00a.m. Diversion Prevention: What’s a Pharmacy to Do? SouthSeasB,Level3 — — — — — —a 8:00a.m.–10:00a.m. Controversial High-Impact Publications in MandalayBayH,Level2 — — — — — —

Hypertension: SPRINTing Toward the Goal (CEcreditavailable;allattendeeswelcome)

8:00a.m.–11:00a.m. ResidencyShowcase BaysideB,Level1

a 8:45a.m.–9:15a.m. (Management Case Study) A Systematic Approach SouthSeasD,Level3 — — — — — — to Medication Error Evaluation Leads to Implementation of Standardized Dosing of Vasopressors

a 9:00a.m.–11:00a.m. Decision 2016: An Examination of Key Pharmacy MandalayBayL,Level2 — — — — — — Issues Within the Context of a New Administration, Congress, and Statehouses

a 9:00a.m.–11:00a.m. Management Pearls 2016 OceansideD,Level2 — — — — — —a 9:30a.m.–10:00a.m. (Management Case Study) Challenges of SouthSeasD,Level3 — — — — — —

Transitioning Patients to Outpatient Parenteral Antibiotic Therapy (OPAT)

a 9:30a.m.–10:30a.m. Drug Accountability: Using Data and Analytics MandalayBayD,Level2 — — — — — — for Enhanced Inventory Management

a 9:30a.m.–11:00a.m. Pediatric Antimicrobial Stewardship: Focusing on OceansideC,Level2 — — — — — — What Matters (CEcreditavailable;allattendeeswelcome)

a 10:00a.m.–11:00a.m. A Toolkit for Pharmacy — LagoonF,Level2 — — — — — — Managing Prior Authorizations

6DEC

TUESDAY

Schedule-at-a-glance Tuesday


8 TIME SESSION/EVENT ROOM ATTENDANCE CODE

a 10:00a.m.–11:00a.m. Pharmacotherapy Considerations in Patients LagoonL,Level2 — — — — — — on Extracorporeal Membrane Oxygenation

a 10:00a.m.–11:00a.m. FDA Update 2016: Public Health and Regulatory SouthSeasF,Level3 — — — — — — Initiatives Impacting Today’s Practice

a 10:00a.m.–11:00a.m. Incorporating Medication Indications OceansideB,Level2 — — — — — — into the Prescribing Process

a 10:00a.m.–11:00a.m. Biosimilar Savings: Lowering Prices, MandalayBayJ,Level2 — — — — — — But Who Saves Money?

a 10:00a.m.–11:00a.m. Updates in Transplantation 2016 SouthSeasJ,Level3 — — — — — — 10:00a.m.–11:00a.m. AskthePharmacyResidencyAccreditation LagoonH,Level2 SurveyorsRoundtableDiscussion


a 10:15a.m.–10:45a.m. (Management Case Study) 2016 CDC Warning on SouthSeasD,Level3 — — — — — — Fluoroquinolone Antibiotic Use: Rolling Back Use for Patient Safety


11:15a.m.–12:15p.m. Networking Session: Immunology/Transplant SouthSeasF,Level3

11:15a.m.–12:15p.m. Networking Session: Medication Management LagoonG,Level2 Across the Continuum

11:15a.m.–12:15p.m. Networking Session: BanyanB,Level3 Pharmacoeconomics/Drug Development

11:15a.m.–12:15p.m. Networking Session: Small and Rural Hospitals LagoonH,Level2

11:15a.m.–12:15p.m. Networking Session: Strategic Planning SouthSeasD,Level3

11:30a.m.–12:30p.m. StudentPosters BaysideB,Level1

a 11:30a.m.–1:00p.m. Midday Symposia Seepage107 — — — — — — (MandalayBayNorth ConventionCenter)

12:30p.m.–1:30p.m. Networking Session: Ambulatory Care Practice LagoonG,Level2 and Billing Outside of the Box

12:30p.m.–1:30p.m. Networking Session: Cardiology BanyanB,Level3

12:30p.m.–1:30p.m. Networking Session: Informatics SouthSeasF,Level3 Professional Development

12:30p.m.–1:30p.m. Networking Session: Medication Safety LagoonH,Level2

1:00p.m.–4:00p.m. ResidencyShowcase BaysideB,Level1

1:00p.m.–5:30p.m. StudentProgramming Seepage49

a 2:00p.m.–2:30p.m. (Management Case Study) Navigating Hospital SouthSeasD,Level3 — — — — — — and Health-System Integration: Clinical and Formulary Frontiers

2:00p.m.–3:00p.m. (Repeated)AskthePharmacyResidency LagoonH,Level2 AccreditationSurveyorsRoundtableDiscussion

a 2:00p.m.–3:15p.m. Optimizing Health-System Resources to MandalayBayL,Level2 — — — — — — Deliver Systemwide Antimicrobial Stewardship

a 2:00p.m.–3:15p.m. Report from the Field 2016: Focus Points OceansideA,Level2 — — — — — — for a Successful Joint Commission Survey

a 2:00p.m.–3:30p.m. Caring for Two in the ICU: Managing Critical Illness SouthSeasJ,Level3 — — — — — — in Pregnancy

a 2:00p.m.–3:30p.m. Current Considerations for Conducting Root Cause SouthSeasF,Level3 — — — — — — Analysis: Developing Your Plan

continues >

6DEC

TUESDAY





9DEC


a 2:00p.m.–3:30p.m. Beyond the Basics: Billing Opportunities for MandalayBayJ,Level2 — — — — — — Pharmacist-led Clinical Services

a 2:00p.m.–3:30p.m. Slowing CKD Progression: SouthSeasB,Level3 — — — — — — Are We Making Any Progress?

a 2:00p.m.–3:30p.m. Lessons from History: Advocating Effectively LagoonL,Level2 — — — — — — for Pharmacy’s Public Policy Agenda

a 2:00p.m.–4:00p.m. BCOP Clinical Sessions: Multiple Myeloma MandalayBayB,Level2 — — — — — — and Pediatric CINV (CEcreditavailable;allattendeeswelcome)

a 2:00p.m.–4:00p.m. #EvidenceBased? Exploring Challenges with the OceansideC,Level2 — — — — — — Quality, Reporting, and Transparency of Evidence in Healthcare Research (CEcreditavailable;allattendeeswelcome)

a 2:00p.m.–4:00p.m. Reining in the Variants — Approaches to Using MandalayBayD,Level2 — — — — — — Pharmacogenomics in Clinical Medicine

a 2:00p.m.–4:00p.m. Risky Business: The Pharmacist’s Role in OceansideD,Level2 — — — — — — Population Health Management

a 2:00p.m.–4:00p.m. USP 800: Strategies for Compliance BreakersC,Level2 — — — — — — with Handling Hazardous Drugs

a 2:00p.m.–4:00p.m. Clinical Pearls 2016 MandalayBayF,Level2 — — — — — — 2:30p.m.–4:00p.m. ProfessionalandFellowsPosters BaysideB,Level1

a 2:45p.m.–3:15p.m. (Management Case Study) Lessons Learned SouthSeasD,Level3 — — — — — — on a Pharmacy Leadership Reorganization Journey

a 3:30p.m.–4:00p.m. (Management Case Study) Navigating Pharmacy’s SouthSeasD,Level3 — — — — — — Relationship with the Hospital Supply Chain

a 3:30p.m.–5:00p.m. Patient Assessments in Heart Failure: MandalayBayH,Level2 — — — — — — New Opportunities for Pharmacists

a 3:45p.m.–5:00p.m. Make Them an Offer They Can’t Refuse: LagoonF,Level2 — — — — — — A Novel Approach to a Pharmacy Intern Program

a 4:00p.m.–5:15p.m. Pharmacist-managed Transitions of Care: MandalayBayJ,Level2 — — — — — — Monitoring and Documenting Continued Outpatient Parenteral Antimicrobial Therapy

a 4:00p.m.–5:15p.m. Heart Failure Advanced Therapeutic Approaches: SouthSeasB,Level3 — — — — — — Know When to Hold ‘Em and When to Fold ‘Em

a 4:15p.m.–4:45p.m. (Management Case Study) Expediting the SouthSeasD,Level3 — — — — — — Standardization of Formulary in a Multi-Hospital Health System

a 4:15p.m.–5:15p.m. New Drugs in Opioid-Induced Constipation: SouthSeasJ,Level3 — — — — — — How Much Is That Bowel Movement Gonna Cost You?

a 4:15p.m.–5:15p.m. Emergence of Multidisciplinary Pulmonary Embolism LagoonL,Level2 — — — — — — Response Teams: Potential Role of the Pharmacist

a 4:15p.m.–5:15p.m. PrEPping for Prevention: Engaging Pharmacists in SouthSeasF,Level3 — — — — — — HIV Prevention Strategies

a 4:15p.m.–5:15p.m. Methadone: Refining and Defining Safety and MandalayBayL,Level2 — — — — — — Efficacy in Clinical Practice

4:30p.m.–5:30p.m. ManagedCarePharmacyResidencyOpenForum PalmC,Level3

a 5:15p.m.–6:15p.m. Residents Meetup: An Opportunity to Engage BaysideB,Level1 with Pharmacy’s Leaders

a 5:30p.m.–7:30p.m. Satellite Symposia Seepage107 — — — — — —a 8:00p.m.–12:00a.m. Students’ Night Out LAXatLuxor

6DEC

TUESDAY

Schedule-at-a-glance Tuesday WednesdayAll rooms are located in the Mandalay Bay South Convention Center

unless otherwise noted.C

ON

TIN

UE

D



7:30a.m.–5:00p.m. PersonnelPlacementService(PPS) ShorelineExhibitHall,Level2

a 8:00a.m.–8:30a.m. (Management Case Study) Antimicrobial SouthSeasD,Level3 — — — — — — Stewardship: Small Hospital Strategies

a 8:00a.m.–9:30a.m. Results from the 2016 ASHP National Survey: LagoonF,Level2 — — — — — — The Current State of Pharmacy Practice in Hospitals

a 8:00a.m.–9:30a.m. Basics of GI Access and Clogged Access Devices SouthSeasJ,Level3 — — — — — —a 8:00a.m.–9:30a.m. Fitting into Our Genes: Demystifying MandalayBayL,Level2 — — — — — —

Pharmacogenomic Tests Using Online Databases

a 8:00a.m.–9:30a.m. Propelling Resident Research Projects MandalayBayD,Level2 — — — — — — into the Center Ring

a 8:00a.m.–9:30a.m. Asking the Right Questions: Preventing Technology MandalayBayJ,Level2 — — — — — — Adoption and Implementation Blunders

a 8:00a.m.–9:30a.m. Prevention and Management of Drug-Induced QT BreakersC,Level2 — — — — — — Interval Prolongation and Torsades de Pointes: Essential Tips for Pharmacists

a 8:00a.m.–9:45a.m. Emergency Medicine Pearls 2016 OceansideD,Level2 — — — — — —a 8:00a.m.–9:45a.m. Data and Dollars: 2017 Updates for Financial Success OceansideB,Level2 — — — — — —a 8:00a.m.–9:45a.m. Jackpot! Integration of Information Technology SouthSeasF,Level3 — — — — — —

and Antimicrobial Stewardship

a 8:00a.m.–9:45a.m. Feedback Landscape: The Artistry of Giving and OceansideA,Level2 — — — — — — Receiving Effective Feedback

a 8:00a.m.–9:45a.m. An ISMP Update for 2017 SouthSeasB,Level3 — — — — — —a 8:00a.m.–9:45a.m. Contemporary Considerations: OceansideC,Level2 — — — — — —

Cutting-Edge Advances in Vancomycin Therapy

a 8:30a.m.–9:30a.m. Piecing Together the Pharmacotherapy Puzzle MandalayBayB,Level2 — — — — — — for Children with Autism Spectrum Disorder (CEcreditavailable;allattendeeswelcome)


a 8:30a.m.–9:45a.m. Caring for Transgender Patients: LagoonL,Level2 — — — — — — Considerations for Pharmacists

a 8:45a.m.–9:15a.m. (Management Case Study) Establishing Pharmacy SouthSeasD,Level3 — — — — — — Participation in Antimicrobial Stewardship Program in a Large Academic Medical Center: One Year Experience

a 10:00a.m.–11:00a.m. Spotlight on Science: Precision Medicine — MandalayBayH,Level2 — — — — — — Using Big Data to Predict Drug Response and Optimize Care

10:00a.m.–11:00a.m. ResidentPosters BaysideB,Level1


11:15a.m.–12:15p.m. Networking Session: Pharmacy Operations LagoonH,Level2 and Automation

11:15a.m.–12:15p.m. Networking Session: Primary Care/Pharmacotherapy LagoonG,Level2

11:15a.m.–12:15p.m. ResidentPosters BaysideB,Level1

a 11:30a.m.–1:00p.m. Midday Symposia Seepage107 — — — — — — (MandalayBayNorth ConventionCenter)

12:30p.m.–1:30p.m. Networking Session: Innovation in Pharmacy LagoonH,Level2

12:30p.m.–1:30p.m. Networking Session: Psychopharmacy/Neurology LagoonG,Level2

12:30p.m.–1:30p.m. ResidentPosters BaysideB,Level1

continues >

7DEC

WED

NESDAY

Wednesday a Continuing Educationa Special Eventa Intensive Studies for Recertification




a 2:00p.m.–2:30p.m. (Management Case Study) Practice Model SouthSeasD,Level3 — — — — — — Transformation Across a National Health System

a 2:00p.m.–3:15p.m. Focus on Neuromuscular Blocking Agents: OceansideA,Level2 — — — — — — New SCCM Guidelines

a 2:00p.m.–3:30p.m. Improving Care Transitions: Pharmacy-led Models LagoonF,Level2 — — — — — —a 2:00p.m.–3:30p.m. Maximizing Your Leadership Potential: OceansideB,Level2 — — — — — —

Getting the Right Woman in Charge

a 2:00p.m.–3:30p.m. Optimizing Experiential Student and Resident SouthSeasF,Level3 — — — — — — Layered-Learning: Advancing Clinical Services and Preceptor Development

a 2:00p.m.–3:30p.m. Update on the Management of Pain, Agitation, OceansideC,Level2 — — — — — — and Delirium in the ICU (CEcreditavailable;allattendeeswelcome)

a 2:00p.m.–3:45p.m. Informatics Pearls 2016: Bytes of Informatics OceansideD,Level2 — — — — — —a 2:00p.m.–3:45p.m. The ACLS 2015 Guidelines: Discussion and Debate MandalayBayD,Level2 — — — — — —a 2:00p.m.–4:00p.m. Drug-Induced Diseases: Prevention, Detection, MandalayBayJ,Level2 — — — — — —

and Management

a 2:00p.m.–4:00p.m. Antibiotic Stewardship: Innovative Practices LagoonL,Level2 — — — — — — in the Community Hospital Setting

a 2:00p.m.–4:00p.m. Parenteral Nutrition Primer: Balancing Acid-Base, MandalayBayL,Level2 — — — — — — Fluids, and Electrolytes

a 2:00p.m.–4:00p.m. Interpreting the Quality of Evidence Supporting MandalayBayB,Level2 — — — — — — New Drug Approvals for the Geriatric Population (CEcreditavailable;allattendeeswelcome)

a 2:00p.m.–4:00p.m. The Joint Commission Update for 2017 SouthSeasB,Level3 — — — — — —a 2:45p.m.–3:15p.m. (Management Case Study) Six Months to Initiate SouthSeasD,Level3 — — — — — —

a Self-Sustaining Specialty Pharmacy


a 3:00p.m.–4:45p.m. Creating Positive Outcomes for Gram-Negative BreakersC,Level2 — — — — — — Infections: Deciphering Antibiograms for Best Results

a 3:30p.m.–4:00p.m. (Management Case Study) Implementation of SouthSeasD,Level3 — — — — — — Ambulatory Specialty Pharmacy Services in a Women’s Health Clinic: Exploring Fertile Ground

a 3:45p.m.–5:00p.m. Is Coagulopathy Reversal Becoming Alphabet Soup? OceansideA,Level2 — — — — — — A Look at New Reversal Strategies

a 4:00p.m.–5:00p.m. Improving Performance on Bundled Payment SouthSeasJ,Level3 — — — — — — Initiatives: Pharmacy’s Role on the Interdisciplinary Team

a 4:00p.m.–5:00p.m. Preceptor Development: Meeting the Standards OceansideB,Level2 — — — — — — for Continuous Preceptor Development

a 4:00p.m.–5:00p.m. The Internet of Things and Pharmacy: OceansideD,Level2 — — — — — — Let’s Get Talking!

a 4:00p.m.–5:00p.m. Current Controversies in the Management SouthSeasF,Level3 — — — — — — of Hyperkalemia

a 4:15p.m.–4:45p.m. (Management Case Study) Development of a SouthSeasD,Level3 — — — — — — Collaborative Workflow for Oncologic Viral Therapy

a 8:30p.m.–9:45p.m. Wednesday Evening Event MandalayBayH,Level2 (ticketrequired;doorsopen7:30p.m.)

9DEC

7DEC

WED

NESDAY

Schedule-at-a-glance WednesdayC

ON

TIN

UE

D


8DEC

THU

RSDAYa Continuing Educationa Special Eventa Intensive Studies for Recertification


unless otherwise noted. TIME SESSION/EVENT ROOM ATTENDANCE CODE

a 9:00a.m.–10:00a.m. A Straight Shot: Update on Adult Vaccination MandalayBayJ,Level2 — — — — — — Recommendations

a 9:00a.m.–10:00a.m. Welcome to the E-Patient Movement: LagoonF,Level2 — — — — — — Patients Becoming More Involved in Their Health Through Technology

a 9:00a.m.–10:30a.m. First, Do No Harm: Ethical Controversies MandalayBayD,Level2 — — — — — — in Palliative Care

a 9:00a.m.–10:30a.m. Check or Hold? Investigating Three Clinical MandalayBayB,Level2 — — — — — — Controversies in Cardiovascular Pharmacotherapy

a 9:00a.m.–11:00a.m. Implementing ISMP’s Targeted Medication Safety MandalayBayL,Level2 — — — — — — Best Practices

a 10:00a.m.–12:00p.m. Practice Innovations 2016: Strategies Worth Sharing LagoonL,Level2 — — — — — —a 10:30a.m.–12:00p.m. On a Scale of 0 to 10, How Scared Are You? MandalayBayJ,Level2 — — — — — —

Taking the Fear out of Chronic Pain Management

a 10:30a.m.–12:00p.m. Information Overdose! Managing an BreakersC,Level2 — — — — — — Information-Saturated Environment

a 11:00a.m.–12:00p.m. Albumin or Balanced Salt Solutions for Resuscitation MandalayBayD,Level2 — — — — — — in Severe Sepsis and Septic Shock: It’s Debatable!

a 11:00a.m.–12:00p.m. Safety and Efficacy Updates in the Management LagoonF,Level2 — — — — — — of Invasive Fungal Infections

a 1:00p.m.–2:00p.m. HRO: A Path to Highly-Reliable MandalayBayL,Level2 — — — — — — Medication Delivery Systems

a 1:00p.m.–3:00p.m. Balancing Pharmacy Benchmarking, Productivity, LagoonF,Level2 — — — — — — and the Work of Clinical Pharmacists

a 1:00p.m.–3:00p.m. Getting Patients to Make the Stick: A Hands-on BreakersC,Level2 — — — — — — Approach to Injectable Agents in Diabetes

a 1:00p.m.–3:00p.m. Rolling the Dice with Triple Therapy LagoonL,Level2 — — — — — —

Thursday

a free registration to the 52nd Midyear Clinical Meeting and Exhibition!StaythroughtheendoftheThursdayafternoonsessionsforachancetowinafreeregistrationtonextyear’sMidyearClinicalMeetinginOrlando,Florida.JustdropyourbadgeinoneofthebadgerecyclingbinsinsidethesessionroomsonThursdayafternoon.Oneluckywinnerwillberandomlyselected. Good luck!

Win




SUNDAY, DECEMBER 48:30 a.m.–9:30 a.m. Breakers C, Level 2

a First-Time Attendee Welcome Event IsthisyourfirstMidyearClinicalMeeting?Thenyoushouldplanonattendingthisspecialwelcomesessionthatwillpro-videtipsonhowtomakethemostoftheMidyearmeetingexperienceaswellasachancetoconnectwithyourfellowattendees.TakepartinanicebreakersessionwithASHPleaders,learnwhicheventsyouwon’twanttomiss,discoverthebenefitsofASHPmembership,andmore.

10:10 a.m.–11:20 a.m. Mandalay Bay H, Level 2

a First-Time Attendee Welcome KeynoteFeaturing: Josh Sundquist

OneMoreThing,OneMoreTimeAsachild,Joshlosthisleftlegandbeganalifelongprocessofadaptingtochangeandlearningtoexcelwithinhiscircumstances.Inhisspeech,hesharesstoriesabouttrainingfortheParalympicsandplayingjokeswithhisartificiallegtogiveaudiencememberspracticalmotivationandstrategiesfor

adaptingtoanewworkplaceenvironment.Asapersonwithadisability,hispresentationhelpsprofessionalsunderstandandcommunicateeffectivelywithcoworkersofdifferentability,background,orage.

AttendeeswillleavethepresentationwithideasabouthowtouseJosh’sParalympictrainingmotto1mt1mt(onemorething,onemoretime)tohelpthemreachtheirpro-fessionalgoalsbyputtingtheirbestattributestoworkintheircareers.Pharmacystudentswillbeinspiredtodoonemorething,onemoretimetofindastrongmatchfortheirfirstjobandtoenterthehealth-systemsectorwiththemindsetthatwillbringthemlong-termsuccess.

1:00 p.m.–2:30 p.m. Oceanside D, Level 2

a The ASHP Federal Forum: Welcome and KeynoteThe2016FederalForumwillbeginwithapatrioticopeningceremony,followedbywelcomingremarksfromtheASHPPresident.ThekeynotepresentationwillbedeliveredbyCommander Christopher Jones, Pharm.D., M.P.H.,U.S.PublicHealthService,Director,DivisionofSciencePolicy,OfficeoftheAssistantSecretaryforPlanningandEvaluation,U.S.DepartmentofHealthandHumanServices.CommanderJoneswillspeakontheopioidandpainman-agementcrisisintheUnitedStates,andtheimportantopportunityandcalltoactionforpharmacistsaskeymembersofthehealthcareteam.

Formoreinformation,seepage65.

2:00 p.m.–5:00 p.m. Lagoon L, Level 2

a State Affiliate Volunteer ConferenceHow Can State Affiliates Foster Change and Advance Practice?Changedoesn’tcomeeasily.Tofosterprofessionwidegrowth,health-systempharmacistsneedtofocusondevelopingforward-thinkingpracticestokeeppacewithchangesinhealthcaredeliveryandtohelpsatisfypatientandcaregiverdemandforhigherqualityandsafercareatlowercosts.

AttheMidyearmeeting’sAffiliateConference,leadersofASHP-affiliatedstatesocietieswilllearnhowtohelptheirmembersadvancepharmacypracticeinbothacuteandambulatorycaresettings.

TheinteractivesessionwillprovideanintroductiontothePharmacyAdvancementInitiative(PAI),apresentationonexpandingpracticeinthestatelegislativeandregulatoryarena,sharingofsuccessstoriesfromfourstateaffiliates,andaQ&AonhowtoprepareaPAIgrantapplication.Thissessionisforallstateaffiliateleaders—presidentialofficers,boardmembers,executives,andcommitteemembers.

5:00 p.m.–6:30 p.m. Jasmine F, Level 3

a LGBTQ Networking ReceptionASHPishostingaLGBTQprofessionalnetworkingeventtoprovidemeetingattendeesthechancetogatherandcon-nectwithfriendsandcolleagues.AlsolearnaboutASHP’sactivitiestopromoteLGBTQpatientcenteredcare.

5:00 p.m.–7:00 p.m. Breakers F, Level 2

a ASHP Foundation Donor Match Reception: Match for Med Safety!JointheASHPFoundationstaffandboardmemberstomatchformedicationsafety.Oneofthemostimportantresponsibilitiesthatpharmacistshaveispreventingadversedrugeventsandensuringmedicationsafetyforpatients.Thisyear’sDonorMatchReceptionwillfocusonraisingmoneyfortheFoundation’sannualfund,whichsupportsresearch,traineeships,leadershiptraining,andthedevel-opmentofpracticetools—allofwhichstrivetoassistpharmacistsinensuringappropriate,safeandeffectivemedicationuse.SponsorsNovoNordiskandOmnicellwillmatchalldonationsmadeatthereceptiondollarfordollar.

5:30 p.m.–7:00 p.m. Reef E, Level 2

a ASHP Best Practices Award Poster ReceptionThisposterreceptionwillhonortheawardeesofthe2016ASHPBestPracticesAward.Thesixawardeeswillpresentpostersofprogramsthathavebeennationallyrecognizedtodemonstratebestpracticesinpharmacypractice,especiallyinareasthatsignificantlyimprovethequalityofpatientcare.Joinusforauniqueopportunitytolearnaboutbestpracticesandtohonortheawardrecipientsduringthisreception.

Awarded by ASHP and sponsored by Amgen.

SPECIAL EVENTS & ACTIVITIES

9:00 a.m.–10:30 a.m. Mandalay Bay Events Center

a Opening Session and Keynote

KEYNOTE SPEAKER

Peyton ManningDenverBroncosquarterbackPeytonManning,theNFL’sonlyfive-timeMostValuablePlayeranda14-timeProBowlselection,hasearnedhisplaceamongthegreatestquarterbacksinleaguehistoryastheactiveleaderinnearlyeverystatisticalpassingcategory.

SinceenteringtheNFLin1998withtheIndianapolisColtsasthefirstoveralldraftpick,Manninghasthrownthemosttouchdownpasses(530)inleaguehistoryinadditiontorank-ingsecondall-timeinwinsbyaquarterback(179),completions(5,927),andpassingyards(69,691).

IneachofhisthreeseasonswithDenver,ManninghasledtheBroncostoanAFCWestDivisiontitleandafirst-roundplayoffbye.Duringthattime,heranksfirstintheNFLinregular-seasonwins(38),passingtouchdowns(131),andcompletionpercentage(67.7).

ManningcompiledthebeststatisticalseasonbyaquarterbackinNFLhistoryduringthe2013campaign,settingsingle-seasonrecordsforpassingyards(5,477)andtouchdownpasses(55).HeledthemostprolificoffenseinNFLhistoryastheBroncossetaleaguesingle-seasonrecordforpointsscored(606)whileextendinghisNFLrecordwithhisfifthMVPawardfromtheAssociated Press.

Named2013SportsmanoftheYearbySports Illustrated,ManningendedhisseasonwithatriptoSuperBowlXLVIII,makinghimonlythethirdquarterbackinNFLhistorytoleadmul-tipleteamstoaSuperBowl.

InhisfirstyearwiththeBroncosin2012—andaftermissingtheentire2011campaignwithaneckinjury—ManningfinishedastheAssociated PressNFLComebackPlayeroftheYearandrunner-upfortheleague’sMVP.

Duringhisfirst14NFLseasonswiththeColts,Manningsetclubrecordsinnearlyeverycareerpassingcategory.HeledthefranchisetoitsfirstWorldChampionshipin36yearsdur-ingthe2006season,earningMVPhonorsintheColts’29-17winovertheChicagoBearsinSuperBowlXLI.

DuringhistimeattheUniversityofTennessee,Manningepitomizedtheterm“student-athlete.”Heclaimed43recordsattheschool,conference,andnationallevelswhilegraduatingwithPhiBetaKappahonors.

HeledTennesseetoanSECChampionshipasaseniorin1997andearnedconsensusAll-Americahonors.Followinghisseniorseason,ManningwashonoredwiththeSullivanAwardforthenation’stopamateurathletebasedoncharacter,leadership,athleticability,andtheidealsofamateurism.

ManningattendedIsidoreNewmanHighSchoolinNewOrleans,wherehewasnamedGatoradeCircleofChampionsNationalPlayeroftheYearandColumbus(Ohio)TouchdownClubNationalOffensivePlayeroftheYearasasenior.

Forhisactionsoffthefield,ManningwashonoredastherecipientoftheByron“Whizzer”WhiteHumanitarianAwardandtheNFL’sWalterPaytonManoftheYearin2005aswellastheBartStarrAwardin2014.

ManningservesasamemberoftheAmericanRedCrossNationalCelebrityCabinetandThePatSummitFoundationAdvisoryBoard.Heandhiswife,Ashley,establishedthePeyBackFoundationin1999topromotethefuturesuccessofdisadvantagedyouthbyassistingpro-gramsthatprovideleadershipandgrowthopportunitiesforchildrenatrisk.

ThePeyBackFoundationhasprovidedmorethan$10millionofimpacttoat-riskyouththroughitsgrantsandprogramssinceitsinception.

ManningcontinuestomaintainastrongrelationshipwithSt.Vincent’sChildren’sHospital(Indianapolis),whichin2007wasrenamedthe“PeytonManningChildren’sHospitalatSt.Vincent.”

Manning’sfather,Archie,wasanAll-AmericanattheUniversityofMississippiin1969and1970andhada14-yearplayingcareerintheNFLwithNewOrleans(1971-82),Houston(1982-83),andMinnesota(1983-84).Hisbrother,Eli,alsoattendedOleMissandwasnamedtheMVPofSuperBowlsXLIIandXLVIwiththeNewYorkGiants.

MONDAY, DECEMBER 4

Tips for AttendingPlease note that recording of the keynote speaker is PROHIBITED. Violators’ may have their device confiscated. The same applies in the designated overflow rooms.

PlanAheadPlantoregisterandpickupyourbadgebefore Mondaymorningtoavoidlinesandwaittimes.

ArriveEarlyDoorsopenat7:50a.m.Seatswillbeavailableonafirst-comebasis.Reserving or holding seats will not be per-mitted.Additionalseat-ingwillbeavailableinseveraloverflowroomstoviewtheOpeningSession.

For the most up-to-the-minute

information, download the

ASHP LIVE app or visit www.ashp.org/ashplive.

continues >3151st ASHP MIDYEAR CLINICAL MEETING AND EXHIBITION

Special Events & Activities

a PRESIDENTIAL ADDRESS<< ASHPPresident Lisa M. Gersema, Pharm.D., M.H.A., BCPS, FASHP, DirectorofPharmacy

andResidencyProgramDirectoratUnitedHospitalinSt.Paul,Minn.

a CEO AWARD FOR STAFF EXCELLENCEPresented by ASHP CEO Paul W. Abramowitz, Pharm.D., Sc.D. (Hon.), FASHPTheCEOAwardforStaffExcellencerecognizesanindividualstaffmemberwho,inadditiontoperformingallhis/hernormaljobdutieswithexcellence,hasalsodemonstratedexcep-tionalinitiativeincontributingtoASHP.Specifically,thisawardrecognizesastaffmemberwhohasprovidedanoutstandingcontributionbyleadingordevelopingaprojectofsignifi-cantvalueforASHPandhasdemonstratedsustainedexcellenceovertimetotheadvance-mentofASHP.

<< Awardee: Bruce Hawkins, EditorialDirector,OfficeofPolicy,PlanningandCommunications,PracticeStandardsDivision

a ACKNOWLEDGEMENT OF THE DONALD E. FRANCKE MEDALIST Lee C. Vermeulen, B.S.Pharm., M.S., FCCP, FFIP, Director,OfficeforValueandInnovationinHealthcareDelivery,UniversityofKentuckyandUKHealthcare,Lexington,Ky.TheASHPBoardofDirectors’DonaldE.FranckeMedalhonorspharmacistswhohavemadesignificantinternationalcontributionstoadvancepharmacypractice.


a ASHP BOARD OF DIRECTORS AWARDlASHP BOARD OF DIRECTORS’ DISTINGUISHED LEADERSHIP AWARDTheASHPBoardofDirectors’DistinguishedLeadershipAwardrecognizespharmacistswhohaveachievedexcellenceinpharmacypracticeleadershipinacuteandambulatorycaresettings.

<< Mary Ann Kliethermes, Pharm.D., isViceChairandProfessorintheDepartmentofPharmacyPracticeatChicagoCollegeofPharmacyatMidwesternUniversityinDownersGrove,Ill.

Dr.Kliethermeshasextensiveexperienceinclinicalpracticeinavarietyofsettingsandexpertiseinqualitymeasurementandbilling.AttheChicagoCollegeofPharmacy,Dr.Kliethermessupportsthepharmacypracticefacultywithpractice,research,andscholar-ship.SheisalsoVicePresidentofClinicalServicesandCo-ownerofClinicalPharmacySystemsinElmhurst,Ill.

PriortojoiningthefacultyatChicagoCollegeofPharmacy,Dr.KliethermeswasManageroftheMTMClinicandClinicalAssistantProfessorattheUniversityofIllinoisatChicagoCollegeofPharmacy;Co-DirectoroftheIllinoisCenterforPharmaceuticalCareDivisionoftheIllinoisPharmacyFoundation;practicedinandwaspart-ownerofahomeinfusioncompany;andwasaclinicalpharmacistinthehospitalsetting.

Dr.KliethermesisaPastChairoftheASHPSectionofAmbulatoryCarePractitioners.ShehasrepresentedASHPonseveralinterdisciplinarycommittees,includingtheAmericanMedicalAssociation’sPhysicianConsortiumforPerformanceAdvisoryGrouponCompensationandPracticeSustainability,theJointCommissionAmbulatoryProfessionalTechnicalAdvisoryCommittee,andtheASPEAmbulatorySafetyProjectTechnicalExpertPanelMeeting.ShehasbeenactivelyinvolvedwiththePharmacyQualityAlliancesinceitsinception,holdinganumberofleadershippositions.ShevolunteersontwoPharmacyHealthInformationTechnologyCollaborativeworkgroupsandisamemberoftheIllinoisMedicationSafetyCoalition’sAdvisoryCouncil.

SheisPastChairoftheAmericanPharmacistAssociation’sPatient-CenteredMedicalHome/AccountableCareOrganizationSpecialInterestGroup,aPastChairoftheIllinoisCouncilofHealth-SystemPharmacists’EducationalCommittee,andhasservedasadelegatefromIllinoistotheASHPHouseofDelegates.

a ASHP RESEARCH AND EDUCATION FOUNDATION 2016 AWARD FOR EXCELLENCE IN MEDICATION SAFETYPresented by William “Bill” P. Owad, Jr., B.S., MBA FACHE, ChairoftheASHPFoundationBoardofDirectorsSVP,CardinalHealthSupported by a grant from the Cardinal Health Foundation.

OPENING SESSION continued



Awidelypublishedauthor,Mr.VermeulenservesontheeditorialadvisoryboardofPharmacotherapy.Heisarecipi-entoftheASHPFoundationAwardforInnovationinPharmacyPracticeandtheWinstonJ.DurantLectureAward,andheisaFellowofFIPandtheAmericanCollegeofClinicalPharmacy.


4:45 p.m.–5:45 p.m. South Seas Foyer, Level 3

a International Registrants Gathering and ReceptionInternationalregistrantsareinvitedtojointheircolleaguesandfriendsfromaroundtheworldatthisspecialreception.Itistheperfectopportunitytonetworkandenjoylighthorsd’oeuvresinacasualsetting.

TUESDAY, DECEMBER 68:00 a.m.–10:00 a.m. Breakers C, Level 2

a Pharmacy Forecast 2017: Trends That Will Shape Your Future TheASHPFoundationdebutsitsnewestissueofthePharmacyForecastReportseries.ThisCEsessionwillidentifycompo-nentsoftheexternalenvironmentthatareexpectedtohaveamajorimpactonhospitalandhealth-systempharmacypracticeoverthenextfiveyears.Sixoftheauthorswillalsopresentsomeofthereport’smostimportantstrategicrec-ommendations,whichwillbehelpfultopharmacistswhoareplanningthefutureoftheirdepartments.Afterthesession,from11:00a.m.tonoon,visittheASHPFoundation’sexhibitbooth(#1465)tomeetandspeakwiththereport’sauthors.


5:15 p.m.–6:15 p.m. Bayside B, Level 1

a Residents Meetup: An Opportunity to Engage with Pharmacy’s Leaders Residents–thiseventisespeciallyforyou!ASHPhasarrangedauniqueopportunityforpharmacyresidentstospeakwithwell-knownpharmacyluminariesfromawidevarietyofpracticesettingsandleadershiproles. Thisone-houreventwillallowresidentsaccesstopacesettersoftheprofession.Tofacilitatethenetworkingexperienceandprovideforthemostengagement,pharmacyleadersassociatedwithASHPandtheASHPFoundationwillbeindesignatedareas.Leadersforthisyear’smeetupareidentifiedaspartofoneofthesegroups:

l Whitneyawardeesl ASHPandASHPFoundationawardeesl ASHPelectedandappointedleadersl ASHPandASHPFoundationboardsofdirectors

TheASHPLIVEappwillcontainalistofparticipantnamesandamaptohelpyounavigate.Wehopetoseeyouthere!

MONDAY, DECEMBER 4continued

11:00 a.m.–12:00 p.m. Banyan D, Level 3

a Pharmacy Technician Meet-and-Greet Networking SessionGatherandnetworkwithfellowtechnicianstoenhanceyourexperienceattheMidyearmeeting.ThisnetworkingsessionishostedbythePharmacyTechnicianEducatorsCouncil.

12:30 p.m.–1:30 p.m. Jasmine F, Level 3

a ASHP-PAC Donors Luncheon

2:00 p.m.–4:30 p.m. South Seas J, Level 3

a Pharmacy Practice Pearls from Around the Globe 2016Featuring the Donald E. Francke Medal LectureDonaldE.FranckeMedalistMr.LeeC.Vermeulenpresents“Transcending Borders, Surpassing Boundaries”from2:00p.m.to2:30p.m.TheeducationalsessionstartsimmediatelyafterfollowedbytheInternationalRegistrantsGatheringandReception.

Donald E. Francke Medalist, LeeC.Vermeulen,B.S.Pharm.,M.S.,FCCP,FFIP,recentlyjoinedtheUniversityofKentuckyandUKHealthcareasDirectoroftheirOfficeforValueandInnovationinHealthcareDelivery(OVIHD).HepreviouslyservedasthefoundingDirectoroftheUWHealthCenterforClinicalKnowledgeManagement

andClinicalProfessorofPharmacyattheUniversityofWisconsin-MadisonSchoolof

PharmacyinMadison.InhispastroleatUWandcur-rentroleatUK,Vermeulenhasfocusedontheevaluationofmedications,devices,procedures,diagnostics,andhealthcareprograms,aswellasthedevelopmentandimplementationofpoliciesandclinicalpracticetoolsthatguidetheefficientdeliveryofhealthcare.

Mr.VermeulenhasservedinseveralleadershiproleswithintheHospitalPharmacySectionoftheInternationalPharmaceuticalFederation(FIP)andasamemberoftheFIPBoardofPharmaceuticalPractice.HeisactivelyinvolvedintheFIPPharmabridgeprogram,whichseekstoimprovepharmacyservicesinlow-incomeandemergingcountries.Hehasalsocontributedtotheworkofseveralotherinternationalorga-nizations,includingtheInternationalSocietyofPharmaco-economicsandOutcomesResearch(ISPOR),theInternationalSocietyofOncologyPharmacyPractitioners(ISOPP),andtheEuropeanAssociationofHospitalPharmacy(EAHP).

In2008,heledtheplanningandexecutionoftheFIPGlobalConferenceontheFutureofHospitalPharmacyheldinBasel,Switzerland.Thislandmarkconferenceincludedrepresentativesfromnearly100countriesandproducedconsensusstatementsonthefutureofpharmacypracticeworldwide,knownasthe“FIPBaselStatements.”Translatedinto20languages,theseguidelineshaveinflu-encedpracticestandardsaroundtheworld.Mr.VermeulenalsocontributedtoasimilareffortundertakenbyEAHPtodevelopasetofEuropeanpracticestandardsdrawingontheBaselStatements.


Special Events & Activities

theU.S.PresidentialEarlyCareerAwardforScientistsandEngineersaswellasaNationalScienceFoundationCAREERAward.HeisafellowoftheAmericanCollegeofPhysicians(ACP),theAmericanCollegeofMedicalInformatics(ACMI),theAmericanInstituteofMedicalandBiologicalEngineering(AIMBE),andtheAmericanAssociationfortheAdvancementofScience(AAAS).HeisalsoamemberoftheInstituteofMedicineoftheNationalAcademies.HeisaPastPresident,foundingboardmember,andaFellowoftheInternationalSocietyforComputationalBiology(ISCB)aswellasaPastPresidentoftheAmericanSocietyforClinicalPharmacology&Therapeutics(ASCPT).HehaschairedtheScienceBoardadvisingtheFDACommissionerandcurrentlyservesontheNIHDirector’sAdvisoryCommittee.HeisanorganizeroftheannualPacificSymposiumonBiocomputing(http://psb.stanford.edu/)andafounderofPersonalis,Inc.Dr.Altmanisboard-certifiedinInternalMedicineandinClinicalInfor-matics.HereceivedtheStanfordMedicalSchoolgraduateteachingawardin2000andthementorshipawardin2014.

The following awards will also be presented: l ASHPResearchandEducationFoundation2016LiteratureAwards

l ASHPResearchandEducationFoundation2016AwardforSustainedContributionstotheLiteratureofPharmacyPractice,presentedto C. Michael White, Pharm.D., FCCP, FCP,ProfessorandChair,PharmacyPractice,UniversityofConnecticutSchoolofPharmacy,Storrs,Conn.


WEDNESDAY, DECEMBER 7

Featured Speaker: Russ B. Altman, M.D., Ph.D.,KennethFongProfessorandProfessorofBioengineering,ofGenetics,ofMedicine(GeneralMedicalDiscipline),ofBiomedicalDataScienceand,bycourtesy,ofComputerScience,StanfordUniversity,Stanford,Calif.

Learnaboutharnessingbigdata’spowertopredicthowmedicationswillworkbasedonindividualizedpatientfac-tors.Thisnewtechnologyisenablingpractitionerstoopti-mizecareandcustomizetreatments.Pharmacistsneedtoprepareforbeingpartoftheprecisionmedicineteam.Hearfromapioneerandexpertinthisexcitingfield.

RussBiagioAltmanisaprofessorofbioengineering,genetics,andmed-icine(andofcomputerscience,bycourtesy)andPastChairmanoftheBioengineeringDepartmentatStanfordUniversity.Hisprimaryresearchinter-estsareintheapplicationofcomput-ingandinformaticstechnologiesto

problemsrelevanttomedicine.Heisparticularlyinterestedinmethodsfor

understandingdrugactionatmolecular,cellu-lar,organism,andpopulationlevels.Hislabstudieshowhumangeneticvariationimpactsdrugresponse(e.g.,http://www.pharmgkb.org/).Otherworkfocusesontheanalysisofbiologicalmoleculestounderstandtheaction,interaction,andadverseeventsofdrugs(http://features.stanford.edu/).Dr.AltmanholdsanA.B.fromHarvardCollege,anM.D.fromStanfordMedicalSchool,andaPh.D.inMedicalInformationSciencesfromStanford.Hereceived


a Spotlight on SciencePrecision Medicine — Using Big Data to Predict Drug Response and Optimize Care






Iflaughtertrulyisthebestmedicine,thisyear’sWednesdayEveningEventpromisestoprovideafulldoseandhaveyoulaughingoutloud.

Sayingwhatwe’reallthink-inghasalwaysbeenSebastian

Maniscalco’sspecialty.Exceptwhenhesaysit,it’sawholelotfun-

nierandthathasfansacrossNorthAmericashowingupindrovesforhisshows

andmillionstuninginforhisnetworkspecials.DistinguishedbyTheNew York Timesasacomicwithhis

“ownkindofpanache,”Sebastianhastakenoneverythingfromselfiesthathecalls“lonelies”(“Doyouknowhowaloneyouhavetobetohave838photosofyourselfinyourbath-room?”)toonlinerestaurantreviews(“Who’sgotthetimetowritean18pageessayonasparagus?”)toairportcheck-ins(“I’mtakingoutaboot…asock…atoothpaste…doesanyoneknowwhattwopoundsis?”).

FeaturedEntertainer:SebastianManiscalco Opening Act: Scott Keo,

No. 1 Michael Bublé tribute act in the U.S. and Canada

Joinfriendsandcolleaguesforthismust-attend,after-dinnershow,andseeforyour-selfwhySebastianManiscalcohasbecomeoneofthemostsought-aftercomedianstoday!

Doorsopenat7:30p.m.Showstartsat8:30p.m.Lightfareandcashbarswillbeprovided.

NOTE:Absolutelynopictures,audio,orvideorecordingofanykindwillbeallowedduringtheperformance.

Ticket InfoEntrancetotheshowrequiresaticketandentitlestheholdertoonefreedrink.Aticketisincludedinthefullregistrationprice.AdditionalticketscanbepurchasedattheTicketSalescounterintheRegistrationarea.Tickets are $45andmustbepurchasednolaterthan3:00p.m.onWednesday,December7.Therearenorefundsforthisevent.

8:30 p.m.–9:45 p.m. Mandalay Bay H, Level 2

a Wednesday Evening Event

Thefuncontinuesaftertheshow!LIGHTNightclub,locatedinMandalayBay,isextendingcompli-mentaryentrytoASHPattendeesandexhibitorswithameetingbadge(value$30formen&$20forwomen).LIGHTcombinescutting-edgecreativitywithincrediblemusic,toproduceanewkindofnightlifeexperienceyouwon’twanttomiss!

NOTE:OffervalidonWednesday,December7only.Allguestsmustbe21+yearsoldandpresentagovernmentissuedphotoIDtoenter.Nolargebags,backpacks,orcamerasarepermittedintothevenue;allguestsmustbeindresscode—nohats,sneakers,orathleticwear.Doorsopenat10:30pmManagementreservesallrights.

Doorsopenat7:30p.m.Showstartsat8:30p.m.ShuttleservicewillbeprovidedfortheWednesdayEveningEventfrom7:00p.m.to10:30p.m.fromofficialASHPMidyearmeetinghotels,exceptthosewithinwalkingdistanceoftheMandalayBayConventionCenter.

Follow #ASHP16Stay connected to everything happening at the Midyear Clinical Meeting with #ASHP16, the official hashtag for the Midyear meeting. Don’t forget to tag your tweets, photos, and videos with the hashtag so others can follow along with your experiences on Twitter, Facebook, and Instagram.


ASHP SPECIALTY REVIEW AND RECERTIFICATION EVENTS—LIVE!

ASHP offers a contemporary way to prepare for a specialty pharmacy board examination and innovative, highly rated programs for board recertification. Our approach is multifaceted, scenario-based, and interactive — the opposite of the didactic learning norm. Our board review and recertification programs will have an immediate and lasting impact on your practice.

SATURDAY AND SUNDAY, DECEMBER 3-4

7:30 a.m.–6:00 p.m. Islander Ballroom F, Lower Level Mandalay Bay North Convention Center

a Live Pharmacotherapy Specialty Review and Recertification Course Thistwo-daycourseprovidesarobustcurriculumforthehigh-levelpharmacyprofessionalwhoiseitherplanningtotakethecertificationexaminationorseekingrecertificationcredit.

Courseparticipantsfollowfictionalpatientsinreal-lifescenarios,includinginitialpresentation,medicalhistory,riskfactors,andcomplicationsthroughouttheirtreatmentsandoutcomes.Participantslearnastheyapplyvarioustreatmentoptionsbasedonnationalstandardsandguide-lines.Strongemphasisisplacedonthethoughtprocessesneededtosolvepatientcareproblemsineachtherapeuticarea.Aspatientcasesarediscussed,facultymembersansweryourquestionstoillustratekeyconcepts.

HighlightsoftheASHPreviewandrecertificationcourseinclude:

l Aninteresting,application-basedreviewcourseapproachusingcomplex,case-basedinteractivelearningforhigh-levelpractitionersandspecialists.

l System-BasedStandardsandPopulation-BasedPharmacotherapy,whichaccountsfor20%ofthenewlydevelopedBCPSFall2016exam.

l Publichealthandpatientadvocacyinformationineverytopicarea.

l Educationalcoursematerialsthatcanbedownloadedandprintedinadvance,aswellasapracticeexamcontainingmorethan100practicequestionswithanswersexplainedandlinkstooriginalreferences.

l Confidentlypreparefortheexaminonlytwodays,savingyoutimeawayfromworkandhome,anddrasticallyreducingtravelexpenses.

l Accesstoacoursedevelopedbyleadingcontinuingeducationproviders,preparatorycontentexperts,andfaculty.

YoumustselecteithertheBasic Review Course Package,thePremium Package,ortheRecertification Package:

l Basic Review Course:Includeslivecoursewitheducationalcoursematerials(PDF)andpracticeexam

l Premium (BEST VALUE):Includeslivecoursewitheducationalcoursematerials(PDF),onlinecourse,CoreTherapeuticModulepackage*,andpracticeexam

l Recertification:Includeslivecoursewitheducationalcoursematerials(PDF)andrecertificationassessment(forthoseseekingrecertificationonly)

*Core Therapeutic Modules are on-demand, web-based activities that help identify knowledge gaps on various topics or disease states.

This course is eligible for up to 16 hours of recertification credit after successful completion of the online assess-ments, which will be available in January 2017.

Formoreinformationandtoregister,visitwww.ashp.org/boardreview2016.

7:30 a.m.–6:00 p.m. Islander Ballroom G, Lower Level Mandalay Bay North Convention Center

a Live Geriatric Pharmacy Specialty Review and Recertification Course Thistwo-daycourseprovidesarobustcurriculumforthehigh-levelpharmacyprofessionalwhoiseitherplanningtotakethecertificationexaminationorseekingrecertificationcredit.

Courseparticipantsfollowfictionalpatientsinreal-lifescenarios,includinginitialpresentation,medicalhistory,riskfactors,andcomplicationsthroughouttheirtreatmentsandoutcomes.Participantslearnastheyapplyvarioustreatmentoptionsbasedonnationalstandardsandguide-lines.Strongemphasisisplacedonthethoughtprocessesneededtosolvepatientcareproblemsineachtherapeuticarea.Aspatientcasesarediscussed,facultymembersansweryourquestionstoillustratekeyconcepts.

HighlightsoftheASHPreviewcourseincludethefollowing:

l Aninteresting,application-basedreviewcourseapproachusingcomplex,case-basedinteractivelearningforhigh-levelpractitionersandspecialists

l Coverageofhealth-relatedproblemsandsocioeconomicfactors

l Educationalmaterialsthatcanbedownloadedandprinted



FOR REVIEW AND RECERTIFICATION


ClinicalSessions,whilenameddifferently,followthesameformatastheLiveIntensiveStudies.

For pharmacists who maintain more than one certification, some of these sessions provide credit for more than one specialty.

Ambulatory Care Pharmacy Intensive Studies Package (6.5 hours of recertification credit)NEW FORMAT:ThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregis-trantmayattendthesethought-provokingandhighlyedu-cationalsessions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtytoreceivetherecertificationassessmentandclaimtherecertificationcredit.Thispackageincludesthelivesessions,recordedversionsofthelivesessions,andtherecertificationassess-mentavailableinFebruary2017.

TheBCACPrecertificationactivitiesaredevelopedinpartnershipwiththeAmericanPharmacistsAssociation(APhA).

Sessions included in the Ambulatory Care Intensive Studies package include the following:

MONDAY, DECEMBER 52:00 p.m.–3:30 p.m. Mandalay Bay H, Level 2

a Antimicrobial Stewardship for All: What You Need to Know (1.50 hours)Recertification credit for:BCACP,BCCCP,BCPPS,BCPS,CGP

Antimicrobialstewardshiphasbeenhighlightedinapresi-dentialexecutiveorderanditsassociatedNationalActionPlanforCombatingAntibiotic-ResistantBacteria;however,thereisalargedisparityinhowantimicrobialstewardshipispracticed.Inthisactivity,facultywilldescribeemergingtrendsinantimicrobialresistanceamongcommonpatho-gens,aswellasmethodsforantimicrobialresistancesur-veillance.Next,facultywillfocusondefiningthepersonnelandresourcesnecessaryforoptimalandadequateantimi-crobialstewardship.Finally,metricstotrackantimicrobialconsumptionwillbediscussed,includingbenefitsandpit-fallsofeachmethod.Further,facultywilladdressthecom-parativeabilityofthemetrics(i.e.,benchmarks)andtheintricaciesofcomparingantimicrobialusageacrossvariousfacilities.Engagingwiththefacultythroughaudienceresponseactivity,learnerswillgainknowledgeofreadilyimplementablemethodologiesfortrendingantimicrobialusewithintheirpracticesites.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP), Board Certified Critical Care Pharmacist (BCCCP), Board Certified Pediatric Pharmacy Specialist (BCPPS), Board Certified Pharmacotherapy Specialist (BCPS), and Certified Geriatric Pharmacist (CGP) recertification credit.

inadvanceaswellasapracticetestcontainingmorethan100practicequestionswithexplainedanswersandlinkstooriginalreferences

l CoreTherapeuticModuleforhome-study,coveringstatis-tics,evidence-basedmedicine,andresearchdesign

l Chapter3,“BiomedicalPrinciplesofAging”byLisaC.HutchisonfromFundamentals of Geriatric Pharmacotherapy, Second Edition,forhomestudypriortothecourse

l Confidentlypreparefortheexaminonlytwodays,savingyoutimeawayfromworkandhome,anddrasticallyreduc-ingtravelexpenses

l Accesstoacoursedevelopedbyleadingcontinuingeduca-tionproviders,preparatorycontentexperts,andfaculty

YoumustselecteithertheBasic Review Course Package,thePremium Package,ortheRecertification Package:

l Basic Review Course:Includeslivecourse,CoreTherapeuticModule*coveringstatistics,pre-meetingread-ingmaterial**,andpracticeexam

l Premium Package (BEST VALUE):Includeslivecourse,CoreTherapeuticModule*coveringstatistics,pre-meetingread-ingmaterial**,onlinecourse,ASHP’sFundamentals of Geriatric Pharmacotherapy, 2nd edition(printorebook),andpracticeexam

l Recertification Package:Includeslivecourse,CoreTherapeuticModulecoveringstatistics,pre-meetingread-ingmaterial,andrecertificationexam

*Core Therapeutic Modules are on-demand, web-based activities that help identify knowledge gaps on various top-ics or disease states.** Pre-meeting reading materials: Prior to the live event, ASHP will provide all registrants with a PDF of Chapter 3 from FundamentalsofGeriatricPharmacotherapy,2ndedition.

This course is eligible for 16 hours of recertification credit after successful completion of an online assessment, which will be available in February 2017.

Formoreinformationandtoregister,visitwww.ashp.org/boardreview2016.

NEW Format! Live Intensive Study and BCOP Clinical Session PackagesThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregistrantmayattendthesethought-provokingandhighlyeducationalsessions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtyinordertoreceivetherecerti-ficationassessmentandtoclaimtherecertificationcredit.

Ifyouarecurrentlyenrolledinthe3-yearrecertificationsubscriptionortheResidentRewardandRecertificationprogram,theIntensiveStudyPackageisalreadyincludedinyoursubscription.

PleasenotethattheBCOPClinicalSessionsarearepeatofthesessionspresentedinOctober2016attheACCPAnnualMeeting.Learnersmayclaimcreditonlyonce.BCOP


2:00 p.m.–4:00 p.m. Oceanside C, Level 2

a #EvidenceBased? Exploring Challenges with the Quality, Reporting, and Transparency of Evidence in Healthcare Research (2.00 hours)Recertification credit for:BCACP,BCPS

Thisinteractiveactivitywillexaminerecentcontroversiesrelatedtothequalityofevidenceinregardtoresearchdesign,includingtheuseofsurrogateoutcomes,stoppingtrialsearly,factorialdesigns,andadaptivedesigns.Addition-ally,issuesobservedwiththereportingofevidence—includingreportingbias,reportingdiscrepancies,retractions,anderratum—willbediscussed.Lastly,theactivitywillexplorechallengeswiththetransparencyofevidenceandregulatoryinitiativesaimedatimprovingpublicaccesstorawresearchdata.Learnerswillbepresentedwithaudi-enceresponsequestionsthathighlightthesechallengesandwillbeprovidedwithresourcestoassistinthecriticalappraisalofbiomedicalliterature.Facultywillemphasizeactionablechangespharmacistscanmakewhileparticipat-inginresearch,servingaspeerreviewers,andformulatingrecommendationsforevidence-basedmedicationuse.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit.

Critical Care Pharmacy Intensive Studies Package (4 hours of recertification credit)NEW FORMAT:ThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregis-trantmayattendthesethought-provokingandhighlyedu-cationalsessions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtytoreceivetherecertificationassessmentandclaimtherecertificationcredit.Thispackageincludesthelivesessions,recordedversionsofthelivesessions,andtherecertificationassess-mentavailableinFebruary2017.

Sessions included in the Critical Care Intensive Studies package include the following:



Antimicrobialstewardshiphasbeenhighlightedinapresi-dentialexecutiveorderanditsassociatedNationalActionPlanforCombatingAntibiotic-ResistantBacteria;however,thereisalargedisparityinhowantimicrobialstewardshipispracticed.Inthisactivity,facultywilldescribeemergingtrendsinantimicrobialresistanceamongcommonpatho-gens,aswellasmethodsforantimicrobialresistancesur-veillance.Next,facultywillfocusondefiningthepersonnelandresourcesnecessaryforoptimalandadequateantimi-crobialstewardship.Finally,metricstotrackantimicrobialconsumptionwillbediscussed,includingbenefitsand

4:15 p.m.–5:15 p.m. Mandalay Bay B, Level 2

a Preparing for Change: Antimicrobial Stewardship in Ambulatory Care (1.00 hours)Recertification credit for:BCACP

Duetothelackofnewantimicrobialdrugdiscoveryandanincreaseinantimicrobialresistanceinthecommunity,thereisapressingneedforhealthcarepractitionerstoevaluateantimicrobialprescribingpracticesandtoimple-menteffectivestrategiesforantimicrobialstewardshipinallpracticesettings.Furthermore,proposedregulatorystandardsrequireantimicrobialstewardshipeffortsintheambulatorysettingatanunprecedentedlevel.Thepurposeofthisactivityistoidentifyantimicrobialresistancepat-ternsofconcern,describeproposedregulatorystandardsrelatedtoantimicrobialstewardship,andillustratemeth-odsforimplementingantimicrobialstewardshipintheambulatorycaresetting.Innovativemethods,includingthosefordevelopinganeffectivestewardshipteamandcollaborativepracticeagreements,willbeprovided.Engagingwiththefacultythroughaudienceresponsetech-nology,learnerswillgainconfidenceintheirabilitytoapplythesemethodsuponreturntotheirpracticesites.

This activity is approved for Board Certified Ambulatory Care Pharmacist (BCACP) recertification credit.

TUESDAY, DECEMBER 68:00 a.m.–10:00 a.m. Mandalay Bay H, Level 2

a Controversial High-Impact Publications in Hypertension: SPRINTing Toward the Goal (2.00 hours)Recertification credit for:BCACP,BCPS

ThisactivityisdesignedtoprovidelearnerswithnewevidencefromtheSPRINTtrialrelatedtobloodpressuregoals,contrastthisevidencewithotherdataandconsensusrecommenda-tions,andenableparticipantstomakepatient-centereddecisionswhenselectingbloodpressuregoalsandtranslatethesedatatopatientcare.Speakerswilldebatetheadvan-tagesanddisadvantagesofusinglower-than-standardbloodpressuregoals.Learnerswillbechallengedwithcase-basedquestionshighlightingimportantaspectsofmanagingpatientswithhypertension,focusingonsituationswhereselectionofthemostappropriate,evidence-basedbloodpressuregoalischallenging.


ASHP Specialty Review and Recertification Events—Live!


toimprovethequalityofPADmanagement.ThisactivityisdesignedtoevaluaterecentliteratureandnewlypublishedguidelinesforthemanagementofPAD.Thefacultywillapplythisinformationtopatientcasescenarios,andlearnerswillhavetheopportunitytoparticipateinthedecision-makingprocessthroughaudienceresponsetechnology.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) recertification credit.

Geriatric Pharmacy Intensive Studies Package (5 hours of recertification credit)NEW FORMAT:Thisyearthesessionswillbeheldlivethrough-outtheMidyearmeeting,andanymeetingregistrantmayattendthesethought-provokingandhighlyeducationalses-sions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtytoreceivetherecertificationassessmentandclaimtherecertificationcredit.Thispackageincludesthelivesessions,recordedversionsoftheliveses-sions,andtherecertificationassessmentavailableinFebruary2017.

Sessions included in the Geriatric Pharmacy Intensive Studies package include the following:



Antimicrobialstewardshiphasbeenhighlightedinapresi-dentialexecutiveorderanditsassociatedNationalActionPlanforCombatingAntibiotic-ResistantBacteria;however,thereisalargedisparityinhowantimicrobialstewardshipispracticed.Inthisactivity,facultywilldescribeemergingtrendsinantimicrobialresistanceamongcommonpatho-gens,aswellasmethodsforantimicrobialresistancesur-veillance.Next,facultywillfocusondefiningthepersonnelandresourcesnecessaryforoptimalandadequateantimi-crobialstewardship.Finally,metricstotrackantimicrobialconsumptionwillbediscussed,includingbenefitsandpit-fallsofeachmethod.Further,facultywilladdressthecom-parativeabilityofthemetrics(i.e.,benchmarks)andtheintricaciesofcomparingantimicrobialusageacrossvariousfacilities.Engagingwiththefacultythroughaudienceresponseactivity,learnerswillgainknowledgeofreadilyimplementablemethodologiesfortrendingantimicrobialusewithintheirpracticesites.


pitfallsofeachmethod.Further,facultywilladdressthecomparativeabilityofthemetrics(i.e.,benchmarks)andtheintricaciesofcomparingantimicrobialusageacrossvar-iousfacilities.Engagingwiththefacultythroughaudienceresponseactivity,learnerswillgainknowledgeofreadilyimplementablemethodologiesfortrendingantimicrobialusewithintheirpracticesites.



a Improving Antimicrobial Dosing for Critically Ill Patients: How to Translate Current Evidence into Practice (1.00 hours)Recertification credit for:BCCCP,BCPS

TheCentersforDiseaseControlandPrevention,theInfectiousDiseasesSocietyofAmerica,theSocietyforHealthcareEpidemiologyofAmerica,ASHP,andtheJointCommissionhaveallcalledforthecoreelementsofantimicrobialstew-ardshiptobeimplemented.Onecoreelementinwhichbothinfectiousdiseases(ID)andnon-IDspecialistscanparticipateistheimplementationofpoliciesandinterventionsaimedatimprovingantibioticuse.Clinicalstudiessuggestthatstandarddosingregimensforbothbeta-lactamsandami-noglycosidesareinadequatetoachievedefinedpharmaco-kinetic/pharmacodynamictargetexposuresthatpredictimprovedoutcomes.Amongsomecriticallyillpatients,improvedtargetexposureattainmenthastranslatedintoimprovedinfection-relatedoutcomes.Thisactivityisdesignedtoexpandlearners’knowledgeofcurrentevidencesupportingimplementationofdose-optimizationqualityimprovementprogramswithinindividualcenters.Sucheffortswillultimatelyleadtointerventionsthatwillimprovepopulation-levelandindividualcare.Learnerswillhavetheopportunitytoapplythisknowledgetopatientcases,usingactivelearningstrat-egiesandreal-timefeedback.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit.

WEDNESDAY, DECEMBER 72:00 p.m.–3:30 p.m. Oceanside C, Level 2

a Update on the Management of Pain, Agitation, and Delirium in the ICU (1.50 hours)Recertification credit for:BCCCP

Managementofpain,agitation,anddelirium(PAD)isessentialtooptimalcareofcriticallyillpatients.Implementationofassessmenttools,goal-orientatedpharmacotherapy,dailyinterruptionstrategies,anduseofselectpharmacologicalagentshaveimprovedmorbidityvariablessuchasdurationofmechanicalventilationandICUlengthofstay.However,organizationsstillstrugglewithimplementingbestpractices,especiallyincomplexpatients.Pharmacistsareideallysuited


ASHP Specialty Review and Recertification Events—Live!Thispackageincludesthelivesessions,recordedversionsofthelivesessions,andtherecertificationassessmentavailableinFebruary2017.Sessions included in the Pediatric Pharmacy Intensive Studies package include the following:



Antimicrobialstewardshiphasbeenhighlightedinapresi-dentialexecutiveorderanditsassociatedNationalActionPlanforCombatingAntibiotic-ResistantBacteria;however,thereisalargedisparityinhowantimicrobialstewardshipispracticed.Inthisactivity,facultywilldescribeemergingtrendsinantimicrobialresistanceamongcommonpathogens,aswellasmethodsforantimicrobialresistancesurveillance.Next,facultywillfocusondefiningthepersonnelandresourcesnecessaryforoptimalandadequateantimicrobialsteward-ship.Finally,metricstotrackantimicrobialconsumptionwillbediscussed,includingbenefitsandpitfallsofeachmethod.Further,facultywilladdressthecomparativeabilityofthemetrics(i.e.,benchmarks)andtheintricaciesofcomparingantimicrobialusageacrossvariousfacilities.Engagingwiththefacultythroughaudienceresponseactivity,learnerswillgainknowledgeofreadilyimplementablemethodologiesfortrendingantimicrobialusewithintheirpracticesites.


TUESDAY, DECEMBER 69:30 a.m.–11:00 a.m. Oceanside C, Level 2

a Pediatric Antimicrobial Stewardship: Focusing on What Matters (1.50 hours)Recertification credit for: BCPPS

Althoughthebodyofliteratureevaluatingpediatricantimicrobialstewardshiphasgrown,moststudiesaddresstheadultpopulation,presentingachallengeforpediatricclinicians.Inaddition,whilemanypediatricpharmacistsarefamiliarwithantimicrobialstewardshipconcepts,theymaybeunawareofthedailyopportunitiesthatexistforstewardshipinterventions.Thisactivityisdesignedtoassistpharmacistsinusingcurrentevidencetoapplypediatricantimicrobialstewardshipprinciplesintheirpractices.Keycomponentsfornewandestablishedprogramswillbediscussed,includingconsiderationsforpriorauthorizationandprospectiveauditwithfeedbackstrategies.Importantmedicalandsurgicaltargetsforpediatricantimicrobial


a Antimicrobial Stewardship: Considerations and Limitations in Geriatric Care Settings (1.50 hours)Recertification credit for:CGP

Astandardforantimicrobialstewardshipinlong-termcaresettingsisanticipatedfromtheCentersforMedicare&MedicaidServices(CMS).Atpresent,manyconsultantphar-macistsdonotunderstandhowtoincorporatethesechangesintotheirpractice.Thisactivityisdesignedtobridgethatknowledgegap.Facultywillapplythemostrecentantibioticstewardshipevidenceandguidelinestogeriatricpatientcases,engaginglearnersthroughaudienceresponsetechnology.Considerationsandpotentiallimitationstoperforminganti-microbialstewardshipingeriatriccaresettingswillbedis-cussed.Tobetterequipthegeriatricpharmacisttomakeappropriateantimicrobialrecommendations,facultywilladdressthepotentialimpactoftransitionsofcareonanti-bioticprescribingandmonitoringandwillprovidetoolstoaiddevelopmentofappropriateantibiotictherapyandmonitoringrecommendations.

This activity is approved for Certified Geriatric Pharmacist (CGP) recertification credit.

WEDNESDAY, DECEMBER 72:00 p.m.–4:00 p.m. Mandalay Bay B, Level 2

a Interpreting the Quality of Evidence Supporting New Drug Approvals for the Geriatric Population (2.00 hours)Recertification credit for:CGP

Newdrugclinicaltrialsareconductedinadultpatientswhoaregenerallyhealthy.Asthesenewdrugsbecomeavailable,itisimportanttoknowhowtheywillbereceivedbyotherpopulations.Thisactivityisdesignedtoassessthepotentialroleofrecentlyapprovedmedicationsingeriatricpatientcare.Facultywillevaluateavailableliteraturetodeterminewhetherdatamaybeextrapolatedtogeriatricpatients,consideringage-relatedphysiologicalchangesthatmayaffectdrugsafetyandefficacy.Throughtheuseofinterac-tivepatientcasescenarios,learnerswillhavetheopportu-nitytoparticipateinthedecision-makingprocessregardingdrugselectioningeriatricpatients.

This activity is approved for Certified Geriatric Pharmacist (CGP) recertification credit.

Pediatric Pharmacy Intensive Studies Package (4 hours of recertification credit)NEW FORMAT:ThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregistrantmayattendthesethought-provokingandhighlyeducationalsessions.However,ifyouareboard-certified,youmustpur-chasethepackage(s)foryourspecialtytoreceivetherecer-tificationassessmentandclaimtherecertificationcredit.



a Antimicrobial Stewardship for All: What You Need to Know (1.50 hours)Recertification credit for: BCACP,BCCCP,BCPPS,BCPS,CGP

Antimicrobialstewardshiphasbeenhighlightedinapresiden-tialexecutiveorderanditsassociatedNationalActionPlanforCombatingAntibiotic-ResistantBacteria;however,thereisalargedisparityinhowantimicrobialstewardshipisprac-ticed.Inthisactivity,facultywilldescribeemergingtrendsinantimicrobialresistanceamongcommonpathogens,aswellasmethodsforantimicrobialresistancesurveillance.Next,facultywillfocusondefiningthepersonnelandresourcesnecessaryforoptimalandadequateantimicrobialsteward-ship.Finally,metricstotrackantimicrobialconsumptionwillbediscussed,includingbenefitsandpitfallsofeachmethod.Further,facultywilladdressthecomparativeabilityofthemetrics(i.e.,benchmarks)andtheintricaciesofcomparingantimicrobialusageacrossvariousfacilities.Engagingwiththefacultythroughaudienceresponseactivity,learnerswillgainknowledgeofreadilyimplementablemethodologiesfortrendingantimicrobialusewithintheirpracticesites.



a Improving Antimicrobial Dosing for Critically Ill Patients: How to Translate Current Evidence into Practice (1.00 hours)Recertification credit for: BCCCP,BCPS

TheCentersforDiseaseControlandPrevention,theInfectiousDiseasesSocietyofAmerica,theSocietyforHealthcareEpidemiologyofAmerica,ASHP,andtheJointCommissionhaveallcalledforthecoreelementsofantimicrobialstew-ardshiptobeimplemented.Onecoreelementinwhichbothinfectiousdiseases(ID)andnon-IDspecialistscanparticipateistheimplementationofpoliciesandinterventionsaimedatimprovingantibioticuse.Clinicalstudiessuggestthatstan-darddosingregimensforbothbeta-lactamsandaminogly-cosidesareinadequatetoachievedefinedpharmacokinetic/pharmacodynamictargetexposuresthatpredictimprovedoutcomes.Amongsomecriticallyillpatients,improvedtargetexposureattainmenthastranslatedintoimprovedinfection-relatedoutcomes.Thisactivityisdesignedtoexpandlearn-ers’knowledgeofcurrentevidencesupportingimplementationofdose-optimizationqualityimprovementprogramswithinindividualcenters.Sucheffortswillultimatelyleadtointer-ventionsthatwillimprovepopulation-levelandindividualcare.Learnerswillhavetheopportunitytoapplythisknowl-edgetopatientcases,usingactivelearningstrategiesandreal-timefeedback.

This activity is approved for Board Certified Critical Care Pharmacist (BCCCP) and Board Certified Pharmacotherapy Specialist (BCPS) recertification credit.

stewardshipwillbehighlighted,andspeakerswillprovideevidence-basedrecommendationsforchoice,design,implementation,andevaluationofstewardshipinitiatives.Evidencesupportinginitiativesforcommonantibioticindicationsinpediatricpatients—includingcommunity-acquiredpneumonia,appendicitis,andurinarytractinfection—willbehighlighted.Usingaudienceresponsetechnology,participantswillhavetheopportunitytoapplywhattheyhavelearnedtopatient-centeredcases.This activity is approved for Board Certified Pediatric Pharmacist (BCPPS) recertification credit.

WEDNESDAY, DECEMBER 78:30 a.m.–9:30 a.m. Mandalay Bay B, Level 2

a Piecing Together the Pharmacotherapy Puzzle for Children with Autism Spectrum Disorder (1.00 hours)Recertification credit for: BCPPS

Astheprevalenceofautismincreases,researchhasidenti-fiedariseinantipsychoticmedicationuseinpediatricpatients.Onestudyrevealedthat27%ofchildrenandado-lescentswithautismweretakingatleastonepsychotropicmedication.Thepatientsoftenhadacomorbiddiagnosissuchasattentiondeficithyperactivitydisorder(ADHD)ordepression,andinitiationofpharmacotherapyregimensoccurredinchildrenasyoungasthreeyearsofage.Pharmacotherapyforautismdoesnottreattheunderlyingdisorder.Rather,therapyisgearedtowardtreatingclinicalmanifestationsthatmayarisewithapatientwithautism(e.g.,aggressivebehaviors,inattention,repetitivebehav-iors).Thisactivityisdesignedtoreviewpracticeguidelinesandupdatedrecommendationsbasedontheexpandeduseofmultiplemedicationstotreatcomorbidconditionsinpatientswithautism.Throughaudienceresponsetechnol-ogy,learnerswillhavetheopportunitytoapplythisinfor-mationtopediatricpatientcases.

This activity is approved for Board Certified Pediatric Pharmacy Specialist (BCPPS) recertification credit.

Pharmacotherapy Intensive Studies Package (6.5 hours of recertification credit)NEW FORMAT:ThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregis-trantmayattendthesethought-provokingandhighlyedu-cationalsessions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtytoreceivetherecertificationassessmentandclaimtherecertificationcredit.Thispackageincludesthelivesessions,recordedversionsofthelivesessions,andtherecertificationassess-mentavailableinFebruary2017.

Sessions included in the Pharmacotherapy Intensive Studies package include the following:


ASHP Specialty Review and Recertification Events—Live!BCOP Clinical Sessions (4 hours of recertification credit)NEW FORMAT:ThisyearthesessionswillbeheldlivethroughouttheMidyearmeeting,andanymeetingregis-trantmayattendthesethought-provokingandhighlyedu-cationalsessions.However,ifyouareboard-certified,youmustpurchasethepackage(s)foryourspecialtytoreceivetherecertificationassessmentandclaimtherecertificationcredit.Thispackageincludesthelivesessions,recordedversionsofthelivesessions,andtherecertificationassess-mentthatiscurrentlyavailable.

PleasenotethattheBCOPClinicalSessionsarearepeatofthesessionspresentedinOctober2016attheACCPAnnualMeeting.Learnersmayclaimcreditonlyonce.BCOPClinicalSessions,whilenameddifferently,followthesameformatastheLiveIntensiveStudies.

BCOPrecertificationactivitiesaredevelopedinpartnershipwiththeAmericanCollegeofClinicalPharmacy(ACCP).

Sessions included in the BCOP Clinical Sessions package include the following:

TUESDAY, DECEMBER 68:00 a.m.–10:00 a.m. Mandalay Bay B, Level 2

a BCOP Clinical Sessions: Lung Cancer Therapy and Molecular Targets (2.00 hours)Recertification credit for: BCOP


a BCOP Clinical Sessions: Multiple Myeloma and Pediatric CINV (2.00 hours)Recertification credit for: BCOP

TheACCP/ASHPBCOPClinicalSessionswillexplorecutting-edgeandcontemporarytherapeutictopics.The2016BCOPClinicalSessionsfocusonadvancesinlungcancerthera-pies,treatmentstrategiesofmultiplemyeloma,andman-agementofpediatricCINV.

These activities are approved for Board Certified Oncology Pharmacist (BCOP) recertification credit.

Foradditionalinformation,includingacompletelistoffac-ultyandlearningobjectives,visitwww.ashp.org/boardreview2016.

TUESDAY, DECEMBER 68:00 a.m.–10:00 a.m. Mandalay Bay H, Level 2

a Controversial High-Impact Publications in Hypertension: SPRINTing Toward the Goal (2.00 hours)Recertification credit for: BCACP,BCPS

Thisactivityisdesignedtoprovidelearnerswithnewevi-dencefromtheSPRINTtrialrelatedtobloodpressuregoals,contrastthisevidencewithotherdataandconsensusrecommendations,andenableparticipantstomakepatient-centereddecisionswhenselectingbloodpressuregoalsandtranslatethesedatatopatientcare.Speakerswilldebatetheadvantagesanddisadvantagesofusinglower-than-standardbloodpressuregoals.Learnerswillbechal-lengedwithcase-basedquestionshighlightingimportantaspectsofmanagingpatientswithhypertension,focusingonsituationswhereselectionofthemostappropriate,evi-dence-basedbloodpressuregoalischallenging.



a #EvidenceBased? Exploring Challenges with the Quality, Reporting, and Transparency of Evidence in Healthcare Research (2.00 hours)Recertification credit for: BCACP,BCPS

Thisinteractiveactivitywillexaminerecentcontroversiesrelatedtothequalityofevidenceinregardtoresearchdesign,includingtheuseofsurrogateoutcomes,stoppingtrialsearly,factorialdesigns,andadaptivedesigns.Addition-ally,issuesobservedwiththereportingofevidence—includingreportingbias,reportingdiscrepancies,retractions,anderratum—willbediscussed.Lastly,theactivitywillexplorechallengeswiththetransparencyofevidenceandregulatoryinitiativesaimedatimprovingpublicaccesstorawresearchdata.Learnerswillbepresentedwithaudi-enceresponsequestionsthathighlightthesechallengesandwillbeprovidedwithresourcestoassistinthecriticalappraisalofbiomedicalliterature.Facultywillemphasizeactionablechangespharmacistscanmakewhileparticipat-inginresearch,servingaspeerreviewers,andformulatingrecommendationsforevidence-basedmedicationuse.





Unless otherwise noted, the following applies to all workshops:

l On-siteregistrationmaybeavailable,spacepermitting.Ifon-siteregistrationisavailableforaparticularworkshop,proceedtoAttendeeOn-SiteRegistrationinBayside A, Level 1.

l Lunchisincludedforallfull-dayworkshopsunlessotherwisenoted.

l Workshopsarenotaudio-recorded.

SATURDAY, DECEMBER 38:00 a.m.–5:00 p.m.

a Residency Program Design and Conduct (RPDC)Onsite Workshop Fee: $510(spacepermitting)

NOTE:CEcreditswillnotbeofferedforthisworkshop.

Reviewaccreditationstandardsforthedesignandconductofaresidencyprogram,includingrequirementsrelatedtoprogrampurpose,competencyareas,goalsandobjectives,programstructure,learningexperiences,orientation,useofpreceptorroles,evaluation,residentdevelopmentplans,andcontinuousresidencyprogramimprovement.Participantsmaybringmaterialsfromtheirprogramforreviewduringtheworkshop.Takeadvantageoftheoppor-tunitytohaveyourquestionsansweredandtoshareideaswithyourfellowparticipants.

Room Locations:

l RPDC A: PGY1 New Programs Lagoon F, Level 2

l RPDC B: PGY1 Existing Programs Breakers B, Level 2

l RPDC C: PGY2 New and Lagoon L, Level 2Existing Programs

Faculty:RPDCA:PGY1NewProgramsMargaret Chrymko, Pharm.D., FASHP,ClinicalPharmacySpecialist,ErieVAMedicalCenter,Erie,Pa.Andrea Haron, Pharm.D.,AccreditationServicesAssociate,AccreditationServices,ASHP,Bethesda,Md.Andrea G. Roberson, Pharm.D.,DirectorofQualityandProcessImprovement,AccreditationServices,ASHP,Bethesda,Md.

RPDCB:PGY1ExistingProgramsBeth Bryles Phillips, Pharm.D., BCPS, FASHP, FCCP,RiteAidProfessor,UniversityofGeorgiaCollegeofPharmacy,Athens,Ga.;ClinicalPharmacySpecialist,CharlieNorwoodVAMedicalCenter,Augusta,Ga.Susan Francis, Pharm.D.,AccreditationServicesAssociate,AccreditationServices,ASHP,Bethesda,Md.Kimberly Mattox, Pharm.D.,ClinicalPharmacySpecialist,Geriatrics,JamesA.HaleyVeteransHospital,Tampa,Fla.

Christopher M. Scott, Pharm.D., BCPS, FASHP, FCCM,AssociateVicePresidentofPharmacyandRespiratoryCare,EskenaziHealth,Indianapolis,Ind.David J. Warner, Pharm.D.,Director,CenteronPracticeDevelopment,PracticeAdvancement,ASHP,Bethesda,Md.

RPDCC:PGY2NewandExistingProgramsWilliam A. Miller, Pharm.D., FASHP, FCCP,ConsultantPharmacist,Charleston,S.C.Steven Pass, Pharm.D., BCPS, FASHP, FCCM, FCCP,AssociateProfessorandViceChairofResidencyPrograms,TexasTechUniversityHealthSciencesCenterSchoolofPharmacy,Dallas,Texas

SUNDAY, DECEMBER 48:00 a.m.–5:00 p.m. Mandalay Bay B, Level 2

a Basic Statistics: A Nonthreatening Approach to the Use of Statistics in Clinical Trials 2016ACTIVITY #0204-0000-16-317-L04-P

7.50 CONTACT HOURS | APPLICATION-BASED

Onsite Workshop Fee: $510(spacepermitting)

Learnhowtoapplybasicstatisticalteststoresearchreportstypicallyseeninmedicalliterature.Thisworkshopexploresthemostcommonlyusedtestsincludingt-tests,analysisofvariance,testsforequivalence,Z-testofpropor-tions,oddsratiosandrelativeriskratios,chi-square,corre-lation,andlinearregression.Practicalexamplesandproblemsdrawnfromscientificresearchwillbeusedtoillustratestatisticalconceptsandmathematicalprocedures.Emphasisisontheappropriateuseofstatisticsandtheinterpretationoftheirresults.

Faculty:James E. DeMuth, Ph.D.,ProfessorEmeritus,UniversityofWisconsin-Madison,Madison,Wis.

8:00 a.m.–5:15 p.m. MGM Grand Conference Center, Room 319, 3rd Floor

a 340B University™PlannedandofferedbyApexus,thecontractorawardedmanagementofthe340BPrimeVendorProgramforHealthResourcesandServices

Administration’sOfficeofPharmacyAffairs.

ThereisnofeetoattendthisworkshopandMidyearmeet-ingregistrationisnotrequired.

PRE-MEETING WORKSHOPS

Seepage134forpresenterdisclosures.




Areyouinyourfirstfiveyearsofpharmacypractice?You’reprobablystillfindingyourway—andyourconcerns,needs,andinterestsaren’tthesameasthoseofyourmoreseasonedcolleagues.

ASHPdevelopedthisprogrammingtoaddresstheuniqueneedsofresidentsandnewpractitionersattheMidyearmeeting.Exploreworkplacechallenges,mentorship,andclinicalissuesinanencouragingandmotivationalatmosphere.

Bestofall,entryintothisprogrammingisincludedinyourfullMidyearmeetingregistrationfee.

Ensureyoursuccess.Spendyourweekendwithotherresidentsandnewpractitioners,andseeyourwaytoagreatfuture.

Career DevelopmentLearntipsandtricksthatyourcolleagueshaveusedsuccessfullytoadvancetheircareers.

Mastering Your Clinical PracticeYou’veearnedtherighttobeamemberofthehealthcareteam.Onaday-to-daybasis,youmustdemonstrateyouarecompetent,professional,intelligent,andcredible.Learnwaystoimproveyourclinicalskills,regardlessofyourareaofpractice.

RESIDENT AND NEW PRACTITIONER PROGRAMMING


SUNDAY, DECEMBER 4 CAREER DEVELOPMENT MASTERING YOUR CLINICAL PRACTICE

South Seas F, Level 3 South Seas D, Level 3 South Seas B, Level 3

9:00 a.m.–10:15 a.m. DoorDoNot:Understanding DialyzingofftheConfusion: GetinRhythmwiththe andDevelopingYourInternal DrugDosingAdjustments SafeandEffectiveUseof Leader inRenalReplacement AntiarrhythmicDrugs Therapies

10:30 a.m.–12:00 p.m. SteppingintoAcademia: OvercomingBarriersof StoptheBloodshed: FindingtheRightFit BiosimilarImplementation WhataPharmacistNeeds toKnowAboutEmergent ReversalofAnticoagulation

12:00 p.m.–1:00 p.m. L U N C H O N O W N

1:00 p.m.–2:15 p.m. SteppingItUp: TheOtherSideofthe AlcoholUseDisorder Implementationofa Curtain:TransitionsofCare Pharmacotherapy: PharmacistCareerLadder intheEmergency TraditionalApproachesand Program Department NewStrategies

2:30 p.m.–4:00 p.m. TheBestofTimes, Don’tRolltheDice: StrategiesforSuccessful TheWorstofTimes: PreventingFallsinOlder ParenteralNutritionOrder NavigatingthePeerReview Adults Writing Process

4:15 p.m.–5:15 p.m. Credentialingand APracticalApproachto FromAdmissionto Privileging:APrimerfor ObesityManagement: Discharge:Optimizing PharmacyResidentsand WeighingtheOptions theManagementof NewPractitioners HospitalizedPatients withNewOptionsfor Type2Diabetes


9:00 a.m.–10:15 a.m. South Seas F, Level 3

a Do or Do Not: Understanding and Developing Your Internal LeaderPlanned in cooperation with the ASHP New Practitioners Forum

ACTIVITY #0204-0000-16-322-L04-P


EDUCATIONAL LEVEL: GENERAL INTEREST

Program Chair/Moderator:Jillian Foster, Pharm.D., MBA,SystemPharmacyServiceLineAdminsitrator,BaptistMemorialHealthCareCorp,Memphis,Tenn.

Learning Objectives:l Listavailableleadershipself-assessmentinstruments.l Applytheleadershipprofiletemplatetoassessanindividu-al’sleadershipdevelopment.

l Constructtheframeworkforapersonalizedleadershipdevelopmentstrategy.

Presenters:Joseph K. Bonnarens, B.S.Pharm., Ph.D., M.S.,AssociateDeanforStudentAffairs,andTreasurerandNationalExecutiveCommitteeMember,PhiLambdaSigmaPharmacyLeadershipSociety,ManchesterUniversity,FortWayne,Ind.Jillian Foster, Pharm.D., MBA

9:00 a.m.–10:15 a.m. South Seas D, Level 3

a Dialyzing off the Confusion: Drug Dosing Adjustments in Renal Replacement TherapiesPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-327-L01-P


EDUCATIONAL LEVEL: ADVANCED

Program Chair/Moderator:Suprat S. Wilson, Pharm.D., BCPS,PharmacyCoordinator,EmergencyMedicineServices,DetroitReceivingHospital,Detroit,Mich.

Learning Objectives:l Discusskeyconceptsandrecentliteraturerelatedtocon-tinuousrenalreplacementtherapy(CRRT)andhybriddialy-sistherapies.

l EvaluaterecentliteratureondrugdosingconsiderationsforCRRTandhybriddialysistherapies.

l RecommendstrategiesfordrugdosingadjustmentsinCRRTandhybriddialysistherapysettings.

Presenters:Bruce A. Mueller, Pharm.D., FASN, FCCP, FNKF,ProfessorandAssociateDeanofAcademicAffairs,UniversityofMichiganCollegeofPharmacy,AnnArbor,Mich.Bridget Scoville, Pharm.D., BCPS,ClinicalPharmacist,SaintAlexiusMedicalCenter,HoffmanEstates,Ill.

9:00 a.m.–10:15 a.m. South Seas B, Level 3

a Get in Rhythm with the Safe and Effective Use of Antiarrhythmic DrugsACTIVITY #0204-0000-16-332-L01-P



Program Chair/Moderator:Karen J. McConnell, Pharm.D., BCPS-AQ Cardiology, FCCP,ClinicalDirector,CardinalHealth,CastleRock,Colo.;ClinicalAssociateProfessor,UniversityofColoradoSchoolofPharmacy,Aurora,Colo.

Learning Objectives:l Compareantiarrhythmictreatmentandmonitoringplansforatrialarrhythmias.

l Distinguishbetweentreatmentagentsandmonitoringstrategiesforventriculararrhythmiasuppression.

l Justifypatientfactorstoconsidertohelpensurethatanti-arrythmicdrugsaredosedsafelyandeffectively.

l Discussdruginteractionsthatmaycontributetopotentialadverseeffects.

Presenters:Shannon W. Finks, Pharm.D., BCPS-AQ Cardiology, FCCP,ProfessorofClinicalPharmacy,UniversityofTennesseeCollegeofPharmacy;ClinicalPharmacySpecialist,VeteransAffairsMedicalCenter,Memphis,Tenn.Karen J. McConnell, Pharm.D., BCPS-AQ Cardiology, FCCP

10:30 a.m.–12:00 p.m. South Seas F, Level 3

a Stepping into Academia: Finding the Right FitPlanned in cooperation with the American Association of Colleges of Pharmacy

ACTIVITY #0204-0000-16-323-L04-P

1.50 CONTACT HOURS | KNOWLEDGE-BASED


Program Chair/Moderator:Michelle L. Hilaire, Pharm.D., BCACP, BCPS, CDE, FCCP,ClinicalProfessor,UniversityofWyoming,Laramie,Wyo.;ClinicalPharmacist,FortCollinsFamilyMedicineResidency,FortCollins,Colo.

Learning Objectives:l Identifytrendsinpharmacyeducationthatareshapingtheworkforceofthepharmacyprofession.

l Explainthepotentialbenefits,opportunities,andchal-lengesassociatedwithacareerinacademia.

l Explaintherequirementsforpromotionandtenurethatarerelevantforclinicianeducators.

l Discussstrategiestoenhanceone’sprofessionalcareerinanacademicsetting.

Presenters:Joseph T. DiPiro, Pharm.D.,Dean,VirginiaCommonwealthUniversity,Richmond,Va.Joel C. Marrs, Pharm.D., ASH-CHC, BCPS-AQ Cardiology, BCACP, CLS, FASHP , FCCP, FNLA,AssociateProfessor,UniversityofColorado,Aurora,Colo.Alan Zillich, Pharm.D., FCCP,ProfessorandHead,PurdueUniversity,DepartmentofPharmacyPractice,WestLafayette,Ind.

continues >


Resident and New Practitioner Programming1:00 p.m.–2:15 p.m. South Seas F, Level 3

a Stepping It Up: Implementation of a Pharmacist Career Ladder ProgramPlanned in cooperation with the ASHP New Practitioners Forum

ACTIVITY #0204-0000-16-324-L04-P



Program Chair/Moderator:Eric M. Tichy, Pharm.D., BCPS, FAST, FCCP,Manager,ClinicalPharmacyServices,andDirector,PGY2ResidencySolidOrganTransplantation,Yale-NewHavenHospital,NewHaven,Conn.

Learning Objectives:l Listfivedomainsthatcouldbeincludedinapharmacistcareerladder.

l Compareandcontrastthebenefitsapharmacistcareerlad-derprogramcanprovidetoanorganization.

l Developanoutlineforacareerladderprogramthatcanbeimplementedatyourorganization.

Presenters:Mojdeh S. Heavner, Pharm.D., BCCCP, BCPS,Supervisor,ClinicalPharmacyServices,andDirector,CriticalCareResidencyProgram,Yale-NewHavenHospital,NewHaven,Conn.Eric M. Tichy, Pharm.D., BCPS, FCCP, FAST

1:00 p.m.–2:15 p.m. South Seas D, Level 3

a The Other Side of the Curtain: Transitions of Care in the Emergency DepartmentACTIVITY #0204-0000-16-329-L04-P


EDUCATIONAL LEVEL: INTERMEDIATE

Program Chair/Moderator:Laurimay Laroco, Pharm.D.,PharmacyClinicalCoordinator–AdultEmergencyDepartmentandClinicalEvaluationAreas,WakeMedHealth&Hospitals,Raleigh,N.C.

Learning Objectives:l OutlineaprocessfortheEDpharmacisttotakepartinthereviewofdischargeprescriptions.

l ChoosemethodsforEDpharmacistinvolvementinthefol-low-upofDVT/PEpatients.

l Evaluateopportunitiesforchronicdiseasemanagementatdischargeandcommunicationtooutsideproviders.

l Createpharmacist-interventionstrategiesfortransitionsofcarerelatedtoED-boardedpatients.

Presenters:Joseph Halfpap, Pharm.D., BCPS,EmergencyMedicinePharmacist,UWHealth,Madison,Wis.Christi Jen, Pharm.D., BCPS,ClinicalPharmacist–EmergencyMedicine,BannerBoswellMedicalCenter,SunCity,Ariz.

Panelist:Jennifer L. Adams, Pharm.D., Ed.D.,SeniorAdvisor,StudentAffairs,AmericanAssociationofCollegesofPharmacy,Alexandria,Va.

10:30 a.m.–12:00 p.m. South Seas B, Level 3

a Stop the Bloodshed: What a Pharmacist Needs to Know About Emergent Reversal of AnticoagulationPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-328-L01-P



Program Chair/Moderator:Zlatan Coralic, Pharm.D., BCPS,EmergencyMedicineClinicalPharmacist,UniversityofCaliforniaSanFrancisco,SanFrancisco,Calif.

Learning Objectives:l Discusstheliteraturerelatedtothepharmacologicreversalofwarfarinduringlife-threateningbleeding.

l DiscusstheliteraturerelatedtothepharmacologicreversalofXainhibitorsduringlife-threateningbleeding.

l Discusstheliteraturerelatedtothepharmacologicreversalofdirectthrombininhibitorsduringlife-threateningbleeding.

Presenters:Nicole M. Acquisto, Pharm.D., BCPS,EmergencyMedicineClinicalPharmacySpecialist,UniversityofRochesterMedicalCenter;AssistantProfessor,DepartmentofEmergencyMedicine,UniversityofRochester,Rochester,N.Y.Zlatan Coralic, Pharm.D., BCPSBryan D. Hayes, Pharm.D., DABAT, FAACT,ClinicalPharmacist,EmergencyMedicineandToxicology,MassachusettsGeneralHospital;AssistantProfessorofEmergencyMedicine,HarvardMedicalSchool,Boston,Mass.

10:30 a.m.–12:00 p.m. South Seas D, Level 3

a Overcoming Barriers of Biosimilar ImplementationACTIVITY #0204-0000-16-333-L04-P



Program Chair/Moderator:Edward Li, Pharm.D., M.P.H., BCOP,AssociateProfessor,UniversityofNewEnglandCollegeofPharmacy,Portland,Maine

Learning Objectives:l Identifypoliciesthatmayhinderbiosimilarimplementation.

l Composeanswerstoquestionsaskedfrequentlybypre-scribersregardingbiosimilaruse.

l Recommendstrategiestoassistinovercomingbiosimilarimplementationbarriers.

Presenters:Edward Li, Pharm.D., M.P.H., BCOPJames G. Stevenson, Pharm.D., FASHP,President,Visante,Inc.,St.Paul,Minn.



Program Chair/Moderator:Mollie A. Scott, Pharm.D., BCACP, CPP,RegionalAssociateDean,UNCEshelmanSchoolofPharmacy,Asheville,N.C.;ClinicalAssociateProfessor,UNCSchoolofMedicine,ChapelHill,N.C.

Learning Objectives:l Chooseatherapeuticplantodecreasetheriskoffallsusingrecommendationsfromthe2015AmericanGeriatricsSocietyBeersCriteria.

l EvaluateclinicaltrialsthatexaminetherelationshipbetweenvitaminDandfallsinhigh-riskgeriatricpatients.

l Comparescreeningtoolsthatidentifyseniorswhoareatriskforfalls.

l Describeworkflowstrategiesforincorporatingfalls-reduc-tionstrategiesintotheAnnualWellnessVisitforMedicarerecipients.

Presenters:Melanie A. Dodd, Pharm.D., Ph.C., BCPS,DepartmentVice-Chair,AssociateProfessor,DepartmentofPharmacyPracticeandAdministrativeSciences,CollegeofPharmacy,TheUniversityofNewMexico,Albuquerque,N.M.Michelle A. Fritsch, Pharm.D., BCACP, CGP,FounderandPresident,MedsMASH,LLC,Monkton,Md.Mollie A. Scott, Pharm.D., BCACP, CPP

2:30 p.m.–4:00 p.m. South Seas B, Level 3

a Strategies for Successful Parenteral Nutrition Order WritingACTIVITY #0204-0000-16-335-L01-P



Program Chair/Moderator:Karrie Derenski, Pharm.D., BCNSP, CNSC,ClinicalCoordinator,CriticalCare,MetabolicSupport&EmergencyMedicine,DepartmentofPharmacy,CoxHealth,Springfield,Mo.

Learning Objectives:l Calculateanindividualizedparenteralnutritionformulaforapatientincorporatingage,disease,anduniquenutritionrequirementsintodesign.

l Assessskillsformonitoringparenteralnutritionformulafrominitiationtoachievementofcompositiongoal.

l Justifystrategiesformanagingelectrolyteabnormalities.l Describesafeparenteralnutritioncompoundingpracticesandparenteralnutritionformuladesign.

Presenters:Mary Petrea Cober, Pharm.D., BCNSP,ClinicalCoordinator–NeonatalIntensiveCareUnit,AkronChildren’sHospital,Akron,Ohio;AssociateProfessor–PharmacyPractice,SectionLead–SpecialtyCare,NortheastOhioMedicalUniversity,CollegeofPharmacy,Rootstown,OhioKarrie Derenski, Pharm.D., BCNSP, CNSCAnne Tucker, Pharm.D., BCNSP,ClinicalPharmacySpecialist,MDAndersonCancerCenter,Houston,Texas


a Alcohol Use Disorder Pharmacotherapy: Traditional Approaches and New StrategiesACTIVITY #0204-0000-16-334-L01-P



Program Chair/Moderator:Megan Sarashinsky, Pharm.D., BCPP,PsychiatryClinicalSpecialist,CJWMedicalCenter–ChippenhamHospital,Richmond,Va.

Learning Objectives:l Comparethediagnosticcriteria,biomarkers,andscreeningtoolsusedfordetectingalcoholusedisorder.

l Appraisetheefficacyofmedicationsusedtotreatalcoholusedisorder.

l Constructapharmacotherapyplanforapatientwithalco-holusedisorder.

l Designamedication-specificmonitoringplanforpatientswithalcoholusedisorder.

Presenter:Sarah J. Popish, Pharm.D., BCPP,ProgramManager,AcademicDetailingProgramOffice,DepartmentofVeteransAffairs,Sarasota,Fla.

2:30 p.m.–4:00 p.m. South Seas F, Level 3

a The Best of Times, the Worst of Times: Navigating the Peer Review ProcessACTIVITY #0204-0000-16-325-L04-P



Program Chair/Moderator:William L. Baker, Pharm.D., FACC, FCCP,AssistantProfessor,UniversityofConnecticutSchoolofPharmacy,Storrs,Conn.

Learning Objectives:l Describetheroleofthepeerreviewerfromtheperspectiveofajournal.

l Evaluatetheelementsofahigh-qualitypeerreviewprocess.l Applytheprocessofrespondingtopeer-reviewandeditorialcomments.

Presenters:William L. Baker, Pharm.D., FACC, FCCPDaniel J. Cobaugh, Pharm.D., DABAT, FAACT, AssistantVicePresidentandEditorinChief,AJHP,Bethesda,Md.Robert J. DiDomenico, Pharm.D., BCPS-AQ Cardiology, FCCP,ClinicalProfessor,UniversityofIllinoisatChicago;CardiovascularClinicalPharmacist,UniversityofIllinoisHospital,Chicago,Ill.


a Don’t Roll the Dice: Preventing Falls in Older AdultsPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-330-L01-P




Resident and New Practitioner ProgrammingLearning Objectives:

l Assesstheroleofnewantihyperglycemicagentsinhospi-talizedpatientsandtheirimplicationsonformularymanagement.

l Explainchallengesinmanagingbloodglucosefluctuationsininpatientswithdiabetes.

l Formulateasystematicapproachtofacilitatingtransitionsfrominpatienttooutpatientcare.

Presenters:Amy C. Donihi, Pharm.D., BCPS,AssociateProfessor,UniversityofPittsburghSchoolofPharmacy,Pittsburgh,Pa.Jacqueline L. Olin, Pharm.D., M.S., BCPS, CDE, FASHP, FCCP,ProfessorofPharmacy,WingateUniversitySchoolofPharmacy,Wingate,N.C.;ClinicalPharmacySpecialist,NovantHealth,Charlotte,N.C.


a A Practical Approach to Obesity Management: Weighing the OptionsACTIVITY #0204-0000-16-336-L01-P




Learning Objectives:l DescribetheprevalenceofoverweightandobesepatientsintheU.S.

l Discussrecommendationsincludedintherecentobesitymanagementguidelines.

l Evaluatetheefficacy,safety,andclinicalutilityofcurrentlyavailablepharmacologictherapiesintendedtoaidweightlossandmaintenance.

l Developastrategyformedicationmanagementinapatientwhohasundergonebariatricsurgery.

Presenters:Sarah L. Anderson, Pharm.D., BCPS,AssistantProfessor,UniversityofColoradoSkaggsSchoolofPharmacy&PharmaceuticalSciences,Aurora,Colo.;ClinicalPharmacySpecialist,DenverHealthMedicalCenter,Denver,Colo.Jaime R. Hornecker, Pharm.D., BCPS, CDE,ClinicalAssociateProfessor,UniversityofWyomingSchoolofPharmacy,Laramie,Wyo.


a Credentialing and Privileging: A Primer for Pharmacy Residents and New PractitionersPlanned in cooperation with the ASHP New Practitioners Forum

ACTIVITY #0204-0000-16-326-L04-P



Program Chair:Tracy Carter, Pharm.D., BCPS,DecentralizedPharmacist–CriticalCareandInternalMedicine,DCHRegionalMedicalCenter,Tuscaloosa,Ala.Moderator:Jamie Sebaaly, Pharm.D., BCPS,AssistantProfessorofPharmacy,WingateUniversitySchoolofPharmacy,Wingate,N.C.

Learning Objectives:l Explainthebenefitsofcredentialingandprivilegingofpharmacists.

l Compareavailablecertificationsandcredentials.l Evaluateprivilegingprogramsatselectorganizations.l Assessopportunitiesforinitiatingaprivilegingprogramatyourorganization.

Presenters:Brian Cross, Pharm.D., BCACP, CDE,AssociateProfessorandVice-ChairDepartmentofPharmacyPractice,BillGattonCollegeofPharmacy;InterimDirectorforInterprofessionalEducation&Research,EastTennesseeStateUniversityAcademicHealthSciencesCenter,JohnsonCity,Tenn.Joel Hennenfent, Pharm.D., MBA, BCPS, FASHP,SystemDirectorofPharmacyServices,TrumanMedicalCenters,KansasCity,Mo.


a From Admission to Discharge: Optimizing the Management of Hospitalized Patients with New Options for Type 2 DiabetesPlanned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-331-L01-P



Program Chair/Moderator:Linda M. Spooner, Pharm.D., BCPS-AQ ID, FASHP,ProfessorofPharmacyPractice,MassachusettsCollegeofPharmacyandHealthSciences(MCPHS)UniversitySchoolofPharmacy-Worcester/Manchester,Worcester,Mass.





ASHP PHARMACY STUDENT FORUM PROGRAMMING

SATURDAY, DECEMBER 37:00 a.m.–6:00 p.m. Banyan B, Level 3

a Clinical Skills Competition Semi-Final Round(closed session)

Sponsored by the ASHP Research and Education Foundation and Supported by Wolters Kluwer HealthIt’sthebattleofthebestandbrightest.Winningteamsfromthepreliminaryround(school-level)competitionsateachcol-legeofpharmacywillcompeteinthesemi-finalroundatthenationallevel,showcasingtheirclinicalskillsandknowledge.

SUNDAY, DECEMBER 47:00 a.m.–8:30 a.m.

a Pharmacy Student Forum Advisory Group Meetings(closedsessionbyinvitationonly)

8:30 a.m.–10:00 a.m. Lagoon L, Level 2

a SSHP Leaders WorkshopCurrentofficersoremergingleadersinStudentSocietiesofHealth-SystemPharmacy(SSHP)willjoinotherstudentleadersfromacrossthenationtonetwork,share,andreap-plybestpracticesfromfundraisingtoprogramming.

Presenters:Lauren Stanz, Pharm.D.Candidate2018, UniversityofTexasCollegeofPharmacy,andViceChair,PharmacyStudentForumExecutiveCommittee,SanAntonio,TexasKelsey Stephens, Pharm.D.Candidate2017, UniversityofMississippiSchoolofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,Jackson,Miss.

9:00 a.m.–10:00 a.m. Mandalay Bay D, Level 2

a Strategies for Personal and Professional SuccessBeinspiredandmotivatedtotakeactioninachievingyourpersonalandprofessionalcareergoals.Panelistsofphar-macyleaderswillprovideexamplesofhowtosuccessfullylearnandincorporateskillsincludingwork-lifeintegration,emotionalintelligence,self-assessment,andmentor-coach-sponsorrelationships.

Speakers: Rick Couldry, M.S., B.S.Pharm., FASHP,ExecutiveDirectorofPharmacyServices,UniversityofKansasHospital,KansasCity,Kan.Lynette Moser, Pharm.D., ClinicalAssociateProfessor,AssociateChairandDirectorofProfessionalandAcademicDevelopment,WayneStateUniversity,Detroit,Mich.Rita Shane, Pharm.D., FASHP, FCSHP, ChiefPharmacyOfficer,CedarsSinaiMedicalCenter,andAssistantDean,Clinical

Pharmacy,UniversityofCaliforniaSanFrancisco,LosAngeles,Calif.Elva A. Van Devender, Pharm.D., Ph.D., BCPS, ProgramManager,ClinicalPharmacyEducation,ProvidenceHeath&Services,OregonRegion,Portland,Ore.

Moderators:Elizabeth Dow, Pharm.D., Hematology/OncologyClinicalPharmacist,UniversityofWisconsinHospitalandClinics,Madison,Wis.Ashley Duty, Pharm.D., M.S., PharmacyManager,Children’sMercyHospital,OverlandPark,Kan.


a Pharmacy Student Forum Opening SessionJoinyourfellowASHPPharmacyStudentForummemberstokickofftheMidyearmeeting.Thissessionwillstartwithalotofexcitementasthetop10finalistteamsfromthenationalClinicalSkillsCompetitionareannounced.

Moderator:Jenna Fancher, Pharm.D. Candidate 2017, JeffersonCollegeofPharmacy,andChair,PharmacyStudentForumExecutiveCommittee,Philadelphia,Pa.

OneMoreThing,OneMoreTimeAsachild,Joshlosthisleftlegandbeganalifelongprocessofadaptingtochangeandlearningtoexcelwithinhiscircumstances.Inhisspeech,hesharesstoriesabouttrainingfortheParalympicsandplayingjokeswithhisartificiallegtogiveaudiencememberspracticalmotivationandstrategiesforadaptingtoanewworkplaceenvironment.Asapersonwithadisability,hispresentationhelpsprofessionalsunderstandandcommunicateeffectivelywithcoworkersofdifferentability,background,orage.

AttendeeswillleavethepresentationwithideasabouthowtouseJosh’sParalympictrainingmotto1mt1mt(onemorething,onemoretime)tohelpthemreachtheirprofes-sionalgoalsbyputtingtheirbestattributestoworkintheircareers.Pharmacystudentswillbeinspiredtodoonemorething,onemoretimetofindastrongmatchfortheirfirstjobandtoenterthehealth-systemsectorwiththemindsetthatwillbringthemlong-termsuccess.

11:30 a.m.–12:30 p.m. Mandalay Bay H, Level 2

a Mysteries of the MatchAreyouinterestedinaresidencybutafraidoftheMatch?Don’tbe!Comelearnhowthepharmacyresidencymatchingserviceworks,learnstrategiestosuccessfullynavigatethroughtheMatch,andgettipsonwhattodoifyoudon’tmatch.

Speaker: Mary Hess, Pharm.D., FASHP, FCCM, FCCP, AssociateDean,StudentAffairs,JeffersonCollegeofPharmacy,ThomasJeffersonUniversity,Philadelphia,Pa.


ASHP Pharmacy Student Forum Programming NOTE: Thisworkshopbuildsonthewebinarpresentation“InterviewPreparation:AnOverview”(availableatwww.ashp.org/students).Youwilllearnaboutinterviewformatsandhowtodevelopyourpersonalinterviewstrategy.Itisstronglyrecommended,butnotmandatory,thatyouviewthewebinarpriortoattendingtheworkshop.

Moderator:Mary Hess, Pharm.D., FASHP, FCCM, FCCP,AssociateDean,StudentAffairs,JeffersonCollegeofPharmacy,Philadelphia,Pa.

5:00 p.m.–6:30 p.m. Oceanside A, Level 2

a Awards Ceremony and Student Society ShowcaseJoinusaswerecognizeandcelebratetheaccomplishmentsofourASHPstudentleaders.StudentSocietiesofHealth-SystemPharmacy(SSHPs)willspotlighttheirachievementsintheannualStudentSocietyShowcase.TakethisopportunitytolearnaboutbestpracticesfromSSHPsacrossthenation,andfindouthowyoucanreapplytheirsuccessfuleventsonyourcampus.StickaroundtocheerontherecipientsoftheASHPStudentLeadershipAwardandASHPFoundationStudentResearchAward—anddon’tmisstheannounce-mentoftheNationalClinicalSkillsCompetitionwinners.

Presenters:Adam Smith, Pharm.D.Candidate2017, PurdueUniversityCollegeofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,Brownsburg,Ind.Kelsey Stephens, Pharm.D.Candidate2017, UniversityofMississippiSchoolofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,Jackson,Miss.

MONDAY, DECEMBER 57:00 a.m.–9:00 a.m. Banyan B, Level 3

a SSHP Faculty Advisor Breakfast Workshop(closedsessionbyinvitationonly)Speaker: Diana L. Dabdub,Director,ASHPPharmacyStudentForum,Bethesda,Md.

7:30 a.m.–5:00 p.m. Shoreline Exhibit Hall, Level 2

a Personnel Placement Service (PPS)Formoreinformation,seepage6.

9:00 a.m.–10:30 a.m. Mandalay Bay Events Center

a Opening Session & KeynoteFormoreinformation,seepage31.

10:45 a.m.–11:45 a.m. Bayside B, Level 1

a Student Poster SessionImpressyourprofessors,potentialemployers,andpeersbypresentingaposterattheprestigiousASHPMidyearClinicalMeeting.

11:00 a.m.–3:00 p.m. Bayside CD, Level 1

a Exhibit Hall

11:30 a.m.–1:00 p.m. Mandalay Bay D, Level 2

a Student Advocacy WorkshopThissessionwillprovideanoverviewofthecomponentsofpoliticaladvocacyaswellasbackgroundonkeyissuesaffectingpharmacystudents.Duringtheinteractivesession,participantswillworkinteamstodeveloplobbyingtalkingpointsandpreparetestimonyforamockhearing.

Speakers:John Hertig, Pharm.D., M.S., CPPS, AssociateDirector,PurdueCenterforMedicationSafetyAdvancement,Indianapolis,Ind.Mindy (Throm) Burnworth, Pharm.D., BCPS, FASHP, FAzPA,Professor,DepartmentofPharmacy,MidwesternUniversityCollegeofPharmacy–Glendale,Glendale,Ariz.

1:00 p.m.–3:50 p.m. Banyan B, Level 3

a Clinical Skills Competition Final Round PresentationsSponsored by the ASHP Research and Education Foundation and Supported by Wolters Kluwer Health

It’sthebattleofthebestandbrightest.OnSaturday,winningteamsfromthepreliminaryround(school-level)competitionsateachcollegeofpharmacycompetedinthesemi-finalroundatthenationallevel,showcasingtheirclinicalskillsandknowledge.IfyouthinkyouhavewhatittakestobeachampioninyourpharmacyschoolorevenattheNationalClinicalSkillsCompetitionnextyear,checkoutthefinalroundpresentationsfromthetop10finalistteams.YouareinvitedtostopinasanobservertogetanideaofwhatittakestobeanationalfinalistintheNationalClinicalSkillsCompetitionandenjoytherangeofpresentationsatthisinspiringandimpressivesession.Stickaroundfollowingthepresenta-tionsforthecasereviewwiththenationalcasewriter.


a PhORCAS: The Centralized Application System for Pharmacy ResidenciesPhORCASisthePharmacyOnlineCentralizedApplicationService.Learnabouttheprocessandhowitwillsaveyoutimewhensubmittingyourresidencyapplication.You’llalsohavetheopportunitytoaskquestionsabouttheservice.

Speakers:Brendan J. Reichert, R.Ph., M.S.,PhORCASAdvisoryCommittee,InformaticsConsultantandProjectManagerforJohnsHopkins,Powell,OhioDeborah Erdner, M.S.,VicePresident,AccountManagement,LiaisonInternational,LLC,Watertown,Mass.


a Make a Lasting Impression: Evaluating Your Interview SkillsInterviewsarealwaysonthehorizon.Asyoupursueaninternship,residency,orothercareeroptions,bereadytomakealastingimpression.Thisworkshopincludesrole-playandliveexamplesofcommoninterviewformatsaswellasquestionsyoumayencounter.


Presentations: Group 212:20 p.m.–1:00 p.m.

EmergencyMedicine: Diana Park, Pharm.D., EmergencyMedicineClinicalPharmacist,HuntingtonHospital,Pasadena,Calif.EmergingSciences-Pharmacogenomics: Cyrine Haidar, Pharm.D., BCOP, BCPS, ClinicalPharmacogeneticsCoordinator,St.JudeChildren’sResearchHospital,Memphis,Tenn.Informatics:Thomas Moniz, Pharm.D.,InformaticsPharmacist,BostonChildren’sHospital,Boston,Mass.MedicationSafety: Jaclyn A. Jeffries, Pharm.D., C.Ph.,ClinicalPharmacist,FloridaHospital,Melbourne,Fla.PediatricSpecialist: Kyle Mays, Pharm.D., ClinicalPharmacist,PICU,andResidencyProgramDirector,SSMHealthCardinalGlennonChildren’sHospital,SaintLouis,Mo.Surgery: Calvin Ice, Pharm.D., BCOP, BCPS, ClinicalPharmacySpecialist,Surgery&Anesthesia,SpectrumHealth,GrandRapids,Mich.



1:30 p.m.–3:00 p.m. Oceanside B, Level 2

a Fundamental Strategies to Secure a Residency: Getting a Head Start as a P1-P3Inthetoughcompetitionforpostgraduatepositions,howcanyoustandout?Afterthispresentation,youwillhavefundamentaltips,atimeline,andanswerstosomeofthequestionsyoumayhave,includingthefollowing:WhendoIstartplanningmyresidencysearchstrategy?HowcanIsetupaplanandtasklisttokeepmyselfontargetforsuccessasaP1student?HowcanIexcelintheinterviewprocess?

11:30 a.m.–1:00 p.m. Oceanside B, Level 2

a Career Pearls for StudentsUndecidedaboutyourcareerpath?Fromclinicaltoman-agement,informaticstoambulatorycare—theoptionsseemendless!Hearfrom12pharmacistswhoworkinvari-ouspharmacypracticesettingstolearnmoreaboutwhatadayinthelifeislike.Takeawayinformationaboutcareersyouhaveinterestinbutnevertookthetimetolearnabout—youmayevenfindsomethingyouneverknewexisted.

Moderator: Kristy Nguyen, Pharm.D.Candidate2017, WesternNewEnglandUniversityCollegeofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,NewHaven,Conn.

Presentations: Group 111:35 a.m.–12:15 p.m.

Academia: Alexander Kantorovich , Pharm.D., BCPS, ClinicalAssistantProfessor,ChicagoStateUniversityCollegeofPharmacy,Chicago,Ill.CriticalCareSpecialist:Molly J. Trent, Pharm.D., PGY2CriticalCarePharmacyResident,GradyHealthSystem,Atlanta,Ga.Government:Teresa Rubio, Pharm.D., HealthProgramsCoordinator&SafetyEvaluator,FDA,WhiteOak,Md.InfectiousDiseaseSpecialist: Curtis Collins, Pharm.D., M.S., BCPS-AQ ID, FASHP, ClinicalSpecialist,InfectiousDiseases,St.JosephMercyHealthSystem,AnnArbor,Mich.ManagementandAdministration:Steven J. Davis, Pharm.D., M.S.,PharmacyManager,TexasChildren’sHospital,Houston,TexasSmall/RuralHospitalPractice: Jason T. Strow, Pharm.D., CGP, Mid-AtlanticPharmacyDirector,HealthSouth,Barboursville,W.V.

a Residency ShowcaseBayside B, Level 1Monday, December 5: 1:00p.m.–4:00p.m.

Tuesday, December 6: 8:00a.m.–11:00a.m. 1:00p.m.–4:00p.m.

TheResidencyShowcaseisforindividualspursuingresidencypositionsin2017-18.Maketheroundsallinoneplace—andsavetimeandmoney.TheResidencyShowcaseisdesignedforyourconvenience,allowingyoutomeetwithrepresen-tativesfromhundredsofprogramsacrossthecountry.TheshowcaseiscontinuedonTuesday,buteachprogramwillbeavailableonlyduringoneofthethreetimeslots,soplanahead.Businessattireisrecommended.

For those students interested in visiting the Residency Showcase but who will not be pursuing a residency in 2017, please wait until the second half to enter the showcase. Be courteous — do not engage programs in a discussion at this point, as this prevents them from talking to those pursuing residency positions next year. We recommend attending the student educational sessions on Monday and Tuesday, which are designed exclusively for P1-P3 students.

l Fundamental Strategies to Secure a Residency: Getting a Head Start as P1-P3l Effective CV and Resume Writing

continues >


ASHP Pharmacy Student Forum Programing 1:00 p.m.–3:00 p.m. Oceanside B, Level 2

a Effective CV and Resume WritingGettingreadytoenterthepharmacyworkforce?Beforeyouknowit,potentialemployerswillstartrequestingyourCVorresume.Getreal-worldadviceonhowtomarketyourskillseffectively,andlearnimportanttipsaboutpreparingyourCVandresume—andhowtoavoidcommonmistakes.

Speaker: Joseph K. Bonnarens, B.S.Pharm., Ph.D., M.S.,AssociateDeanforStudentAffairs,ManchesterUniversityCollegeofPharmacy,FortWayne,Ind.

Moderator: Lauren Stanz, Pharm.D.Candidate2018, UniversityofTexasCollegeofPharmacy,andViceChair,PharmacyStudentForumExecutiveCommittee,SanAntonio,Texas


a Residency ShowcaseFormoreinformation,seepage51.


a Practice Advancement: Maximize Your Role in Patient CareLearnaboutthePracticeAdvancementInitiative(PAI)andhowyou,asastudent,cangetinvolved.ThispresentationwilldescribePAIimplementationactivities,resources,andmeasurescoordinatedbyASHPandtheASHPFoundation.Waysinwhichthepharmacyprofessionmustchangetoadvancepharmacy’spatientcarerolewillalsobepresented.Thissessionwilldiscusshowtoadvancepharmacypracticethroughintegratingstudentsinpracticesites,currentpractices-in-action,andareasforstudentstogetinvolved.

Speakers:Thomas S. Achey, Pharm.D., BCPS,Health-SystemPharmacyAdministrationResident,ClevelandClinic,Cleveland,OhioEric Maroyka, Pharm.D., BCPS, Director,CenteronPharmacyPracticeAdvancement,ASHP,Bethesda,Md.

Moderator: Adam Smith, Pharm.D.Candidate2017, PurdueUniversityCollegeofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,Brownsburg,Ind.


a Clinical Pearls for StudentsBasedonthepopularClinicalPearlssessionforpracticingpharmacists,thissessioniscustom-tailoredforastudentaudience.Comehearthevaluablelessonslearnedasnewpractitionersshareclinicalpearlsthatcanhelpyouprepareforresidencytrainingorenteringpractice.

Presenters:The ABCs of Peds: What You Need to Know to Care for Pediatric PatientsJordan Burdine, Pharm.D., MBA, PGY2PediatricResident,TexasTechUniversityHealthSciencesCenter,Amarillo,Texas

Youwillreceivecandidadviceandguidancethatwillbedirectlyapplicabletoyourhuntforapostgraduateresidencyorfellowship.YouwillbeabletofollowanoutlineofwhatyouwillneedtodoasastudentduringtheP1toP3yearstosuccessfullyprepareyourselffortheresidencyorfellow-shipapplicationprocess.

Speaker:Joshua Caballero, Pharm.D., BCPP,AssociateProfessor,NovaSoutheasternUniversityCollegeofPharmacy,FortLauderdale-Davie,Fla.

Moderator: Lauren Stanz, Pharm.D. Candidate 2018, UniversityofTexasCollegeofPharmacy,andViceChair,PharmacyStudentForumExecutiveCommittee,SanAntonio,Texas


a Dollars and Good SenseThedaysoflivingoffstudentloansandfastfoodarecomingtoanend.Youareenteringtherealworldofworkingpro-fessionals—andtherealworldofmortgages,debt,bills,andinvestmentopportunities.Thispopularsessionwillhelpyoumanageyourfinancesandlearnstrategiestohelpyouhandleyourcurrentresponsibilitieswhileplanningforthefuture.

Speakers:Eric Truvillion,FinancialAdvisor,PrincipalFinancialGroup,Tampa,Fla.Alonzo Barnes, Jr.,FinancialAdvisor,PrincipalFinancialGroup,Tampa,Fla.

Moderator: Kelsey Stephens, Pharm.D.Candidate2017,UniversityofMississippiSchoolofPharmacy,andMember,PharmacyStudentForumExecutiveCommittee,Jackson,Miss.

TUESDAY, DECEMBER 67:30 a.m.–5:00 p.m. Shoreline Exhibit Hall, Level 2





a Exhibit Hall

11:30 a.m.–12:30 p.m. Bayside B, Level 1



WEDNESDAY, DECEMBER 77:30 a.m.–5:00 p.m. Shoreline Exhibit Hall, Level 2





a Exhibit Hall


a Wednesday Evening EventFormoreinformation,seepage31.

Update Your Status: Treatment of Status Epilepticus, a Neurological EmergencyTracy Carter, Pharm.D., BCPS, DecentralizedPharmacist–CriticalCareandInternalMedicine,Tuscaloosa,Ala.

Tyrosine Kinase: Identifying and Managing Tyrosine Kinase Inhibitor-Induced ToxicitiesJordan A. Miller, Pharm.D., CPP, PGY2Hematology/OncologyPharmacyResident,ChapelHill,N.C.

Using ATLAS to Map Clostridium Difficile Infection Management and OutcomesBrandon Hill, Pharm.D.,PGY1PharmacyPracticeResident,PalmettoHealthRichland,Columbia,S.C.

Pre-Exposure Prophylaxis in HIVThomas S. Achey, Pharm.D., BCPS, Health-SystemPharmacyAdministrationResident,ClevelandClinic,Cleveland,Ohio

8:00 p.m.–12:00 a.m. LAX at Luxor Hotel Las Vegas

a Students’ Night OutPartywithapurpose!Afteralongweekofeducationprogramming,interviews,posterpresentations,andmore,it’stimetokickbackand

relax.Joinpharmacystudentsfromacrossthecountryforafunnightoutinthelavish,leather-adornedLasVegasnightclub.

NOTE:Meetingbadgeandticketarerequiredforentrance.Allguestsmustbe21+yearsoldandpresentagovernmentissuedphotoID.

June 4–8, 2017 I Minneapolis, Minnesotawww.ashp.org/summermeetings

Four Targeted Meetings, One Unifying EventMake meaningful connections that will impact your practice.

SM17_STD_HPH.indd 1 11/2/16 2:54 PM





a A Toolkit for Achieving Quality Antimicrobial Stewardship in Small and Rural HospitalsPlanned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-338-L04-P



Learning Objectives:l Discusscurrentrecommendationsforantimicrobialstew-ardshipprogramswithintheinpatientsetting.

l Illustratechallengesindevelopingandmaintainingantimi-crobialstewardshipprogramsinsmallandruralhospitals.

l Developasystematicapproachtocreatingandmaintainingantimicrobialstewardshipprogramsinsmallandruralhospitals.

Presenter:Linda M. Spooner, Pharm.D., BCPS-AQ ID, FASHP,ProfessorofPharmacyPractice,MassachusettsCollegeofPharmacyandHealthSciences(MCPHS)UniversitySchoolofPharmacy-Worcester/Manchester,Worcester,Mass.


a Expanding Pharmacy’s Footprint: EMR and TelepharmacyPlanned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-339-L04-P/0204-0000-16-339-L04-T



Program Chair/Moderator:Jillian Foster, Pharm.D., MBA,SystemPharmacyServiceLineAdminsitrator,BaptistMemorialHealthCareCorp,Memphis,Tenn.

Learning Objectives:l Discusstelepharmacyusesinpharmacypractice.l Describehowtousetheelectronicmedicalrecord(EMR)toexpandthefootprintofpharmacy.

l Describevideotechnologysystemsthatallowapharmacisttoprovidemeaningfulmedicationmanagementtoaremotelocation.

Presenters:Jillian Foster, Pharm.D., MBAAlexander Quesenberry, Pharm.D., BCOP, BCPS,PharmacyManagerandPGY2ResidencyProgramDirector,BaptistCancerCenter,Memphis,Tenn.


a The Joint Commission Update 2016: Focus on Small and Rural HospitalsPlanned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-340-L03-P/0204-0000-16-340-L03-T



Program Chair/Moderator:Debra L. Cowan, Pharm.D., B.S.Pharm., FASHP,PharmacyDirector,AngelMedicalCenter,Franklin,N.C.

Learning Objectives:l Describethemostproblematicmedicationstandardsforsmallandruralhospitals.

l Liststrategiestoensurecompliancewiththetopscoredstandards.

l Identifychangestothemedicationstandardsthatareexpectedin2017.

Presenter:Jeannell Mansur, Pharm.D., FASHP,PracticeLeader,MedicationManagementandSafety,JointCommissionResources,OakBrook,Ill.

PROGRAMMING FOR SMALL & RURAL HOSPITAL PRACTITIONERS

SUNDAY, DECEMBER 412:00 p.m.–1:15 p.m. Oceanside B, Level 2

a 2016 Small and Rural Hospital Track Keynote: The Changing Landscape of Rural HospitalsPlanned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-337-L04-P/0204-0000-16-337-L04-T



Learning Objectives:l Describefactorsdrivinghealthcareservicesprovidedinsmallandruralhospitals.

l Discussissuesandtrendsinsmallandruralhospitalsimpact-ingpharmacyservicesprovidedtopatientsinthissetting.

Presenter:Brock Slabach, M.P.H., FACHE, SeniorVicePresident,MemberServices,NationalRuralHealthAssociation,Leawood,Kan.





SUNDAY, DECEMBER 412:00 p.m.–1:00 p.m. South Seas J, Level 3

a ORCAS: How Programs Can Optimize the WebAdMIT Portal Within PhORCASPhORCAShascompletelyrevampedtheoldselectionportalthroughtheimplementationoftheenhancedWebAdMITsoftware.WebAdMITturbochargesthepreviousselectionportalcapabilitiesforprogramsandaddsawealthofnewfeaturessuchasfacilitationofinterviewscheduling,inte-grationofscoringmodels,customaccessrightsonaper-userbasis,asinglesign-onforuserswithmultipleprogramswithinanorganization,andmuchmore.ComelearnhowWebAdMITcanhelpyourprogramimprovetheefficiencyoftheresidencyselectionprocessforthecurrentapplicationseason.

1:00 p.m.–2:00 p.m. Palm C, Level 3

a Getting Started and Applying for Accreditation — Finding the Pathway and Taking the Right Steps

AttendanceatthissessionshouldbeoneofthefirststepsforindividualscontemplatingsubmissionofanapplicationforASHPaccreditationofapharmacyresidency.Criteria,steps,andtimelinesforapplyingforpre-candidatestatusandaccreditation(candidatestatus)willbedetailed.Comeandlearntheessentialsforgettingyourprogramofftoagoodstart.


a Using PharmAcademic to Support Resident LearningPharmAcademicisaweb-basedprogramdevelopedbytheMcCreadieGrouptoassistprogramswithorganizingandmaintainingcertainaspectsofresidencytraining.Thegoalofthissessionistohelpresidencyprogramdirectors,pre-ceptors,andresidentsunderstandthestructure,use,andfeaturesofPharmAcademictosupportresidencytraining.VariousfeaturesofPharmAcademicwillbediscussedanddemonstrated,whichmayassistprogramsinthedesign,implementation,andoptimizationofPharmAcademic.

3:00 p.m.–5:00 p.m. Breakers C, Level 2

a Residency Program Directors and Preceptors Town Hall: Updates from the Commission on Credentialing TheResidencyProgramDirectorsandPreceptorsTownHallwillfocusonthegoalsandobjectivesforthenewcommunitypharmacyresidencystandardandseveralPGY2advancedpracticeareas.ThenewPGY1managedcarepharmacyresi-dencyaccreditationstandardwillbeintroduced,andthescheduleforthe2017Matchwillbepresented.TheCommissiononCredentialing(COC)planningsessionandprocessimprovementresultswillalsobediscussed,includ-ingtheResidencyAdvisoryCommitteerecommendations.

PHARMACY RESIDENCY & TECHNICIAN TRAINING ACTIVITIES

SUNDAY, DECEMBER 41:00 p.m.–2:00 p.m. Palm B, Level 3

a New and Prospective Pharmacy Technician Training Program Directors and Instructors MeetingAttendingthissessionisoneofthefirststepsforthosecontemplatingthesubmissionofanapplicationforaccredi-tationorthosewhohaverecentlysubmittedanapplicationandhaveneverbeenthroughanaccreditationsitesurvey.Theessentialquestionsaskedbyprogramdirectorsandinstructorsaboutrecentlyestablishedornewlydevelopingprogramswillbediscussed.Timepermitting,othertopicsmayincludeareviewofthecriticalaspectsofaccreditationandcommentaryonspecificelementsoftheaccreditationstandards.Comeandlearntheessentialsforgettingyourpharmacytechniciantrainingprogramofftoagoodstart.

2:00 p.m.–3:00 p.m. Palm B, Level 3

a Pharmacy Technician Training: What’s New for 2017 Thisgatheringisaperfectforumforpharmacytechniciantrainingprogramdirectorsandinstructorstonetworkandlearnaboutissuesimpactingpharmacytechniciantrainingprogramaccreditation.Comehearwhat’snewandexcitingregardingthenewPharmacyTechnicianAccreditationCommission(PTAC)andlearnhelpfulinformationfromtheleadsurveyorswhoconductaccreditationvisits.

Pharmacy Technician Training Program Directors and Instructors

Residency Program Directors and Preceptors

continues >


Pharmacy Residency & Technician Training ActivitiesTimewillbeallottedforadditionalupdatesfromASHPandtheCOC.ThesessionwillbeledbyJanetSilvester,VicePresidentoftheAccreditationServicesOfficeatASHPandBethBrylesPhillips,PastChairoftheCommissiononCredentialing.Thisisaforumnottobemissed!Allcurrentandfutureresidencyprogramdirectors,preceptors,andresidentsareencouragedtoattend.

MONDAY, DECEMBER 56:30 a.m.–9:00 a.m. Mandalay Bay L, Level 2

a Veterans Affairs Residency Open ForumThisopenforumwillprovideanopportunityforresidencyprogramdirectorsandpreceptorstodiscussissuescon-cerningresidencytrainingintheVAsystemwithmembersoftheDepartmentofVeteransAffairs,ASHPCommissiononCredentialing,andASHPAccreditationServicesOfficestaff.ComesharethisexcellentopportunitytonetworkwithotherpractitionersintheVeteransAffairsenvironment.



4:30 p.m.–5:30 p.m. Palm B, Level 3

a Community Pharmacy Residency Open ForumThisopenforumwillprovideanopportunityforresidencyprogramdirectorsandpreceptorstodiscussissuescon-cerningcommunitypharmacyresidencytrainingwithmembersoftheASHPCommissiononCredentialing,ASHPAccreditationServicesOfficestaff,andAPhAstaff.Comesharethisexcellentopportunitytonetworkwithotherpractitionersinthecommunitypharmacyarena.

4:30 p.m.–5:30 p.m. Palm D, Level 3

a Regional Residency Conference Planners MeetingThismeetingprovidesanopportunityfortheplannersoftheannualregionalresidencyconferencestoshareideasanddiscussissuestoimproveeachregionalresidencyconference.

TUESDAY, DECEMBER 68:00 a.m.–11:00 a.m. Bayside B, Level 1


10:00 a.m.–11:00 a.m. Lagoon H, Level 2

a Ask the Pharmacy Residency Accreditation Surveyors Roundtable Discussion ASHPAccreditationServicesOfficestaffleadsurveyorswillbeavailabletoansweranyquestionsregardingstartingaresidencytrainingprogram,gettingreadyforanaccredita-tionsurvey,andmore.Comeouttoagreatsessionwhereyoucanspeakone-on-onewithleadsurveyorstogettheinformationthatyouneed.Therearetwosessions,10:00-11:00amand2:00-3:00pm,toaccommodatethebusyschedulesofthoseexhibitingattheResidencyShowcase.



2:00 p.m.–3:00 p.m. Lagoon H, Level 2

a (Repeated) Ask the Pharmacy Residency Accreditation Surveyors Roundtable Discussion ASHPAccreditationServicesOfficestaffleadsurveyorswillbeavailabletoansweranyquestionsregardingstartingaresidencytrainingprogram,gettingreadyforanaccredita-tionsurvey,andmore.Comeouttoagreatsessionwhereyoucanspeakone-on-onewithleadsurveyorstogettheinformationthatyouneed.Therearetwosessions,10:00-11:00amand2:00-3:00pm,toaccommodatethebusyschedulesofthoseexhibitingattheResidencyShowcase.


a Managed Care Pharmacy Residency Open Forum Thisopenforumwillprovideanopportunityforpharmacyresidencyprogramdirectorsandpreceptorstodiscussmanagedcareresidencyissues.AnupdateontherevisionprocessforthenewPGY1managedcarestandardwillbeprovidedbymembersoftheASHPCommissiononCredentialing,ASHPAccreditationServicesOfficestaff,andAMCPstaff.Comesharethisexcellentopportunitytonet-workwithotherpractitionersinthemanagedcarephar-macyenvironment.Follow #ASHP16

Stay connected to everything happening at the Midyear Clinical Meeting with #ASHP16, the official hashtag for the Midyear meeting. Don’t forget to tag your tweets, photos, and videos with the hashtag so others can follow along with your experiences on Twitter, Facebook, and Instagram.




SUNDAY, DECEMBER 411:15 a.m.–12:15 p.m. Lagoon G, Level 2

a Networking Session: Investigational Drug ServicesHosted by the Section of Inpatient Care Practitioners

Facilitator: Marjorie Shaw Phillips, B.S.Pharm., M.S., FASHP, PharmacyCoordinatorClinicalResearch,AugustaUniversity/AUMedicalCenterandClinicalProfessorofPharmacyPracticeWOS,UniversityofGeorgiaCollegeofPharmacy,Augusta,Ga.

Discussion Topics:l Perpetualchallengesandpotentialsolutionsforclinicalresearchpharmacists

l Staffingmodelsandmetrics—financialissuesforinvestiga-tionaldrugservices

l Track-and-tracechallengeswithinvestigationaldrugs

11:15 a.m.–12:15 p.m. Lagoon H, Level 2

a Networking Session: Optimizing the Pharmacy Revenue CycleHosted by the Section of Pharmacy Practice Managers

Facilitator: Jason Glowczewski, Pharm.D., MBA, FASHP, DirectorofPharmacy,UniversityHospitalsHealthSystem,Cleveland,Ohio

Discussion Topics:l Challengesinrevenuecycleprocessforpharmaciesl Optimizationstrategiesforthepharmacyrevenuecyclel Revenuegeneration

11:15 a.m.–12:15 p.m. Lagoon L, Level 2

a Networking Session: Preceptor Skills DevelopmentHosted by the Section of Clinical Specialists

Facilitator: Winter Smith, Pharm.D., BCPS, AssociateProfessor,UniversityofOklahomaCollegeofPharmacy,OklahomaCity,Okla.

Discussion Topics:l Managingcriticalevaluationsbystudentsandresidentsl Motivatingpreceptorstostepoutsidetheirteachingcom-fortzone

l Coordinatingperformanceevaluationsacrosssingleandmultipleorganizations

l Strategiesforimprovinglearners’communicationskillsandconfidencewithinthehealthcareteam

l Recommendationsforimprovingclinicalproblem-solvingskillsinstudentsandresidents


a Networking and Poster Session: Emergency CareHosted by the Section of Clinical Specialists and Scientists

Facilitator: Kathleen Hidalgo, Pharm.D., M.S., EmergencyMedicinePharmacist,BrowardHealth,CoralSprings,Fla.

Discussion Topics:l RoleoftheEDpharmacistwithZikaandothervirusesl ChronicpainmanagementintheEDl Collaborationwithmid-levelpractitionersintheEDl BuildingyourEmergencyMedicinePharmacyResidencyl AntimicrobialstewardshipintheED


a Networking Session: Advancing Pharmacy Practice with TechniciansHosted by the Section of Inpatient Care Practitioners

Facilitator: Jason Bergsbaken, Pharm.D., BCOP, PharmacyCoordinator,RegionalOncologyServices,UWHealth,Madison,Wis.

Discussion Topics:l Innovative,advancedpharmacytechnicianrolesl Advancedcertificationandtrainingforpharmacytechniciansl Pharmacytechniciancareerladdersandretentionstrategies


a Networking Session: Clinical LeadershipHosted by the Section of Clinical Specialists and Scientists

Facilitator: Linda Gore Martin, Pharm.D., MBA, BCPS, FASHP,Professor,SocialandAdministrativePharmacy(Ret.),UniversityofWyomingSchoolofPharmacy,Laramie,Wyo.

Discussion Topics:l ChangeMakers:PreparingClinicalLeadershipl Levelsofpharmacyclinicalleadershipl Pharmacyclinicalleadershipontheinterdisciplinaryteaml Roleofclinicalmetricsanddashboards

12:30 p.m.–1:30 p.m. Lagoon G, Level 2

a Networking Session: OR/AnesthesiologyHosted by the Section of Inpatient Care Practitioners

Facilitator: Julie Golembiewski, Pharm.D., FASHP,ClinicalPharmacist,UniversityofIllinoisHospitalandHealthSciencesSystem,Chicago,Ill.

Discussion Topics:l Diversionpreventionofcontrolledsubstancesl CMSSafeInjectionPracticesandISMPIVPushMedicationGuidelines

l Clinicalandfiscalconundrumsofhigh-costdrugs

PHARMACY PRACTICE SECTIONS NETWORKING SESSIONS


Pharmacy Practice Sections Networking Sessions12:30 p.m.–1:30 p.m. Lagoon F, Level 2

a Networking Session: Pain Management and Palliative CareHosted by the Section of Ambulatory Care Practitioners

Facilitator: Kashelle Lockman, Pharm.D., ClinicalAssistantProfessor,Hospice&PalliativeCare,UniversityofIowa,IowaCity,Iowa

Discussion Topics:l ImpactofCDCGuidelineforPrescribingOpioidsforChronicPainl Outpatientpalliativecarepracticemodelsl Personalresilience

2:30 p.m.–3:30 p.m. Lagoon F, Level 2

a Networking Session: AnticoagulationHosted by the Section of Clinical Specialists and Scientists

Facilitator: Jeremy Vandiver, Pharm.D., BCPS, ClinicalAssistantProfessorofPharmacyPractice,UniversityofWyomingSchoolofPharmacy,SwedishMedicalCenter,Englewood,Colo.

Discussion Topics:l Directoralanticoagulantsinuniquepatientpopulationsl Co-prescribingofanticoagulantsandantiplatelettherapiesl Anticoagulationreversal:sharedexperiencesl Managementofisolatedunprovokedvenousthromboembolism


a Networking Session: Hematology/OncologyHosted by the Section of Clinical Specialists and Scientists

Facilitator: Marco Martino, Pharm.D., MBA, BCOP, BCPS, OperationsTeamLead(Hematology/Oncology),NorthwesternMedicine,Chicago,Ill.

Discussion Topics:l USP800l Expandeduseofimmunotherapyl Transitionsofcarel Specialtypharmacymonitoringl CMSPartBpaymentmodels

MONDAY, DECEMBER 511:15 a.m.–12:15 p.m. Lagoon H, Level 2

a Networking Session: Ambulatory Care InformaticsHosted by the Section of Pharmacy Informatics and Technology

Facilitator: Carol White, Pharm.D., BCPS, CGP, CHHIMS, AssistantProfessor,UniversityofTennesseeCollegeofPharmacy,andAmbulatoryInformaticsPharmacist,HospitalCorporationofAmerica,Nashville,Tenn.

Discussion Topics:l Optimizationoftechnologyinspecialtypharmacypracticel Ambulatorycareperspectiveontransitionsofcarel Landscapeof340Btechnologyimplementationandoptimization


a Networking Session: Home InfusionHosted by the Section of Ambulatory Care Practitioners

Facilitator, Don Filibeck, Pharm.D., MBA, FASHP, NationalDirector,Pharmacy,OptionCare,Bannockburn,Ill.

Discussion Topic:l Newissuesandfreshperspectivesintheoperational,regu-latory,andclinicalconcernsofhomeinfusionessentials

11:15 a.m.–12:15 p.m. Banyan B, Level 3

a Networking Session: Pediatrics/Neonatal/OBHosted by the Section of Clinical Specialists and Scientists

Facilitator: Peter Johnson, Pharm.D., BCPPS, BCPS, AssociateProfessorofPharmacyPractice,UniversityofOklahomaCollegeofPharmacy,OklahomaCity,Okla.

Discussion Topics:l Systemiccorticosteroidsforasthmaexacerbationsl RoutineuseofprobioticsforNECpreventionl Sedationandanalgesiaforcriticallyillchildrenl Useofinhaledantibioticsforinfantsandchildrenwithoutcysticfibrosis

11:15 a.m.–12:15 p.m. Lagoon G, Level 2

a Networking Session: Reducing ReadmissionsHosted by the Section of Pharmacy Practice Managers

Facilitator: Robert J. Moura, R.Ph., M.S., FMSHP, DirectorofPharmacyandClinicalServices,EmersonHospital,Concord,Mass.

Discussion Topics:l Improvingtransitionsofcarel Identifyingyourpatientpopulationl Multidisciplinaryteamworkl Datacollection,analysis,andsavings

11:15 a.m.–12:15 p.m. Lagoon F, Level 2

a Networking Session: Pharmacy Practice ExperiencesHosted by the Section of Inpatient Care Practitioners

Facilitator: Trisha LaPointe, Pharm.D., BCPS, FASHP, AssociateProfessorofPharmacyPracticeMCPHSUniversity,Boston,Mass.andPharmacyInstructorLowellGeneralHospital,Lowell,Mass.

Discussion Topics:l IntroducinginterprofessionaleducationintoyourAPPErotation

l Preceptordevelopmentl ImplementingalayeredlearningpracticemodelwithinAPPEandresidencyrotations


11:15 a.m.–12:15 p.m. South Seas F, Level 3

a Networking Session: Women in Pharmacy LeadershipFacilitators: Sharon Murphy Enright, B.S.Pharm., MBA,EnvisionChange,LLC,Atlanta,Ga.;Sara J. White, M.S., FASHP,MountainView,Calif.

Discussion Topics:l Connectingwithexperiencedsuccessfulwomenleadersandbenefitingfromtheirexperiencesandstories

l Workingsuccessfullyintoday’shealthcareenvironmentl Workingsuccessfullywithmenandwomen,andsupportandsponsorshipofotherwomen

l Integratingpersonalandcareerlife

11:15 a.m.–12:15 p.m. South Seas J, Level 3

a Networking Session: Pharmacogenetics and Biomarkers Hosted by the Section of Clinical Specialists and Scientists

Facilitator: Martha Roberts, Pharm.D., BCCCP,ClinicalPharmacist,KentCountyHospital,Warwick,R.I.

Discussion Topics:l Newdefinitionofsepsisl Useofbiomarkersinacutekidneyinjuryl Pharmacogenetictestinginpediatricsl Certificateprogramforpharmacogenetics


a Networking Session: Advice from the Trenches: Building and Sustaining Successful Ambulatory Care ServicesHosted by the Section of Ambulatory Care Practitioners

Facilitator: Emily Ashjian, Pharm.D., BCACP, BCPS, ClinicalPharmacySpecialist,AmbulatoryCare,UniversityofMichiganHealthSystem,AnnArbor,Mich.

Discussion Topics:l Qualityimprovementinitiativestosupportambulatorycarepharmacyservices

l Billingforambulatorycarepharmacyservicesl Comprehensivemedicationmanagementinambulatorycarel Specialtypharmacyprogramsinambulatorycare


a Networking Session: Clinical Information SystemsHosted by the Section of Pharmacy Informatics and Technology

Facilitator: Jeff Chalmers, Pharm.D., PharmacyInformaticsManager,ClevelandClinic,Cleveland,Ohio

Discussion Topics:l Clinicaldecisionsupportinpharmacogenomicsl Inpatientcareperspectiveontransitionsofcarel Theeffectofnationalhealthcareinformationtechnologyinitiativesoncurrentpractice


a Networking Session: Critical CareHosted by the Section of Clinical Specialists and Scientists

Facilitator: Phillip Mohorn, Pharm.D., BCCP, BCPS, ClinicalPharmacySpecialist-CriticalCare,Spartanburg,RegionalHealthcareSystem,Spartanburg,S.C.

Discussion Topics:l Enteralnutritioninpatientsreceivingvasopressorsl KetamineforsedationintheICUl Expandingpharmacists’scopeofpracticeintheICU


a Networking Session: GeriatricsHosted by the Section of Clinical Specialists and Scientists

Facilitator: Deirdre Pierce, Pharm.D., BCPS, CGP, AssistantProfessor,St.JohnFisherCollege,WegmansSchoolofPharmacy,Rochester,N.Y.

Discussion Topics:l Affectingpatientattitudesandwillingnessl Protonpumpinhibitorsuseintheelderlyl Psychoactivemedicationsuseintheelderlyl Medicalmarijuanainnursinghomes/assistedlivingfacilities


a Networking Session: Infectious DiseasesHosted by the Section of Clinical Specialists and Scientists

Facilitator: Brian Potoski, Pharm.D., BCPS, AssociateProfessor,DepartmentofPharmacyandTherapeutics,UniversityofPittsburghSchoolofPharmacy,Pittsburgh,Pa.

Discussion Topics:l CMSconditionsforparticipationandTJCrequirementsforhospital-basedantibioticstewardship;insightsanddiscus-sionpointsonchallengesandopportunities

l Dataanalystsinstewardshipteamsanddata/metricsl Antibioticstewardshipandthestewardshipofrapiddiagnostics


a Networking Session: Nutrition SupportHosted by the Section of Clinical Specialists and Scientists

Facilitator: Phil Ayers, Pharm.D., BCNSP, FASHP, Chief,ClinicalPharmacyServices,BaptistHealthSystems,DepartmentofPharmacy,Jackson,Miss.

Discussion Topics:l Newin-linefilterrecommendationsforintravenousfatemulsions

l FunctionalityoftheEHRandtheparenteralnutritionprocessl Safeuseofmultichamberparenteralnutritionproducts


Pharmacy Practice Sections Networking Sessions3:30 p.m.–4:30 p.m. Lagoon H, Level 2

a Networking Session: Expanding Pharmacy Services Across Care TransitionsHosted by the Section of Pharmacy Practice Managers

Facilitator: Rafael Saenz, Pharm.D, M.S., FASHP, Administrator,PharmacyServices,UniversityofVirginiaHealthSystem,andAssistantDean,VCUSchoolofPharmacy-UVADivision,Charlottesville,Va.

Discussion Topics:l Identifyingnon-acutecareopportunitiesforpharmacyser-viceexpansion

l Managementofpharmacycareissuesacrossthecontinuuml Customerserviceandthepatientexperiencel Providingpatientswitha“PharmacyHome”

TUESDAY, DECEMBER 611:15 a.m.–12:15 p.m. South Seas F, Level 3

a Networking Session: Immunology/TransplantHosted by the Section of Clinical Specialists and Scientists

Facilitator: Nicole Pilch, Pharm.D., MSCR, BCPS, FAST, DirectorofQualityandComplianceTransplantService,TransplantClinicalSpecialist,MUSC,Charleston,S.C.

Discussion Topics:l DefininganddevelopingPGY2residencystandardsforsolidorgantransplant

l Collaborativeresearchacrossorganizationsl Boardcertificationforsolidorgantransplant


a Networking Session: Medication Management Across the ContinuumHosted by the Section of Ambulatory Care Practitioners

Facilitator: Brigid Groves, Pharm.D., M.S., ClinicalCoordinator,TheKrogerCo.,ColumbusDivision,Columbus,Ohio

Discussion Topics:l Medicationtherapymanagement(MTM)incommunityandambulatorysettings

l OpportunityforcollaborationbetweensettingsthroughMTMl InvolvementofancillarypersonneltofacilitateMTMcommunication

11:15 a.m.–12:15 p.m. Banyan B, Level 3

a Networking Session: Pharmacoeconomics/ Drug DevelopmentHosted by the Section of Clinical Specialists and Scientists

Facilitator: Karen M. Whalen, B.S.Pharm., BCPS, DrugInformationPharmacist,St.Joseph’sHospital,Syracuse,N.Y.

Discussion Topics:l Process/policydevelopmentforhandlingin-patientnon-formularymedicationrequests(i.e.,newFDAapprovals,highcost)

l Strategiesformanaginginventoryandtherapeuticinterchangesafteradrugshortageends

l Novelandhigh-techdeliverysystemsl P&Tcommitteestrategiesforinclusionofbiosimilarsinformulary

11:15 a.m.–12:15 p.m. Lagoon H, Level 2

a Networking Session: Small and Rural Hospitals Hosted by the Section of Inpatient Care Practitioners

Facilitator: Denise C. Fields, Pharm.D., FASHP, SeniorClinicalConsultant,ExpressScripts,CumminsLiveWellCenter,Columbus,Ind.

Discussion Topics:l Challengesformeetingregulatorycriteria,clinicalguidelines,andsafetystandards

l Strategiesforadvancingpracticel Bestpracticesinovercomingrisingcostsandshrinkingresourceschallenges


a Networking Session: Strategic PlanningHosted by the Section of Pharmacy Practice Managers

Facilitator: Dominick A. Caselnova III, B.S.Pharm., M.H.A., FASHP, DirectorofPharmacy,SouthwestWashingtonRegion,ProvidenceHealthandServices,Olympia,Wash.

Discussion Topics:l Strategicplanning:definitionandimportancel Stepsinthestrategicplanningprocessl Characteristicsofagoodstrategicplanningteaml Effectivelymovingfromplanningtoimplementation


a Networking Session: Ambulatory Care Practice and Billing Outside of the BoxHosted by the Section of Ambulatory Care Practitioners

Facilitator: Jessica Skelley, Pharm.D., BCACP, AssistantProfessorofPharmacyPractice,SamfordUniversity,Birmingham,Ala.

Discussion Topics:l Revenuestreams(WellnessVisits,ChronicCareManagement,TransitionalCareManagement)

l Telehealthl Interdisciplinaryteamapproachestoreducingcostl Costcontainment


a Networking Session: CardiologyHosted by the Section of Clinical Specialists and Scientists

Facilitator: Michael Scalese, Pharm.D., BCPS, ClinicalAssistantProfessor,AuburnUniversityHarrisonSchoolofPharmacy,Mobile,Ala.

Discussion Topics:l Developmentsinthemanagementofheartfailurewithapreservedejectionfraction(HFpEF)


l Antiplateletconsiderationsforthesecondarypreventionofischemicstroke

l NovelapproachestoloweringLDL-Cl Beta-blockerdosevs.heartrategoalinheartfailurewithareducedejectionfraction(HFrEF)


a Networking Session: Informatics Professional DevelopmentHosted by the Section of Pharmacy Informatics and Technology

Facilitator: Julie Pawola, Pharm.D., ClinicalPharmacist,UWHealth,Madison,Wis.

Discussion Topics:l Statusandperceptionsofinformaticseducationincurrentpractice

l Recognitionofinformaticstrainingandcertificationsinpracticeadvancements

l Roleoftheinformaticsleaderinhealthsystems


a Networking Session: Medication Safety Hosted by the Section of Inpatient Care Practitioners

Facilitator: James R. Rinehart, B.S.Pharm., M.S., FASHP, Principal,WinovationAssociatesLLC,Indianapolis,Ind.

Discussion Topics:l Alertfatiguepreventionstrategiesl Pharmacist-requiredmedicationorderreviewl Systematicapproachestoupdatingsmartpumpdruglibrariesl Pediatricmedicationsafetychallengesintheemergencydepartment

WEDNESDAY, DECEMBER 711:15 a.m.–12:15 p.m. Lagoon H, Level 2

a Networking Session: Pharmacy Operations and AutomationHosted by the Section of Pharmacy Informatics and Technology

Facilitator: Jonna Fink, Pharm.D., M.S.Pharm., MedicationSafetyPharmacist,VeteransAffairs,Marion,Ill.

Discussion Topics:l Theprogressoftrack-and-tracetechnology,ayear’sprogress

l Standardize4Safetyandtheuseofsmartpumpdatal Automationsuccessesandfailuresacrosstheenterprisel Thecreative,out-of-boxuseforIVroomsoftware


a Networking Session: Primary Care/PharmacotherapyHosted by the Section of Clinical Specialists and Scientists

Facilitator: Amy Lugo, Pharm.D., BC-ADM, BCPS, FAPhA, ClinicalPharmacySpecialistandFormularyManager,DoD/DefenseHealthAgency/TRICARE,SanAntonio,Texas

Discussion Topics:l Pharmacists’prescribingpracticesl Sclerostininhibitor’sroleinosteoporosisl UtilizationofnewCHFdrugsinpracticeandchangesintreatmentstrategiesforheartfailure

l Antibioticstewardshipl Formularyandclinicalconsiderationsofnaloxoneformula-tionsintreatmentforopioidabuse


a Networking Session: Innovation in PharmacyHosted by the Section of Pharmacy Practice Managers

Facilitator: Ashley Purohit, Pharm.D., MBA, SpecialtyPharmacyCoordinator,AuroraHealthCare,Milwaukee,Wis.

Discussion Topics:l Innovativepharmacyservicesdevelopedbyleveragingtech-nologyandcaregiverrolesorcollaboratingwithoutsidecompanies

l Innovationcenterswithinorganizationsandhowpharmacyfitsin

l Strategiestofosteraninnovativeculturewithinyourdepartment


a Networking Session: Psychopharmacy/NeurologyHosted by the Section of Clinical Specialists and Scientists

Facilitator: Amen T. Ogunmekan, Pharm.D., BCPP, CGP,ClinicalLeadPharmacist-BehavioralHealthInternClinicalProgramTrainingCoordinator,TrumanMedicalCenterHospitalHill,KansasCity,Mo.

Discussion Topics:l Ketamineuseintreatmentofresistantdepressionl Gabapentinprescribingtrendsandpotentialnewdrugofabuse

l Monitoringandmanagementofmetabolicandcardiovas-cularsideeffectsforatypicalantipsychotics

l Controversiesinmanagingbipolardisorderl Psychotropictreatmentoptionsforpatientsinrenaldialysis




EDUCATIONAL SESSIONS

NOTE:AlleducationalsessionslistedhereareavailableforCEunlessotherwisenoted.Presenterdisclosurescanbelocatedonpage134.

SUNDAY, DECEMBER 48:00 a.m.–8:30 a.m. Mandalay Bay J, Level 2

a (Management Case Study) Development of ACPE-accredited Comprehensive Professional Education in a Large Health SystemACTIVITY #0204-0000-16-369-L04-P/0204-0000-16-369-L04-T



Learning Objectives:l DescribestrategiestoimplementacomprehensiveneedsassessmentforACPE-accreditededucation.

l EvaluateadvantagesanddisadvantagesofinternalandexternalACPEaccreditationincludingcost-effectiveness.

l Listbarrierstoimplementationofhealth-system-widepro-fessionaldevelopmentprogram.

Presenters:Richard H. Ensign, Pharm.D., MBA, BCPS,PharmacyEducationandResearchManager,IntermountainHealthcare,SaltLakeCity,UtahElizabeth Sebranek Evans, Pharm.D., BCPS, CGP,PharmacyEducationandResearchManager,IntermountainHealthcare,SaltLakeCity,Utah

8:45 a.m.–9:15 a.m. Mandalay Bay J, Level 2

a (Management Case Study) Implementation of Medication Reconciliation Order Pending Across a Multi-Hospital Health SystemACTIVITY #0204-0000-16-370-L04-P/0204-0000-16-370-L04-T



Learning Objectives:l Listtwostepsimportanttoensuringsuccessfulimplemen-tationofanewpharmacist-providedservice.(Ponly)

l Identifykeyconsiderationsfordevelopinganewworkflowwithinyourelectronicmedicalrecord.(P/T)

l Describecomponentsnecessarytoevaluatewhenchoos-ingapilotsiteforsystemwideimplementation.(P/T)

Presenters:Kristin Cannon, R.Ph.,SeniorDirector,PharmacyOperations,AuroraHealthCare,GreenBay,Wis.Ellen Prichard, Pharm.D., MBA, BCPS,PharmacyOperationsManager,UniversityofKansasHospital,KansasCity,Kan.

9:00 a.m.–11:00 a.m. Oceanside C, Level 2

a Innovations in Drug Information Practice and Research 2016ACTIVITY #0204-0000-16-314-L04-P

2.00 CONTACT HOURS | APPILCATION-BASED


Program Chair/Moderator:Patrick M. Malone, Pharm.D., FASHP,ProfessorandAssociateDeanofInternalAffairs,TheUniversityofFindlay,Findlay,Ohio

Learning Objectives:l Discussnewservicesandmethodsusedbydruginformationspecialistsandcenters.

l Designasystemtoapplynewservicesandmethodsinyourpractice.

l Evaluatetheimportanceofthesenewmethodsinyourpracticeenvironment.

Presenters:Ashish Advani, Pharm.D.,ClinicalAssociateProfessorandDirector,DrugInformationCenter,MercerUniversityCollegeofPharmacy;Founder,InpharmD,Atlanta,Ga.Gregory A. Heindel, Pharm.D., BCPS,HealthSystemMedicationUseManagementPGY2Resident,UNCMedicalCenter,ChapelHill,N.C.Lauren I. Karel, Pharm.D., BCPS,DrugInformationPharmacist,ThomasJeffersonUniversityHospital,Philadelphia,Pa.Ashley Pappas, Pharm.D., M.H.A., BCPS,PharmacyClinicalManager,UNCHospitals,ChapelHill,N.C.Pinaki Shah, Pharm.D.,DrugInformationSpecialist,MedStarHealth,Columbia,Md.Amy Heck Sheehan, Pharm.D.,AssociateProfessorofPharmacyPractice,PurdueUniversity;DrugInformationSpecialist,IndianaUniversityHealth,Indianapolis,Ind.


a (Management Case Study) Clinical Decision Support System Enhancements to Reduce Order Entry Errors for Pediatric Infusion OrdersACTIVITY #0204-0000-16-371-L04-P/0204-0000-16-371-L04-T



Learning Objectives:l Identifytypesofmedicationerrorsassociatedwithmedicationinfusionorders.

l Describetheprocessformedicationdripconcentrationauto-selection.

l Outlinehowautomationprocessesimprovepatientsafety.

Presenters:Amy Y. Chan, Pharm.D., M.S., SeniorTechnicalSpecialist,NewYork-PresbyterianHospital,NewYork,N.Y.Elena Mendez-Rico, Pharm.D.,ClinicalPharmacyManager,NewYork-PresbyterianHospital,NewYork,N.Y.



9:30 a.m.–11:00 a.m. Mandalay Bay L, Level 2

a Professional and Academic Book Publishing: Putting Your Ideas into Practice 2016ACTIVITY #0204-0000-16-318-L04-P/0204-0000-16-318-L04-T



Program Chair/Moderator:Jack R. Bruggeman, MBA,Director,SpecialPublishing,ASHP,Bethesda,Md.

Learning Objectives:l Describehowtoprepareaneffectivepublishingproposal.l Explainhowtoevaluateapracticeimprovementideaforpublishingpotentialandcommercialviability.

l Listfivekeystepsforturningyourideaintoapublishedwork.

Presenters:Ruth Bloom, B.S.,EditorialProjectManager,ASHP,Bethesda,Md.Jack R. Bruggeman, MBABeth Campbell, B.A.,AcquisitionsEditor,ASHP,Bethesda,Md.Mate M. Soric, Pharm.D., BCPS,ClinicalPharmacySpecialist,InternalMedicine,UniversityHospitalsGeaugaMedicalCenter,Chardon,Ohio;AssociateProfessor,PharmacyPractice,NortheastOhioMedicalUniversityCollegeofPharmacy,Rootstown,Ohio

10:00 a.m.–11:00 a.m. Oceanside D, Level 2

a Antibiotic Stewardship — CDC Update on National ActivitiesACTIVITY #0204-0000-16-385-L03-P



Learning Objectives:l Listupcomingapprovedandproposedregulatoryand

accreditationrequirementsforantibioticstewardship.l DescribetheperformanceelementsofTheJointCommission

Accreditationstandardforantibioticstewardship.l Describethenewlyendorsedstandardizedantimicrobial

administrationratiomeasurefromtheCDC.

Presenter:Arjun Srinivasan, M.D., CAPT,FSHEA,USPHS,AssociateDirectorforHealthcareAssociatedInfectionPreventionPrograms,DivisionofHealthcareQualityPromotion,CentersforDiseaseControlandPrevention,Atlanta,Ga.


a (Management Case Study) Effects of Inventory Optimization on Pharmacy Metrics Pre- and Post-Electronic Health Record (EHR) ImplementationACTIVITY #0204-0000-16-372-L04-P/0204-0000-16-372-L04-T



Learning Objectives:l Describethemethodologyusedtooptimizemedicationinventoryinautomateddispensingsystemsinanacademicmedicalcenter.

l EvaluatetheeffectsofinventoryoptimizationonpharmacymetricsbeforeandafterimplementationofanewEHR.

l Outlinethechallengesassociatedwiththecontinuousmanagementofinventorybetweenthevariousautomateddispensingsystems.

Presenters:Amanda M. Beck, Pharm.D.,PGY1/PGY2Health-SystemPharmacyAdministrationResident,HoustonMethodistHospital,Houston,TexasLinda P. Nguyen, Pharm.D.,PGY1/PGY2Health-SystemPharmacyAdministrationResident,HoustonMethodistHospital,Houston,TexasPatrick Birney, Pharm.D., M.S.,PharmacyOperationsManager,HoustonMethodistHospital,Houston,Texas


a (Management Case Study) Standardizing Systemwide Primary National Drug Code for Improved Inventory Management and Cost SavingsACTIVITY #0204-0000-16-373-L04-P/0204-0000-16-373-L04-T



Learning Objectives:l Identifythedatapointsrequiredtocompleteananalysisofgenericcodenumberstoidentifythepreferrednationaldrugcode.

l Identifytheworkefforttochangepreferrednationaldrugcodeinapharmacyinformationsystemdatabase.

l Calculatethefinancialbenefitrealizedbystandardizingtopreferrednationaldrugcodes.

Presenters:Barbara L. Giacomelli, Pharm.D., MBA, FASHP,AreaVicePresidentPharmacyPracticeConsulting,McKessonHealthSystems,Vineland,N.J.;AdjunctProfessor,RutgersUniversitySchoolofNursing-Camden,Camden,N.J.Brad Myers, Pharm.D., MBA, BCPS,Director–PharmacyServices,UniversityofMissouriHealthSystem,Columbia,Mo.Julia Chisholm, Pharm.D.,AmbulatoryPharmacyManager,UniversityofMissouri,Columbia,Mo.





Educational Sessions Sunday, December 4 continued11:30 a.m.–12:30 p.m. Mandalay Bay L, Level 2

a Creating a Values-based Culture in Health-System PharmacyPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-319-L04-P



Program Chair/Moderator:Matthew Eberts, Pharm.D., MBA, FASHP,Director,PharmacyServices,LancasterGeneralHealth/PennMedicine,Lancaster,Pa.

Learning Objectives:l Discusstheimportanceofcreatingavalue-basedcultureinhealth-systempharmacy.

l Designaninterviewingandonboardingprocesstosupportahealthyorganizationalculture.

l Evaluatethebehaviorsandnormsofahigh-functioningteam.

Presenters:John S. Clark, Pharm.D., M.S., BCPS, FASHP,DirectorofPharmacy,UniversityofMichiganHospitalsandHealthCenters;ClinicalAssociateProfessor,UniversityofMichiganCollegeofPharmacy,AnnArbor,Mich.Matthew Eberts, Pharm.D., MBA, FASHP

11:30 a.m.–12:30 p.m. Oceanside C, Level 2

a Contemporary Considerations: Update on the ASHP Standardize 4 Safety ProjectACTIVITY #0204-0000-16-382-L04-P/0204-0000-16-382-L04-T



Learning Objectives:l Describehowstandardizationcanbeusedasanerrorpre-ventiontool.

l StatetheimportanceoftheStandardize4Safetyproject.l Listthemostcurrentversionsofthestandardconcentra-tionsforIVadultcontinuous,pediatriccontinuousinfu-sions,andoralcompoundedliquids.

l Statehowtosupporttheprojectandstartimplementationofthestandardconcentrations.

l Describethepotentialroleofvendorsandpharmaceuticalcompaniesintheproject.

Presenter:Deborah A. Pasko, Pharm.D., M.H.A., Director,MedicationSafety&Quality,ASHP,Bethesda,Md.

11:45 a.m.–12:15 p.m. Mandalay Bay J, Level 2

a (Management Case Study) Evaluation and Implementation of a Time and Materials Maintenance Arrangement for Pharmacy Automation EquipmentACTIVITY #0204-0000-16-374-L04-P/0204-0000-16-374-L04-T



Learning Objectives:l Describekeydifferencesbetweentheservicecontractandtimeandmaterialsapproachesforequipmentmaintenance.

l Identifyimportantconsiderationswhenevaluatingthefea-sibilityofatimeandmaterialsarrangement.

l Describepotentialdisadvantagesofatimeandmaterialsarrangement.

Presenter:Christopher J. Wickesberg, Pharm.D., BCPS,PharmacyManager,InpatientServices,EskenaziHealth,Indianapolis,Ind.

12:30 p.m.–1:00 p.m. Mandalay Bay J, Level 2

a (Management Case Study) Optimization of Automated Dispensing Cabinets in a Multi-site Health SystemACTIVITY #0204-0000-16-375-L04-P/0204-0000-16-375-L04-T



Learning Objectives:l Developspecificgoalstoimplementanoptimizationplanforhospitalautomateddispensingcabinets(ADCs).

l IdentifypotentialbarrierstoinitiatinganoptimizationplanforADCs.

l DescribehowoptimizingADCscanenhancemedicationavailabilityonnursingunits.

Presenters:Arpita T. Sammons, Pharm.D.,PharmacistInCharge,AtlantiCareRegionalMedicalCenter,Pomona,N.J.Kashyap Patel, PharmacyITTechnician,AtlantiCareRegionalMedicalCenter,Pomona,N.J.Andrew Karcsh, Pharm.D., MBA,DirectorPharmacyOperations,AtlantiCareRegionalMedicalCenter,Pomona,N.J.


a Practical Guide to Resourcing a Pharmacy Transitions-of-Care ProgramPlanned in cooperation with the ASHP Section of Pharmacy Practice ManagersACTIVITY #0204-0000-16-315-L04-P/0204-0000-16-315-L04-T



Program Chair/Moderator:Tara Behring Vlasimsky, Pharm.D., BCPS,AssistantDirector,AmbulatoryClinicalPharmacyServices,DenverHealth,Denver,Colo.

Learning Objectives:l Assessyourorganization’smedicationtransitionprocessesforopportunitiestoincorporatepharmacyresources.

l Evaluatearecruitingandhiringstrategy,training,andcom-petenciestoimplementapharmacytechnician-driven,home-medication-historycollectionprocess.

l Evaluatedifferentmodelsfordischargepharmacyservicesandidentifykeytakeawaysforyourorganization.

l Describeapharmacytransitions-of-caremanagementdashboard.

Presenters:Megan Hoesly, Pharm.D., BCPS,ClinicalPharmacySpecialist-EmergencyMedicine,SentaraVirginiaBeachGeneralHospital,VirginiaBeach,Va.Tara Behring Vlasimsky, Pharm.D., BCPS


The2016FederalForumwillkickoffwithapatrioticopeningceremony,followedbywelcomingremarksfromtheASHPPresident.ThekeynotepresentationwillbedeliveredbyCommander Christopher Jones, Pharm.D., M.P.H.,U.S.PublicHealthService,Director,DivisionofSciencePolicy,OfficeoftheAssistantSecretaryforPlanningandEvaluation,U.S.DepartmentofHealthandHumanServices.CommanderJoneswillspeakontheopioidandpainmanagementcrisisintheUnitedStates,andtheimportantopportunityandcalltoactionforpharmacistsaskeymembersofthehealthcareteam.

ThesessionwillalsoincludeapresentationbyDr.JeremyMcKelvey,Pharm.D.;Dr.MitchNazario,Pharm.D.,fromtheDepartmentofVeteransAffairs;andDr.EvelynRitchie,Pharm.D.,representingtheU.S.Army.Thispresentationwillfocusontherolesofclinicalpharmacistsandpharmacytechniciansindealingwiththeopioidcrisisinthefederalhealthcaresector.

TheFederalForumwillconcludewiththeFederalForum:MeettheResearcherPosterPresentationssession,withcontrib-utedpostersfromFederalPharmacyResidentsandFederalPharmacyprofessionals.

NOTE:ThefullprogramdescriptioncanbefoundintheMidyear News & ViewsandontheASHPLIVEapp.

Moderator: Heather Ourth, Pharm.D., BCPS, VACOPBMProgramManager:ClinicalPharmacyPracticeProgramOutcomesAssessment,PharmacyBenefitsManagementServicesDepartmentofVeteransAffairs,Hines,Ill.


a Federal Forum: Role of the Clinical Pharmacist and Pharmacy Technician in Dealing with the Opioid CrisisACTIVITY #0204-0000-16-342-L01-P



Learning Objectives:l Describestrongpracticeexamplesinpainandopioidman-agement,mentalhealthtreatment,andsubstanceusedis-ordersaswellastherolesthattheclinicalpharmacistandpharmacytechniciansplayinthosepractices.

l Discussbarrierstoincreasedpharmacistinvolvementinthesepracticesdespitethewidespreadneedforclinicians.

l Explorepossiblesolutionstoidentifiedbarrierstopracticeexpansion.

Presenters:Jeremiah McKelvey, Pharm.D., ClinicalPharmacySpecialist–PainManagement,VeteransAffairsPaloAltoHealthCareSystem,PaloAlto,Calif.Mitchell Nazario, Pharm.D., CPE, VISN8PBMClinicalProgramManagerforPainManagement,WestPalmBeachVeteransAffairsMedicalCenter,WestPalmBeach,Fla.Evelyn Ritchie, Pharm.D.,PainManagementClinicalPharmacist,MartinArmyCommunityHospital,FortBenning,Ga.


a Federal Forum: Meet the Researchers Poster PresentationsACTIVITY #0204-0000-16-343-L04-P/0204-0000-16-343-L04-T



Learning Objectives:l Identifyemergingissuesintheprofessionofpharmacy.l Discusscurrentandcutting-edgeresearch.l Describekeyelementstoevaluatearesearchproject.

1:00 p.m.–5:15 p.m.

a The ASHP 2016 Federal Forum


a Welcome Event


a Federal Forum Keynote: The Pain and Opioid Crisis — A Call to Action for the Pharmacy ProfessionACTIVITY #0204-0000-16-341-L01-P/0204-0000-16-341-L01-T



Program Chair:William M. (Mike) Heath, R.Ph., MBA,PresidentandCEO,HeathHealthcareConsulting,Lexington,Ky.

Learning Objectives:l Describethemagnitudeandimpactsofoveruseofopioidsinthenationandwithinthefederalsector.

l Discusshowmentalillnessandsubstanceabusecomplicateachievementofthegoalsofopioidmanagementaswellastheskillsthatmightbeneededacrossallhealthcareproviders.

l Exploreopportunitiesandbarrierstoclinicalpharmacyinvolvementinthistriadofdiseases.

Featured Speaker: Commander Christopher M. Jones, Pharm.D., M.P.H., U.S.PublicHealthService,OfficeoftheAssistantSecretaryforPlanningandEvaluation,U.S.DepartmentofHealthandHumanServices,Washington,DC



Educational Sessions Sunday, December 4 continued1:00 p.m.–2:30 p.m. Mandalay Bay L, Level 2

a On the Record: A Guide to Working Effectively with the MediaACTIVITY #0204-0000-16-320-L04-P/0204-0000-16-320-L04-T



Program Chair/Moderator:Linda Tyler, Pharm.D., FASHP,ChiefPharmacyOfficer,UniversityofUtahHealthCare;AssociateDean,PharmacyPractice,UniversityofUtahCollegeofPharmacy,SaltLakeCity,Utah

Learning Objectives:l Discusstheimportanceofworkingeffectivelywithmedia.l Planmethodstointeractwiththemediaeffectively.l Developwaystoaddressbarrierstoworkingwiththemedia.l Designaplantoworkwithyourpublicrelationsdepart-mentmoreeffectively.

Presenters:Erin Fox, Pharm.D., FASHP,Director,DrugInformationService,UniversityofUtahHealthCare,SaltLakeCity,UtahKathy Wilets, M.P.A.,Director,MediaRelations,UniversityofUtahHealthCare,SaltLakeCity,Utah


a (Management Case Study) Evaluation of a Pharmacy Workplace Safety Training Program to Ensure Regulatory ComplianceACTIVITY #0204-0000-16-376-L04-P/0204-0000-16-376-L04-P

0204-0000-16-376-L04-T



Learning Objectives:l IdentifyfederalagenciesthatregulateworkplacesafetyanddescribethemaincomponentsoftheOSHAhazardouscommunicationstandard.

l ListkeyfactsabouttheUnitedNationsGloballyHarmonizedSystem(GHS)ofClassificationandLabellingofChemicals.

l Identifycommondeficienciesinpharmacyworkplacesafetytrainingprograms.

Presenters:Vaiyapuri Subramaniam, Pharm.D., M.S., FASCP, FASHP, FCP,AssociateChiefConsultant,DepartmentofVeteransAffairs,PharmacyBenefitsManagementServices,Washington,DCBrenda Jensen, MBA, CNMT, CPhT,PharmacyConsultant,CompoundingConsultants,LLC,Canton,S.D.Mary L. Li, Pharm.D.,Pharmacist,UniversityofMarylandSchoolofPharmacy,Baltimore,Md.


a Continuing Professional Development (CPD): A Cascade of Benefits for EmployersPlanned in cooperation with the Accreditation Council for Pharmacy Education

ACTIVITY #0204-0000-16-381-L04-P/0204-0000-16-381-L04-T



Program Chair/Moderator: Jennifer Baumgartner, Pharm.D., BCCP,AssistantDirector,AccreditationCouncilforPharmacyEducation,Chicago,Ill.

Learning Objectives:l Describethecontinuingprofessionaldevelopment(CPD)approachtoself-directedlifelonglearning.

l Discusspotentialbenefitsofemployer-supportedCPDforpharmacyprofessionals.

l SummarizeeffortsbyhealthsystemsinintegratingCPDforemployeedevelopment.

l Outlineavailabletoolsandresourcesforadvancingemployer-supportedCPD.

Presenters:John A. Armitstead, R.Ph., M.S., FASHP, SystemDirectorofPharmacy,LeeHealth,FortMyers,Fla.Jennifer Baumgartner, Pharm.D., BCCPDennis Brierton, Pharm.D., BCPS, FASHP,Director,ClinicalPharmacyServices,AuroraHealthCare,Milwaukee,Wis.Suzanne Turner, Pharm.D., FASHP,PharmacyEducationandResidencyCoordinator,LeeHealth,FortMyers,Fla.

2:45 p.m.–4:15 p.m. Mandalay Bay L, Level 2

a Advocacy, Healthcare, and You: Not a House of CardsPlanned in cooperation with the ASHP Political Action Advisory Committee

ACTIVITY #0204-0000-16-321-L04-P/0204-0000-16-321-L04-T



Program Chair/Moderator:Jeff Little, Pharm.D., M.P.H., BCPS,DirectorofPharmacy,SaintLuke’sHospital,KansasCity,Mo.

Learning Objectives:l Listtacticsthatcanbeusedtobeasuccessfuladvocateatthefederal,state,andregulatorylevels.

l Identifylegislativeandregulatoryadvocacyissuesatthestateandnationallevels.

l Describemethodstobuildrelationshipswithelectedofficials.l Justifytheimportanceofbeinganadvocatefortheprofession.

Presenters:Leigh Briscoe-Dwyer, Pharm.D., BCPS, FASHP,VicePresidentClinicalAffairs,PharMEDiumLLC,LakeForest,Ill.;Chair,NewYorkStateBoardofPharmacy,Albany,N.Y.Thomas Johnson, Pharm.D., MBA, BCCCP, BCPS, FASHP, FCCM,AssistantVice-PresidentHospitalPharmacy,AveraHealth,SiouxFalls,S.D.Linda Tyler, Pharm.D., FASHP,ChiefPharmacyOfficer,UniversityofUtahHealthCare;AssociateDean,PharmacyPractice,UniversityofUtahCollegeofPharmacy,SaltLakeCity,Utah




a The 2016 ISMP Medication Safety Assessment and Strategies for Antithrombotic Therapy in HospitalsPlanned in cooperation with the Institute for Safe Medication Practices

ACTIVITY #0204-0000-16-316-L05-P



Program Chair:Matthew P. Fricker, Jr., R.Ph., M.S., FASHP, ProgramDirector,InstituteforSafeMedicationPractices,Horsham,Pa.Moderator:Christina Michalek, R.Ph., B.S., FASHP,MedicationSafetySpecialist,InstituteforSafeMedicationPractices,Horsham,Pa.

Learning Objectives:l DescribechangestotheInstituteforSafeMedicationPractices(ISMP)MedicationSafetySelf-AssessmentforAntithromboticTherapyinHospitals.

l Evaluatesafetyconcernswiththeuseofrecentlyapprovedneworalanticoagulantagents.

l Discussmedicationeventsreportedwithneworalantico-agulantagents.

Presenters:Matthew P. Fricker, Jr., R.Ph., M.S., FASHPMichael Gulseth, Pharm.D., BCPS, FASHP,ProgramDirectorforAnticoagulationServices,SanfordUSDMedicalCenter;President,MichaelP.GulsethAnticoagulationConsulting,Inc.,SiouxFalls,S.D.Rhonda Hammerquist, Pharm.D., BCPS,MedicationSafetyOfficer,SanfordUSDMedicalCenter,SiouxFalls,S.D.


a (Management Case Study) Small Intradepartmental Groups Drive Pharmacy Improvement Process in a Large Community HospitalACTIVITY #0204-0000-16-378-L04-P/0204-0000-16-378-L04-T



Learning Objectives:l Discusstheuseofintradepartmentalgroupstoimplementnewprocess-improvementprojects.

l Describetheprocessmappingtooltoidentifysolutionsandopportunitiesforprocess-improvementprojects.

l Identifybenefitsofemployeeengagementbyempower-mentthroughparticipationinintradepartmentalgroups.

Presenters:Nathan P. Wirick, Pharm.D., BCPS,ClinicalPharmacist,ClevelandClinicHillcrestHospital,MayfieldHeights,OhioFrank S. Rigelsky, Pharm.D., BCPS,ClinicalPharmacist,ClevelandClinicHillcrestHospital,MayfieldHeights,OhioNicholas A. Link, Pharm.D., BCOP,ClinicalPharmacist,ClevelandClinicHillcrestHospital,MayfieldHeights,Ohio


a (Management Case Study) Implementation of a Pharmacy Technician Residency Program in a Teaching HospitalACTIVITY #0204-0000-16-379-L04-P/0204-0000-16-379-L04-T



Learning Objectives:l Listtheadvantagesofadvancingpharmacytechnicianroles.

l Describeapharmacytechnicianprogramaimedateducat-ingandtrainingpharmacytechniciansforspecialtyroles.

l Identifypotentialmeasuresofsuccessofapharmacytech-nicianresidencyprogram.

Presenters:Karen V. Youmbi, Pharm.D., BCPS,PharmacyRegulatorySurveillanceSupervisor,Cedars-SinaiMedicalCenter,LosAngeles,Calif.Margarita Fedorova, CPhT,PharmacyTechnicianSupversior,Cedars-SinaiMedicalCenter,LosAngeles,Calif.Rita Shane, Pharm.D., FASHP, FCSHP,ChiefPharmacyOfiicer,Cedars-SinaiMedicalCenter,LosAngeles,Calif.


a (Management Case Study) Transformation from a Dispensing Model to Patient-centered Clinical Practice in a Small Urban HospitalACTIVITY #0204-0000-16-380-L04-P/0204-0000-16-380-L04-T



Learning Objectives:l Describethemethodsandrationaleusedtoimplementapatient-centeredpharmacypracticewithlimitedresources.

l Describehowgenerationaldifferencescanaffecttheabilitytoinitiateclinicalserviceseffectivelyatthedepartmentallevel.

l Discussthebenefitsofincreasingeducationalofferingsandopportunitiestostaffthroughinteractionswithresidentsandstudents.

Presenter:Michelle A. Lewis, Pharm.D., M.H.A., BCACP,DirectorofPharmacy,NiagaraFallsMemorialMedicalCenter,NiagaraFalls,N.Y.



Educational SessionsMONDAY, DECEMBER 5

11:15 a.m.–12:15 p.m. Palm B, Level 3

a ACPE Update 2016Planned in cooperation with the Accreditation Council for Pharmacy Education

NOTE:CEwillnotbeofferedwiththissession.

TheAccreditationCouncilforPharmacyEducation(ACPE)PresidentandExecutiveDirectorwillpresentupdatesonACPEactivitiesincludingthestateofimplementationofthenewProfessionalDegreeProgramAccreditationStandards(S2016);thestatusoftheHealthProfessionsAccreditorsCollaborative;theContinuingEducationProviderAccredita-tionProgram,includingthegrowthoftheJointAccreditationforInterprofessionalContinuingEducation;thestatusoftheASHP-ACPECollaborationforPharmacyTechnicianEducation/TrainingAccreditationandtheplansforthe2017technicianstakeholderconference;andthegrowthoftheACPEInternationalServicesProgram.

Presenters:Michael A. Mone, B.S.Pharm., J.D., FAPhA,VicePresidentAssociateGeneralCounsel–Regulatory,CardinalHealth,DublinOhio;President,AccreditationCouncilforPharmacyEducation,Chicago,Ill.Peter Vlasses, Pharm.D., D.Sc. (Hon.), BCPS, FCCP,ExecutiveDirector,AccreditationCouncilforPharmacyEducation,Chicago,Ill.


a (Management Case Study) Using Data Analytics to Decrease Renal Failure Cost Per CaseACTIVITY #0204-0000-16-351-L04-P/0204-0000-16-351-L04-T



Learning Objectives:l Discusshowdataanalyticscanbeusedtoquicklygatherandassessdatarelatedtomedicationcosts.(P/T)

l Describeaprocessusedtosuccessfullyreducecostpercaseby46%inoneorganization.(Ponly)

l Evaluatethepotentialforapartnershipwithfinancetobeinvolvedintheinterdisciplinaryclinicalteam.(P/T)

Presenters:Rebecca A. Taylor, Pharm.D., MBA, BCPS,DirectorofPharmacy,ClevelandClinicMarymountHospital,GarfieldHeights,OhioMike Stilgenbauer, M.H.A.,SeniorDirectorofFinance,ClevelandClinic,Cleveland,Ohio


a Brain Matters and Blood Splatters: Drug Therapy in the Emergency Trauma PatientACTIVITY #0204-0000-16-209-L01-P



Program Chair/Moderator: Asad E. Patanwala, Pharm.D., BCPS, FASHP, FCCP,AssociateProfessor,TheUniversityofArizona,Tucson,Ariz.

Learning Objectives:l Selectanappropriatepharmacologicaltherapyregimenforaneurotraumapatient.

l Determinetheappropriatenessofpharmacologicalagentsusedfortraumatichemorrhage.

l Evaluatethepharmacist’sroleduringtraumaticresuscitation.

Presenters:Nicole M. Acquisto, Pharm.D., BCPS,EmergencyMedicineClinicalPharmacySpecialist,UniversityofRochesterMedicalCenter;AssistantProfessor,DepartmentofEmergencyMedicine,UniversityofRochester,Rochester,N.Y.Asad E. Patanwala, Pharm.D., BCPS, FASHP, FCCP


a Interprofessional Education: Preparing Students for Team-based CarePlanned in cooperation with the American Association of Colleges of Pharmacy

ACTIVITY #0204-0000-16-200-L04-P




Learning Objectives:l ReviewtheAccreditationCouncilforPharmacyEducation’s(ACPE’s)2016Standardsthatfocusoninterprofessionaleducation.

l Evaluateinterprofessionaleducationactivitiesinthedidac-ticcurriculum.

l Developinnovativeinterprofessionaleducationforexperi-entialrotations.

l Applythefundamentalskillsforprecepting,facilitating,androle-modelingininterprofessionaleducationandinprac-ticeintheclinicalenvironment.

Presenters:Joel C. Marrs, Pharm.D., ASH-CHC, BCACP, BCPS-AQ Cardiology, CLS, FASHP, FCCP, FNLA,AssociateProfessor,UniversityofColoradoSkaggsSchoolofPharmacy,Aurora,Colo.Sarah Shrader, Pharm.D.,ClinicalAssociateProfessor,UniversityofKansas,KansasCity,Kan.


a Beyond the Pillbox: Improving Medication Adherence and Health OutcomesPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-202-L04-P



Program Chair/Moderator:Sandra Cuellar, Pharm.D., BCOP,ClinicalOncologyPharmacist,ClinicalAssistantProfessor,UniversityofIllinoisHospital&HealthSciencesSystem,Chicago,Ill.



Learning Objectives:l Identifybarrierstomedicationadherenceandevidence-basedstrategiestoimproveadherence.

l Categorizechallengesassociatedwithspecialtymedica-tionsandtheroleofpharmacistsinimprovingmedicationadherenceandhealthoutcomes.

l Evaluatesuccessfulmodelsandinitiativesusedwithinhealthsystemsforimprovingmedicationadherence.

Presenters:Sandra Cuellar, Pharm.D., BCOPDiana Isaacs, Pharm.D., BC-ADM, BCPS, CDE,ClinicalPharmacySpecialist,ClevelandClinic,Cleveland,OhioNate M. Rickles, Pharm.D., Ph.D.,AssociateProfessorofPharmacyPractice,UniversityofConnecticut,Storrs,Conn.


a All In for Specialty PharmacyPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-203-L04-P/0204-0000-16-203-L04-T



Program Chair/Moderator:Lorraine A. Lee, B.S.Pharm., M.H.A.,ExecutiveDirector,PharmacyServices,YaleNewHavenHealthSystem,NewHaven,Conn.

Learning Objectives:l Discusstheelementsofanimplementationplanandastakeholderanalysisneededtoinitiateaspecialtyphar-macyservice.

l Evaluatestrategiesofpatientcaptureandretentioninspe-cialtypharmacyservices.

l Synthesizetheassociateddataelementswithinitiationandexpansionofspecialtypharmacy.

l Discussthemanagementandcommunicationofthesedatatothevariousstakeholders,includingproviders,insurers,andpharmaceuticalmanufacturers.

Presenters:Howard Cohen, R.Ph., M.S., FASHP,Director,OncologyPharmacyServices,SmilowCancerHospitalatYaleNewHaven,NewHaven,Conn.Renee Havriliak, B.S.Pharm., CGP,AssociateDirector,SpecialtyPharmacyServices,YaleNewHavenHospital,NewHaven,Conn.Kyle Skiermont, Pharm.D.,ChiefOperatingOfficer,FairviewPharmacyServices,Minneapolis,Minn.


a CDC Opioid Prescribing Guidelines: Controversy, Opiophobia, and the Role of the PharmacistPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-210-L03-P



Program Chair/Moderator:Ernest J. Dole, Pharm.D., BCPS, FASHP,ClinicalPharmacist,UniversityofNewMexicoPainConsultation&TreatmentCenter;ClinicalAssociateProfessor,UniversityofNewMexicoHealthSciencesCenterCollegeofPharmacy,Albuquerque,N.M.

Learning Objectives:l DebatetheprosandconsforimplementationoftheCentersforDiseaseControlandPrevention(CDC)GuidelineforPrescribingOpioidsforChronicPain.

l Discussthepharmacist’srole,orlackthereof,inthedevel-opmentoftheCDCGuidelineforPrescribingOpioidsforChronicPain.

l SummarizecontroversiesrelatedtothedevelopmentoftheCDCGuidelineforPrescribingOpioidsforChronicPain.

l FormulateyourownprofessionalopinionrelatedtotheCDCGuidelineforPrescribingOpioidsforChronicPain.

Presenters:Ernest J. Dole, Pharm.D., BCPS, FASHPJeffrey Fudin, Pharm.D., B.S., FASHP, FCCP,PresidentandDirector,ScientificandClinicalAffairs,Remitigate,LLC;ClinicalPharmacySpecialistandDirector,PGY2PainPalliativeCareResidency,StrattonVAMedicalCenter;AdjunctAssociateProfessor,AlbanyCollegeofPharmacy&HealthSciences,Albany,N.Y.


a Beyond the Numbers: An Innovative, Patient-centered Approach to Diabetes CarePlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-211-L01-P



Program Chair/Moderator:Mary E. Fredrickson, Pharm.D., BCPS,ClinicalPharmacySpecialist,InternalMedicine,St.JosephWarrenHospital,MercyHealthYoungstown,Warren,Ohio

Learning Objectives:l Choosestrategiesforoptimizingpatientengagementthroughimplementationofself-managementgoalsanddirectinvolvementincareplandevelopment.

l Developacomprehensivediabeticcareplanwithanemphasisonapatient’sindividualgoalspertainingtomedi-cal,psychosocial,andmentalwell-being.

l Evaluatehowbillingforancillaryservices,withanemphasisonpharmacyservices,canbeinstitutedinthesettingofaninterdisciplinarydiabetesclinic.

Presenters:Patrick L. Brine, M.D.,AssociateProgramDirectorSEHCInternalMedicineResidency,MercyHealth-Youngstown,Youngstown,OhioMary E. Fredrickson, Pharm.D., BCPS

Panelists:Kay M. Leonhart, RN, M.S.N., CDE,DiabetesEducationManagerforSt.Elizabeth,St.JosephandSt.ElizabethBoardmanHospitals,MercyHealth–YoungstownMarket,Youngstown,OhioMary Jo Penk, LSW,LicensedSocialWorkerTodd Stanley, RN,RNCareCoordinator,MercyHealth–Youngstown,Youngstown,Ohio


Educational Sessions Monday, December 5 continued2:00 p.m.–3:30 p.m. Mandalay Bay H, Level 2

a Antimicrobial Stewardship for All: What You Need to KnowPlanned in cooperation with the American Pharmacists Association

ACTIVITY #0204-9999-16-213-L04-P



Recertification credit for: BCACP, BCCCP, BCPPS, BCPS, CGP

Program Chair/Moderator: Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID,AssociateProfessor,MidwesternUniversity,DownersGrove,Ill.;InfectiousDiseasesPharmacist,NorthwesternMedicine,Chicago,Ill.

Learning Objectives:l Discussemergingissuesinantimicrobialresistanceamongpathogenscommonlycausinginfectiousdiseasesandtheimplicationsforantimicrobialdruguseinhealthcarefacilities.

l Describeanddevelopmethodsforsurveillanceofantimi-crobialresistanceinhealthcarefacilities.

l Explainthecomponentsofaneffectiveantimicrobialstew-ardshipprogram.

l Applyappropriatemetricsforevaluatingantimicrobialcon-sumptioninhealthcarefacilities.

l Developmethodsformonitoringtrendsandidentifyingopportunitiesforimprovementinantimicrobialusewithinahealthcarefacility.

Presenters:Heather M. Draper, Pharm.D., BCPS,ClinicalPharmacist,EmergencyMedicine,MercyHealthSaintMary’s,GrandRapids,Mich.Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID


2:00 p.m.–3:45 p.m. Mandalay Bay D, Level 2

a Trends in 340B: Central Distribution and Medicaid ReimbursementACTIVITY #0204-0000-16-205-L04-P/0204-0000-16-205-L04-T



Program Chair/Moderator:Christopher A. Hatwig, R.Ph., M.S., FASHP,President,Apexus,Irving,Texas

Learning Objectives:l DiscusstheHealthResourcesandServicesAdministration(HRSA)and340BPrimeVendorProgramupdates.

l Describechallengesandsolutionsregardingcentraldistri-butionina340Bsetting.

l ExplainleadingpracticesinapproachingMedicaidabout340Breimbursementandduplicatediscounts.

Presenters:Jason Atlas, R.Ph., MBA,Manager,340BEducationandComplianceSupport,Apexus,Irving,TexasChristopher A. Hatwig, R.Ph., M.S., FASHPChad Johnson, Pharm.D., MBA,340BProgramManager,FroedtertHospital,Milwaukee,Wisc.Krista Pedley, Pharm.D., Director,OfficeofPharmacyAffairs,HealthResourcesandServicesAdministration,Rockville,Md.


a Safety & Quality Pearls 2016Planned in cooperation with the ASHP Section of Inpatient Care Practitioners

ACTIVITY #0204-0000-16-207-L05-P/0204-0000-16-207-L05-T



Program Chair/Moderator:B. Jane Adams, B.S.Pharm., M.S.,ClinicalPharmacist,MedicationSafetyandQuality,BaylorSt.Luke’sMedicalCenter,Houston,Texas

Learning Objectives:l Describethreeexamplesofinterventionsthathaveimprovedsafetyorqualityofpatientcareinhealthsystems.

l Liststepsforimplementationofatleastonesafetyimprovementprogram.

l Explainhowtoapplythreestrategiesforpreventingpatientharm.

Presentations:IVPushBestPractices:SeeingisBelievingDan Degnan, Pharm.D., M.S., CPPS, FASHP,SeniorProjectManager,PurdueUniversityCollegeofPharmacy,CenterforMedicationSafetyAdvancement,WestLafayette,Ind.

WhyWeSwitchedtoaMoreExpensiveDrugforSafetyReasons:Ryanodex®vs.Dantrium®Jennifer Robertson, Pharm.D., BCPS,MedicationOutcomes&SafetyOfficer,St.JudeChildren’sResearchHospital;AssistantProfessor,DepartmentofPharmacy,UniversityofTennesseeHealthScienceCenter,CollegeofPharmacy,Memphis,Tenn.

BabyDoses:ReducingErrorsinPediatricDosePreparationSara J. D. Bork, Pharm.D., MBA,AssistantDirector–MedicationSafety&Education,TexasChildren’sHospital,Houston,Texas

BreakingEdgeDeliveryTracking:EnsuringtheRightDrugGetstotheRightPlaceStephen J. Davis, Pharm.D., M.S., CPPS,PharmacyOperationsManager,TexasChildren’sHospital,Houston,Texas

WeDon’tKnowWhatWeDon’tKnow:AutomatingtheIHITriggerToolforMeasuringADEsPaul Milligan, Pharm.D.,SystemMedicationSafetyPharmacist,BJCHealthCare;ClinicalPharmacist,WashingtonUniversity,St.Louis,Mo.

OrganizationalImplementationtheNIOSHHazardousDrugListCorbin Bennett, Pharm.D., M.P.H.,DirectorofOutpatientInfusionandOncologyInfusion,KaiserPermanente,Fresno,Calif.

InvestigationalDrugsintheICU:4ThingstoGetRightJohn Petrich, M.S.,InvestigationalDrugServiceManager,ClevelandClinic,Cleveland,Ohio



ImplementingSafetyStrategiesforU-500InsulinBill A. Templeman, Jr., Pharm.D.,InpatientQualitySupervisor,KaiserPermanente,Riverside,Calif.;AssistantClinicalProfessor,LomaLindaSchoolofPharmacy,LomaLinda,Calif.

Pharmacist-ledOralChemotherapyPrescriptionReviewJason Bergsbaken, Pharm.D., BCOP,PharmacyCoordinator,RegionalOncologyServices,UWHealth,Madison,Wis.

WhereDoISign?ExpandinganInpatientandOutpatientTechnologicalChemotherapyOrderingSafeguardAli-Reza Shah-Mohammadi, Pharm.D., M.S., CMQ, FISMP,ClinicalPharmacySpecialist–MedicationSafety,TheUniversityofTexasMDAndersonCancerCenter,Houston,Texas

OverhaulingtheOverrideListAmanda D. Wollitz, Pharm.D., BCPS, FISMP,AssistantDirector,FloridaHospital,Orlando,Fla.

AssessmentofAppropriateAntidote,ReversalAgent,andRescueAgentAvailabilityandReadinessataLargeHealthSystemIndrani Kar, Pharm.D.,ClinicalPharmacySpecialist–DrugPolicy/Formulary,UniversityHospitals,Cleveland,Ohio

IdentificationofRiskFactorsforHospitalReadmissionDuetoBleedingAssociatedwithNon-VitaminKOralAnticoagulants(NOACs)Janelle R. Lenz, Pharm.D.,InternalLiaison,EliLillyandCompany,Indianapolis,Ind.

FDAMedWatch:YourReportMakesaDifferenceTeresa Rubio, Pharm.D.,HealthProgramsCoordinator,OfficeofHealthandConstituentAffairs,U.S.FoodandDrugAdministration,SilverSpring,Md.

ReportingtoFDAMedWatch:UseofaStandardizedAdverseDrugReactionReportingAlgorithminaComprehensiveCancerCenterP. Sayer Monroe, Pharm.D., CJCP, CMQ,MedicationSafetyConsultant,TheUniversityofTexasMDAndersonCancerCenter,Houston,Texas

AWeightyProposal:UsingGravimetricsintheIVPreparationProcessKelley Reece, Pharm.D.,AssistantPharmacyManager,MDAndersonCancerCenter,Houston,Texas

UtilizingaMedicationSafetyDashboardtoDriveQualityCareMichael C. Dejos, Pharm.D., BCPS,MedicationSafetyOfficer,AlfredIDuPontHospitalforChildren,Wilmington,Del.

ACostAvoidanceModelforMedicationSafetyProgramsElizabeth Wade, Pharm.D., BCPS,MedicationSafetyOfficer,ConcordHospital,Concord,N.H.

ASystemQualityEfforttoTransformMedicationSafetyElizabeth Rebo, Pharm.D.,MedicationSafetyOfficer,WellStarHealthSystem,Atlanta,Ga.


a Debates in Therapeutics 2016Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-208-L01-P



Program Chair/Moderator:Kevin E. Anger, Pharm.D., BCPS,ManagerInvestigationalDrugServices,BrighamandWomen’sHospital,Boston,Mass.

Learning Objectives:l Explainwhytherapeuticcontroversiesmightoccurinclini-calpractice.

l Identifythreetherapeuticareasinwhichcontroversiesmayexist.

l Discusstheprosandconsofselectedtherapeuticissues.

Debate Topics:IfIRuledtheWorld:Opioid-basedTherapyvs.Non-Opioid-basedTherapyforNASChristopher McPherson, Pharm.D.,ClinicalPharmacist,NeonatalICU,St.LouisChildren’sHospital;AssistantProfessor,WashingtonUniversitySchoolofMedicine,St.Louis,Mo.;Sara Rostas, Pharm.D., BCPS,ClinicalPharmacySpecialist,NeonatalICU,Brigham&Women’sHospital,DepartmentofPharmacy,Boston,Mass.

OldSchoolvs.NewSchool:Anti10avs.aPttTestingforIntravenousHeparinProtocolMonitoringRuchi Jain, Pharm.D., BCPS,ClinicalPharmacySpecialist–MedicalIntensiveCareUnit,HackensackUniversityMedicalCenter,Hackensack,N.J.;Jeremy W. Vandiver, Pharm.D., BCPS,AssistantProfessorofPharmacyPractice,UniversityofWyomingSchoolofPharmacy,Laramie,Wyo.

PRODexorNOdexforSevereAlcoholWithdrawalPatrick Bridgeman, Pharm.D., BCPS,ClinicalAssistantProfessor,ErnestMarioSchoolofPharmacy,Piscataway,N.J.;ClinicalPharmacySpecialist–EmergencyMedicine,RobertWoodJohnsonUniversityHospital,NewBrunswick,N.J.;Scott W. Mueller, Pharm.D., BCCCP,AssistantProfessor,UniversityofColoradoSkaggsSchoolofPharmacyandPharmaceuticalSciences;CriticalCareClinicalSpecialist,UniversityofColoradoHealth,Aurora,Colo.





Educational Sessions Monday, December 5 continued2:00 p.m.–4:00 p.m. Oceanside A, Level 2

a Joint Commission: Don’t Roll the Dice; Be Prepared!ACTIVITY #0204-0000-16-212-L03-P/0204-0000-16-212-L03-T



Program Chair/Moderator:John P. Uselton, R.Ph., B.S.,DirectorofQualityandPharmacyPractice,CardinalHealth,Houston,Texas

Learning Objectives:l Identifyimportantcomplianceissuesinpreparingforaccreditationsurveysusingmedicationmanagementprocesses.

l Explainhowtoidentifyproblematicareaspriortosurveys,anddevelopanactionplan.

l Designbasic,easy-to-implementstrategiestoprepareforsurveyoractivities.

l Compareandcontrastthedifferencesinstrategyforsurveypreparationininpatientandambulatorysettings.

Presenters:Robert Jordin, R.Ph., B.S.,DirectorAccreditationandMedicationSafety,CardinalHealthInnovativeDeliverySolutions,Houston,TexasPatricia C. Kienle, R.Ph., M.P.A., FASHP,Director,AccreditationandMedicationSafety,CardinalHealth,Laflin,Pa.Lee B. Murdaugh, R.Ph., Ph.D.,DirectorofAccreditationandMedicationSafety,CardinalHealthInnovativeDeliverySolutions,Houston,TexasJohn P. Uselton, R.Ph., B.S.

2:00 p.m.–4:00 p.m. Mandalay Bay F, Level 2

a Balancing Act: Managing Bleeding and Thrombosis with Direct Oral AnticoagulantsACTIVITY #0204-0000-16-214-L01-P



Program Chair/Moderator:William Dager, Pharm.D., BCPS, FASHP, FCCM, FCCP, MCCM,PharmacistSpecialist,UniversityofCaliforniaDavisMedicalCenter,Sacramento,Calif.

Learning Objectives:l Evaluateavailableoptionsforreversingtheeffectsofdirectoralanticoagulants(DOACs).

l Determinecommonconsiderationswhenmanagingbleed-inginapatientreceivinganticoagulationtherapy.

l DebatetheprosorconswiththeuseofadirectantidoteorconcentratedclottingfactortomanagebleedinginapatientonaDOAC.

Presenters:William Dager, Pharm.D., BCPS, FASHP, FCCM, FCCP, MCCMJohn Fanikos, R.Ph., MBA, AssistantDirectorofPharmacy,Brigham&Women’sHospital/PartnersHealthcare,Boston,Mass.Michael Gulseth, Pharm.D., BCPS, FASHP,ProgramDirectorforAnticoagulationServices,SanfordUSDMedicalCenter;President,MichaelP.GulsethAnticoagulationConsulting,Inc.,SiouxFalls,S.D.

Aaron J. Roberts, Pharm.D., BCPS-AQ Cardiology,SeniorClinicalPharmacist,UCDavisMedicalCenter,Sacramento,Calif.;AssociateClinicalProfessorofPharmacy,UCSanFrancisco,SchoolofPharmacy,SanFrancisco,Calif.;AssociateClinicalProfessorofMedicine,UCDavisSchoolofMedicine,Sacramento,Calif.


a Pharmacy Practice Pearls from Around the Globe 2016Featuring the Donald E. Francke Medal Lecture

ACTIVITY #0204-0000-16-201-L04-P/0204-0000-16-201-L04-T



Program Chair/Moderator:Eric M. Maroyka, Pharm.D., BCPS,Director,CenteronPharmacyPracticeAdvancement,ASHP,Bethesda,Md.

DonaldE.FranckeMedalistMr.LeeC.Vermeulenpres-ents“Transcending Borders, Surpassing Boundaries”at2:00pmTheeducationalsessionstartsimmediatelyafterthelectureat2:30pmTheDonaldE.FranckeMedalwasestablishedtohonorpharmacistswhohavemadesignificantinternationalcontributionstoadvancepharmacypractice.

AllattendeesofthissessionareinvitedtojoinMr.Vermeulenafterthesessiontooffercongratulationsataspecialrecep-tionforInternationalRegistrants.Thereceptionisanopportunitytonetworkwithyourfriendsandcolleaguesfromaroundtheworld.Lightrefreshmentswillbeserved.

Learning Objectives:l Identifypracticechallengesfromaglobalperspectiveandstrategiestoovercomethesechallenges.

l Describehowinternationalpharmacypracticescanbeadaptedtoyourpracticesetting.

l Compareandcontrastinternationalpharmacypracticestandards.

Presenters:Ahmed Aljedai, Pharm.D., MBA, BCPS, FCCP, ProfessorandDirector,PharmaceuticalCareDivision,KingFaisalSpecialistHospitalandResearchCenter,Riyadh,SaudiArabiaAlistair H. Gray, B.Sc. (Hons.), MRPharmS, DipClinPharm,ClinicalServicesLeadPharmacist,EastLancashireHospitalsNHSTrust,Blackburn,Lancashire,EnglandYimei Huang, Pharm.D., B.S.,ClinicalPharmacist,WestChinaHospital/WestChinaSchoolofMedicine,SichuanUniversity;AssistantProfessor,Chengdu,Sichuan,ChinaShuaib Mahomed, B.Pharm., M.Sc., SeniorInpatientPharmacist,OperatingRoomPharmacyProjectLeader,ClevelandClinicAbuDhabi,AbuDhabi,UAERaliat Onatade, B.Pharm. (Hons.), M.Sc., MRPharmS, DeputyDirectorofPharmacy,ClinicalServices,London,U.K.Carmen Guadalupe Rodriguez Gonzalez, Ph.D., HospitalPharmacist,Madrid,SpainJihan H. Safwan Saade, Pharm.D., ClinicalAssistantProfessor,Ghazir,Lebanon





a Overcoming the Headwinds of Change: Proactive Focus on Career Inflection Points in Women’s Leadership AdvancementPlanned in cooperation with the ASHP Women in Leadership Steering Committee

ACTIVITY #0204-0000-16-204-L04-P/0204-0000-16-204-L04-T



Program Chair/Moderator:Sharon Murphy Enright, B.S.Pharm., MBA,President,EnvisionChangeLLC,Atlanta,Ga.

Learning Objectives:l Evaluatecriticalcareerinflectionpointsforwomen’ssuc-cessfuladvancementinleadershiprolesandlevels.

l Differentiateinflectionpointsbasedonprofessionalroleandfocus,administrativeversusclinical.

l Strategizeindividualandorganizationalfactorsandprac-ticesassociatedwithsuccessfulcareertrajectory.

Presenters:Steven Cano, M.S., FASHP,ChiefPharmacyOfficer,CambridgeHealthAlliance,Cambridge,Mass.Meghan D. Swarthout, Pharm.D., MBA, BCPS,DivisionDirector,AmbulatoryandCareTransitionsPharmacy,TheJohnsHopkinsHealthSystem;AssociateDirector,ClinicalServices,JohnsHopkinsHomeCareGroup,Baltimore,Md.Sara J. White, M.S., B.S., FASHP,(Ret.)DirectorofPharmacy,StanfordHospitalandClinics,PaloAlto,Calif.


a (Management Case Study) Pharmacist Population Health Interventions Based on Data Generated Risk and Care GapsACTIVITY #0204-0000-16-352-L04-P



Learning Objectives:l Describehowpharmacistscanparticipateindiseaseman-agementandpopulationhealthusinglaboratory-baseddata.

l Definethreehealthconditionsthatarehighriskandhighcostforhealthcareorganizationsandareidealforpopula-tionhealthinitiatives.

l Identifyhowgapsincarecanbeidentifiedusinglaboratorydatafordiseasemanagementandpopulationhealth.

Presenters:Kathleen Swanson, R.Ph., M.S.,DirectorEnterpriseClinicalSolutions,TriCoreReferenceLaboratories,Albuquerque,N.M.Monique Dodd, Pharm.D.,PharmacyFellowTranslationalResearch,TriCoreReferenceLaboratories,Albuquerue,N.M.


a (Management Case Study) Business Intelligence Strategies: Improving Access and Analysis of Ad Hoc Reports Across the Pharmacy EnterpriseACTIVITY #0204-0000-16-353-L04-P/0204-0000-16-353-L04-T



Learning Objectives:l Identifythreekeyresourcestoestablishapharmacybusinessintelligencestrategy.

l Listfivecasescenariosthatwouldhelpaddressthemajorityofdepartmentalneeds.

l Describetwobarriersthatneedtobeovercomeinimple-mentingapharmacybusinessintelligencestrategy.

Presenters:Ashley Purohit, Pharm.D., MBA,SpecialtyPharmacyCoordinator,AuroraHealthCare,Milwaukee,Wis.Al Loeb, M.S.,SeniorDirectorPharmacyOperations,AuroraHealthCare,Milwaukee,Wis.


a Chronic Opioid Therapy for Patients with Substance Use Disorder: Between the Devil and the Deep Blue SeaPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-223-L01-P



Program Chair/Moderator:Ernest J. Dole, Pharm.D., BCPS, FASHP,ClinicalPharmacist,UniversityofNewMexicoPainConsultation&TreatmentCenter;ClinicalAssociateProfessor,UniversityofNewMexicoHealthSciencesCenterCollegeofPharmacy,Albuquerque,N.M.

Learning Objectives:l IdentifythemostappropriateopioidforpaincontrolincontextoftheCentersforDiseaseControlandPrevention(CDC)forapatientwithchronicnoncancerpain(CNCP)andsubstanceabusedisorder(SUD).

l Selecttheappropriateurinedrugmonitoring(UDM)testinthecontextoftheCDCguidelinesforapatientwithCNCPandSUD.

l Prepareanindividualizedpharmacotherapeuticregimenforapatient,includingcontrolledsubstanceagreement(CSA),rescuenaloxone,andmonitoring.

Presenters:Ernest J. Dole, Pharm.D., BCPS, FASHPMichele Matthews, Pharm.D., BCACP, CPE, FASHP,AssociateProfessorofPharmacyPractice,MCPHSUniversity;AdvancedPharmacistPractitioner–PainManagement,BrighamandWomen’sHospital,Boston,Mass.


Educational Sessions Monday, December 5 continued3:45 p.m.–5:15 p.m. Oceanside C, Level 2

a Antimicrobial Stewardship: Considerations and Limitations in Geriatric Care SettingsACTIVITY #0204-0000-16-222-L04-P



Recertification credit for: CGP

Learning Objectives:l Describerecentregulationsandgovernmentguidancestatementscallingforuseofantimicrobialstewardshipingeriatriccaresettings.

l Applycurrentliteraturedescribingantimicrobialsteward-shiptechniquesinthegeriatriccaresetting.

l Discusstheimplicationsofnewinfectiousdiseasesguide-linesfortheuseofantimicrobialagentsinthegeriatricpatientpopulation.

l Recommendappropriateantibiotictherapyforageriatricpatient,takingintoconsiderationinfectious-diseasesman-agementprinciplesandpatient-specificvariables.

l Makeappropriateantimicrobial-monitoringrecommenda-tionsforageriatricpatientbasedonpatient-specificvari-ablesandantimicrobialstewardshipprinciples.

Presenter:Kalin Clifford, Pharm.D., BCPS,AssistantProfessorofPharmacyPractice,GeriatricsDivision,TexasTechUniversityHealthSciencesCenterSchoolofPharmacy,Dallas,Texas



a Improving Antimicrobial Dosing for Critically Ill Patients: How to Translate Current Evidence into PracticeACTIVITY #0204-0000-16-225-L01-P



Recertification credit for: BCCCP, BCPS

Learning Objectives:l Applytheresultsofclinicalstudiesoftheimpactoftheseverityofillnessonbeta-lactamantibioticpharmacokinet-icsandpharmacodynamicswhenrecommendingantimi-crobialtherapyforacriticallyillpatient.

l Developanantimicrobialdrugregimenforacriticallyillpatient,takingintoconsiderationtherelationshipbetweenthepharmacokineticchangesobservedinpatientswithcriticalillnessandthevariabilityinpharmacokineticandpharmacodynamictargetattainmentratesforconcentra-tion-dependentantibiotics.

Presenter:Nathaniel J. Rhodes, Pharm.D., M.S., BCPS,AssistantProfessorofPharmacyPractice,MidwesternUniversity,DownersGrove,Ill.;InfectiousDiseasesClinicalPharmacist,NorthwesternMedicine,Chicago,Ill.



a Combating Illegal Internet Pharmacy Websites: National Association of Boards of Pharmacy’s View from the TopACTIVITY #0204-0000-16-215-L03-P/0204-0000-16-215-L03-T



Program Chair/Moderator:Melissa A. Madigan, Pharm.D., J.D.,PolicyandCommunicationsDirector,NationalAssociationofBoardsofPharmacy,MountProspect,Ill.

Learning Objectives:l Summarizethecurrentillegalonlinedrugenvironmentanditsnegativeimpactonpatientoutcomesglobally.

l Listthecurrentmethodsusedtocurbillegalonlinedrugsales.l Identifypotentialtechnicalsolutionsthatwillleadtosafeonlinepharmacypractice.

Presenters:Martin Allain, J.D.,PharmacySeniorManager,NationalAssociationofBoardsofPharmacy,MountProspect,Ill.Melissa A. Madigan, Pharm.D., J.D.


a What Happens in the Cath Lab Stays in the Cath Lab: An Update of Old, New, and Controversial Topics in Interventional CardiologyPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-217-L01-P



Program Chair/Moderator:Jessica Starr, Pharm.D., BCPS, FCCP,AssociateClinicalProfessor,AuburnUniversity,Birmingham,Ala.

Learning Objectives:l Describedifferentrisk-assessmentstrategiesforbleedingandthrombosusandhowtheyapplytoappropriatemedi-cationselection.

l Analyzecomparativeliteratureandidentifypatientswhomaybecandidatesforunfractionatedhepariunvs.Bivalirudin.

l OutlinetheevolutionofP2Y12inhibitorsandevaluatetheroleofcangrelorinmodernpercutaneouscoronaryinterventions.

Presenters:Douglas Jennings, Pharm.D., BCPS-AQ Cardiology, FAHA, FCCP,ClinicalPharmacyManager,NewYorkPresbyterianColumbiaUniversityMedicalCenter,NewYork,N.Y.Philippe Mentler, BCPS,SeniorConsultant,VizientInc,Cary,N.C.




a Biosimilar Therapeutics in Hematology Malignancies — A Contemporary ReviewPlanned in cooperation with the ASHP Section of Clinical Specialists and ScientistsACTIVITY #0204-0000-16-218-L01-P



Program Chair/Moderator:Eve Segal, Pharm.D.,ClinicalOncologyPharmacist,UniversityofWashingtonMedicalCenter/SeattleCancerCareAlliance,Seattle,Wash.

Learning Objectives:l AnalyzeFoodandDrugAdministration(FDA)guidancedoc-umentsanddiscusstheapprovalprocessforbiosimilars.

l Describecurrentapplicationsfortheuseofbiosimilarsinpatientswithhematologymalignancies.

l Evaluatecurrentclinicalpracticeguidelinesfortheuseofbiosimilarsinoncologyandpotentialshortcomings.

l Describedesiredtherapeuticoutcomesforbiosimilars.

Presenters:Ali McBride, Pharm.D., M.S., BCOP, BCPS,ClinicalCoordinator,Hematology/Oncology,TheUniversityofArizonaCancerCenter,Tucson,Ariz.John Valgus, Pharm.D., M.H.A., BCOP,ClinicalManager,Hematology/OncologyPharmacyServices,UniversityofNorthCarolinaMedicalCenter,ChapelHill,N.C.


a What’s New in Diabetes? Insulin Products, Concentrations, and Multimodal TherapyACTIVITY #0204-0000-16-224-L01-P



Program Chair/Moderator:LaDonna M. Oelschlaeger, Pharm.D., BCPS,AssociateProfessor,MarshallB.KetchumUniversityCollegeofPharmacy,Fullerton,Calif.

Learning Objectives:l Evaluatetherapeuticuseofnewinsulinproducts.l Constructaninsulinregimenusingnewinsulinproductsforspecificpatientcases.

l Describetheprocessforimplementingamultimodaldos-ingpharmacyprotocol.

l Explaintheprocessforconvertingapatientwithdiabetestoamultimodalinsulinregimen.

Presenters:Angela Hodges, Pharm.D., BC-ADM, LSSYB,ClinicalPharmacistDiabetesSpecialist,TexasHealthHuguleyHospitalFortWorthSouth,Burleson,TexasNathan A. Painter, Pharm.D., CDE,AssociateClinicalProfessor,UCSanDiegoSkaggsSchoolofPharmacy,LaJolla,Calif.


a (Management Case Study) Ace the MACE (Medication-Related Acute Care Episode): Assessment of the Impact of Pharmacists’ Post-Discharge Follow-up on High-Risk PatientsACTIVITY #0204-0000-16-354-L04-P

0204-0000-16-354-L04-T



Learning Objectives:l ApplytheMedicationRelatedAcuteCareEpisodes(MACE)toolkittodeterminetheseverityofdrug-relatedproblemsidentifiedduringpost-dischargefollow-upandthepotentialformedication-relatedacutecareepisodes.

l Identifystrategiestoengagehealth-careprovidersintheMACEtoolkit.

l DescribehowtousetheMACEtoolkittoimplementneworexpandexistingpharmacisttransitionsofcareprogramsatotherhealthsystems.

Presenters:Lydia E. Noh, Pharm.D.,PGY-2Health-SystemPharmacyAdministrationResident,Cedars-SinaiMedicalCenter,LosAngeles,Calif.Kristina Bennwitz, Pharm.D.,PGY-2AmbulatoryCarePharmacyResident,UWHealthPharmacyServices,Madison,Wis.Rita Shane, Pharm.D., FASHP, FCSHP,ChiefPharmacyOfficer,Cedars-SinaiMedicalCenter,LosAngeles,Calif.


a Preparing for Change: Antimicrobial Stewardship in Ambulatory CarePlanned in cooperation with the American Pharmacists Association

ACTIVITY #0204-9999-16-219-L04-P



Recertification credit for: BCACP

Learning Objectives:l Discussproposedregulatorystandardsforantimicrobialstewardshipintheambulatorycaresettinganddescribeaneffectiveinterprofessionalantimicrobialstewardshipteamtomeetorexceedthestandards.

l Useantimicrobialsurveillancedatatoidentifypotentialtar-getsforantimicrobialstewardshipactivitiesintheambula-torycaresetting.

l Designinnovativestrategiesforantimicrobialstewardshipintheambulatorycaresetting,includingcollaborativeprac-ticeagreementsandlocalprescribingguidelines.

Presenter:Heather M. Draper, Pharm.D., BCPS,ClinicalPharmacist,EmergencyMedicine,MercyHealthSaintMary’s,GrandRapids,Mich.



Educational Sessions Tuesday, December 6 continued4:30 p.m.–5:15 p.m. Mandalay Bay D, Level 2

a Data Science Principles of Predictive and Prescriptive Analytics: Streamlining Your Pharmacy PracticePlanned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-220-L04-P/0204-0000-16-220-L04-T



Learning Objectives:l Discussseveraldatasciencetechniquesforpredictingoutcomes.

l Describehowtointerpretthediscriminatorypowerofapredictivemodel.

l Evaluateseveralapplicationsforpredictiveandprescriptiveanalyticsinpharmacypractice.

Presenter:Sandra L. Eldridge, Pharm.D., BCACP,ClinicalRulesConsultant,MedSavvy,Portland,Ore.


a Pediatric Clinical Pearls 2016Planned in cooperation with the ASHP Section of Clinical Specialists and ScientistsACTIVITY #0204-0000-16-221-L01-P



Program Chair/Moderator:Audrey Kennedy, Pharm.D., BCPS,ClinicalSafetyOfficer,Children’sMercyKansasCity,KansasCity,Mo.

Learning Objectives:l Discussclinicalpediatricscenariosthatmightnotbewidelyknownorpublished.

l Identifynovelclinicalpracticeoptionsforpatientcareinpediatrichealth-systemsettings.

l Describemedication-managementstrategiesindifficultorcontroversialpediatricpatientcaresituations.

Presentations:StatinsinPediatricHeartTransplantationEmily Benefield, Pharm.D., BCPS, ResidencySiteCoordinator,PGY2PediatricResidencyDirector,IntermountainHealthcare,SaltLakeCity,Utah

PediatricInsomnia:TheAtoZzz’sofMelatoninUseChelsey J. Jensen, Pharm.D., BCPS,PediatricClinicalPharmacist–MedicationTherapyManagement,Children’sHospitalsandClinicsofMinnesota,Minneapolis,Minn.

CysticFibrosisTransmembraneConductanceRegulator(CFTR)Modulators:ChangingTheFutureofCysticFibrosisTreatment&ManagementE. Claire Elson, Pharm.D.,ClinicalPharmacySpecialist,Children’sMercyHospital;AdjunctFaculty,UniversityofMissouriKansasCitySchoolofPharmacy,KansasCity,Mo.

GettingHigherandHigher:LevetiracetamLoadingDosesinStatusEpilepticusStephanie Weightman, Pharm.D., BCPS, BCPPS,Clinical

Pharmacist–EmergencyDepartment,Children’sHealth–Children’sMedicalCenterDallas,Dallas,Texas

SheddingLightonBarrierstoTotalParenteralNutritionLightProtectionThroughouttheCompoundingProcessBob John, Pharm.D., BCPS,NICUClinicalPharmacySpecialist,TheChildren’sHospitalatSaintFrancis,Tulsa,Okla.

NotThisAgain:VancomycinPKPrimerKyana D. Stewart, Pharm.D., M.S., BCPS,SeniorClinicalPharmacist,PediatricInfectiousDisease,Children’sHealth,Children’sMedicalCenterDallas,Dallas,Texas

TUESDAY, DECEMBER 68:00 a.m.–8:30 a.m. South Seas D, Level 3

a (Management Case Study) Exploring the Use of Rapid Diagnostic Tests to Ensure Timely Treatment of InfectionsACTIVITY #0204-0000-16-355-L04-P



Learning Objectives:l Describetypesofrapiddiagnostictests.l Describetherapiddiagnostictestalgorithm.l Describepharmacists’potentialimpactonimprovingtimetoeffectivetherapy.

Presenter:Hai Tran, Pharm.D.,DrugUsePolicyManager,Cedars-SinaiMedicalCenter,LosAngeles,Calif.


a When Patients Outweigh the Mold: Pharmacotherapy in Pediatric ObesityPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-232-L01-P



Program Chair/Moderator:Audrey Kennedy, Pharm.D., BCPS,ClinicalSafetyOfficer,Children’sMercyKansasCity,KansasCity,Mo.

Learning Objectives:l Interpretliteratureonpharmacokineticalterationsandspe-cificdose-adjustmenttoolsintheobesepediatricpopulation.

l Justifydrugdosingforcommonandhigh-riskmedicationsinoverweight/obesepediatricpatients.

l Evaluatedosingstrategiesforcommonagentsusedascon-tinuousinfusions.

Presenters:Peter N. Johnson, Pharm.D., BCPPS, BCPS, FPPAG,AssociateProfessor,UniversityofOklahomaCollegeofPharmacy;ClinicalPharmacySpecialist–PediatricCriticalCare,TheChildren’sHospitalatOUMedicalCenter,OklahomaCity,Okla.Brady S. Moffett, Pharm.D., M.P.H.,ClinicalPharmacySpecialist,TexasChildren’sHospital;AssistantProfessor–Pediatrics,BaylorCollegeofMedicine,Houston,Texas




a Doing the Right Things and Doing Things Right: Tips and Tricks for Relevant and Efficient Inpatient Drug SurveillancePlanned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-233-L04-P/0204-0000-16-233-L04-T



Learning Objectives:l List10frequentlyfiringdrug-druginteractions.(Ponly)l Identifytheadditionalpatient-specificdataneededtopre-ventirrelevantalerting.(P/T)

l Explainwhyirrelevantalertingofdruguseinrenalfailureoccurs,despiteimplementingrenalfailurecutoffpointsfromanationaldatabase.(Ponly)

l Reviewtheadvantagesofamedication-monitoringsystemasopposedtoanalertingsystematthetimeofinitiatinganorder.(P/T)

l Identifythreekeypointsofthepresentationthattheaudi-encecanimplementimmediately.(P/T)

Presenter:Pieter J. Helmons, Pharm.D., PhD, M.A.S.,HospitalPharmacist,St.JansdalHospital,Harderwijk,Netherlands


a Combat the Opioid Crisis: Fuel the Battle with Nonpharmacologic AlternativesPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-236-L01-P



Program Chair/Moderator:Maria Foy, Pharm.D., BCPS, CPE,ClinicalSpecialist,PalliativeCare,AbingtonHospitalJeffersonHealth,Abington,Pa.

Learning Objectives:l Describethecurrentopioidcrisisandcurrentrecommen-dationsforopioiduseinchronicnon-cancerpain(CNCP).

l GivenapatientwithCNCPonmedication,developathera-peuticregimentusingauricularacupuncture.

l Applymindfulmeditationtechniquesforrelaxationthatcanbeusedforpaincontrol.

Presenters:Ernest J. Dole, Pharm.D., BCPS, FASHP,ClinicalPharmacist,UniversityofNewMexicoPainConsultation&TreatmentCenter;ClinicalAssociateProfessor,UniversityofNewMexicoHealthSciencesCenterCollegeofPharmacy,Albuquerque,N.M.Maria Foy, Pharm.D., BCPS, CPE

8:00 a.m.–9:30 a.m. Lagoon F, Level 2

a Washington State Pharmacist Billing for Care Services: Successful Collaboration Among Provider Associations, Health Systems, and Health PlansPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners and the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-226-L04-P/0204-0000-16-226-L04-T



Program Chair/Moderator:Shirley J. Reitz, Pharm.D., B.S.,Manager,PharmacyStrategicRelations,OmedaRx/RegenceHealthPlan,Seattle,Wash.

Learning Objectives:l ExplainWashingtonstateeffortsonhealthinsurancecom-pensationcoverageforpharmacistservices.

l Describestateadvocacyeffortsthatledtothepassageoflegislationthatincludespharmacistsinmedicalprovidernetworks.

l Recommendstrategiesthathealthsystemscanusetocol-laboratewithprofessionalsocietiesandpayerstosupportapharmacistaspartofateam-basedcaremodel.

l Assessmethodsthatcanbeusedtoidentifystakeholdersandrecommendkeyimplementationstepsthatensureeffectiveprovisionandbillingofpatientcareservices.

l Justifytheroleoftheprofessionalsociety,health-systemleaders,healthplans,andothersintheadvancementofproviderstatusandreimbursementforservicesprovided.

Presenters:Shirley J. Reitz, Pharm.D., B.S.Jeff Rochon, Pharm.D.,ChiefExecutiveOfficer,WashingtonStatePharmacyAssociation,Renton,Wash.Roger Woolf, Pharm.D.,AdministrativeDirector,VirginiaMasonMedicalCenter,Seattle,Wash.






Educational Sessions Tuesday, December 6 continued8:00 a.m.–9:30 a.m. South Seas J, Level 3

a Transitioning Your Antibiotic Patients Through the Healthcare System: Practical Approaches for Seamless CarePlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-227-L01-P



Program Chair/Moderator:Barbara Petroff, R.Ph., M.S., FASHP,PharmacyManager,SoleoHealth,Novi,Mich.;Principal,ShawlerpetroffLLC,Livonia,Mich.;Faculty,UniversityofPhoenix,Southfield,Mich.

Learning Objectives:l Identifyfactorsthatshouldbeconsideredwhenchoosingantibiotictherapyforpatientstransitioningfromonehealth-caresettingtoanother.

l Describetherolesoftheinpatientpharmacist,dischargeplanner,andambulatorycareclinicalpharmacistwhenworkingtosuccessfullytransitionpatients.

l Defineatransitions-of-careplanforapatientrequiringcon-tinuedantibiotictherapybeyondhospitaldischarge.

Presenters:Spencer Durham, Pharm.D., BCPS-AQ ID,AssistantClinicalProfessor,AuburnUniversityHarrisonSchoolofPharmacy,Auburn,Ala.Barbara Petroff, R.Ph., M.S., FASHPCarol J. Rollins, Pharm.D., M.S., FASHP,ClinicalProfessor,CollegeofPharmacy,UniversityofArizona,Tucson,Ariz.


a Pharmacy Technicians: Essential Pieces of the Specialty Pharmacy PuzzlePlanned in cooperation with the Pharmacy Technician Certification Board

ACTIVITY #0204-0000-16-228-L04-P/0204-0000-16-228-L04-T



Program Chair:Angela T. Cassano, Pharm.D., BCPS, FASHP,President,PharmfusionConsulting,LLC,Midlothian,Va.Moderator: Miriam Mobley Smith, Pharm.D., B.S.Pharm., FASHP,DirectorofStrategicAlliances,PharmacyTechnicianCertificationBoard,Washington,D.C.

Learning Objectives:l DiscussaspectsoftheASHPSpecialtyPharmacyResourceGuidespecifictopharmacytechnicians.

l Listtheoperationalrolesandresponsibilitiesofpharmacytechniciansinspecialtypharmacy.

l Identifyhowtotrainandassesscompetencyforpatientcaresupportandtechnicalsupportrolesofpharmacytechnicians.

l Evaluatecaseexamplesofspecialtypharmacyprogramsspecifictopharmacytechnicianrolesandresponsibilities.

Presenters:Gina Batterman, R.N.,Supervisor,MedicationPriorAuthorizationDept,UniversityofWisconsinHospitalandClinics,Madison,Wis.Joe Cesarz, Pharm.D., M.S.,Manager,AmbulatoryPharmacyServices,UWHealth,Madison,Wis.Ryan Cranyon, Pharm.D.,SeniorAdministrativeResident,UWHealth,Madison,Wis.


a Welcome to Your Future: Credentialing and Privileging Processes for PharmacistsPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-231-L04-P




Learning Objectives:l Definecredentialingandprivilegingasitrelatestohealth-carepractitioners.

l Explainhowcredentialingandprivilegingprocesseswereimplementedinvarioushealthcaresystems.

l Discussthebenefitsofcredentialingandprivilegingpro-gramsfortheadvancementofpatientcareservices.

l IdentifytoolsandinformationfromtheASHPCredentialingandPrivilegingResourceCenterthatcanbeusedtoestab-lishorexpandprograms.

Presenters:Julie Groppi, Pharm.D., FASHP,PBMProgramManager:ClinicalPharmacyPracticePolicyandStandards,DepartmentofVeteransAffairs,PharmacyBenefitsManagement(10P4P),ClinicalPharmacyPracticeOffice(CPPO),Washington,D.C.David Reardon, Pharm.D., BCPS,SolidOrganTransplantClinicalPharmacist,Yale-NewHavenHospital,NewHave,Conn.Betsy Shilliday, Pharm.D., BCACP, CDE, CPP, FASHP,Director,AdvancedPracticeProviderCenter,UniversityofNorthCarolina;ClinicalPharmacistPractitioner,UNCSchoolofMedicineandEshelmanSchoolofPharmacy,ChapelHill,N.C.


Stay connected to everything happening at the Midyear Clinical Meeting with #ASHP16, the official hashtag for the Midyear meeting. Don’t forget to tag your tweets, photos, and videos with the hashtag so others can follow along with your experiences on Twitter, Facebook, and Instagram.

Follow #ASHP16


8:00 a.m.–9:30 a.m. Oceanside B, Level 2

a Help After a Tragic Medication Error: The Implementation of a Second Victim ProgramACTIVITY #0204-0000-16-235-L05-P/0204-0000-16-235-L05-T



Program Chair/Moderator:Natasha Nicol, Pharm.D., FASHP,DirectorofGlobalPatientSafetyAffairs,CardinalHealth,PawleysIsland,S.C.

Learning Objectives:l Definethetermsecondvictimandthestagesofrecovery.l Assesstheeffectanerrorhasonsecondvictimsandwhatcanbedonepost-eventinordertolearnfromtheeventandactaccordingly.

l EvaluatetheScottThree-TieredInterventionalModelofSupport.l Developaplantocreateasecondvictimprogram.l Explainwaystoassesstheimpactofasecondvictimprogram.

Presenters:James M. Hoffman, Pharm.D., M.S., BCPS,ChiefPatientSafetyOfficer,St.JudeChildren’sResearchHospital,MemphisTenn.Kara D. Krzan, Pharm.D., M.S.,Chief,PediatricandWomen’sClinicalPharmacyServices,UniversityofFloridaHealthShands,Gainesville,Fla.Jenna Merandi, Pharm.D., M.S.,MedicationSafetyCoordinator,NationwideChildren’sHospital;ResidencyDirector,NationwideChidren’sHospital,Columbus,OhioNatasha Nicol, Pharm.D., FASHP

8:00 a.m.–9:30 a.m. Oceanside A, Level 2

a Dazed and Confused in the Intensive Care Unit: Managing Delirium Is More Than Just a State of MindACTIVITY #0204-0000-16-239-L01-P



Program Chair/Moderator:Mitchell Buckley, Pharm.D., BCCCP, FASHP, FCCM, FCCP,ClinicalPharmacySpecialist,Banner–UniversityMedicalCenterPhoenix,Phoenix,Ariz.

Learning Objectives:l EvaluatetheassociationbetweenICUdeliriumandbenzo-diazepineuse.

l Compareandcontrastrapidlyreversible,sedation-relateddeliriumwithpersistent,acutebraindysfunction.

l Recommendimplementationstrategiesforsedation,delir-ium,andmobilityforbestpracticesinICUpatients.

Presenters:Earnest Alexander, Jr., Pharm.D., FCCM, AssistantDirector,ClinicalPharmacyServices,TampaGeneralHospital,Tampa,Fla.Mitchell Buckley, Pharm.D., BCCCP, FASHP, FCCM, FCCPGilles Fraser, Pharm.D., MCCM,ClinicalSpecialistinCriticalCare,MaineMedicalCenter,PortlandMaine;ProfessorofMedicine,TuftsUniversitySchoolofMedicine,Boston,Mass.

8:00 a.m.–10:00 a.m. Mandalay Bay B, Level 2

a BCOP Clinical Sessions: Lung Cancer Therapy and Molecular TargetsPlanned in cooperation with the American College of Clinical Pharmacy

ACTIVITY #0217-9999-16-135-L01-P



Recertification credit for: BCOP

Moderator: Gary W. Jean, Pharm.D., BCOP,AssistantProfessor,TexasTechUniversityHealthSciencesCenterSchoolofPharmacy;ClinicalCoordinator,ClementsUniversityHospital–UTSouthwesternMedicalCenter,Dallas,Texas

Learning Objectives:l ReviewthecommonmutationspresentinNSCLC.l ReviewthehistoryoftargetedtherapyinadvancedNSCLC.l DiscussthecommontargetedtreatmentmodalitiesinadvancedNSCLC.

l IdentifythecurrentbarrierstotargetedtherapyinthemanagementofadvancedNSCLC.

l Explainthepurposeofamoleculartumorboardanddem-onstratethevaluetheyaddtotreatmentrecommendations.

l Outlinethesupportandprocessforobtainingofflabelgenetic-guidedtherapywhenclinicaltrialsarenotavailable.

l DiscusslesscommongeneticalterationsinNSCLCandtheirassociatedtreatmentsandoutcomes.

l Identifyfuturechallengestotheimplementationofgenetic-guidedtherapyintostandardoncologyclinicalpractice.

Presenters:Gary W. Jean, Pharm.D., BCOPChristine M. Walko, Pharm.D., BCOP, FCCP, PersonalizedMedicineSpecialist,DeBartoloFamilyPersonalizedMedicineInstitute,MoffittCancerCenter;AssociateProfessor,DepartmentofOncologicSciences,USFMorsaniCollegeofMedicine,Tampa,Fla.


8:00 a.m.–10:00 a.m. Breakers C, Level 2

a Pharmacy Forecast 2017: Trends That Will Shape Your FuturePlanned in cooperation with the ASHP Research and Education Foundation

ACTIVITY #0204-0000-16-237-L04-P/0204-0000-16-237-L04-T



Program Chair/Moderator:William A. Zellmer, B.S.Pharm., M.P.H.,President,PharmacyForesightConsulting,Bethesda,Md.

Learning Objectives:l Identifyfiveormoretrendsintheexternalenvironmentthatwillhaveamajorimpactonhealth-systempharmacypracticeoverthenextfiveyears.

continues >


Educational Sessions Tuesday, December 6 continued8:00 a.m.–10:00 a.m. Mandalay Bay H, Level 2

a Controversial High-Impact Publications in Hypertension: SPRINTing Toward the GoalPlanned in cooperation with the American Pharmacists Association

ACTIVITY #0204-9999-16-240-L01-P



Recertification credit for: BCACP, BCPS

Program Chair/Moderator: Joseph J. Saseen, Pharm.D., BCACP, BCPS,ProfessorandViceChair,DepartmentofClinicalPharmacy;Professor,DepartmentofFamilyMedicine,UniversityofColoradoAnschutzMedicalCenter,Aurora,Colo.

Learning Objectives:l Compareandcontrastguidelinesandconsensusrecom-mendationsforthetreatmentofpatientswithhypertension.

l ExplainthefindingsfromandstrengthsandweaknessesoftheSPRINTtrial,anddiscusstheimplicationsforestablish-ingthebloodpressuregoalforapatientwithhypertension.

l Designpatient-centeredantihypertensivetreatmentplansincomplexpatientswithhypertension.

Presenters:Eric MacLaughlin, Pharm.D., BCPS, FASHP, FCCP,ProfessorandChair,TexasTechUniversityHealthScienceCenter,Amarillo,TexasJoel C. Marrs, Pharm.D., ASH-CHC, BCACP, BCPS-AQ Cardiology, CLS, FASHP, FCCP, FNLA,AssociateProfessor,UniversityofColorado,Aurora,Colo.Joseph J. Saseen, Pharm.D., BCACP, BCPS



a (Management Case Study) A Systematic Approach to Medication Error Evaluation Leads to Implementation of Standardized Dosing of VasopressorsACTIVITY #0204-0000-16-356-L05-P



Learning Objectives:l Listanddescribekeyconsiderationswhenevaluatingmedi-cationerrors.

l Constructacommunicationstrategytogetbuy-infromkeystakeholders.

l Listthefourfunctionalaspectsofactionwhendevelopingastrategicplanfollowingamedicationerror.

Presenters:Christian S. Conley, Pharm.D., M.S.,AcuteCarePharmacyManager,UABHospital,Birmingham,Ala.Michael Denaburg, Pharm.D., BCCCP,CriticalCarePharmacySupervisor,UABHospital,Birmingham,Ala.

l Translatethestrategicadviceofnationalauthoritiestothespecificneedsofaparticularpracticesetting.

l Identifythreeormorewaystoapplyknowledgeofkeytrendstowardimprovingpatientcare.

Presenters:Scott J. Knoer, Pharm.D., M.S., FASHP,ChiefPharmacyOfficer,ClevelandClinic,Cleveland,OhioEdward Li, Pharm.D., M.P.H., BCOP,AssociateProfessor,UniversityofNewEnglandCollegeofPharmacy,Portland,MainePamela Phelps, Pharm.D.,Director,FairviewPharmacyServices,Minneapolis,Minn.Cynthia Williams, B.S.Pharm., FASHP,VicePresident/ChiefPharmacyOficer,RiversideHealthSystem,NewportNews,Va.William A. Zellmer, B.S.Pharm., M.P.H.David A. Zilz, B.S.Pharm., M.S., FASHP, (Ret.)SeniorConsultant,UWHealth,Madison,Wis.


a Diversion Prevention: What’s a Pharmacy to Do?Planned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-238-L03-P/0204-0000-16-238-L03-T



Program Chair/Moderator:Philip Brummond, Pharm.D., M.S.,DirectorofPharmacy,Froedtert,Milwaukee,Wis.

Learning Objectives:l DefinethescopeofthecontrolledsubstancediversionproblemwithinU.S.hospitalsandhealthsystems.

l Definetheroleofthepharmacyleaderincontrolledsub-stancediversion,detection,andsurveillance.

l Designcountermeasurestocombatdiverterswithinhealthsystems.

l Interpretandrecommendinterventionswithinyourorgani-zationbasedondiversionscenarios.

l Evaluatethecommoncontrolled-substancediversionhur-dlesandpitfallswhendealingwithregulatoryagenciesafteradiversionevent.

Presenters:Philip Brummond, Pharm.D., M.S.Robert Fink, Pharm.D., MBA, BCNSP, BCPS, FACHE, FASHP, VicePresident–AncillaryServicesandChiefPharmacyExecutive,QuorumHealthCorporation,Brentwood,Tenn.Christopher Fortier, Pharm.D., FASHP, ChiefPharmacyOfficer,MassachusettsGeneralHospital,Boston,Mass.Stan Kent, R.Ph., M.S., FASHP,ChiefPharmacyOfficer,UniversityofMichiganHealthSystem,AnnArbor,Mich.




a Decision 2016: An Examination of Key Pharmacy Issues Within the Context of a New Administration, Congress, and StatehousesACTIVITY #0204-0000-16-230-L03-P/0204-0000-16-230-L03-T



Program Chair:Joseph Hill, M.A.,Director,GovernmentAffairs,ASHP,Bethesda,Md.Moderator:Kasey Thompson, Pharm.D., M.S., MBA,ChiefOperatingOfficerandSeniorVicePresident,ASHP,Bethesda,Md.

Learning Objectives:l Identifycurrentfederalregulatoryandlegislativeissuesimpactinghealth-systempharmacistsinavarietyofsettings.

l Discusscurrentregulatoryandlegislativeissuesinthestatesthatimpacthealth-systempharmacists.

l Provideanoutlookinto2017onkeyissuesfacinghealth-systempharmacists.

Presenters:Nicholas Gentile, B.A.,Director,StateGrassrootsAdvocacyandPoliticalAction,ASHP,Bethesda,Md.Joseph Hill, M.A.Jillanne Schulte, J.D., Director,FederalRegulatoryAffairs,ASHP,Bethesda,Md.Christopher Topoleski, B.A.,Director,FederalLegislativeAffairs,ASHP,Bethesda,Md.


a Management Pearls 2016Planned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-234-L04-P



Program Chair/Moderator:Doina Dumitru, Pharm.D., MBA, FASHP,Director,ProfessionalServices,BD,Houston,Texas

Learning Objectives:l Identifyoneinitiativethatwillimproveclinicalpharmacyservicesatyourorganization.

l Describeoneperformanceimprovementactivitythatcanbeusedtoimproveoperationalefficiencyinthepharmacy.

l Listtwohealthcareenvironmentfactorsthatrequirephar-macydepartmentstoadaptoperationstomeetchanginghealth-systempriorities.

Presentations:WhatHappenswithPracticeModelTransformationShouldbeSharedbyAll!Lynn Eschenbacher, Pharm.D., MBA,NationalDirectorofPharmacyOperations,TheResourceGroup/Ascension,St.Louis,Mo. PrescriptionRenewalsbyPharmacyTechniciansJordan Ambrose, Pharm.D., AmbulatoryPharmacyManager, FroedtertHospital, Milwaukee,Wis. PreventingHarm:TechniciansCatchNearMissesKaren Youmbi, Pharm.D., BCPS,PharmacyRegulatorySurveillanceSupervisor,Cedars-SinaiMedicalCenter,LosAngeles,Calif. ImplementinganAntibioticStewardshipProgramataSmallHospitalwithLimitedResourcesHelena Lee, Pharm.D., M.S., BCPS,DirectorofPharmacy,ComprehensivePharmacyServices,Washington,D.C. Patients’AwarenessandExpectationsofPharmacists’ServicesDuringHospitalStay:DoPatientsReallyKnowWhatWeDo?Philip K. King, Pharm.D., BCPS,ClinicalLeadPharmacist,Neurology/Cardiology,SummaHealthSystem,AkronCityHospital,Akron,Ohio;AssistantProfessor,PharmacyPractice,NortheastOhioMedicalUniversity,Rootstown,Ohio UtilizingaDrugRevenueDashboardtoImproveFinancialManagementofanOncologyInfusionCenterWilliam Kernan, Pharm.D., MBA,DirectorofPharmacy,ClevelandClinicFlorida,Weston,Fla. Pharmacy-LedRevenueCycleOutpatientInfusionTeamCarrie Morton, Pharm.D., MBA,DirectorofPharmacy,DeaconessHospital,Inc.,Evansville,Ind. IVBarcodeAssistedMedicationPreparation(BCMP)Technology:CraftingaBusinessCaseHeather Helsel, Pharm.D., M.S.,PharmacyManager,OncologyServices,UWHealth,Madison,Wis. Design,Build,andImplementaMedicationSynchronizationDatabasetoImprovePatentAdherence





continues >


Educational Sessions Tuesday, December 6 continuedJerame Hill, Pharm.D., M.S.,PharmacyManager,SupplyChain,UWHealth,Madison,Wis. TotheBedsideandBeyond:EmbracingEducation,Innovation,andTechnologytoExpandBedsideDeliveryServicesMatthew J. Hoover, Pharm.D., BCPS, PharmacyClinicalSpecialist,ClevelandClinicMarymountHospital,GarfieldHeights,Ohio;NortheastOhioMedicalUniversity,AssistantProfessorofPharmacyPractice,Rootstown,Ohio DevelopmentofanInterdisciplinaryDrugDiversionResponseTeamBrian C. O’Neal, Pharm.D., M.S., FASHP, SeniorDirectorofPharmacyandBiomedicalEngineering,ChildrensMercyHospital,KansasCity,Mo. CombatingtheOpioidAbuseEpidemic:WhatCanaHospitalPharmacyDotoHelp?Brian D. Latham, Pharm.D., SeniorDirectorofPharmacyandBiomedicalEngineering,St.Rita’sMedicalCenter,Lima,Ohio DevelopmentofanInterdisciplinaryDrugDiversionResponseTeamThomas S. Achey, Pharm.D., BCPS, Health-SystemPharmacyAdministrationResident,ClevelandClinic,Cleveland,Ohio DrivingEmployeeEngagementThroughStandardizedCommunicationToolsandPracticesDavid Chantal, Pharm.D., PMP, DirectorofComplianceandRegulatoryServices,ComprehensivePharmacyServices,Norfolk,Mass.

IntegrationofNewHospitalsIntoExistingHealthSystemsTricia Killingsworth, R.Ph., B.S.Pharm., SeniorDirector,AcuteCarePharmacyServices,BannerHealth,Phoenix,Ariz.


a (Management Case Study) Challenges of Transitioning Patients to Outpatient Parenteral Antibiotic Therapy (OPAT)ACTIVITY #0204-0000-16-357-L04-P/0204-0000-16-357-L04-T



Learning Objectives:l Describepotentialbarrierstodischargeinagivencasesce-nario.(Ponly)

l Listfactorsrelatedtoantibioticstabilitythatmayneedtobeconsideredwhenapatienttransitionstohomecare.(P/T)

l Discusstheimportanceofcoordinationbetweenhospitalpharmacists,casemanagers,andthehomeinfusioncareteaminsuccessfullydischargingapatientonintravenousantibiotics.(P/T)

Presenters:Juan E. Villanueva-Quirino, Pharm.D.,PGY2InfectiousDiseasesPharmacyResident,UniversityofArizona/BannerUniversityMedicalCenter–Tucson,Tucson,Ariz.Carol J. Rollins, Pharm.D., M.S., R.D., BCNSP, FASHP,ClinicalProfessor,CollegeofPharmacy,UniversityofArizona,Tucson,Ariz.


a Drug Accountability: Using Data and Analytics for Enhanced Inventory ManagementPlanned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-245-L04-P/0204-0000-16-245-L04-T



Program Chair/Moderator:Barbara L. Giacomelli, Pharm.D., MBA, FASHP,AreaVicePresidentPharmacyPracticeConsulting,McKessonHealthSystems,Vineland,N.J.;RutgersUniversitySchoolofNursing–Camden,Camden,N.J.

Learning Objectives:l Defineamechanismtomonitorpharmacymedicationinventoryfrompointofreceiptofadruginthepharmacytostorage,dispensation,andadministrationtoapatient.

l Describeanautomatedperpetualinventoryprocessanddataanalyticstomonitordrugaccountability.

l Explainaprocesstotrackinventoryfromreceiptinthepharmacytodispensing.

Presenters:Barbara L. Giacomelli, Pharm.D., MBA, FASHPSamuel R. Wetherill, IV, Pharm.D., M.H.A., Director,PharmacySupplyChainandAutomation,ChristianaCareHealthSystem,Newark,Del.;SmallGroupInstructor,U.S.Army,Ft.Dix,N.J.


a Pediatric Antimicrobial Stewardship: Focusing on What MattersACTIVITY #0204-0000-16-244-L04-P



Recertification credit for: BCPPS

Program Chair/Moderator: Kristen R. Nichols, Pharm.D., BCPPS, BCPS-AQ ID,AssistantProfessor,PharmacyPractice,ButlerUniversityCollegeofPharmacyandHealthSciences;AntimicrobialStewardshipPharmacist,RileyHospitalforChildrenatIndianaUniversityHealth,Indianapolis,Ind.

Learning Objectives:l Definemajorgoalsforantimicrobialstewardshipinthepediatricpopulationandevaluateprogressinachievingthosegoals.

l Applyantimicrobialstewardshipprinciplesintheevaluationofapatientcaseandrecommendevidence-basedaltera-tionstoantimicrobialtherapy.

l Designpediatricantimicrobialstewardshipinterventionsthattargetspecificantimicrobialagents,infectiousdis-eases,orpathogens,andoutlinetherolesofantimicrobialstewardshipteammembersandthemetricsusedtoassesseffectivenessoftheintervention.

Presenters:Kristen R. Nichols, Pharm.D., BCPPS, BCPS-AQ IDKyana D. Stewart, Pharm.D., M.S., BCPS,SeniorClinicalPharmacist,PediatricInfectiousDiseaseandCo-ChairAntimicrobialStewardshipProgram,Children’sHealth,Children’sMedicalCenterDallas,Dallas,Texas





a A Toolkit for Pharmacy — Managing Prior AuthorizationsPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-241-L04-P/0204-0000-16-241-L04-T



Program Chair/Moderator:Julia Glowczewski, Pharm.D., BCPS,DirectorofPharmacy,ClevelandClinicHealthSystem–EuclidHospital,Euclid,Ohio

Learning Objectives:l Describethestepsnecessarytoimplementorimproveapriorauthorizationprogram.

l Applystrategiesfortrainingtechnicalandclinicalstafftoperformorsupportpriorauthorizations.

l Developprocessesforovercomingadenialorrejection.l Developstrategiestoclinicallysupportthepriorauthoriza-tionprocess.

l Evaluateopportunitiestoimprovethepriorauthorizationprocessandquantifyresults.

Presenters:Donald Carroll, B.S.Pharm., M.H.A.,SeniorDirector,SpecialtyandAmbulatoryPharmacy,ClevelandClinic,Cleveland,OhioNiesha L. Griffith, R.Ph., M.S., FASHP, VicePresident,CancerServices,WestVirginiaUniversityHealthSystem,Morgantown,W.V.Sarah Hudson-Disalle, Pharm.D.,PharmacyManager,TheWexnerMedicalCenterattheOhioStateUniversity,Columbus,Ohio


a Pharmacotherapy Considerations in Patients on Extracorporeal Membrane OxygenationPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-242-L01-P



Program Chair/Moderator:Kevin E. Anger, Pharm.D., BCPS,ManagerInvestigationalDrugServices,BrighamandWomen’sHospital,Boston,Mass.

Learning Objectives:l Discusstheroleofextracorporealmembraneoxygenation(ECMO)inadultcriticallyillpatientsandtheroleofsupportivepharmacotherapy.

l EvaluaterecentliteratureonthepharmaceuticalmanagementofpatientsreceivingECMO.

l AssesswaystoprovideoptimalmedicationmanagementtopatientsreceivingECMOtherapy.

Presenters:Amy L. Dzierba, Pharm.D., BCCCP, BCPS, FCCM,ClinicalPharmacist,AdultCriticalCare,NewYork-PresbyterianHospital,NewYork,N.Y.David Reardon, Pharm.D., BCPS,SolidOrganTransplantClinicalPharmacist,Yale-NewHavenHospital,NewHaven,Conn.


a FDA Update 2016: Public Health and Regulatory Initiatives Impacting Today’s PracticeACTIVITY #0204-0000-16-243-L03-P/0204-0000-16-243-L03-T



Program Chair/Moderator:Kimberly W. Chiu, Pharm.D.,Pharmacist,FoodandDrugAdministration,SilverSpring,Md.

Learning Objectives:l DescribetheFoodandDrugAdministration’s(FDA’s)DivisionofDrugInformationanditsroleinpublichealth.

l Identifykey2016FDAinitiativesandtheirgoals.l Describethepotentialimpactof2016FDAinitiativesonpharmacistsandtheirpractice.

Presenters:Adesola Adejuwon, Pharm.D., MBA,Pharmacist,FoodandDrugAdministration,SilverSpring,Md.Kimberly W. Chiu, Pharm.D.


a Incorporating Medication Indications into the Prescribing ProcessACTIVITY #0204-0000-16-246-L04-P



Program Chair:Gordon Schiff, M.D.,AssociateDirector,CenterforPatientSafetyResearchandPractice,BrighamandWomen’sHospitalDivisionofGeneralInternalMedicine;HarvardMedicalSchool;AHRQIndications-basedPrescribingPI,BrighamandWomen’sHospitalDivisionofGeneralInternalMedicine,Boston,Mass.Moderator: Mary G. Amato, Pharm.D., M.P.H., BCPS, FCCP, ProfessorofPharmacyPractice,MCPHSUniversity;SponsoredStaff,BrighamandWomen’sHospital,Boston,Mass..

Learning Objectives:l Assessthevalueandbenefitsofintegratingmedicationindicationsintotheprescribingprocess.

l Estimatetheimplicationsandbarriersofincorporatingmedicationindicationswithrespecttophysicians,patients,andpharmacists;describehowthisinformationcouldbetransformativefortheroleofpharmacists.

l Evaluatewhatpharmacistscandotoimprovepatientcarethroughtheuseofindicationinformation.

Presenters:Mary G. Amato, Pharm.D., M.P.H., BCPS, FCCPAaron Nathan, B.S.,SeniorResearchAssistant,BrighamandWomen’sHospital,Boston,Mass.


Educational Sessions Tuesday, December 6 continued10:00 a.m.–11:00 a.m. Mandalay Bay J, Level 2

a Biosimilar Savings: Lowering Prices, But Who Saves Money?ACTIVITY #0204-0000-16-247-L04-P/0204-0000-16-247-L04-T



Program Chair/Moderator:Steven Lucio, Pharm.D., BCPS,AssociateVicePresident,ClinicalPharmacySolutions,Vizient,Irving,Texas

Learning Objectives:l IdentifytheopportunitiesforcostsavingswithbiosimilarsbasedontheEuropeanexperienceaswellastheinitialcompetingbiologicsapprovedintheU.S.

l EvaluatetheanticipatedapproachofMedicare,Medicaid,privatepayers,andotherentitiestowardbiosimilarsandhowthesestrategieswillaffectpharmaceuticalcosts.

l Appraisethekeycomponentsofaneconomicevaluationprocessforbiosimilarsthatencompassestheimpactandvalueforhealthsystemsandpatients.

Presenters:Molly Leber, Pharm.D., BCPS, FASHP,Manager,MedicationPolicyandFormularyManagement,YaleNewHavenHealthSystem,NewHaven,Conn.Steven Lucio, Pharm.D., BCPS

10:00 a.m.–11:00 a.m. South Seas J, Level 3

a Updates in Transplantation 2016Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists and the American Society of Transplantation Pharmacy Community of Practice

ACTIVITY #0204-0000-16-310-L01-P



Program Chair/Moderator:Lindsey Pote, Pharm.D., BCPS,ClinicalPharmacySpecialist,SolidOrganTransplantation,TheJohnsHopkinsHospital,Baltimore,Md.;ClinicalPharmacySpecialist,HIV/InfectiousDiseases,TheJohnsHopkinsHospital,Baltimore,Md.;ClinicalPharmacist,LiverTransplant,HospitaloftheUniversityofPennsylvania,Philadelphia,Pa.

Learning Objectives:l SummarizethemajorupdatesintransplantationinthepastyearforHIVpositiverecipients.

l EvaluateimmunosuppressionandopportunisticinfectionprophylaxisregimensfortheHIVpositivetransplantrecipient.

l PrepareaneffectiveposttransplantmedicationregimenforanHIVpositivetransplantrecipient.

Presenters:Janessa Smith, Pharm.D.,ClinicalPharmacySpecialist,HIV/InfectiousDiseases,TheJohnsHopkinsHospital,Baltimore,Md.Erin H. Ticehurst, Pharm.D.,ClinicalPharmacySpecialist,SolidOrganTransplantationResidencyProgramDirector,PGY-2SolidOrganTransplantation,HospitaloftheUniversityofPennsylvania,Philadelphia,Pa.


a (Management Case Study) 2016 CDC Warning on Fluoroquinolone Antibiotic Use: Rolling Back Use for Patient SafetyACTIVITY #0204-0000-16-358-L04-P



Learning Objectives:l Describesystemwidedevelopmentofantimicrobialstew-ardshipteamsinalargehealthsystem.

l Discussstrategiesforprospectivemonitoring.l Explaintheuseofvarioustoolstoensureaccountabilityandresultingoutcomes.

Presenter:Roy Guharoy, Pharm.D., MBA, FASHP, FCCP,VicePresident,ClinicalIntegrationandChiefPharmacyOfficer,AscensionHealth,St.Louis,Mo.


a (Management Case Study) Navigating Hospital and Health-System Integration: Clinical and Formulary FrontiersACTIVITY #0204-0000-16-359-L04-P



Learning Objectives:l Describethedifferencebetweenverticalandhorizontalpharmacyintegration.

l Determinehowtoprioritizeintegrationobjectives.l Identifystrategiesthatcanbehelpfulinovercomingroadblocks.

Presenters:Amy Beatty, Pharm.D., BCPS,ClinicalDirectorPharmacyServices,OhioHealth,Dublin,OhioJohn Emanuel, Pharm.D., M.S., BCPS,ClinicalPharmacyManager,OhioHealth,Dublin,Ohio


a Optimizing Health-System Resources to Deliver Systemwide Antimicrobial StewardshipACTIVITY #0204-0000-16-263-L04-P



Program Chair/Moderator:Brad R. Laible, Pharm.D., BCPS-AQ ID,Professor,DepartmentofPharmacyPractice,SouthDakotaStateUniversityCollegeofPharmacy;LeadPharmacist,AveraHealthAntimicrobialStewardshipProgram,AveraMcKennanHospital&UniversityHealthCenter,SiouxFalls,S.D.

Learning Objectives:l Discussinitialapproachestoantimicrobialstewardshipwhenstartingaprogram.

l Describewaystouseexistingpersonneltoenhancepatient-levelstewardshipacrossthehealthsystem.

l Describehowasystem-levelASPcanimpactanindividualfacilitywithlimitedantimicrobialstewardshipresources.



Presenters:Jamie Grosdidier, Pharm.D.,ClinicalPharmacis,AveraQueenofPeaceHospital,Mitchell,S.D.Brad R. Laible, Pharm.D., BCPS-AQ IDJawad Nazir, M.D., FACP,Consultant,InfectiousDisease,InfectiousDiseasesSpecialists,PC,SiouxFalls,S.D.


a Report from the Field 2016: Focus Points for a Successful Joint Commission SurveyPlanned in cooperation with The Joint Commission

ACTIVITY #0204-0000-16-267-L03-P/0204-0000-16-267-L03-T



Learning Objectives:l Discussregulatoryexpectationsfororderingandadminis-teringmedicationsthroughtitration.

l Assessappropriateorderingandadministrationofrangeorders.l Listregulatoryexpectationsforrequiredoversightofcom-poundinginhospitalsandtheirambulatorysites.

l Explainhowtoappropriatelyimplementprotocolsformedications.

Presenter:Robert C. Campbell, Pharm.D., Surveyor,TheJointCommission,OakbrookTerrace,Ill.


a Caring for Two in the ICU: Managing Critical Illness in PregnancyPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-248-L01-P



Program Chair/Moderator:Sarah Bush, Pharm.D., BCPS,PharmacyManager,TridentMedicalCenter,Charleston,S.C.

Learning Objectives:l Deviseatreatmentstrategyforthemanagementofpulmo-naryembolisminthecriticallyillpregnantpatient.

l Appraisetherecentliteratureontheapplicationofprinci-plesrelatedtomaternalresuscitationduringcardiacarrest.

l Distinguishbetweenthetreatmentstrategiesrelatedtopreeclampsiaandassociatedcomplications.

Presenters:Nadia I. Awad, Pharm.D., BCPS,EmergencyMedicinePharmacist,RobertWoodJohnsonUniversityHospital,NewBrunswick,N.J.Julie J. Kelsey, Pharm.D.,ClinicalPharmacist,UniversityofVirginiaHealthSystem,Charlottesville,Va.Melinda J. Ortmann, Pharm.D., BCPS,ClinicalPharmacySpecialist–EmergencyMedicine,TheJohnsHopkinsHospital,Baltimore,Md.


a Current Considerations for Conducting Root Cause Analysis: Developing Your PlanACTIVITY #0204-0000-16-249-L05-P/0204-0000-16-249-L05-T



Program Chair/Moderator:Karen M. Ryle, R.Ph., M.S.,AssociateChiefofPharmacyforAmbulatoryCare,MassachusettsGeneralHospital,Boston,Mass.

Learning Objectives:l Describeamedicationerrorthatnecessitatesarootcauseanalysis(RCA)andusetoolsfortheRCAprocesstoidentifytheprimarycauseofthesentinelevent.

l PrepareanactionplanfromtheRCAthatincludesrisk-reduction,communication,andimplementationstrategies.

l DiscusswaystomeasuretheeffectivenessofanRCAactionplan.l IdentifylatentfailuresinthesystemdiscoveredduringanRCA.l Compareandcontrasthigh-leverageandlow-leveragesafetystrategies.

Presenters:Donna Horn, R.Ph., D.Ph. (Hon.),DirectorPatientSafety–CommunityPharmacy,InstituteforSafeMedicationPractices,Horsham,Pa.;AdjunctInstructor,MCPHSUniversity,Boston,Mass.Karen M. Ryle, R.Ph., M.S.


a Beyond the Basics: Billing Opportunities for Pharmacist-led Clinical ServicesACTIVITY #0204-0000-16-253-L04-P



Program Chair/Moderator:Brooke Griffin, Pharm.D., BCACP,ProfessorofPharmacyPractice,MidwesternUniversity,DownersGrove,Ill.

Learning Objectives:l Explainbillingopportunitiesforthreemajorpharmacist-ledclinicalservices:transitionsofcare,chroniccaremanage-ment,andannualwellnessvisits.

l Discussimportantelementsofbillingopportunitiestohelpensurereimbursement.

l Evaluatetheroleofpayermixandproviderstatusinambu-latorycarebillingopportunities.

Presenters:Brooke Griffin, Pharm.D., BCACPSandra Leal, Pharm.D., M.P.H.,VicePresidentforInnovation,SinfoniaRx,Tucson,Ariz.Anne Misher, Pharm.D.,ClinicalAssistantProfessor,UniversityofGeorgia,Savannah,Ga.


Educational Sessions Tuesday, December 6 continued2:00 p.m.–3:30 p.m. South Seas B, Level 3

a Slowing CKD Progression: Are We Making Any Progress?ACTIVITY #0204-0000-16-256-L01-P



Program Chair/Moderator:Thomas Dowling, Pharm.D., Ph.D.,AssistantDean,FerrisStateUniversity,GrandRapids,Mich.

Learning Objectives:l Usingasetofcriteria,evaluateapatient’scomprehensivekidneyfunction.

l Givenrecentcontroversiesandliterature,discussandrec-ommendstrategiesforslowingtheprogressionofrenaldis-easeinpatientswithdiabeticnephropathy.

l Givenrecentcontroversiesandliterature,discussandrec-ommendstrategiesforslowingtheprogressionofrenaldis-easeinpatientswithhypertensivenephropathy.

Presenters:Thomas Dowling, Pharm.D., Ph.D.John Jameson, Pharm.D., B.S., FASHP,ChairandProfessorofPharmacyPractice,FerrisStateUniversity,GrandRapids,Mich.Asha L. Tata, Pharm.D., BCPS,ClinicalPharmacySpecialist,UniversityofMarylandMedicalCenter,Baltimore,Md.


a Lessons from History: Advocating Effectively for Pharmacy’s Public Policy AgendaPlanned in cooperation with the American Institute of the History of Pharmacy

ACTIVITY #0204-0000-16-344-L03-P/0204-0000-16-344-L03-T



Program Chair/Moderator:William A. Zellmer, B.S.Pharm., M.P.H.,President,PharmacyForesightConsulting,Bethesda,Md.

Learning Objectives:l Explainhowpharmacy-relatedpublicpolicyproposalsaretypicallydeveloped,refined,andrecycledonthepathtowardnewlawsorregulations.

l Identifythevalueofhistoryinpolicyanalysisandadvocacyfromtheperspectivesofpharmacypractitioners,students,andnationalandstatepharmacistassociationleaders.

l Outlinelessonsfromhistorytotheassessmentofthreecontemporaryissuesinpublicpolicythathavepracticeimplicationsinhealth-systempharmacy.

Presenters:Gregory Higby, R.Ph., Ph.D.,ExecutiveDirector,AmericanInstituteoftheHistoryofPharmacy;SeniorLecturer,UniversityofWisconsin-Madison,Madison,Wis.Brian M. Meyer, B.A., MBA,Consultant,SilverSpring,Md.Stephen Schondelmeyer, Pharm.D., Ph.D., M.P.A., FAPhA, ProfessorandDirector,PRIMEInstitute,Minneapolis,Minn.


a BCOP Clinical Sessions: Multiple Myeloma and Pediatric CINVPlanned in cooperation with the American College of Clinical Pharmacy

ACTIVITY #0217-9999-16-145-L01-P



Recertification credit for: BCOP

Moderator: Jennifer L. Thackray, Pharm.D., BCPPS, BCPS,PediatricOncologyClinicalPharmacySpecialist,MemorialSloanKetteringCancerCenter,NewYork,N.Y.

Learning Objectives:l Definethephasesofchemotherapy-inducednauseaandvomiting(CINV)andrecognizetheriskfactorsforCINVinapediatricpatient.

l Analyzethesafetyandefficacyofaprepitantandpalonose-troninpediatricpatients.

l DevelopaplanforpreventionandtreatmentofeachphaseofCINV.

l ModifyanantiemeticregimenforapediatricpatientwithbreakthroughCINV.

l Examineprognosticimplicationsandoutlinepatient-spe-cifictreatmentformultiplemyeloma.

l Discusspertinentliteraturerelatedtodaratumumab,elotu-zumab,andixazomib.

l Illustratecurrentroleintherapyofnovelagentstotreatmultiplemyeloma.

Presenters:Jill Bates, Pharm.D., M.S., BCOP,ClinicalPharmacistPractitioner,UniversityofNorthCarolinaMedicalCenter,ChapelHill,N.C.Jennifer L. Thackray, Pharm.D., BCPPS, BCPS



a #EvidenceBased? Exploring Challenges with the Quality, Reporting, and Transparency of Evidence in Healthcare ResearchPlanned in cooperation with the American Pharmacists Association

ACTIVITY #0204-9999-16-251-L01-P



Recertification credit for: BCACP, BCPS

Program Chair/Moderator: Ashley N. Johnson, Pharm.D., BCPS,ClinicalPharmacySpecialist,JonathanMWainwrightMemorialWallaWallaVAMedicalCenter,WallaWalla,Wash.;AssistantAdjunctProfessorofPharmacyPractice,PalmBeachAtlanticUniversity,WestPalmBeach,Fla.

Learning Objectives:l Evaluateclinicaltrialreportsforissuesimpactingthequal-ityofevidence,includingconfoundingvariablesandtheuseofsurrogateoutcomesaswellasfactorialandadaptivestudydesigns.



l Describeexamplesofreportingbiasandreportingdiscrep-anciesinthemedicalliterature.

l Recommendstrategiestoimprovethetransparencyofevi-denceobtainedthroughclinicalresearch,thepeerreviewprocess,andadvocacy.

Presenters:Ashley N. Johnson, Pharm.D., BCPSKrisy-Ann Thornby, Pharm.D., BCPS,AssociateProfessorofPharmacyPractice,PalmBeachAtlanticUniversity,WestPalmBeach,Fla.


2:00 p.m.–4:00 p.m. Mandalay Bay D, Level 2

a Reining in the Variants — Approaches to Using Pharmacogenomics in Clinical MedicineACTIVITY #0204-0000-16-252-L04-P/0204-0000-16-252-L04-T



Program Chair/Moderator:Shannon Manzi, Pharm.D., FPPAG, NREMT,Director,ClinicalPharmacogenomicsService,BostonChildren’sHospital,Boston,Mass.;Manager,EmergencyandICUPharmacyServices,BostonChildren’sHospital,Boston,Mass.;LeadPharmacist,MA-1DMAT,NDMS,ASPR,HHS,Washington,D.C.

Learning Objectives:l Explaincommonbarrierstotheimplementationofphar-macogeneticsintopractice.(P/T)

l Assessthevalueofpharmacogenomicdataduringmedica-tionprescribing.(Ponly)

l Developalistofpharmacogenomicresources.(P/T)l Describecoreconceptsintheimplementationofclinicaldeci-sionsupportrulesforpharmacogenomic-baseddosing.(Ponly)

l Evaluatethebenefitsofusinginformaticstoenhancetheuptakeofpharmacogeneticsinpractice.(P/T)

Presenters:Ben L. Kong, Pharm.D.,Oncology/ResearchClinicalPharmacist,OregonHealth&ScienceUniversity,Portland,Ore.Shannon Manzi, Pharm.D., FPPAG, NREMTTeresa Vo, Pharm.D.,AssistantProfessor,USFCollegeofPharmacy,Tampa,Fla.


a Risky Business: The Pharmacist’s Role in Population Health ManagementPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-254-L04-P/0204-0000-16-254-L04-T



Program Chair/Moderator:Scott J. Knoer, Pharm.D., M.S., FASHP,ChiefPharmacyOfficer,ClevelandClinic,Cleveland,Ohio

Learning Objectives:l Definepopulationhealthmanagement(PHM).l IdentifytheroleofthepharmacyenterpriseinprovidingPHM.l Assesshowtodevelopeffectivepharmacy-drivenPHMinitiatives.

l Analyzecommonpharmacy-basedPHMhurdlesandstrate-giestoaddressthem.

Presenters:Felicity Homsted, Pharm.D., BCPS,ChiefPharmacyOfficer,PenobscotCommunityHealthCare,Bangor,MaineScott J. Knoer, Pharm.D., M.S., FASHPRoger Woolf, Pharm.D.,AdministrativeDirector,VirginiaMasonMedicalCenter,Seattle,Wash.


a USP 800: Strategies for Compliance with Handling Hazardous DrugsACTIVITY #0204-0000-16-255-L03-P/0204-0000-16-255-L03-T



Program Chair/Moderator:Patricia C. Kienle, R.Ph., M.P.A., FASHP,Director,AccreditationandMedicationSafety,CardinalHealth,Laflin,Pa.

Learning Objectives:l IdentifythedocumentsonwhichUSPisbased.l AssessthekeyelementsrequiredbyUSP.l Summarizethetopthreenoncompliantworkpractices.l DefinetheengineeringcontrolsrequiredbyUSP.l Describeelementsthatshouldbecontainedinacertifica-tionreport.

Presenters:Eric S. Kastango, R.Ph., MBA, FASHP, PresidentandChiefExecutiveOfficer,ClinicalIQ,LLC,Madison,N.J.Patricia C. Kienle, R.Ph., M.P.A., FASHPJames T. Wagner, Consultant,ControlledEnvironmentConsulting,LLC,Hellertown,Pa.

2:00 p.m.–4:00 p.m. Mandalay Bay F, Level 2

a Clinical Pearls 2016Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-257-L01-P



Program Chair:Audrey Kennedy, Pharm.D., BCPS,ClinicalSafetyOfficer,Children’sMercyKansasCity,KansasCity,Mo.Moderator:Bruce R. Canaday, Pharm.D., FAPhA, FASHP,Dean,St.LouisCollegeofPharmacy,St.Louis,Mo.

Learning Objectives:l Discussthreeclinicalscenariosthatmightnotbewidelyknownorpublished.

l Identifynovelclinicalpracticeoptionsforpatientcareinvarioushealth-systemsettings.

l Describemedicationmanagementstrategiesindifficultorcontroversialpatientcaresituations.

l Identifyclinicalinformationthatcanbeappliedtoyourworksetting.

Presentations:Ouch!AnUpdateonPediatricImmunizationsKyana D. Stewart, Pharm.D., M.S., BCPS,SeniorClinicalPharmacist,PediatricInfectiousDisease,Children’sHealth,Children’sMedicalCenterDallas,Dallas,Texas

continues >


Educational Sessions Tuesday, December 6 continuedThePresenceofaClotisNotSoHot:NovelTherapiesfortheTreatmentofVentricularAssistDeviceThrombosisNichole Melody, Pharm.D., B.S., BCPS,CardiacSurgeryICUPharmacist,NorthwesternMemorialHospital,Chicago,Ill.

CINV:CanInevervomit?...NovelAgentstoPreventChemotherapy-InducedNauseaandVomitingCaitlin Bowman, Pharm.D., BCOP,ClinicalTeamLeadOncologyPharmacist,NorthwesternMemorialHospital,Chicago,Ill.

RSV:It’sNotAllAbouttheVirus!Kim W. Benner, Pharm.D., BCPS, FASHP, FPPAG,ProfessorofPharmacyPractice/PediatricClinicalSpecialist,SamfordUniversityMcWhorterSchoolofPharmacy,Birmingham,Ala.

OptimizationofLabDisplayontheEpicOrderVerificationScreenStephanie Burton, Pharm.D., BCPS,ClinicalSpecialist,EmergencyMedicine,SaintLuke’sHospitalofKansasCity,KansasCity,Mo.

HowSoonisTooSoon?AnticoagulationTherapyinAcuteCardioembolicStrokeJessica Starr, Pharm.D., BCPS, FCCP,AssociateClinicalProfessor,AuburnUniversity,Birmingham,Ala.

TheBigThreeinHPV:ReviewoftheEfficacyandAvailableProductsoftheHumanPapillomaVirusVaccinesLaura Alwan, Pharm.D., BCOP,ClinicalPharmacist,Oncology,UniversityofWashingtonMedicalCenter/SeattleCancerCareAlliance,Seattle,Wash.

No(IV)Line?StillFeelin’Fine!PainManagementinaSkiTownErin M. Lingenfelter, Pharm.D.,ClinicalPharmacist-EmergencyMedicine/CriticalCare,UniversityofUtahHealthCare,SaltLakeCity,Utah

TheHighPressureSnooze:DosingAntihypertensiveatBedtimeKaren J. McConnell, Pharm.D., BCPS-AQ Cardiology, FCCP,ClinicalDirector,CardinalHealth,CastleRock,Colo.;ClinicalAssociateProfessor,UniversityofColoradoSchoolofPharmacy,Aurora,Colo.

AcetaminophenAbsorptionTestintheICU:WhatCanWeTakeIn?James F. Gilmore, IV, Pharm.D., BCCCP, BCPS, SeniorPharmacist,BrighamandWomen’sHospital,Boston,Mass.

ManagementofPost-OperativeAtrialFibrillationWilliam L. Baker, Pharm.D., FACC, FCCP,AssistantProfessor,UniversityofConnecticutSchoolofPharmacy,Storrs,Conn.

WhentheHammerandWrenchWon’tCutIt:ANo-CostPediatricDrugInformationToolkitforPharmacistsMichelle Bloss, Pharm.D., BCPS, ClinicalPharmacist,ChildrensMercyHospital,KansasCity,Mo.

CultureFollow-upfortheDischargedEDPatientNicole M. Acquisto, Pharm.D., BCPS,EmergencyMedicineClinicalPharmacySpecialist,UniversityofRochesterMedicalCenter;AssistantProfessor,DepartmentofEmergencyMedicine,UniversityofRochester,Rochester,N.Y.

NitrofurantoinandCrCl:HowLowisTooLow?Tadd Hellwig, Pharm.D., BCPS,AssociateProfessor,SouthDakotaStateUniversityCollegeofPharmacy;ClinicalPharmacist,SanfordUSDMedicalCenter,SiouxFalls,S.D.

WeighingAlteplaseDosingDecisions:Estimatedvs.ActualDustin Spencer, Pharm.D., BCPS,ClinicalDirector,CardiopulmonaryDiseases,CardinalHealth,Indianapolis,Ind.

MetforminandDolutegravir:ABittersweetInteractionBhavik M. Shah, Pharm.D., AAHIVP, BCPS,AssociateProfessorofPharmacyPractice,JeffersonCollegeofPharmacy,Philadelphia,Pa.

SayYestotheDress:InfectionControlinCysticFibrosisKimberly J. Novak, Pharm.D., BCPPS, BCPS,AdvancedPatientCarePharmacist–PediatricandAdultCysticFibrosis,NationwideChildren’sHospital,Columbus,Ohio

IsoproterenolintheEPLab:AblationChallengevs.BudgetChallengeSarah Bush, Pharm.D., BCPS,PharmacyManager,TridentMedicalCenter,Charleston,S.C.

PracticeChallengesWithBiosimilarsBrandon Shank, Pharm.D., BCOP,ClinicalPharmacySpecialist,TheUniversityofTexasMDAndersonCancerCenter,Houston,Texas


a (Management Case Study) Lessons Learned on a Pharmacy Leadership Reorganization JourneyACTIVITY #0204-0000-16-360-L04-P/0204-0000-16-360-L04-T



Learning Objectives:l Identifyapharmacyorganizationalstructurethatpromotesstandardizedandconsistentpharmacyservicesacrosstheenterprise.

l Describetheimportanceofleadervisibilitytobeaneffec-tiveleaderandsupportfrontlinestaff.

l Outlinetacticstoincreasetrustandestablishrapportbetweenleadersandfrontlinestaff.

Presenters:Brandon Ordway, Pharm.D., M.S.,DirectorofPharmacy,HealthEastCareSystem,SaintPaul,Minn.Leah Frantzen, Pharm.D., BCPS,ClinicalPharmacyManager,HealthEastCareSystem,SaintPaul,Minn.





a (Management Case Study) Navigating Pharmacy’s Relationship with the Hospital Supply ChainACTIVITY #0204-0000-16-361-L04-P/0204-0000-16-361-L04-T



Learning Objectives:l Describethreerolesthesupplychaincanplayinpharma-ceuticsupplydecisions.

l Discussdifferencesbetweenpharmaceuticalsandmedicalsuppliesfromabusinessandregulatoryperspective.

l Describewhatmetricsthesupplychainmayusetotrackprojectsuccess.

Presenters:Susan Samet, Pharm.D.,Director,ClinicalOperations,CardinalHealth,St.Louis,Mo.Michael Schroeder, MBA,DirectorofSupplyUtilization,BJCHealthCare,St.Louis,Mo.


a Patient Assessments in Heart Failure: New Opportunities for PharmacistsPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-258-L01-P



Program Chair/Moderator:Amber Lanae Smith, Pharm.D., BCPS,AssistantClinicalProfessor,WayneStateUniversity;AmbulatoryCareSpecialist,HenryFordHospital,Detroit,Mich.

Learning Objectives:l Compareandcontrastpatientassessmenttoolsstudiedintheliterature.

l Evaluatethetherapeuticoptionsforthetreatmentofheartfailure.

l Developamedicationregimenthatreflectstheapplicationofthebestevidenceandprovidescostconsiderations.

l Outlineapharmacist-runheartfailureservicethatincorpo-ratesthepatientassessmenttoolsstudiedintheliterature.

Presenters:Barry Bleske, Pharm.D., FCCP,ChairandProfessor,UniversityofNewMexico,Albuquerque,N.M.Lynette Moser, Pharm.D.,AssociateProfessor(Clinical),WayneStateUniversity,Detroit,Mich.Benjamin Van Tassell, Pharm.D.,AssociateProfessorofPharmacotherapy,VirginiaCommonwealthUniversity,Richmond,Va.


a Make Them an Offer They Can’t Refuse: A Novel Approach to a Pharmacy Intern ProgramACTIVITY #0204-0000-16-259-L04-P



Program Chair/Moderator:Jennifer R. Hamner, Pharm.D., BCPPS,ManagerofProfessionalDevelopment,Children’sHospitalColorado,Aurora,Colo.

Learning Objectives:l Recallthekeycomponentsforestablishingamutuallyben-eficialpharmacyinternprogramforboththeinternandpharmacyadministration.

l Listtheprojectsandtasksthatcanbeeffectivelydelegatedtopharmacyinternstoprovideamutualbenefitfortheinternandpharmacyadministration.

l Assessthepotentialfinancialandadministrativeimpactofhavingamutuallybeneficialpharmacyinternprogram.

Presenters:Casey R. Dugan, Pharm.D., MBA,DirectorofPharmacyServices,Children’sHospitalColorado,Denver,Colo.Jennifer R. Hamner, Pharm.D., BCPPS

Panelists:Ferras Bashqoy, Pharm.D. Candidate 2017,InternPharmacist,Children’sHospitalColorado,Aurora,Colo.Ada Z. Koch, Pharm.D., MBA, BCPS,ManagerofClinicalPharmacyServices,Children’sHospitalColorado,Aurora,Colo.Sarah Newman, Pharm.D.,OncologyClinicalPharmacySpecialist,NicklausChildren’sHospital–MiamiChildren’sHealthSystem,Miami,Fla.


a Pharmacist-managed Transitions of Care: Monitoring and Documenting Continued Outpatient Parenteral Antimicrobial TherapyPlanned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-264-L04-P



Program Chair/Moderator:Kerry A. Goldrosen, Pharm.D.,ClinicalPharmacist,UWHealth,Madison,Wis.

Learning Objectives:l Defineoutpatientparenteralantimicrobialtherapy(OPAT)history,challenges,andrisks.

l RecommendstrategiestoidentifyOPATpatientsatriskforcomplicationsorreadmission.

l DescribeanOPATtransition,ambulatorypharmacyencoun-ter,workflows,anddocumentationinanelectronichealthrecord(EHR).

l DefineandevaluatepatientcaregoalswithregardstoOPATandbroaderambulatorypharmacymonitoringprograms.

Presenters:Kerry A. Goldrosen, Pharm.D.Jerame Hill, Pharm.D., M.S.,PharmacyManager,SupplyChain,UWHealth,Madison,Wis.Julie Pawola, Pharm.D.,ClinicalPharmacist,UWHealth,Madison,Wis.


Educational Sessions Tuesday, December 6 continued4:00 p.m.–5:15 p.m. South Seas B, Level 3

a Heart Failure Advanced Therapeutic Approaches: Know When to Hold ‘Em and When to Fold ‘EmPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-266-L01-P



Program Chair/Moderator: Joel C. Marrs, Pharm.D., ASH-CHC, BCACP, BCPS-AQ Cardiology, CLS, FASHP FCCP, FNLA,AssociateProfessor,UniversityofColoradoSkaggsSchoolofPharmacy,Aurora,Colo.

Learning Objectives:l Interpretclinicaltrialdatawithangiotensinreceptor/nepri-lysininhibitors(ARNIs)andivabradineinheartfailurewithreducedejectionfraction.

l Interpretclinicaltrialdatawithspironolactoneinheartfail-urewithpreservedejectionfraction.

l Compareandcontrastthenewrecommendationsintheheartfailureguidelineswithpreviousguidelines.

l Recommendappropriateheartfailuretreatmentregimensforpatientswithreducedandpreservedejectionfractions.

Presenters:Joel C. Marrs, Pharm.D., ASH-CHC, BCACP, BCPS-AQ Cardiology, CLS, FASHP FCCP, FNLARobert L. Page, II, Pharm.D., BCPS, CGP, FASCP, FAHA, FASHP, FCCP, FHFSA, MSPH, Professor,UniversityofColorado;ClinicalSpecialist,DivisionofCardiology,SectionofAdvancedHeartFailure/Transplant,UniversityofColoradoHospital,Aurora,Colo.


a (Management Case Study) Expediting the Standardization of Formulary in a Multi-Hospital Health SystemACTIVITY #0204-0000-16-362-L04-P



Learning Objectives:l Describehowaformularyreviewandtherapeuticinterchangeprocesscanberapidlydevelopedinamulti-hospitalsystem.

l Discusshowtoincorporatelayeredlearnersintotheformu-larystandardizationprocess.

l Describehowtodevelopsingletherapeuticinterchangesinadiversehealthsystem.

Presenters:Amanda Hays, Pharm.D., M.H.A., BCPS, CPHQ,SystemPharmacyandOutcomesManager,BJCHealthCare,St.Louis,Mo.Susan Samet, Pharm.D.,Director,ClinicalOperations,CardinalHealth,St.Louis,Mo.Jennifer Smith, Pharm.D., MBA,ClinicalPharmacyManager,BarnesJewishHospital,St.Louis,Mo.


a New Drugs in Opioid-Induced Constipation: How Much Is That Bowel Movement Gonna Cost You?ACTIVITY #0204-0000-16-260-L01-P



Program Chair/Moderator:Leah Sera, Pharm.D., BCPS,AssistantProfessor,UniversityofMarylandSchoolofPharmac,Rockville,Md.

Learning Objectives:l Describethescopeandpathophysiologyofopioid-inducedconstipation.

l Applyevidence-basedpracticesintheapproachtomanag-ingopioid-inducedconstipationwitholdertherapies.

l Applyevidence-basedpracticesintheapproachtojustifyappropriateuseoftargetedtherapies.

Presenters:Nina M. Bemben, Pharm.D., BCPS,AssistantProfessor,UniversityofMarylandSchoolofPharmacy,Baltimore,Md.Leah Sera, Pharm.D., BCPS


a Emergence of Multidisciplinary Pulmonary Embolism Response Teams: Potential Role of the PharmacistACTIVITY #0204-0000-16-261-L04-P



Program Chair/Moderator:George A. Davis, Pharm.D.,AnticoagulationProgramCoordinator,UniversityofKentuckyUKHealthCare;AssociateAdjunctProfessor,UniversityofKentuckyCollegeofPharmacy,Lexington,Ky.

Learning Objectives:l Justifytherationaleandbackgroundfordevelopingamulti-disciplinaryPulmonaryEmbolismResponseTeam(PERT).

l DescribethegoalsoftheNationalPERTConsortiumforadvancingthecareofpatientswithpulmonaryembolism.

l AssessthepotentialroleofapharmacistonaPERT.

Presenters:George A. Davis, Pharm.D.Rachel P. Rosovsky, M.D.,Physician,MassachusettsGeneralHospital,Boston,Mass.


a PrEPping for Prevention: Engaging Pharmacists in HIV Prevention StrategiesPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-262-L02-P



Program Chair/Moderator:Melody L. Berg, Pharm.D., M.P.H., AAHIVP, BCPS-AQ ID,SeniorClinicalContentSpecialist,WoltersKluwerHealth,Indianapolis,Ind.



Learning Objectives:l Evaluateuseoftenofovir/emtricitabineforpre-exposureprophylaxisforappropriatecandidatesandidentifyavailableresourcestohelppatientwithprocurementofmedication.

l Designaneffectivepost-exposureprophylaxisregimenforyourorganizationthatincludesaneffectiveantiretroviralregimenthatlimitsbarrierstomedicationprocurementandensuresappropriatefollow-upcareandtesting.

l JustifyguidelineconcordantintrapartumandpostpartumantiretroviralregimenstopreventperinataltransmissionofHIVfromanHIV-infectedmothertoafetus.

Presenters:Melody L. Berg, Pharm.D., M.P.H., AAHIVP, BCPS-AQ IDEric K. Farmer, Pharm.D., AAHIVP, BCPS,HIVClinicalPharmacist,IndianaUniversityHealth,Indianapolis,Ind.


a Methadone: Refining and Defining Safety and Efficacy in Clinical PracticeACTIVITY #0204-0000-16-265-L01-P



Program Chair/Moderator:Mary Lynn McPherson, Pharm.D., M.A., BCPS, FASHP,Professor,andExecutiveDirectorofAdvancedPost-GraduateEducationinPalliativeCare,UniversityofMarylandSchoolofPharmacy,Baltimore,Md.;HospiceandPalliativeCareConsultantPharmacist

Learning Objectives:l Givenanactualorsimulatedpatientcase,designanevalu-ationplantodetermineifmethadonetherapyisappropriateforthepatient.

l Givenanactualorsimulatedcaseofanopioid-naïvepatient,calculateastartingdoseofmethadone.

l Givenanactualorsimulatedcaseofanopioid-tolerantpatient,calculateastartingdoseofmethadone.

l Givenanactualorsimulatedpatientreceivingmethadone,developamonitoringplantoassessboththerapeuticeffec-tivenessandpotentialtoxicity.

Presenters:Mary Lynn McPherson, Pharm.D., M.A., BCPS, FASHPKathryn A. Walker, Pharm.D., BCPS, CPE,SeniorClinicalDirectorofPalliativeCare,MedStarHealth;AssociateProfessor,UniversityofMarylandSchoolofPharmacy,Baltimore,Md.

WEDNESDAY, DECEMBER 78:00 a.m.–8:30 a.m. South Seas D, Level 3

a (Management Case Study) Antimicrobial Stewardship: Small Hospital StrategiesACTIVITY #0204-0000-16-363-L04-P



Learning Objectives:l Listelementsnecessaryforsuccessfulstewardshipprogrambasedonconsensusguidelines.

l Describetwodifferentapproachestodevelopment,imple-mentation,andmonitoringofstewardshipprogramsinsmallerhospitalswithlimitedresources.

l Indicatestrategiestoreportappropriatestewardshipmetrics.

Presenters:Jennifer L. Richardson, Pharm.D., BCPS, CACP,ClinicalCoordinator,MercyHealthSt.AnneHospital,Toledo,OhioLauryl R. Hanf-Kristufek, Pharm.D., BCPS, CACP,ClinicalCoordinator,MercyHealthSt.CharlesHospital,Oregon,Ohio


a Results from the 2016 ASHP National Survey: The Current State of Pharmacy Practice in HospitalsACTIVITY #0204-0000-16-268-L04-P/0204-0000-16-268-L04-T



Program Chair/Moderator:Douglas Scheckelhoff, M.S., FASHP,SeniorVicePresident,ASHP,Bethesda,Md.

Learning Objectives:l DescribehowtheASHPNationalSurveyresultscanbeusedtoeffectchangeinyourorganization.

l Listthemostsignificantpracticetrendsidentifiedinthe2016ASHPNationalSurvey.

l Describehowpracticetrendsdeviatefromestablishedbestpractices.

Presenters:Craig A. Pedersen, R.Ph., Ph.D., FAPhA,Manager,VirginiaMasonMedicalCenter,Seattle,Wash.Douglas Scheckelhoff, M.S., FASHPPhilip J. Schneider, M.S., FASHP,ProfessorandAssociateDean,UniversityofArizonaCollegeofPharmacy;ProfessorofPracticeinMedicine,DepartmentofBiomedicalInformatics,UniversityofArizonaCollegeofMedicine–Phoenix;Professor,MelandEnidZuckermanCollegeofPublicHealth,UniversityofArizona,Phoenix,Ariz.

8:00 a.m.–9:30 a.m. South Seas J, Level 3

a Basics of GI Access and Clogged Access DevicesACTIVITY #0204-0000-16-269-L04-P



Program Chair/Moderator:Carol J. Rollins, Pharm.D., M.S., FASHP,ClinicalProfessor,CollegeofPharmacy,UniversityofArizona,Tucson,Ariz.

Learning Objectives:l DeterminethedifferencebetweenanNG,PEG,andG-tubewithregardtomedicationadministration.

l Discussfactorsthatcontributetocloggingofenteralaccessdevices,includingmedicationsthatarepronetocauseclogs.

l Evaluateoptionsforunclogginganenteralaccessdeviceandstepsthatmaypreventarecurrenceofclogs.

Presenters:Carol J. Rollins, Pharm.D., M.S., FASHPAmber J. Verdell, Pharm.D., BCNSP, BCPS,AssistantProfessor,PharmacyPractice,WestCoastUniversitySchoolofPharmacy,LosAngeles,Calif.


Educational Sessions Wednesday, December 7 continued8:00 a.m.–9:30 a.m. Mandalay Bay L, Level 2

a Fitting into Our Genes: Demystifying Pharmacogenomic Tests Using Online DatabasesACTIVITY #0204-0000-16-270-L01-P



Learning Objectives:l Describemechanismsofmedicationinteractionsandeffi-cacyrelatedtopharmacogenomicvariations.

l Contrastandcomparevariousonlinepharmacogenomicsdatabases.

l DiscusstheroleofABCtransportersindrugresistance,metabolism,andtoxicity.

l Designamedicationregimenbasedonpharmacogenomictestresults.

Presenter:Edward E. Grace, Pharm.D., AAHIVP, BCPS-AQ ID, Vice-ChairandAssociateProfessor,Clinical&AdministrativeSciencesDepartment,NotreDameofMarylandUniversity,SchoolofPharmacy,Baltimore,Md.


a Propelling Resident Research Projects into the Center RingACTIVITY #0204-0000-16-272-L04-P



Program Chair/Moderator:Tadd Hellwig, Pharm.D., BCPS,AssociateProfessor,SouthDakotaStateUniversityCollegeofPharmacy;ClinicalPharmacist,SanfordUSDMedicalCenter,SiouxFalls,S.D.

Learning Objectives:l DiscussASHPstandardsrelatedtoresidencyprojects.l Describeaflippedresidencyprojectmodel.l Chooseresidencyprojectsthatenhancepharmacyservices.l Developamechanismtoincreasethequalityandrateofresidentresearchprojectssubmittedtopeer-reviewedjournals.

Mallory L. Accursi, Pharm.D., BCACP,ClinicalPharmacySpecialist,ChalmersP.WylieVeteransAffairsAmbulatoryCareCenter,Columbus,OhioStephen Eckel, Pharm.D., M.H.A., BCPS,ClinicalAssociateProfessor,UNCEshelmanSchoolofPharmacy;AssociateDirectorofPharmacy,UNCHospitals,ChapelHill,N.C.Daniel Witt, Pharm.D., BCPS, FCCP,Professor(Clinical)andViceChair,DepartmentofPharmacotherapy,UniversityofUtahCollegeofPharmacy,SaltLakeCity,Utah


a Asking the Right Questions: Preventing Technology Adoption and Implementation BlundersPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-274-L04-P/0204-0000-16-274-L04-T



Program Chair/Moderator:Anthony Carmine Colavecchia, Pharm.D., M.S., BCPS,AdministrativeSpecialist,HoustonMethodistHospital,Houston,Texas

Learning Objectives:l Listthreestrategiestoensuresuccessfulintegrationoftechnologyinoperations.

l Identifycommonunintendedconsequencesoftechnologyimplementation.

l Designasystematicprocesstoassesstechnologybeforeimplementation.

Presenters:Caryn D. Belisle, R.Ph., MBA, BrighamandWomen’sHospital,Boston,Mass.Samuel Calabrese, B.S.Pharm., MBA, FASHP,AssociateChiefPharmacyOfficer,ClevelandClinic,Cleveland,OhioDoina Dumitru, Pharm.D., MBA, FASHP,Director,ProfessionalServices,BD,Houston,Texas

8:00 a.m.–9:30 a.m. Breakers C, Level 2

a Prevention and Management of Drug-Induced QT Interval Prolongation and Torsades de Pointes: Essential Tips for PharmacistsACTIVITY #0204-0000-16-279-L01-P



Program Chair/Moderator:James E. Tisdale, Pharm.D., B.Sc., BCPS, FAHA, FAPhA, FCCP,Professor,PurdueUniversity;AdjunctProfessor,IndianaUniversity,Indianapolis,Ind.

Learning Objectives:l Describecausesandriskfactorsfordrug-inducedQTinter-valprolongationandtorsadesdepointes(TdP)andtheircontributiontotheoccurrenceofTdP.

l Describehowthisarrhythmiacouldhavebeenpreventedinapatientwithdrug-inducedtorsadesdepointes.

l Developapatient-specifictreatmentregimenforapatientwithdrug-inducedtorsadesdepointes.

Presenters:James E. Tisdale, Pharm.D., B.Sc., BCPS, FAHA, FAPhA, FCCPKaty E. Trinkley, Pharm.D., BCAP,AssistantProfessor,UniversityofColoradoSkaggsSchoolofPharmacyandPharmaceuticalSciences;AssistantProfessor,UniversityofColoradoSchoolofMedicine,Aurora,Colo.




a Emergency Medicine Pearls 2016Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-275-L01-P



Program Chair/Moderator:Bryan D. Hayes, Pharm.D., DABAT, FAACT,ClinicalPharmacist,EmergencyMedicineandToxicology,MassachusettsGeneralHospital;AssistantProfessorofEmergencyMedicine,HarvardMedicalSchool,Boston,Mass.

Learning Objectives:l DiscussclinicalpracticeintheEmergencyDepartment.l ExplainapplicationsofclinicalpharmacotherapyintheEmergencyDepartment.

l Discusshowtoapplyclinicalpharmacotherapytouniquecircumstancesandclinicalpresentations.

Presentations:CarbapenemsforValproateOverdoseColgan T. Sloan, Pharm.D., BCPS,ClinicalPharmacySpecialist–EmergencyMedicine,UniversityofUtahHealthCare,SaltLakeCity,Utah LaboratoryMonitoringofTSOACsEmily Kilber, Pharm.D.,PGY2EmergencyMedicinePharmacyResident,TheUniversityofArizona,Tucson,Ariz. KetamineinEtOHWithdrawalLinda H. Barstow, Pharm.D.,EmergencyMedicinePharmacyResident,UniversityofMarylandMedicalCenter,Baltimore,Md. PeripheralVasopressorsMatt Bilhimer, Pharm.D.,EmergencyMedicinePharmacySpecialist,SalinaRegionalHealthCenter,Salina,Kan. ECMOintheEDGiles W. Slocum, Pharm.D.,PGY2PharmacyResident,EmergencyMedicine,UniversityofRochesterMedicalCenter,Rochester,N.Y. TipstoManageStressandBurnoutintheEDPatrick Bridgeman, Pharm.D., BCPS,ClinicalAssistantProfessor,ErnestMarioSchoolofPharmacy,Piscataway,N.J.;ClinicalPharmacySpecialist–EmergencyMedicine,RobertWoodJohnsonUniversityHospital,NewBrunswick,N.J. HydroxocobalaminandLabInterferenceHina Patel, Pharm.D., BCPS,PGY1PharmacyResidencyProgramDirector,NorthShoreUniversityHealthSystem,Evanston,Ill. LoperamideToxicityColleen Martin, Pharm.D., BCPS,ClinicalPharmacist,EmergencyMedicine,NyackHospital,Nyack,N.Y. “GiveMeSomeSuga’!!”—TheAppropriateUseofSugammadexintheEDandItsAddedValueJenny Koehl, Pharm.D.,PGY2EmergencyMedicineResident,UWHealth,Madison,Wis.

TheUseofIVOlanzapineGreta Astrup, Pharm.D.,PGY2EmergencyMedicinePharmacyResident,UniversityofNewMexicoHospital,Albuquerque,N.M. SuxinTBIJuliana Zschoche, Pharm.D.,EmergencyMedicineClinicalPharmacySpecialist,TheJohnsHopkinsHospital,Baltimore,Md. NewTPAContraindicationsEmily Pavich, Pharm.D.,EmergencyMedicineClinicalPharmacist,IUHealthBloomington,Bloomington,Ind. FosfomycinAshley Niemczyk, Pharm.D., BCPS,EmergencyMedicineClinicalPharmacist,FairviewRidgesHospital,Burnsville,Minn. FibrinolyticsinPregnancyEric J. Kanouse, Pharm.D.,EmergencyMedicineClinicalStaffPharmacist,UniversityofRochesterMedicalCenter;PharmacyInformatics,UniversityofRochesterMedicalCenter,Rochester,N.Y. CapsaicinforMarijuana-InducedCVSDaniel Paley, Pharm.D.,ClinicalPharmacist,MercyHospital–partofAllinaHealth,CoonRapids,Minn.


a Data and Dollars: 2017 Updates for Financial SuccessPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-277-L04-P/0204-0000-16-277-L04-T



Program Chair/Moderator:Bonnie Kirschenbaum, M.S., B.S., FASHP, FCSHP,ConsultantandColumnist,Boulder,Colo.

Learning Objectives:l Explain2017changestoMedicarereimbursementandidentifyoperationalchangesrequiredtoimplementthem.(P&T)

l DescribethreeMedicarereimbursementchallengesandcomplexitiesinyourpracticesetting.(P&T)

l ListthecompliancerequirementsforMedicareandhowtheyapplytothe2017changestoOutpatientProspectivePaymentSystems(OPPS).(P&T)

l DescribetheroleofpharmacyleadersineducatingtheirhealthsystemsontheimpactofOPPSchanges,includingbundledpayments.(P&T)

l Synthesizeabasisfornewpractitionersandclinicianstounderstandthefinancialaspectofhealthcare,atopicnotoftencoveredduringtheirformativetraining.(Ponly)

Presenters:Bonnie Kirschenbaum, M.S., B.S., FASHP, FCSHPBeth Roberts, Partner,HoganLovellsUSLLP,Washington,D.C.


Educational Sessions Wednesday, December 7 continued8:00 a.m.–9:45 a.m. South Seas F, Level 3

a Jackpot! Integration of Information Technology and Antimicrobial StewardshipACTIVITY #0204-0000-16-278-L04-P



Program Chair:Riane Ghamrawi, Pharm.D., BCPS,ClinicalPharmacistSpecialist,AntimicrobialStewardship,UniversityHospitalsCaseMedicalCenter,Cleveland,OhioModerator:LeAnne Moore, Pharm.D., BCPS,ClinicalPharmacistSpecialist,RainbowBabies&Children’sHospital,Cleveland,Ohio

Learning Objectives:l Explaintheimportanceofinformationaltechnologyinanti-microbialstewardshipprograms.

l Evaluatethreewaystointegrateinformationtechnologyintoantimicrobialstewardshipprograms.

l Describemethodsofmeasuringantimicrobialstewardshipoutcomesusinginformationtechnology.

Presenters:Riane Ghamrawi, Pharm.D., BCPSLeAnne Moore, Pharm.D., BCPSSharanie Sims, Pharm.D., BCPS-AQ ID,InfectiousDiseasesClinicalPharmacySpecialist,ClevelandVAMedicalCenter,Cleveland,Ohio

8:00 a.m.–9:45 a.m. Oceanside A, Level 2

a Feedback Landscape: The Artistry of Giving and Receiving Effective FeedbackACTIVITY #0204-0000-16-280-L04-P/0204-0000-16-280-L04-T



Program Chair/Moderator:Seena L. Haines, Pharm.D., BCACP, BC-ADM, CDE, FAPhA, FASHP,ProfessorandChairDepartmentofPharmacyPractice,UniversityofMississippiSchoolofPharmacy,Jackson,Miss.

Learning Objectives:l DescribequalitiesthatcharacterizeGenerationYandZstu-dentsandresidentlearners.

l Comparestrategiesthathelpfostereffectivepreceptor-learnerexperiences.

l Analyzefactorsthatcontributetoineffectivefeedback.l Composeformativeandsummativefeed-backresponsesforchallengingpreceptingscenarios.

Presenters:Seena L. Haines, Pharm.D., BCACP, BC-ADM, CDE, FAPhA, FASHPJenny A. VanAmburgh, Pharm.D., BCACP, CDE, FAPhA,ClinicalProfessor/AssistantDeanforAcademicAffairs/ResidencyProgramDirectorPGY1,NortheasternUniversity–SchoolofPharmacy,Boston,Mass.;ClinicalPharmacist,HarborHealthServices,Inc.,Dorchester,Mass.


a An ISMP Update for 2017Planned in cooperation with the Institute for Safe Medication Practices

ACTIVITY #0204-0000-16-282-L05-P/0204-0000-16-282-L05-T



Program Chair:Darryl S. Rich, Pharm.D., MBA, FASHP,MedicationSafetySpecialist,InstituteforSafeMedicationPractices,Horsham,Pa.Moderator:Michael Cohen, R.Ph., Sc.D. (Hon.), D.P.S. (Hon.), M.S., FASHP,President,InstituteforSafeMedicationPractices,Horsham,Pa.

Learning Objectives:l IdentifythetopfivemostimportantmedicationsafetyissuesreportedtotheInstituteforSafeMedicationPractices(ISMP)inthepast12months.

l Describeatleasttwoeffectivestrategiestoreducemedica-tionerrorsrelatedtoeachofthesemedicationsafetyissues.

l ReviewthechangestotheISMPGuidelinesfortheSafePreparationofSterileCompounds.

l ListkeyelementsofthenewISMPGuidelinesontheSafeUseofSubcutaneousInsulinAcrosstheContinuumofCare.

Presenters:Christina Michalek, R.Ph., B.S., FASHP,MedicationSafetySpecialist,InstituteforSafeMedicationPractices,Horsham,Pa.Darryl S. Rich, Pharm.D., MBA, FASHP


a Contemporary Considerations: Cutting-Edge Advances in Vancomycin TherapyACTIVITY #0204-0000-16-292-L01-P



Program Chair/Moderator:Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID,AssociateProfessor,MidwesternUniversity,DownersGrove,Ill.;InfectiousDiseasesPharmacist,NorthwesternMedicine,Chicago,Ill.

Learning Objectives:l Assesstherationaleandlimitationsofvancomycindosingonbodyweightthroughselectedcasescenarios.

l Appraisethe“UpdatestoVancomycinPharmacokineticandPharmacodynamics”andefficacy.

l Evaluatetheliteratureandresearchrelatedtovancomycinnephrotoxicity.

l ContrasttheclinicalresearchfortheroleofvancomycininthetreatmentofGram-positiveorganismscomparedtoothertherapies.

Presenters:Thomas Lodise, Pharm.D., Ph.D.,Professor,AlbanyCollegeofPharmacyandHealthSciences,Albany,N.Y.Manjunath (Amit) Pai, Pharm.D.,AssociateProfessor,CollegeofPharmacy,UniversityofMichigan;DeputyDirectorPKCoreLab,CollegeofPharmacy,UniversityofMichigan,AnnArbor,Mich.Michael J. Rybak, Pharm.D., M.P.H., FCCP,PharmacyFaculty,WayneStateUniversity,Detroit,Mich.Marc H. Scheetz, Pharm.D., M.S., BCPS-AQ ID




a Piecing Together the Pharmacotherapy Puzzle for Children with Autism Spectrum DisorderACTIVITY #0204-0000-16-273-L01-P



Recertification credit for: BCPPS

Learning Objectives:l Designamedicationregimenandmonitoringplanforapediatricpatientwithautismwhopresentswithirritability.

l Makerecommendationsfortheuseandmonitoringofstimulantdrugtherapyinapediatricpatientwithattention-deficithyperactivitydisorderandinattention.

l Makerecommendationsfortheuseandmonitoringofselectiveserotoninreuptakeinhibitortherapyfordepressivesymptomsorrepetitivebehaviorsinapediatricpatientwithautism.

Presenter:Jennifer A. Donaldson, Pharm.D., BCPPS,ClinicalPharmacistSpecialist,RileyHospitalforChildrenatIndianaUniversityHealth,Indianapolis,Ind.



a Caring for Transgender Patients: Considerations for PharmacistsACTIVITY #0204-0000-16-271-L01-P



Learning Objectives:l Definetransgenderandotherrelatedandoftenconfusedterms.l Describepharmacotherapyconsiderationsfortransitioningtransgenderpatients.

l Discussconsiderationsallpharmacistsshouldthinkaboutwhileprovidingcarefortheirtransgenderpatients.

Presenter:Bryan M. Bishop, Pharm.D., BCPS,AssistantProfessor,UniversityofToledo,Toledo,Ohio


a (Management Case Study) Establishing Pharmacy Participation in Antimicrobial Stewardship Program in a Large Academic Medical Center: One Year ExperienceACTIVITY #0204-0000-16-364-L04-P



Learning Objectives:l Describetheprocessofintegrationofallpharmacistsintoantimicrobialstewardshipprogram(ASP)atlevelsbasedontheparticipationinpatientcare.

l Reviewhowinterventionswerestructuredandusedasaprocessmeasure.

l Reportchangesinantimicrobialuseasanoutcomemeasure.

Presenters:Yanina Dubrovskaya, Pharm.D., BCPS-AQ ID,PharmacyClinicalManager,InfectiousDiseases,NYULangoneMedicalCenter,NewYork,N.Y.Marco R. Scipione, Pharm.D., BCPS-AQ ID,ClinicalPharmacotherapySpecialist,InfectiousDiseases,NYULangoneMedicalCenter,NewYork,N.Y.Justin Siegfried, Pharm.D.,ClinicalPharmacotherapySpecialist,InfectiousDiseases,NYULangoneMedicalCenter,NewYork,N.Y.

a Spotlight on Science10:00 a.m.–11:00 a.m. Mandalay Bay H, Level 2

a Precision Medicine — Using Big Data to Predict Drug Response and Optimize CareACTIVITY #0204-0000-16-350-L04-P


EducationalLevel:GeneralInterest

Learning Objectives:l Describenon-traditionalsourcesofinformationrelatedtodrugresponseinprecisionmedicine.l Discusshowprecisionmedicineusesnewdatasourcestooptimizeuseofthemedications.l Summarizehowpharmacistsmayplayanimportantroleinprecisionmedicine.

Featured Presenter:Russ B. Altman, M.D., Ph.D.,KennethFongProfessorandProfessorofBioengineering,ofGenetics,ofMedicine(GeneralMedicalDiscipline),ofBiomedicalDataScienceand,bycourtesy,ofComputerScience,StanfordUniversity,Stanford,Calif.



Educational Sessions Wednesday, December 7 continued


a (Management Case Study) Practice Model Transformation Across a National Health SystemACTIVITY #0204-0000-16-365-L04-P/0204-0000-16-365-L04-T



Learning Objectives:l Describehowtouserapiddesignandchangemanagementtechniquestofacilitatethedevelopmentofatimelineandmilestonesforpracticemodeltransformation.

l Describehowtodevelopandtrackkeyperformanceindica-torsusingadashboard.

l Reviewthelearningsfromrapiddesign,changemanage-ment,anduseofadashboardtodevelopatimelineforyourorganizationforpracticemodeltransformation.

Presenters:Lynn Eschenbacher, Pharm.D., MBA, FASHP,NationalDirectorofPharmacyOperations,TheResourceGroup/Ascension,St.Louis,Mo.Tony Antonopoulos, Pharm.D., MBA,ExecutiveDirectorPharmacyServices,St.VincentIndianapolis,Indianapolis,Ind.


a Focus on Neuromuscular Blocking Agents: New SCCM GuidelinesPlanned in cooperation with the Society of Critical Care Medicine

ACTIVITY #0204-0000-16-383-L01-P



Learning Objectives:l Givenadescriptionofaspecificpatient,developastrategyforassessingthegradeofrecommendationandlevelofevidenceassociatedwiththeimplementationofneuro-muscularblockade.

l Givenadescriptionofapatient,developaneuromuscularblockingagentregimentthatreflectsapplicationofthebestevidenceandcurrentguidelines.

Presenter:Brian L. Erstad, Pharm.D., BCPS, FASHP, FCCP, MCCM,ProfessorandHead,UniversityofArizona,Tucson,Ariz.


a Improving Care Transitions: Pharmacy-led ModelsPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-276-L04-P/0204-0000-16-276-L04-T



Program Chair/Moderator:Cynthia Williams, B.S.Pharm., FASHP,VicePresident/ChiefPharmacyOficer,RiversideHealthSystem,NewportNews,Va.

Learning Objectives:l Summarizekeypracticesdemonstratedtoimprovetransi-tionsofcare.

l Identifyopportunitestoapplymodelsoflayeredlearningintheimprovementofcaretranstions.

l Definespecificinterventionsthatcanbeincorporatedintoexistingpharmacyworkflowatyourorganizationandthatcanleadtoimprovedcaretransitions.

Presenters:Kathy Koehl, Pharm.D., BCNSP, BCPS,SystemDirector,ClinicalPharmacyServices,RiversideHealthSystem,NewportNews,Va.Donna D. Luong, Pharm.D.,MedicationSafety/TransitionsofCarePharmacySupervisor,Cedars-SinaiMedicalCenter,LosAngeles,Calif.Cynthia Williams, B.S.Pharm., FASHP


a Maximizing Your Leadership Potential: Getting the Right Woman in ChargeACTIVITY #0204-0000-16-288-L04-P/0204-0000-16-288-L04-T



Program Chair/Moderator:Jaclyn A. Boyle, Pharm.D., M.S., MBA, BCPS,AssistantProfessorforCommunityPharmacyInnovation,NortheastOhioMedicalUniversity;InnovationsPharmacist,PharmacyInnovations,LLC,Rootstown,Ohio

Learning Objectives:l Explainthebusinesscasebehindsupportingwomeninpharmacyleadership.

l Compareandcontrastmentorshipversussponsorship.l Evaluatedifferencesbetweenfemaleandmalecommuni-cationstyles.

Presenters:Lisa Deal, Pharm.D., R.N., BSN, BCPS,PharmacyClinicalSpecialist,BeebeMedicalCenter,Lewes,Del.Sharon Murphy Enright, B.S.Pharm., MBA,President,EnvisionChangeLLC,Atlanta,Ga.

Panelists:Nishaminy Kasbekar, Pharm.D., B.S., FASHP,CorporateDirectorofPharmacy,UniversityofPennsylvaniaHealthSystem,Philadelphia,Pa.Michael F. Powell, M.S., B.S., FASHP,ExecutiveDirector,Pharmacy&NutritionServices,NebraskaMedicine;AssociateDean,HospitalAffairs,UNMCCollegeofPharmacy,Omaha,Neb.Sara J. White, M.S., B.S., FASHP,(Ret.)DirectorofPharmacy,StanfordHospitalandClinics,PaloAlto,Calif.







a Informatics Pearls 2016: Bytes of InformaticsPlanned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-291-L04-P/0204-0000-16-291-L04-T



Program Chair:Sylvia Belford, Pharm.D., M.S., CPHIMS,Director–ContinuumofCare,MayoClinic,Rochester,Minn.Moderator: Karl F. Gumpper, M.M.I., BCPS, FASHP,PharmacyInformaticsManager,BostonChildren’sHospital,Boston,Mass.

Learning Objectives:l Identifyhowpharmacyinformaticsprogramscanbeusedinyourorganizationtoimprovepatientcare.

l Describeonewayanorganizationhasmadebetteruseofitsclinicalinformationsystemandhowitmaybeimple-mentedinyourorganization.

l Comparevariouspharmacyinformaticsinitiativesandhowtheyimprovethemedication-usesystem.

Presentations:AutomatingMedicalStaffCredentialingandPrivilegingPharmacistDocumentationJoel A. Hennenfent, Pharm.D., MBA, BCPS, FASHP, SystemDirectorofPharmacyServices,TrumanMedicalCenters,KansasCity,Mo. Beyondimplementation—EvaluatingPharmacogenomicsCYP2C19ClopidogrelClinicalDecisionSupportAlertsRilwan Badamas, Pharm.D., CAHIMS,PGY2PharmacyInformaticsResident,MayoClinic,Rochester,Minn. UsingLeaninWorkflowDesignDavid Aguero, Pharm.D.,Manager,PharmacyOperationsandTechnology,St.JudeChildren’sResearchHospital,Memphis,Tenn. AntimicrobialStewardshipCDSinCPOEJoshua Davis, Pharm.D., BCPS,SeniorDirector,PharmacyInformatics,CommunityHealthSystems,Franklin,Tenn. MeropenemDesensitizationDesignforComputerizedPhysicianOrderEntry(CPOE)Tanya O. Ezekiel, Pharm.D., BCPS,ClinicalInformaticsPharmacist,PalmettoHealthRichland,Columbia,S.C. E-prescribingSlidingScaleInsulin:CanWeEnhancetheProcess?Hesham Mourad, Pharm.D., BCCCP, BCPS, CPHIMS,PharmacyInformaticsTeamLeader,MayoClinic,Jacksonville,Fla. Health-SystemPartnershipwithEHRtoEstablishClinicalPharmacyWorkflowsandDocumentPharmacyValueAdrian J. Gonzales, Pharm.D., BCPS, ExecutiveDirectorofPharmacyServices,SanJoaquinCommunityHospital,Bakersfield,Calif.


a Optimizing Experiential Student and Resident Layered-Learning: Advancing Clinical Services and Preceptor DevelopmentACTIVITY #0204-0000-16-290-L04-P/0204-0000-16-290-L04-T



Program Chair/Moderator:Brian Dale Buck, Pharm.D., FASHP,ClinicalAssociateProfessor,UniversityofGeorgiaCollegeofPharmacy,Athens,Ga.

Learning Objectives:l Comparethebenefitsandbarrierstoincorporatingexperi-entialstudentsaspharmacistextenders.

l Constructaframeworkforeffectivelyincorporatingstu-dentsintothepracticesetting.

l Designexperientialtrainingactivitiestooptimizestudentandresidentlearningaswellasclinicalservices.

Presenters:Brian Dale Buck, Pharm.D., FASHPBruce M. Jones, Pharm.D., BCPS,InfectiousDiseasesClinicalPharmacySpecialist,St.Joseph’s/CandlerHealthSystem;ClinicalAdjunctAssistantProfessor,UniversityofGeorgiaCollegeofPharmacy,Savannah,Ga.Hal Richards, Pharm.D., BCNSP,ClinicalPharmacySpecialistCriticalCareMedicine,St.Joseph’s/CandlerHealthSystem;AssistantClinicalProfessor,TheUniversityofGeorgiaCollegeofPharmacy,Savannah,Ga.


a Update on the Management of Pain, Agitation, and Delirium in the ICUPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-295-L01-P



Recertification credit for: BCCCP

Program Chair/Moderator: Kevin E. Anger, Pharm.D., BCPS,ManagerInvestigationalDrugServices,BrighamandWomen’sHospital,Boston,Mass.

Learning Objectives:l Describerecentliteratureonthemanagementofpain,agi-tation,anddeliriumintheintensivecareunit.

l Applykeyconceptsintheselectionofsedatives,analgesics,andantipsychoticagentsincriticallyillpatients.

l Recommendmethodstoovercomekeybarrierstooptimiz-ingpain,sedation,anddeliriumpharmacotherapyincriti-callyillpatients.

Presenters:Kevin E. Anger, Pharm.D., BCPSGilles Fraser, Pharm.D., MCCM,ClinicalSpecialistinCriticalCare,MaineMedicalCenter,Portland,Maine;ProfessorofMedicine,TuftsUniversitySchoolofMedicine,Boston,Mass.Paul M. Szumita, Pharm.D., BCCCP, BCPS, FCCM,ClinicalPharmacyPracticeManager,BrighamandWomen’sHospital;DirectorPGY2CriticalCarePharmacyResidency,BrighamandWomen’sHospital,Boston,Mass.


continues >


Educational Sessions Wednesday, December 7 continued2:00 p.m.–3:45 p.m. Mandalay Bay D, Level 2

a The ACLS 2015 Guidelines: Discussion and DebatePlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-294-L01-P



Program Chair/Moderator:Michael J. Cawley, Pharm.D., CPFT, FCCM, RRT,ProfessorofClinicalPharmacyandVice-Chair,DepartmentofPharmacyPracticeandAdministration,PhiladelphiaCollegeofPharmacy/UniversityoftheSciences,Philadelphia,Pa.

Learning Objectives:l Evaluatedifferencesinadvancedcardiaclifesupport(ACLS)treatment,comparingthe2010and2015AmericanHeartAssociation(AHA)ACLSguidelines.

l DevelopapharmacotherapeuticplanforACLSusingthe2015AHAguidelines.

l Justifytheuseoftherapeutichypothermicstrategiespostcardiacarrest.

Presenters:Michael J. Cawley, Pharm.D., CPFT, FCCM, RRTPhilippe Mentler, BCPS,SeniorConsultant,VizientInc,Cary,N.C.Suprat S. Wilson, Pharm.D., BCPS,PharmacyCoordinator,EmergencyMedicineServices,DetroitReceivingHospital,Detroit,Mich.


a Drug-induced Diseases: Prevention, Detection, and ManagementACTIVITY #0204-0000-16-283-L01-P



Program Chair:James E. Tisdale, Pharm.D., B.Sc., BCPS, FAHA, FAPhA, FCCP,Professor,PurdueUniversity;AdjunctProfessor,IndianaUniversity,Indianapolis,Ind.Moderator:Douglas Miller, Pharm.D.,Professor,WayneStateUniversity,Detroit,Mich.

Learning Objectives:l Describetheepidemiologyofdrug-induceddiseasesandtheirimpactonmorbidity,mortality,andhealth-careresourceutilization.

l Explainmethodsofpreventionfordrug-induceddiseases.· Developapatient-specifictreatmentregimenforapatientwithoneormoredrug-inducedcardiovasculardiseases.

l Developapatient-specifictreatmentregimenforapatientwithoneormoredrug-inducedkidneydiseases.

Presenters:Scott Malinowski, Pharm.D.,ClinicalAssistantProfessor,UniversityofMississippiSchoolofPharmacy;Pharmacist,UniversityofMississippiMedicalCenter,Jackson,Miss.Douglas Miller, Pharm.D.Mary Stamatakis, Pharm.D.,AssociateDeanforAcademicAffairsandEducationalInnovation,WestVirginiaUniversitySchoolofPharmacy,Morgantown,W.V.James E. Tisdale, Pharm.D., B.Sc., BCPS, FAHA, FAPhA, FCCP

Mmm…MacrosandMetricsMonitoringBrian Le, Pharm.D.,PGY-2PharmacyInformaticsResident,HospitalSistersHealthSystem,Belleville,Ill. PharmacyInformaticsCompetenciesHowtoKnowWhatYouNeedtoKnowErica A. Feinberg, Pharm.D.,PGY2PharmacyBioinformaticsResident,HospitalCorporationofAmerica(HCA)andUniversityofTennessee,Nashville,Tenn. DoseStandardizationApproachesinPediatricsandOncologyRyan Markham, Pharm.D.,InformaticsPharmacist,OregonHealth&ScienceUniversity,Portland,Ore. RunningtheRedLight:HarminSight?Adrian Wong, Pharm.D., BCCCP, BCPS,Fellow,OutcomesResearchandPharmacyInformatics,BrighamandWomen’sHospital;ClinicalInstructor,MCPHSUniversity,Boston,Mass. UsingPassiveCDStoReduceAlertFatiguewithDDIsRaymond C. Chan, Pharm.D.,PharmacyISSpecialist,SentaraHealthcare,VirginiaBeach,Va. SmartOrderSetDevelopmentforOralPulmonaryHypertensionMedicationsWithRiskEvaluationandMitigationStrategies(REMS)WithElements-to-Assure-Safe-Use(ETASU)RequirementsJoseph T. Moss, Jr., Pharm.D., MBA, SystemPharmacyInformaticsOfficer,UniversityHospitalsofCleveland,Cleveland,Ohio DecodingtheMysteriesofSmartPumpLibraryUpdatesAsha Kalichira, Pharm.D., M.S.,PGY2PharmacyInformaticsResident,AuroraHealthCare,Milwaukee,Wis. CPOEMedicationOrderVerificationEfficiency:STATandAllofThatJennifer Harris, Pharm.D.,Manager,MedicationManagementandClinicalPharmacyInformatics,HospitalCorporationofAmerica(HCA),Nashville,Tenn. TheHAARTofPatientSafetyDhara Mehta, Pharm.D.,ClinicalPharmacist,BellevueHospitalCenter,NewYork,N.Y.








a Antibiotic Stewardship: Innovative Practices in the Community Hospital SettingACTIVITY #0204-0000-16-285-L04-P



Program Chair/Moderator:Kristi Kuper, Pharm.D., BCPS,SeniorClinicalManager,Vizient,Irving,Texas

Learning Objectives:l Explainrecentnationallegislativeandpolicyeffortsrelatedtoantibioticstewardship.

l Describeinnovativeantibioticstewardshippracticesthatcanbeimplementedinthecommunityhospitalsetting.

l Describehowtheuseoftechnologycanassistwithsup-portingantimicrobialstewardshipefforts.

l Summarizestrategiesthatcanbeusedtoengageprivatepracticephysiciansinstewardshipactivities.

Presenters:David Ha, Pharm.D.,AssistantProfessorofClinicalSciences,KeckGraduateInstituteSchoolofPharmacy,Claremont,Calif.;InfectiousDiseasesPharmacistSpecialist,PomonaValleyHospitalMedicalCenter,Pomona,Calif.Kristi Kuper, Pharm.D., BCPSAmy Schilling, Pharm.D., BCPS,ClinicalPharmacist,MemorialHermannTheWoodlands,TheWoodlands,TexasMontgomery F. Williams, Pharm.D., BCPS,AssistantProfessorofPharmacyPractice,BelmontUniversityCollegeofPharmacy,Nashville,Tenn.;ClinicalPharmacist,InternalMedicineandAntimicrobialStewardship,WilliamsonMedicalCenter,Franklin,Tenn.


a Parenteral Nutrition Primer: Balancing Acid-Base, Fluids, and ElectrolytesACTIVITY #0204-0000-16-287-L01-P



Program Chair/Moderator:Phil Ayers, Pharm.D., BCNSP, FASHP,Chief,ClinicalPharmacyServices,MississippiBaptistMedicalCenter;ClinicalAssociateProfessor,UniversityofMississippiSchoolofPharmacy,Jackson,Miss.

Learning Objectives:l Discusssodiumhomeostasisandtheappropriatemanage-mentoftheparenteralnutritionpatient.

l Describetheimportanceofpotassium,magnesium,cal-cium,andphosphorus,andprovidekeymanagementstrat-egiesforpatientsreceivingnutritionsupport.

l Comparecommonacid-basedisordersanddiscusshowtheyrelatetoparenteralnutritionmanagement.

Presenters:Phil Ayers, Pharm.D., BCNSP, FASHPTodd W. Canada, Pharm.D., BCNSP, FASHP, FTSHP,ClinicalPharmacyServicesManagerandNutritionSupportTeamCoordinator,UniversityofTexasMDAndersonCancerCenter,Houston,TexasMichael Kraft, Pharm.D., BCNSP,ClinicalAssociateProfessor,UniversityofMichiganCollegeofPharmacy,DepartmentofClinicalPharmacy;AssistantDirector-Education&Research,UniversityofMichiganHealthSystem,DepartmentofPharmacyServices,AnnArbor,Mich.Gordon Sacks, Pharm.D., BCNSP,ProfessorandDepartmentHead,AuburnUniversity,HarrisonSchoolofPharmacy,Auburn,Ala.


a Interpreting the Quality of Evidence Supporting New Drug Approvals for the Geriatric PopulationACTIVITY #0204-0000-16-289-L01-P



Recertification credit for: CGP

Program Chair/Moderator: Rebecca B. Sleeper, Pharm.D., BCPS, FASCP, FCCP,Professor,DepartmentofPharmacyPracticeandAssociateDeanofCurriculum,GeriatricsDivision,TTUHSCSchoolofPharmacy,Lubbock,Texas

Learning Objectives:l Discussage-relatedphysiologicalchangesthatcanaffectdrugefficacyandsafety,andexplaintheimplicationsforuseofthedruginageriatricpatient.

l Evaluatethemedicalliteraturetodeterminewhetherdatamaybeextrapolatedtothegeriatricpatientpopulation.

l Recommendappropriateuseofrecentlyintroduceddrugsanddiscusstheirplaceingeriatricpatientcare.

Presenters:Luigi Brunetti, Pharm.D., M.P.H., BCPS, CGP,ClinicalAssociateProfessor,Rutgers,TheStateUniversityofNewJersey,Piscataway,N.J.;ClinicalPharmacist,RobertWoodJohnsonUniversityHospitalSomerset,Somerville,N.J.Rebecca B. Sleeper, Pharm.D., BCPS, FASCP, FCCP


Follow #ASHP16Stay connected to everything happening at the Midyear Clinical Meeting with #ASHP16, the official hashtag for the Midyear meeting. Don’t forget to tag your tweets, photos, and videos with the hashtag so others can follow along with your experiences on Twitter, Facebook, and Instagram.


Educational Sessions Wednesday, December 7 continued2:00 p.m.–4:00 p.m. South Seas B, Level 3

a The Joint Commission Update for 2017Planned in cooperation with The Joint Commission Resources

ACTIVITY #0204-0000-16-296-L03-P/0204-0000-16-296-L03-T



Learning Objectives:l DescribesixareasoffocusofthenewAntimicrobialStewardshipstandard.

l Identifyatleastonekeyissuefoundonsurveyrelatingtothetopfourchallengingmedicationmanagementstandards.

l ListtwosignificantbenefitsofthenewSAFERscoringprocess.l Listthreestrategiesforpreparingforatracerinthepharmacy.

Presenter:Jeannell Mansur, Pharm.D., FASHP,PracticeLeader,MedicationManagementandSafety,JointCommissionResources,OakBrook,Ill.


a (Management Case Study) Six Months to Initiate a Self-Sustaining Specialty PharmacyACTIVITY #0204-0000-16-366-L04-P/0204-0000-16-366-L04-T



Learning Objectives:l Describethebenefitsofaninternalspecialtypharmacyprogramforanintegratedmulti-hospitalhealthsystem.

l Listbarrierstoopeningaspecialtypharmacyandstrategiesforovercomingthesebarriers.

l Discussthefinancialimpactandopportunitiesthataspe-cialtypharmacymayofferahealthsystem.

Presenters:Jason Glowczewski, Pharm.D., MBA, FASHP,DirectorofPharmacy,CommunityHospitals,UniversityHospitalsHealthSystem,Cleveland,OhioShawn Osborne, Pharm.D., MBA,VicePresident,Pharmacy&SupplyChainServices,UniversityHospitalsHealthSystem,Cleveland,OhioKevin Cunningham, R.Ph.,Director,PharmacyOperations,UniversityHospitalsHomeCareServices,Cleveland,Ohio


a Creating Positive Outcomes for Gram-Negative Infections: Deciphering Antibiograms for Best ResultsACTIVITY #0204-0000-16-281-L01-P



Program Chair/Moderator:Edward E. Grace, Pharm.D., AAHIVP, BCPS-AQ ID,Vice-ChairandAssociateProfessor,Clinical&AdministrativeSciencesDepartment,NotreDameofMarylandUniversity,SchoolofPharmacy,Baltimore,Md.

Learning Objectives:l IdentifymarkersofGram-negativeresistancebasedoncur-rentantibiogram.

l CompareGram-negativeresistancerateswithunderlyingmechanismofresistance.

l FormulateempiricandstreamlinedantibioticregimensforpatientswithsuspectedGram-negativeinfections.

l Developanantibioticregimenwithspecificdosesbasedonsuspected/knownorganismandresistancepatterns.

Presenters:Christopher M. Bland, Pharm.D., BCPS, FIDSA,ClinicalAssociateProfessor,UniversityofGeorgiaCollegeofPharmacy;ClinicalSpecialist,St.Joseph’s/CandlerHealthSystem,Savannah,Ga.Edward E. Grace, Pharm.D., AAHIVP, BCPS-AQ ID


a (Management Case Study) Implementation of Ambulatory Specialty Pharmacy Services in a Women’s Health Clinic: Exploring Fertile GroundACTIVITY #0204-0000-16-367-L04-P/0204-0000-16-367-L04-T



Learning Objectives:l Assesstheneedtoexpandspecialtypharmacyservicestoawomen’shealthfertilityclinic.(Ponly)

l Explainthevariouskeyfactorsusedtodeterminefeasibilityofdevelopinganewservice.(P/T)

l Explainthebenefitsofpatientsreceivingfertilitymedica-tionsfromahealthsystem-basedspecialtypharmacy.(P/T)

Presenters:Lisa M. Kumor, Pharm.D.,ClinicalPharmacist,SpecialtyPharmacyServicesandClinicalAssistantProfessor,UniversityofIllinoisHospitalandHealthSciencesSystem,Chicago,Ill.JoAnn Stubbings, B.S.Pharm., MHCA,AssistantDirector,SpecialtyPharmacyServices,UniversityofIllinoisHospitalandHealthSciencesSystem,Chicago,Ill.Rebekah H. Anguiano, Pharm.D., BCACP, BCPS,ClinicalPharmacist,SpecialtyPharmacyServicesandClinicalAssistantProfessor,UniversityofIllinoisHospitalandHealthSciencesSystem,Chicago,Ill.







a Is Coagulopathy Reversal Becoming Alphabet Soup? A Look at New Reversal StrategiesACTIVITY #0204-0000-16-298-L01-P



Program Chair:Gabrielle A. Gibson, Pharm.D., BCCCP, BCPS,Surgical,Trauma,BurnICUClinicalSpecialist,Barnes-JewishHospital,St.Louis,Mo.Moderator:Emily J. Owen, Pharm.D., BCCCP, BCPS,ClinicalPharmacySpecialist,Barnes-JewishHospital,SaintLouis,Mo.

Learning Objectives:l Evaluatethenewandpipelinereversalagentsandtheirpotentialroleinreversaloflife-threateningbleeding.

l Assesstheresultsofavailableliteratureregardingredosingofanticoagulationreversalinapatientwithlife-threateningbleedingwhoisnotachievinghemostasis.

l Appraisecurrentrecommendationsforthereversalofcoagulopathyinlife-threateningbleedinginpatientsnotexposedtoanticoagulation,ifgivenadescriptionofaspe-cificpatient.

Presenters: Gabrielle A. Gibson, Pharm.D., BCCCP, BCPSSarah Welch, Pharm.D.,SurgicalICUClinicalPharmacySpecialist,ClevelandClinic,Cleveland,Ohio


a Improving Performance on Bundled Payment Initiatives: Pharmacy’s Role on the Interdisciplinary TeamPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-286-L04-P/0204-0000-16-286-L04-T



Program Chair/Moderator:Cynthia Williams, B.S.Pharm., FASHP,VicePresidentandChiefPharmacyOficer,RiversideHealthSystem,NewportNews,Va.

Learning Objectives:l DescribethecorecomponentsoftheCentersforMedicare&MedicaidServices(CMS)bundledpaymentinitiative.

l Listthreemedication-relatedinitiativesthathavebeenshowntoimprovepatientoutcomesandlowercostsintheareaofbundledpaymentinitiatives.

l Evaluatethreeopportunitiesforpharmacyinvolvementwithinyourorganizationtoimproveperformanceonbun-dledpaymentinitiatives.

Presenters:David Ferris, Pharm.D., CGP,ClinicalManager,SouthwestGeneralHospital,Cleveland,OhioCynthia Williams, B.S.Pharm., FASHP


a Preceptor Development: Meeting the Standards for Continuous Preceptor DevelopmentPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-293-L04-P/0204-0000-16-293-L04-T



Program Chair/Moderator:Jennifer Sternbach, Pharm.D., BCACP, BCPS,ClinicalCoordinator,ClaraMaassMedicalCenter,Belleville,N.J.

Learning Objectives:l DescribetheASHPstandardsforpreceptordevelopment.l Discussapreceptordevelopmentplanfrombothacom-munityandteachingfacilityperspective.

l Identifythreestrategiesforsuccessfulpreceptordevelopment.

Presenters:Abbie Lyden, Pharm.D., BCPS,ClinicalPharmacist,EmergencyMedicine,NorthwesternMemorialHospital,Chicago,Ill.;AssistantProfessor,PharmacyPractice,RosalindFranklinUniversityofMedicineandScience,NorthChicago,Ill.Sheetal Patel, Pharm.D., BCPS,ClinicalCoordinatorandPGY1ResidencyProgramDirector,NewarkBethIsraelMedicalCenter,Newark,N.J.


a The Internet of Things and Pharmacy: Let’s Get Talking!Planned in cooperation with the ASHP Section of Pharmacy Informatics and Technology

ACTIVITY #0204-0000-16-297-L04-P/0204-0000-16-297-L04-T



Program Chair/Moderator:David Aguero, Pharm.D.,Manager,PharmacyOperationsandTechnology,St.JudeChildren’sResearchHospital,Memphis,Tenn.

Learning Objectives:l DescribetheInternetofThings(IoT)asitappliestophar-macypractice.

l IdentifycurrentexamplesofIoTuseinhealth-system/ambulatorypharmacy.

l DescribetheuseofdesignthinkingtoincorporatetheIoTinpracticeworkflows.

Presenters:David Aguero, Pharm.D.Nate Peaty, Pharm.D., M.S.,AssistantDirectorofPharmacy,WakeForestBaptistHealth,Winston-Salem,N.C.


Educational Sessions Wednesday, December 7 continued4:00 p.m.–5:00 p.m. South Seas F, Level 3

a Current Controversies in the Management of HyperkalemiaPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-299-L01-P



Program Chair/Moderator:Nadia I. Awad, Pharm.D., BCPS,EmergencyMedicinePharmacist,RobertWoodJohnsonUniversityHospital,NewBrunswick,N.J.

Learning Objectives:l Evaluaterecommendationsfordosingandadministrationofparenteralcalciuminthetreatmentofhyperkalemia.

l Applypracticalmethodsforcoadministrationofinsulinanddextroseinthemanagementofhyperkalemia.

l Discussevidence-basedliteraturesurroundingadministra-tionofsodiumbicarbonateandsodiumpolystyrenesulfo-nateinthetreatmentofhyperkalemia.

l Appraiseliteraturerelatedtoclinicaltrialsevaluatingnovelandnewlyapprovedagentsforhyperkalemia.

Presenters:Nadia I. Awad, Pharm.D., BCPSBryan D. Hayes, Pharm.D., DABAT, FAACT,ClinicalPharmacist,EmergencyMedicineandToxicology,MassachusettsGeneralHospital;AssistantProfessorofEmergencyMedicine,HarvardMedicalSchool,Boston,Mass.


a (Management Case Study) Development of a Collaborative Workflow for Oncologic Viral TherapyACTIVITY #0204-0000-16-368-L04-P/0204-0000-16-368-L04-T



Learning Objectives:l Describebarrierstoordering,dispensing,andadminister-ingbiologicallyhazardousmedicationsintheclinicsetting.

l Identifykeystakeholdersfordevelopmentofahigh-riskbiologicmedicationdispensingandadministrationworkflow.

l Describehowthedevelopmentofaworkflowforhigh-riskbiologicmedicationdispensingcanstreamlinetheprocessforotherhigh-riskbiologicmedicationswithsimilarcharacteristics.

Presenters:Anna P. Kempke, Pharm.D., BCPS,ClinicalPharmacistGeneralistandAdjunctClinicalInstructor,UniversityofMichiganHealthSystemandCollegeofPharmacy,AnnArbor,Mich.Shawna Kraft, Pharm.D., BCOP,ClinicalPharmacistSpecialistandClinicalAssistantProfessor,UniversityofMichiganHealthSystemandCollegeofPharmacy,AnnArbor,Mich.

THURSDAY, DECEMBER 89:00 a.m.–10:00 a.m. Mandalay Bay J, Level 2

a A Straight Shot: Update on Adult Vaccination RecommendationsPlanned in cooperation with the Society of Infectious Diseases Pharmacists

ACTIVITY #0204-0000-16-301-L01-P



Program Chair/Moderator:Monica Mahoney, Pharm.D., BCPS-AQ ID,ClinicalPharmacyCoordinator,BethIsraelDeaconessMedicalCenter,Boston,Mass.

Learning Objectives:l DiscussupdatesinvaccinerecommendationsfromACIPandtheCDC.

l Evaluatetheliteraturesupportingthechangesinvaccinerecommendations.

l Determineaplaceintherapyforthenewervaccineproducts,givenapatientscenario.

Presenter:Christopher McCoy, Pharm.D., BCPS-AQ ID,AssociateDirectorAntimocrobialStewardshipandPGY2ResidencyDirectorInfectiousDiseases,BethIsraelDeaconessMedicalCenter,Boston,Mass.


a Welcome to the E-Patient Movement: Patients Becoming More Involved in Their Health Through TechnologyACTIVITY #0204-0000-16-304-L04-P/0204-0000-16-304-L04-T



Program Chair/Moderator:Timothy D. Aungst, Pharm.D.,AssistantProfessorofPharmacyPRactice,MCPHSUniversity,Worcester,Mass.

Learning Objectives:l Describetheroleofonlinepatientactivitiesandthegener-ationofe-patients.

l Identifytheimportanceofpatientportalsandsocialgroupsonpharmacists’practiceandpatientengagement.

l Listqualityresourcesandtoolstoassiste-patientsinbecomingself-directed.

Presenters:Timothy D. Aungst, Pharm.D.Kelly Grindrod, Pharm.D., B.Sc.Pharm., M.Sc.,AssistantProfessor,UniversityofWaterlooSchoolofPharmacy,Waterloo,Ontario,Canada;ClinicalPharmacist,KitchenerDowntownCommunityHealthCentre,Kitchener,Ontario,Canada




a First, Do No Harm: Ethical Controversies in Palliative CarePlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-302-L01-P



Program Chair:Daniel Abazia, Pharm.D., BCPS, CPE,ClinicalAssistantProfessor,ErnestMarioSchoolofPharmacy–Rutgers,TheStateUniversityofNewJersey,Piscataway,N.J.;ClinicalPharmacist,CapitalHealth,Trenton,N.J.Moderator:Maria Foy, Pharm.D., BCPS, CPE,ClinicalSpecialist,PalliativeCare,AbingtonHospitalJeffersonHealth,Abington,Pa.

Learning Objectives:l Evaluatetreatmentbenefitsandburdensatendoflifebasedonavailableevidence.

l Justifymedicationclassesthatshouldnotbestoppedatendoflife,focusingonpatient-specificstrategiesformedi-cationdeprescribing.

l Applycommunicationtacticsforaddressingend-of-lifemedicationmanagementcontroversieswithpatients,care-givers,andhealthcareproviders.

Presenters:Daniel Abazia, Pharm.D., BCPS, CPEMaria Foy, Pharm.D., BCPS, CPE


a Check or Hold? Investigating Three Clinical Controversies in Cardiovascular PharmacotherapyPlanned in cooperation with the ASHP Section of Clinical Specialists and Scientists

ACTIVITY #0204-0000-16-305-L01-P



Program Chair/Moderator:Christopher Betz, Pharm.D., BCPS, FASHP, FKSHP,Professor,SullivanUniversityCollegeofPharmacy,Louisville,Ky.

Learning Objectives:l Compareandcontrastthedatasupportingunfractionatedheparinversusbivalirudininacutecoronarysyndromeanddesignaregimenforpatientsinthecathlab.

l Evaluatethemorbidityandmortailitydataofdigoxinuseinheartfailureandatrialfibrillationpatients,anddetermineiftheuseofdigoxinshouldcontinue.

l RecommendappropriateNSAIDtherapyinpatientswithunderlyingcardiovasculardisease.

Presenters:Christopher Betz, Pharm.D., BCPS, FASHP, FKSHPSnehal Bhatt, Pharm.D., BCPS,AssociateProfessorofPharmacyPractice,MCPHSUniversity,Boston,Mass.


a Implementing ISMP’s Targeted Medication Safety Best PracticesPlanned in cooperation with the Institute for Safe Medication Practices

ACTIVITY #0204-0000-16-300-L05-P/0204-0000-16-300-L05-T



Program Chair/Moderator:Darryl S. Rich, Pharm.D., MBA, FASHP,MedicationSafetySpecialist,InstituteforSafeMedicationPractices,Horsham,Pa.

Learning Objectives:l Citethethreemost-implementedandthreeleast-imple-mentedbestpracticesfrom2016-2017InstituteforSafeMedicationPractices(ISMP)TargetedMedicationSafetyBestPracticesforHospitals,alongwiththemajorimple-mentationbarrriersreported.

l Citeatleastthreeevidence-basedargumentsthatcanbeusedtoovercomeimplementationbarrierstothe2016-2017ISMPTargetedMedicationSafetyBestPracticesforHospitals.

l Listatleastthreesuccessfulstrategiesotherhospitalshaveusedtosuccessfullyimplementthe2016-2017ISMPTargetedMedicationSafetyBestPracticesforHospitals.

Presenters:Sandy Atwater, B.S.Pharm.,PharmacyDirector,LodiMemorialHospital,Lodi,Calif.Steven Meisel, Pharm.D.,DirectorofPatientSafety,FairviewHealthServices,Minneapolis,Minn.Darryl S. Rich, Pharm.D., MBA, FASHP

10:00 a.m.–12:00 p.m. Lagoon L, Level 2

a Practice Innovations 2016: Strategies Worth SharingACTIVITY #0204-0000-16-303-L04-P/0204-0000-16-303-L04-T



Program Chair/Moderator:Dale E. English, II, Pharm.D., R.Ph., FASHP, AssociateDeanforStudentSuccessandAssociateProfessorofPharmacyPractice,NortheastOhioMedicalUniversity,CollegeofPharmacy,Rootstown,Ohio

Learning Objectives:l Describemethodsthatcanbeusedtohighlightwhichprac-ticeadvancementrecommendationsreceivepriorityandresources.

l Describecommonbarriersthataffectpracticeadvancement.l Identifyeffectivestrategiesthatcanbeusedtoimplementpracticeadvancementandexpandtheroleofpharmacistsandtechnicians.

Presenters:Dale E. English, II, Pharm.D., R.Ph., FASHPMatthew T. Jenkins, Pharm.D., M.S.,DirectorofAcuteCarePharmacyServices,UniversityofVirginiaHealthSystem,Charlottesville,Va.Stephen Lirette, Pharm.D., BCPS,ClinicalInstructor,TheUniversityofMississippiSchoolofPharmacy,Jackson,Miss.

continues >


Educational Sessions Thursday, December 8 continuedCourtenay Wilson, Pharm.D., BCACP, BCPS, CDE, CPP,AssociateDirectorofPharmacotherapy,MAHECFamilyHealth,Asheville,N.C.;AssistantProfessorofClinicalEducation,UNCEshelmanSchoolofPharmacy,ChapelHill,N.C.

10:30 a.m.–12:00 p.m. Mandalay Bay J, Level 2

a On a Scale of 0 to 10, How Scared Are You? Taking the Fear out of Chronic Pain ManagementACTIVITY #0204-0000-16-306-L01-P



Program Chair:Kathleen M. Vest, Pharm.D., BCACP, CDE,AssociateProfessorofPharmacyPractice,MidwesternUniversityChicagoCollegeofPharmacy,DownersGrove,Ill.Moderator:Michele Matthews, Pharm.D., BCACP, CPE, FASHP,AssociateProfessorofPharmacyPractice,MCPHSUniversity;AdvancedPharmacistPractitioner–PainManagement,BrighamandWomen’sHospital,Boston,Mass.

Learning Objectives:l Evaluatetheappropriatenessandfeasibilityofintegratingclinicalpharmacyservicesforchronicpainmanagementintheambulatorycaresetting.

l Developacollaborativepracticemodelforchronicpainmanagementwithintheambulatorycaresetting.

l Justifyaplanfortheoptimizationofdrugtherapyinapatientwithchronicpain.

Presenters:Brooke Griffin, Pharm.D., BCACP,ProfessorofPharmacyPractice,MidwesternUniversity,DownersGrove,Ill.Michele Matthews, Pharm.D., BCACP, CPE, FASHPKathleen M. Vest, Pharm.D., BCACP, CDE

10:30 a.m.–12:00 p.m. Breakers C, Level 2

a Information Overdose! Managing an Information-Saturated EnvironmentACTIVITY #0204-0000-16-308-L04-P/0204-0000-16-308-L04-T



Program Chair/Moderator:Scott D. Nelson, Pharm.D., M.S.,AssistantProfessor,BiomedicalInformatics,VanderbiltUniversityMedicalCenter,Nashville,Tenn.

Learning Objectives:l Discussinformation-overloadsignsandsymptoms.l Listatleastthreewaysclinicianstrytocopewithinforma-tionoverload.

l Applybasicdesignstrategiestoreduceinformationoverload.l Compareandcontrastdifferentinterfacedesigns.

Presenters:Scott D. Nelson, Pharm.D., M.S.Alissa L. Russ, Ph.D.,ResearchScientist,DepartmentofVeteransAffairs,RichardL.RoudebushVAMedicalCenter,Indianapolis,Ind.;AdjunctAssistantProfessorofPharmacyPractice,PurdueUniversity,WestLafayette,Ind.;ResearchScientist,RegenstriefInstitute,Indianapolis,Ind.

11:00 a.m.–12:00 p.m. Mandalay Bay D, Level 2

a Albumin or Balanced Salt Solutions for Resuscitation in Severe Sepsis and Septic Shock: It’s Debatable!ACTIVITY #0204-0000-16-307-L01-P



Program Chair/Moderator:Alexander H. Flannery, Pharm.D., BCCCP, BCPS,CriticalCarePharmacist,MedicalIntensiveCareUnit,UniversityofKentuckyHealthCare;AdjunctAssistantProfessor,UniversityofKentuckyCollegeofPharmacy,Lexington,Ky.Learning Objectives:

l Describethebiologicrationaleforalbuminandbalancedsaltsolutionsasresuscitationagentsinsepsisascomparedtotraditionalcrystalloidsolutions.

l Evaluatelandmarktrialsforalbuminandbalancedsaltsolutions.

l Compareandcontrasttheevidenceforandagainstalbu-minandbalancedsaltsolutionsintheresuscitationofasepticpatient.

Presenters:Brian L. Erstad, Pharm.D., BCPS, FASHP, FCCP, MCCM,ProfessorandHead,UniversityofArizona,Tucson,Ariz.Alexander H. Flannery, Pharm.D., BCCCP, BCPS

11:00 a.m.–12:00 p.m. Lagoon F, Level 2

a Safety and Efficacy Updates in the Management of Invasive Fungal InfectionsPlanned in cooperation with the Infectious Diseases Society of America

ACTIVITY #0204-0000-16-309-L01-P



Program Chair/Moderator:Kayla R. Stover, Pharm.D., BCPS-AQ ID,AssociateProfessorofPharmacyPractice,UniversityofMississippiSchoolofPharmacy;AffiliatedFaculty-InfectiousDiseases,UniversityofMississippiMedicalCenter;AffiliatedFaculty-Pharmacotherapy,UniversityofMississippiMedicalCenter,Jackson,Miss.

Learning Objectives:l DiscussupdatedrecommendationsforthemanagementofcandidiasisfromtheInfectiousDiseasesSocietyofAmerica(IDSA).

l Evaluatetherecentreportsoftoxicityassociatedwithcom-monlyusedantifungalagents.

l Developamedicationregimenthatreflectsapplicationofthebestevidenceandcurrentguidelinesgivenadescrip-tionofaspecificpatient.

Presenters:Scott J. Bergman, Pharm.D., BCPS-AQ ID,AssociateProfessorofPharmacyPractice,SouthernIllinoisUniversityEdwardsville,Edwardsville,Ill.;PGY2InfectiousDiseasesPharmacyResidencyProgramDirector,HSHSSt.John’sHospital,Springfield,Ill.Kayla R. Stover, Pharm.D., BCPS-AQ ID




a Getting Patients to Make the Stick: A Hands-on Approach to Injectable Agents in DiabetesPlanned in cooperation with the ASHP Section of Ambulatory Care Practitioners

ACTIVITY #0204-0000-16-312-L01-P



Program Chair:Kristi W. Kelley, Pharm.D., BC-ADM, BCPS, CDE, CDTC,AssociateClinicalProfessor,PharmacyPractice,AuburnUniversityHarrisonSchoolofPharmacy;ClinicalPharmacist,ContinuityClinics,BrookwoodBaptistInternalMedicineResidencyTrainingProgram,Birmingham,Ala.Moderator:Melody Hartzler, Pharm.D., AE-C, BCACP,AssociateProfessorofPharmacyPractice,CedarvilleUniversitySchoolofPharmacy,Cedarville,Ohio;ClinicalPharmacist,WesternMedicineProviders,Enon,Ohio

Learning Objectives:l Analyzeprimaryliteratureofnewanduniquediabetesmedication-deliverydevices.

l Demonstratehowtousenewdiabetesmedication-deliverydevices.

l Choosepatientcounselingtechniquesfortheuseofthesediabetesmedication-deliverydevices.

l Recommendstrategiestohelppatientsobtaindevicesatlowercosts.

Presenters:Melody Hartzler, Pharm.D., AE-C, BCACPSamantha Karr, Pharm.D., BCACP, BC-ADM, BCPS, FCCP,AssociateProfessor,MidwesternUniversity,CollegeofPharmacy,Glendale,Ariz.;EndocrinologyPharmacist,BannerHealth,Peoria,Ariz.


a Rolling the Dice with Triple TherapyACTIVITY #0204-0000-16-313-L01-P



Program Chair/Moderator:Jessie L. Dunne, Pharm.D., BCPS,ClinicalPharmacySpecialist–Cardiology,UniversityofKentucky,Lexington,Ky.

Learning Objectives:l Evaluatethecurrentliteratureontheuseofconcomitantoralanticoagulationandantiplatelettherapypost-percuta-neouscoronaryintervention(PCI).

l Identifypatientriskfactorsforbleedingandthromboembolism.

l Applycurrentliteratureandguidelinestopatientsrequiringbothoralanticoagulantandantiplatelettherapy.

l Assesscurrentgapsinknowledgeoftheoptimalcombina-tionanddurationoftripleantithrombotictherapy.

Presenters:Snehal Bhatt, Pharm.D., BCPS,AssociateProfessorofPharmacyPractice,MCPHSUniversity,Boston,Mass.Jessie L. Dunne, Pharm.D., BCPS


a HRO: A Path to Highly-Reliable Medication Delivery SystemsACTIVITY #0204-0000-16-384-L05-P/0204-0000-16-384-L05-T



Learning Objectives:l Discusshowtodesignhighly-reliablemedi-cationdeliverysystems(howtodealwithourinescapablefallibility).l Describeamethodforembeddingaquali-tativedesignstandardintothemedicationprocess(thethreedice).

l Explainhowtopredictivelymodelhumanchoiceswiththesystem(hazardsandthreatsanalysis).

Presenter:David Marx, J.D.,President,OutcomeEngenuity,Plano,Texas


a Balancing Pharmacy Benchmarking, Productivity, and the Work of Clinical PharmacistsPlanned in cooperation with the ASHP Section of Pharmacy Practice Managers

ACTIVITY #0204-0000-16-311-L04-P/0204-0000-16-311-L04-T



Program Chair/Moderator:Robert P. Granko, Pharm.D., MBA,DirectorofPharmacy,ConeHealth,Greensboro,N.C.

Learning Objectives:l Describecommonlyusedbenchmarkingmetrics.(P/T)l Evaluatetheprocessthatcouldbeusedtochangephar-macyproductivitymetricswithinahospitalorhealthsys-temtobettermeasurethedailyworkloadandpeerhospitalcomparisons.(P/T)

l Assesshowstandardizationofclinicaldocumentationanddispensingprocessescanhelpineffectivelycomparingpharmacymetrics.(P/T)

l Illustrateanacuitymodelapplicationofclinicalpharmacistknowledgeworkatacommunityteachinghospital.(Ponly)

Presenters:Robert P. Granko, Pharm.D., MBABrian Latham, Pharm.D.,DirectorofPharmacy/HomeInfusion,St.Rita’sMedicalCenter,Lima,OhioRyan Naseman, Pharm.D., M.S., BCPS,AssistantDirector,TheOhioStateUniversityJamesCancerHospital,Columbus,Ohio


ASHP PROFESSIONAL CERTIFICATEPROGRAMSSelf-guided, online education and training for pharmacy personnel

NEW PROGRAMS!

Current and upcoming programs offered:

n Advanced Sterile Product Preparation Training and Certificate Program For participants who are proficient in the fundamental skills required for safe and compliant sterile product preparation

n Teaching Certificate for Pharmacists Designed for residency programs and pharmacy preceptors and offers practical education and training

n Sterile Product Preparation Training and Certificate Program Education and training to ensure pharmacists and technicians are prepared to apply aseptic compounding principles to prepare sterile products

n Pharmacy Informatics Certificate Provides pharmacists and technicians with essential knowledge in pharmacy informatics

n Medication Safety Certificates Designed to enhance the skills of pharmacists, physicians, and nurses who lead medicationsafety improvements


Spring 2017


ProCertPro_FP_AD.indd 1 11/1/16 4:32 PM


INDUSTRY-SUPPORTED SYMPOSIA

ThefollowinglistingisprovidedtoyoubyASHPasacourtesy;thesearecommerciallysupportedprogramsheldinconjunc-tionwiththeMidyearClinicalMeetingandExhibitionandarenotpartoftheofficialASHPMidyearmeetingprogram-ming.Anyquestionsrelatedtotheseprogramsshouldbedirectedtothecompanyorindividuallisted.Anypreregis-trationtakenfortheseprogramsisforplanningpurposesonlyanddoesnotguaranteeaseat.Seatingislimitedandprovidedonafirst-come,first-servedbasis.Anearlyarrivalisrecommended.

ThislistingiscurrentasofSeptember 29, 2016.Forthemostcurrentlisting,refertotheaffiliatelistinginthemeet-ingregistrationbag,viewontheASHPLIVEapp,orvisitwww.ashp.org/midyear.

NOTE:Checkthehotelreaderboardsforroomlocations.

SATELLITE SYMPOSIA

SUNDAY, DECEMBER 47:00 a.m.–8:00 a.m. Mandalay Bay

a Antibiotic Stewardship Programs (ASP’s) 2017 and Beyond; Impending Mandatory Conditions for CMS Participation and the Reality of JCAHO ASP Mandatory Medication Management 0.9.01.01 Measures Beginning January 1, 2017Supportedbybiomerieux.ContactSherryHightower,[email protected] Provider:WestVirginiaUniversity.

9:00 a.m.–11:00 a.m. Mandalay Bay

a Planning for a Seamless Transition for Infusion Pump Integration with the EHRSupportedbyBD.ContactRachelCohen,[email protected] Provider: ProCE.

9:00 a.m.–11:30 a.m. MGM Grand

a One Mission. One Goal. One Team: Leadership and Collaboration in HealthcareSupportedbyCardinalHealth.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.

1:00 p.m.–4:00 p.m. Mandalay Bay

a Best Practices in Ensuring the Quality of Compounded Sterile IV Preparations: Updates on Legislation, Standards, and BeyondSupportedbyBaxterHealthcareCorporation.ContactASHPAdvantageatelearning@ashp.org.CE Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/sterileiv

MONDAY, DECEMBER 56:30 a.m.–8:30 a.m. Mandalay Bay

a Evolution of Multiple Sclerosis Management: Pharmacy’s Role (Live Webinar)SupportedbyGenzyme,aSanofiCompany.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.

7:00 a.m.–8:30 a.m. Mandalay Bay

a 503b ComplianceSupportedbyAmerisourceBergen.ContactJulieShallisBurgess,[email protected] Provider: UniversityofFindlay.

TUESDAY, DECEMBER 65:45 a.m.–7:45 a.m. Mandalay Bay

a The Regulatory Outlook for Sterile Compounding in Health Systems: Opportunities and ChallengesSupportedbyPharMEDium.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.

5:30 p.m.–7:30 p.m. Mandalay Bay

a Complex Cases in the Management of Chemotherapy-Induced Severe NeutropeniaSupportedbyTevaPharmaceuticals.ContactSydneyTurner,[email protected] Provider: NACCME.

WEDNESDAY, DECEMBER 75:45 a.m.–7:45 a.m. Mandalay Bay

a Facing the Challenges of Invasive Fungal Infections: Clinical Updates & Best Practices (Live Webinar)SupportedbyAstellasScientificandMedicalAffairs,Inc.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.

ASHP PROFESSIONAL CERTIFICATEPROGRAMSSelf-guided, online education and training for pharmacy personnel

NEW PROGRAMS!

Current and upcoming programs offered:

n Advanced Sterile Product Preparation Training and Certificate Program For participants who are proficient in the fundamental skills required for safe and compliant sterile product preparation

n Teaching Certificate for Pharmacists Designed for residency programs and pharmacy preceptors and offers practical education and training

n Sterile Product Preparation Training and Certificate Program Education and training to ensure pharmacists and technicians are prepared to apply aseptic compounding principles to prepare sterile products

n Pharmacy Informatics Certificate Provides pharmacists and technicians with essential knowledge in pharmacy informatics

n Medication Safety Certificates Designed to enhance the skills of pharmacists, physicians, and nurses who lead medicationsafety improvements


Spring 2017


ProCertPro_FP_AD.indd 1 11/1/16 4:32 PM


Industry-supported Symposia11:30 a.m.–1:00 p.m. South Pacific B

a Biosimilars Out of the Gate: What Are The Latest Developments? (Live Webinar)SupportedbySandozInc.,aNovartisCompany.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.

11:30 a.m.–1:00 p.m. South Pacific D

a Maximizing Benefits of Immune Checkpoint Inhibitors: A Team-Based Approach (Live Webinar)SupportedbyMerckSharp&DohmeCorp.,asubsidiaryofMerck&Co.,Inc.ContactRebeccaWeaver,[email protected] Provider: CreativeEducationalConcepts.

11:30 a.m.–1:00 p.m. South Pacific H

a Clinical and Collaborative Care Strategies for the Successful Management of HemophiliaSupportedbyindependentgrantsfromAlnylamPharmaceuticals,Baxalta,nowpartofShire,NovoNordisk,Inc.ContactStevenCasebeer,ImpactEducation,[email protected] Provider: MedicalEducationResources,Inc.

11:30 a.m.–1:00 p.m. South Pacific J

a From the Front Line: Improving Sterile Compounding SafetySupportedbyBD.ContactRachelCohen,[email protected] Provider:ProCE.

TUESDAY, DECEMBER 611:30 a.m.–1:00 p.m. Islander Ballroom F

a Ensuring Readiness for USP Chapter <800> on Handling Hazardous Drugs: Assessment, Planning, and Implementation (Live Webinar)[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/800

11:30 a.m.–1:00 p.m. Islander Ballroom G

a Understanding the Pharmacology of Immunotherapy: A Look at the Future in Managing Difficult-to-Treat Cancers (Live Webinar)[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.cemidday.com

MIDDAY SYMPOSIAAllroomsarelocatedintheMandalay Bay North Convention Centerunlessotherwisenoted.

NOTE:Foodandbeverage(i.e.,boxedlunches)arenolongerprovidedtoattendeesofMiddaySymposiafundedbycom-mercialsupportersandheldMonday,Tuesday,andWednesdayduringtheMidyearmeeting.ThispolicywasestablishedbyASHPinconsiderationofcommercialsupportersthathaveoptedtoexcludefoodatallcontinuingeducationactivitiesforhealthcareprovidersforwhichgrantsupporthasbeenprovidedbasedontheirpoliciesrelatedtothePhysicianPaymentsSunshineAct.Inaddition,theMiddaySymposiahavebeenshortenedby30minutestoallowattendeestoeatlunchafterthesymposia.Alternatively,attendeesarefreetobringtheirlunchestothemeetingroomandenjoythemduringtheeducationalactivity.

MONDAY, DECEMBER 55:45 a.m.–7:45 a.m. Islander Ballroom F

a Specialty Pharmacy as a Foundation for Population HealthSupportedbyAmerisourceBergen.ContactSidMcFadden,[email protected]. CE Provider: UniversityofFindlay.

11:30 a.m.–1:00 p.m. Islander Ballroom G

a Individualizing Insulin Therapy for Type 2 Diabetes Mellitus: Clinical Case Vignettes (Live Webinar)SupportedbyNovoNordiskInc.ContactASHPAdvantageatelearning@ashp.org.CE Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/type2

11:30 a.m.–1:00 p.m. Islander Ballroom H

a New and Emerging Strategies for the Treatment of Chronic Heart Failure: A Clinical Case Studies WorkshopSupportedbyNovartisPharmaceuticalsCorporation.ContactASHPAdvantageatelearning@ashp.org.CE Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/chf

11:30 a.m.–1:00 p.m. Islander Ballroom I

a Promoting Safety in the Perioperative Setting: Best Practices in Neuromuscular Blockade and Reversal (Live Webinar)[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.


X


WEDNESDAY, DECEMBER 711:30 a.m.–1:00 p.m. Islander Ballroom F

a USP Essentials: Implementing Compounding and Hazardous Drug Standards – USP <797>/<795>/<800>SupportedbyUSP.ContactLoredanaJinga,[email protected] Provider: NABP.


a Creating a Culture of Safety in the Management of Patients at Risk for Malnutrition (Live Webinar)SupportedbyFreseniusKabiUSA,[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/malnutritionrisk


a Making Antimicrobial Stewardship a Priority: Integrating Evidence-based Practices and Guidelines to Improve Antimicrobial Use (Live Webinar)[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.


11:30 a.m.–1:00 p.m. South Pacific B

a What You Need to Know About PAH: Empowering Pharmacists in Management DecisionsSupportedbyActelionPharmaceuticalsUS,Inc.ContactMajaDrenovac,[email protected] Provider: CenterforIndependentHealthcareEducation.


a Better Health Outcomes from Drug Manufacturers, Health Systems and Payers: Collaboration in the New World of Patient-Minded CareSupportedbyAmerisourceBergen.ContactSidMcFadden,[email protected] Provider: UniversityofFindlay.


a Optimizing Outcomes in Hyperkalemia: An Update for Health-System PharmacistsSupportedbyZSPharma.ContactCathyZehr,[email protected] Provider: UniversityofTennesseeCollegeofPharmacy.


a The Changing Landscape of Hypercholesterolemia: The Emerging Role of Non-statin Therapies (Live Webinar)SupportedbyeducationalfundingprovidedbyAmgenandanindependenteducationalgrantbySanofiUSandRegeneronPharmaceuticals.ContactASHPAdvantageatelearning@ashp.org.CE Provider: AmericanSocietyofHealth-SystemPharmacists.

Formoreinformation,visitwww.ashpadvantage.com/go/pcsk9inhibitors


a New Approaches to the Treatment of Hepatitis C Virus Infection (Live Webinar)[email protected] Provider: AmericanSocietyofHealth-SystemPharmacists.


11:30 a.m.–1:00 p.m. South Pacific B

a PAH: The Role of the Pharmacist in Improving Patient OutcomesSupportedbyActelionPharmaceuticals.ContactGailTownley,ProCE,[email protected] Provider: ProCE,Inc.


a Examining the Latest Therapies and Quality Improvement Strategies for Heart FailureSupportedbyanindependenteducationalgrantfromAmgen,Inc.ContactStevenCasebeer,ImpactEducation,[email protected] Provider: MedicalEducationResources,Inc.


a Error Prevention in Chemotherapy: Building Safer Medication Use SystemsSupportedbyEaglePharmaceuticals.ContactRachelCohen,[email protected] Provider: ProCE.

11:30 a.m.–1:00 p.m. South Pacific J

a Containing Hazardous Drugs with CSTDs: Understand the evidence and requirements from USP<800> to the NIOSH Universal Testing ProtocolSupportedbyB.BraunMedicalInc.ContactSharonShapiro,[email protected] Provider: SaxeHealthcareCommunications.

X


POSTER PRESENTATIONS

Professional PostersCategories:AmbulatoryCare,Automation/Informatics,Cardiology/Anticoagulation,ClinicalServicesManagement,Drug-UseEvaluation/DrugInformation,GeneralClinicalPractice,InfectiousDiseases,Leadership,Oncology,PainManagement,PharmacyLaw/Regulatory/Accreditation,PreceptorSkills,QualityAssurance/MedicationSafety

Ambulatory Care1-001 Desensitization and the pharmacist’s role in an

outpatient pharmacy setting, SamiLabib,MonazzahSarwar,StevenMenachof,DanielHaywood

1-002 Dipeptidyl peptidase-IV inhibitors for treatment of Type 2 diabetes mellitus: a pilot study, ChelseaSampadian,CarolBotelho

1-003 Implementation of an innovative residency scheduling model to minimize required rotation experiences and maximize flexibility for residents at an ASHP-accredited PGY1 pharmacy residency at a Veterans Affairs medical center, StevenSparkes,AmyMurdico

Automation/Informatics1-004 Impact of inventory optimization of automated

dispensing cabinets (ADCs) at a Veterans Affairs (VA) medical center, XimenaVallejos,MaraZ.Carrasquillo

Cardiology/Anticoagulation1-005 Design and implementation of a web-based dash-

board to identify and monitor veterans with recent admissions for heart failure, MarkAparicio,AnoliPatel

1-006 Assessing the addition of a direct oral acting anti-coagulation pharmacist to existing anticoagula-tion services to improve patient care, CarlosFreitas,CarolBotelho,BradleyPeterson

Gain insight into successful programs from health systems in the U.S. and around the world!

Professionalposterpresentationsarelistedbelow;Student,Resident,andFellowspresentationsarelistedontheASHPLIVEapp.

SUNDAY, DECEMBER 4


NEW! a Networking and Poster Session: Emergency Care



a The ASHP Federal Forum: Meet the Researchers Poster SessionParticipantsmayearnuptoonehourofCEcredit.Formoreinformation,seepage65.

Professional Posters*

Monday,December5 2:30p.m.–4:00p.m.

Tuesday,December6 2:30p.m.–4:00p.m.

Student Posters

Monday,December5 10:45a.m.–11:45a.m. 12:00p.m.–1:00p.m.

Tuesday,December6 10:00a.m.–11:00a.m. 11:30a.m.–12:30p.m.

Wednesday,December7 8:30a.m.–9:30a.m.

Resident Posters

Wednesday,December7 10:00a.m.–11:00a.m. 11:15a.m.–12:15p.m. 12:30p.m.–1:30p.m. 1:45p.m.–2:45p.m. 3:00p.m.–4:00p.m.

*FellowswillpresentonTuesdayintheProfessionalPostersession.

Share Your Expertise with Students and ResidentsWe invite you to share your expertise with student or resident poster presenters at this year’s meeting.

Discuss a project one-on-one with a student or resident for just 15 to 20 minutes and, in an hour, your thoughtful sharing of your time will help prepare three or more future pharmacists to serve our profession a little better.

Please stop by the desk in the poster hall during any of the poster sessions to participate. Your contribution is highly valued.

All poster sessions are in Bayside B, Level 1


General Clinical Practice1-020 Severe iron deficiency anemia caused by chronic

proton pump inhibitor use, ErinLoesch,DavidDado,SudhaJaganathan

1-021 Review of an unorthodox argatroban infusion rate for anticoagulation in a patient case, ErinLoesch

1-022 Impact of pharmacy participation on number of discrepancies identified during admission medi-cation reconciliation process: a pilot study, RachelMorgans,NicoleAsal,CarolBotelho

Infectious Diseases1-023 Initiation and management of hepatitis C therapy

in a pharmacist-run clinic, BrettBorba,WafaSamara,JenniferSiilata

1-024 Effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C infection in coin-fected HIV/HCV population, EstherChamorro-de-Vega,Carmen-GuadaupleRodriguez-Gonzalez,AlvaroGimenez-Manzorro,AnaHerranz,MariaSanjurjo

1-025 Effectiveness, safety, and adequacy of linezolid therapy, LaraGonzalez,MariaGarcia,SilviaVazquez,MariaFortes,CarlosCrespo-Diz

1-026 Improving antibiotic use through the implemen-tation of a prospective audit-feedback process at a Veterans Affairs hospital in California, JonMalepsy,BrettBorba,WafaSamara,BruceManzo

1-027 Evaluation of empirical treatment for outpatient community-acquired pneumonia (CAP) at a Veterans Affairs healthcare system: a resident-driven quality improvement project, TheodoreOsborn,ShawnDalton,CedarKoetting,TimothySchick,PatriciaTaylor

1-028 Clinical pharmacist specialists in a hepatitis C clinic: best practices for a multidisciplinary team, MitchellSnyder,KendraVermeulen,NancyCelander,SandraKaminski,AlexandraSonyey

1-029 Pharmacist-led quality improvement project uti-lizing a risk assessment intervention tool for reducing healthcare-associated Clostridium diffi-cile infections, KatayounZangeneh,JohnChang,JonMalepsy,JenniferSiilata,BruceManzo

Leadership1-030 Crowdsourcing use in a pharmacy student experi-

ential program, ForestFord

1-007 Evaluation of economic and clinical outcomes of patients receiving direct oral anticoagulants versus warfarin at a Veterans Affairs healthcare system, RenuGaur,AudreyLee,LisaTong

1-008 Quality improvement project to review the appropriateness of triple therapy for a cardiac indication in a veteran population, ErinLoesch,AjayAgarwal,AngelaHamman

1-009 Impact of a clinical pharmacist heart failure clinic on the reduction of 30-day heart failure re-admis-sion rate, AnoliPatel,WafaSamara

Clinical Services Management1-010 Improving veteran’s pharmacy experience

through the establishment of a patient-centered pharmacy call center at VA Central California Health Care Systems (VACCHCS), KateBastian,WafaSamara

1-011 Implementation of a fluoroquinolone restriction policy in a veteran’s healthcare system, SpencerDurham,GeraldJ.Thomas

1-012 Evaluation of patients on long-term warfarin and the potential of switching to a direct oral antico-agulant, IvyTonnu-Mihara,NatashaM.Gonzalez,RichardCavallaro

Drug-Use Evaluation/Drug Information1-013 Effectiveness of oral naltrexone in improving out-

comes in alcohol use disorder in the veteran pop-ulation, VictoriaCho,PatriciaChun,EricTran

1-014 Validity of dabigatran or rivaroxaban for elderly patients with nonvalvular atrial fibrillation, YoungsukCho,ChanghyunLee,BoyeonKim,Youn-jooJung,HyokeunJeong

1-015 Apixaban “no clot about it”: a medication use evaluation of apixaban for the reduction of venous thromboembolism recurrence, SarahFerrell,JessicaMitchell,DaceyBeck

1-016 Safety of oral treatments for pulmonary arterial hypertension, MariaGarcía,MariaFortes,SilviaVázquez,SusanaCastro,CarlosCrespo-Diz

1-017 Response to ustekinumab based on the first-line treatment in moderate-severe psoriasis, SaraGarcíaGil,JonathanGonzálezGarcía,GuillermoAntonioGonzálezdelaFuente,GloriaJuliaNazcoCasariego,FernandoGuitérrezNicolás

1-018 Improvement of prioritization tool developed for reducing critical medicine shortage situations, LoneJensen,LoneSchmidt-Petersen

1-019 Evaluation of naloxone use and expansion of an overdose education and naloxone distribution (OEND) program in a rural Veterans Affairs (VA) healthcare system, CatherineScalley,ShawnM.Dalton,DavidDixon,CedarKoetting


Poster Presentations

MONDAY, DECEMBER 5Categories:AdministrativePractice/FinancialManagement/HumanResources,AmbulatoryCare,Automation/Informatics,Cardiology/Anticoagulation,ClinicalServicesManagement,CriticalCare,Drug-UseEvaluation/DrugInformation,EmergencyMedicine/EmergencyDepartment/EmergencyPreparedness,GeneralClinicalPractice,Geriatrics,IVTherapy/InfusionDevices/HomeCare,InfectiousDiseases,Leadership,Oncology,PainManagement,Pediatrics,Pharmacokinetics,PharmacyLaw/Regulatory/Accreditation,PracticeResearch/OutcomesResearch/Pharmacoeconomics,PreceptorSkills,QualityAssurance/MedicationSafety,SmallandRuralPharmacyPractice

Administrative Practice/Financial Management/Human Resources4-001 Preparing for new challenges in the changing

landscape of accreditation agencies, MayAdra,HollyCreveling

4-002 Hidden talent: the benefits of an In-house train-ing program for pharmacy technicians, JeanBeach,JulieF.Lanza

4-003 Mitigating the increased price of isoproterenol, JenniferBrandt,MargaretBreakenridge,AnilK.Kishore

4-004 Clinical resource utilization pharmacist: a unique, but necessary position, JenniferBrandt,MargaretBreakenridge,AnilK.Kishore

4-005 Evaluation of reimbursement potential for inpa-tient pharmacist services, BethanyChandler,HyeJinGrant,TonyaRobertson,RobertFurrey,MorganRamey

4-006 Use of internet-based survey development soft-ware for documentation of pharmacy compe-tency programs, TeresaCooper,JacynthaA.Sterling

4-007 Impact of implementation of a multidisciplinary approach to nutrition support on appropriate parenteral nutrition utilization at a community hospital, MarkDecerbo,FranciscaAkoh,KristinaLaBouff,VincentYang,DarrenSwenson

4-008 Organizing and maintaining a functional 340B oversight committee in a disproportionate share hospital, CourtneyDelgado,BrianSayre

4-009 The financial impact of an intravenous (IV) work-flow management system in a pediatric hospital, YihongDeng,AlexLin,JohnHingl,JonathanPemn,HeatherMaynard

4-010 One-year cost savings after an interchange from tiotropium to ipratropium/albuterol nebulizer solution in a community medical center, HughEasley,KaciWilhelm

Oncology1-031 Comparison of the safety of high-dose cisplatin

therapy with a continuous hydration regimen versus with a short hydration regimen, PatriciaChun,AlanChung,Ni-ChiWu,PabloBernardson

1-032 UGT1A1, UGT1A7, ABCB1, ABCC2, and SLCO1B1 gene polymorphism influence on irinotecan toxic-ity in the treatment of metastatic colon cancer, SaraGarcíaGil,RuthRamosDíaz,VerónicaCasañasSánchez,GloriaJuliaNazcoCasariego,FernandoGutiérrezNicolás

1-033 Ketoconazole and performance status as predic-tive factors of response to abiraterone in metas-tasic prostate cancer in real-life conditions, MaríaTovar-Pozo,VicenteEscudero-Vilaplana,AlmudenaRibed-Sanchez,AnaHerranz-Alonso,MaríaSanjurjo-Sáez

Pain Management1-034 Urine drug screening in chronic opioid veteran

patients: superheroes save the day!, KellyMoran

Pharmacy Law/Regulatory/Accreditation1-035 Utilization of the FDA inspection classification

database in order to promote public health, KavitaDada,DavidBurrow,JanHewett,JoelleFarano

1-036 Postmarketing violation identification and improving public health, KavitaDada,DavidBurrow,KelleySimms,NamitaKothary,JoelleFarano

Preceptor Skills1-037 Development of a preceptor professional growth

plan at VA central Iowa healthcare system, JennyPhabmixay,SarahBabb,MeganBarajas,MaryRasmussen

Quality Assurance/Medication Safety1-038 Transforming medication reconciliation process

while improving efficiency and enhancing patient safety, JenniferSiilata,WafaSamara,JennyNguyen,KatayounZangeneh

1-039 Effect of electronic medication administration record application on the patient safety, NoeliaVicenteOliveros,TeresaGramageCaro,CovadongaPérezMenendez-Conde,TeresaBermejoVicedo,EvaDelgadoSilveira


Automation/Informatics4-024 Improving medication adherence at the point of

care using healthcare analytics, KevinChiang,CarlDominguez,ThongQ.Dang,AbirF.Makarem

4-025 Using predictive analytics to identify patients at risk of worsening HA1C control, KevinChiang,MohamedUmarji

4-026 Data analysis to optimize primary national drug code at nine university healthsystem ambulatory pharmacy locations for improved inventory man-agement and cost savings, BarbaraGiacomelli,BradMyers,JuliaM.Chisholm,RebeccaSteel

4-027 Initial attempt at smart pump data set optimiza-tion and validation for a 16 hospital health sys-tem, JonGorton,KourtneyPacker,MichaelRutland

4-028 Evaluating the impact of real-time clinical deci-sion support on documented pharmacist inter-ventions, GabrielGuerra,HayleyBurgess,MandelinCooper,JoanKramer,SarahFraker

4-029 Optimizing workflow in a sole community teach-ing hospital by developing best practices for uti-lizing automated dispensing technology in order to improve operational and patient outcomes, JasonHarsanye,MichaelSteiger,WilliamLatimer

4-030 The clinical impact of medication errors pre-vented by an intravenous (IV) workflow manage-ment system in a pediatric hospital, AlexLin,CorySimonavice,GehringAaron,YihongDeng,JonathanPenm

4-031 Implementation of a name verification label/bar code process for insulin pen single patient admin-istration, LaurenMcCormick

Cardiology/Anticoagulation4-032 Acenocoumarol in nonvalvular atrial fibrillation:

assessment of anticoagulation control, PaulaArrabal-Durán,MaríaEstherDurán-García,MaríaGómez-Antúnez,AnaHerranz-Alonso,MaríaSanjurjo-Sáez

4-033 Argatroban use for pulmonary embolism in a crit-ically ill patient with end-stage renal disease, PriscillaAyala

4-034 Clinical and economic impact of an optimization program for reducing bleeding events in patients with acute coronary syndrome, AnadeLorenzo-Pinto,HéctorBueno,AnaHerranz-Alonso,BelénMarzal-Alfaro,MaríaSanjurjo-Sáez

4-035 Evaluation of unfractionated heparin for thera-peutic anticoagulation in obese patients, JennaDietrich,RyanHobbs,JamieSmelser

Ambulatory Care4-011 Antibiotics prescribed in primary care and the

incidence of errors, MohammedAljamal,AhmedS.Aljamal

4-012 Description of prescribing patterns and patient characteristics of patients initiated on target spe-cific oral anticoagulants (TSOACs), ReginaArellano,KathyKomperda,BrianCryder

4-013 Treating hepatitis C virus genotypes 1-4 in an ambulatory care setting: outcomes with direct-acting antiviral regimens, TimothyBach,KathyZaiken

4-014 The impact of an ongoing interdisciplinary patient-centered approach on hemoglobin A1C (A1C) in a low-income, uninsured diabetic patient population in a community free clinic, RamadasBalasubramanian,S.MarieDockery,GracieLiemGall

4-015 Impact of a clinical pharmacist’s interventions on patients’ knowledge of direct oral anticoagulants (DOAC), SimarjitBatth,JenniferBranch,JaneaneGiannini,TeresaKwong,RichardWhite

4-016 Creating the Connecticut community pharmacy practice network through public-private partner-ships, ThomasBuckley,MarissaSalvo,MehulDalal,MonicaJensen,LuisArroyo

4-017 Describing the role of pharmacy in a multidisci-plinary care pathway in evaluation of the use omalizumab in patients with difficult-to-control asthma, LindembergCosta,CharlestonRibeiroPinto,AntonioCarlosMoreiraLemos,AramisTupinadeAlcantera,IlkaMagalhãesSilvaCarneiro

4-018 The effect of bariatric weight-loss surgery on dia-betic glucose control and reduction in diabetic medications, StaciDotson

4-019 Evaluation of the safety of oral antineoplastic agents to implement e-health technologies in the pharmacotherapy follow-up, VicenteEscudero-Vilaplana,RobertoCollado-Borrell,AnaHerranz-Alonso,CarlosCodina-Jane,MariaSanjurjo-Saez

4-020 Evaluating primary medication nonadherence in specialty pharmacy, SviatlanaFerri,RebekahH.Anguiano

4-021 Implementation and evaluation of a pharmacist-led prior authorization service in four primary care clinics, MaRandaHerring,KellyWalls

4-022 Pharmacotherapy clinic implementation in a healthcare-for-the-homeless clinic, JaimeHornecker,MichelleL.Hilaire,CassandraStith

4-023 Community pharmacy experience in Lebanon, KatiaIskandar,PascaleSALAMEH,EtwalBOURAAD


Poster Presentations4-051 The effect on medication reconciliation through

implementation of a pharmacy technician and pharmacist team in the emergency department, KellyMcNorton,AntoinetteDuronio

4-052 Implementing policy to reduce hypnotic use to decrease falls, ParthPatel,MichaelJ.Sweany,FrankButler

Critical Care4-053 Evaluation of vasopressin for septic shock in patients

on chronic renin-angiotensin-aldosterone system (RAAS) inhibitors, BethErwin,MichaelDenaburg,AndrewBarker,PhilipMcArdle,SamuelWindham

4-054 Age-specific effects of an analgesia and sedation protocol in neurocritical care patients, LeanaMahmoud,AndrewR.Zullo,CoreyR.Fehnel,BradfordB.Thompson,LindaWendell

4-055 Effect of modafinil on cognitive function in inten-sive care unit patients: a retrospective cohort study, YoonsunMo,MichaelThomas,ToddMiano,GeorgeKarras,AdamSakiel

Drug-Use Evaluation/Drug Information4-056 Evaluation of stress ulcer prophylaxis in noncriti-

cally ill patients in a regional community hospital, ShannonAllcron,KristanE.Vollman

4-057 Incorporating medication safety technology data into prevented medication-error trends, LyndseyAlmon,MaliaManning,ShelleyCarruba,JedidiahBurroughs

4-058 Restricting intravenous acetaminophen use: effectiveness of an institutional approach, JasonBabby,JashvantPoeran,NicoleZubizarreta,KarenBanoff,MadhuMazumdar

4-059 Utilization of intravenous acetaminophen in a small community hospital: two years later, LeslieBarefoot

4-060 Effect of patiromer on serum potassium in hyper-kalemic patients with Type 2 diabetes on RAAS inhibitors with or without insulin therapy for dia-betes, WadeBenton,PatrickRossignol,ColemanGross,SusanArthur,MatthewWeir

4-061 Drug information resources in community phar-macies in Ohio, KatlynBrown,MaryEllenHethcox,KarenKier

4-062 Evaluation of the diabetic ketoacidosis protocol within a community healthcare system, KathleenCalkins,StaceyDull,RyanDull,ErinSantiago

4-063 Assessment of potential cost-savings with use of newer antimicrobial agents in a small community outpatient infusion center in Hawaii, CherieChu,AlexanderGuimaraes

4-036 Use of the platelet aggregation inhibitor ticagre-lor in the management of atherothrombotic con-ditions: overview of the PARTHENON global clinical trial program, PaulDobesh

4-037 Treatment failure of apixaban in a patient with metastatic pancreatic cancer, NicoleEast,JesseSullivan,JaclynWinnicki

4-038 Clinical response to inhaled treprostinil in patients with pulmonary arterial hypertension, CherEnderby,CharlesBurger

4-039 Evaluation of oral antithrombotic therapy for hospitalized patients with nonvalvular atrial fibrillation, MarthaEspinoza-Friedman,RenaColl

4-040 Evaluation of regadenoson and dipyridamole for use in pharmacologic stress tests, ShelbyGaudet,CaraL.Iacobellis,RudySeelmann

4-041 Clinical pharmacy engagement in a multidisci-plinary acute myocardial infarction patient care program at a community hospital, ShelbyGaudet,MandyBradshaw,RudySeelmann

4-042 Performance of a chromogenic assay in hospital clinical laboratories for the measurement of apix-aban concentration in plasma, JamesGroce,BalaB.Carver,DouglasB.Cines

Clinical Services Management4-043 Glycemic control among Type 2 diabetic patients

in a tertiary hospital, MohammedAlmeziny,AsmaAlMuaither,BashairAlJumah

4-044 Assessment of clinical pharmacists’ practice pat-terns in an inpatient setting, BrittanyDillard,AlexisE.Peeples,JessicaM.Rademacher

4-045 Evaluation of methods for educating pharmacists about pharmacogenomics within a health sys-tem, HenryDunnenberger,JaeShin,AnnetteSereika,PeterHulick

4-046 Practice model transformation across a national health system, LynnEschenbacher,RoyGuharoy

4-047 Bridging the gap: characterization of a dual phar-macist role in drug information and investiga-tional drug services, LaurenKarel,RaniaSadaka,CindyWordell

4-048 Extension of clinical pharmacist drug order can-cellation, MariosaKieran,JenniferBrown,CiaranMeegan

4-049 Impact of pharmacy services on the transition of care in the acute care hospital setting, ViktoriyaMalamud,KiraFedorenko,AlexWang

4-050 Development of a transitions-of-care pharmacist tool to predict 30-day rehospitalization, LauraMcAuliffe,AndrewR.Zullo,SergioPetrillo,RuthDapaah-Afriyie,ChristineBerard-Collins


4-078 Diabetic ketoacidosis associated with olanzapine therapy, StephenDolley,AnnaK.Morin,StephenLarose

4-079 The development of a new focus area list includ-ing STOPP/START at Odense University Hospital, Marie-LouiseDuckert,LouiseSmedGroenkjaer

4-080 Ensuring safe and appropriate use of personal insulin pumps for patients during hospitalization, SarahEagleston,LindaStasiuk

4-081 Survey on reconstitution of freeze-dried vials in pharmacy practice in the United States, EkaterinaEfimova,BakulBhatnagar,JacobMattox,AdamCraig,PaulBelliveau

4-082 Comparison of phenobarbital and benzodiaze-pine treatment for alcohol withdrawal syndrome (AWS), StefanieGeorge,MatthewReale,MateSoric,JessicaCather

4-083 Impact of corticosteroid dosing on length of stay and readmission rates in acute chronic obstructive pulmonary disease exacerbations, BradHein,KellyLaake

4-084 Impact of pharmacist interventions on safety and cost savings, SaraIbáñezGarcía,CarmenRodriguez-Gonzalez,MariaLuisaMartinBarbero,AnaHerranzAlonso,MariaSanjurjoSaez

4-085 Assessing anaphylactic reactions among patient-reported medication allergies, AnnaKabakov,RichardWenzel

4-086 Ensuring patient safety at discharge with the Danish cross-sectorial personal electronic medicine profile (CPEM), FjólaKarlsdóttir,JoleneP.Henriksen

Geriatrics4-087 Introduction of individualized patient medication

cabinets to improve drug supply and administra-tion, MariosaKieran,SusanPotter,CiaraDowling,CiaranMeegan

IV Therapy/Infusion Devices/Home Care4-088 Cost-effectiveness of outpatient parenteral iron

therapy (OPIT) program, MohammedAlmeziny,DaliaAbdelatif

4-089 Implementation of dose error-reduction software on infusion pumps in a community hospital, GrantBunston

4-090 Reducing smart pump alarms in a neonatal inten-sive care unit: challenges in a unique environment of care, KellyBurch,JoanKohorst,JonathanLakamp,JoanA.Kohorst,JonathanLakamp

4-064 Review of patient-controlled analgesia orders in a medical and surgical hospital, MaChu,EricWombwell,KristinB.Peterson,KevinBriner,NicholasNgugi

4-065 Evaluation of medicine information practice addressed towards nurses at hospital wards at the capital region of Denmark, LeneColberg,HelleArmandi

4-066 Sodium-glucose cotransporter2 (SGLT2) inhibitor utilization evaluation at a community hospital, MarshaCrader

4-067 Intravenous immunoglobulin use at an academic medical center: a retrospective observational study to validate current practice and shape future management, SamanthaDelibert,EricKanouse,TravisDick

4-068 Evaluation of the use of liposomal bupivacaine in a community hospital, IshaDesai,SamiaFawzi,LynetteRichards

4-069 Usefulness of intravesical botulinum toxin in the treatment of overactive bladder, BelenEscuderoVilaplana,VirginiaSaavedraQuirós,BlancaBasagoitiCarreño,MariaLuisaIbarraMira,AmeliaSánchezGuerrero

4-070 Intravenous acetaminophen: are we doing it right?, SandraFerrara

General Clinical Practice4-071 Online continuous education sources to develop

pharmacists’ knowledge and skills: an integrative review, HaniAbdelaziz,DaniaAlkhiyami,SaraMustafa,AdhamMohamed,RashaAlanany

4-072 Development of an intravenous-to-oral route conversion program at a Saudi tertiary care hospital, MohammedAlmeziny,HadeelAlbalawi

4-073 Effects of a pharmacist’s participation in a transi-tions-of-care program on 30-day readmission rates in patients with chronic obstructive pulmo-nary disease (COPD) and pneumonia, JessicaBente,DawnM.Howard,JenniferL.Costello

4-074 Palatability profile of patiromer, a once-daily oral potassium binder for the treatment of hyperkalemia, MelanieBrenner,WadeBenton,NataliePanov,CharlesDuMond,DahliaGarza

4-075 Challenges and benefits of converting annual progress examination to electronic format, MichelleCaetano,NormaJ.Owens

4-076 Interprofessional simulation education from pre-operative to community care, NicoleCieri,KirstenButterfoss,StephanieBrian,KarenMlodozeniec

4-077 Rare disease, costly drug: the case of eculizumab for atypical hemolytic uremic syndrome (aHUS), NathanDahl,JulianaPerezBotero


Poster Presentations4-103 Impact of methicillin-resistant staphylococcus

aureus nasal polymerase chain reaction guided stewardship on utilization of vancomycin and linezolid in healthcare-associated pneumonia, ChristopherFronczek,LynneKrop,LawrenceDavila,KathleenShannon,NicholasPiccicacco

4-104 Improvement of outcomes and reduction of cost in pneumonia care by modifying a care protocol through an antibiotic stewardship multidisci-plinary team in a nonacademic community hospi-tal, NathanGoracke,CarlosFrancoPalacios,MichaelMay,CarnitaAllex,LucioMinces

4-105 Improved antibiotic cost in patients receiving antibioitcs through a multidisciplinary antimicro-bial stewardship team in a nonacademic, rural, community hospital, NathanGoracke,CarlosFrancoPalacios,CarnitaAllex,LucioMinces

4-106 Pharmacist-led antimicrobial stewardship in a rural community hospital, PaulGreen,AshleyM.Halloran,ChelseyRashid

4-107 Clinical decision support and antimicrobial stew-ardship: impact on the largest not-for-profit health system in the United States, RoyGuharoy,DanielleSebastian,FlorianDaragjati,KarenSmethersSmethers,MohamadFakih

4-108 Hospital patient days and anti-MRSA agent use in the era of active antimicrobial stewardship pro-grams in a large health system, RoyGuharoy,MohamadFakih,FlorianDaragjati,KarenSmethers,DanLeffler

4-109 Antimicrobial stewardship programs lead to reduction in antibiotic use and cost savings: results from the largest not-for-profit U.S. health system, RoyGuharoy,MohamadFakih,FlorianDargjati,DanLeffler,KarenSmethers

4-110 Healthsystem compliance with CDC core ele-ments of hospital antibiotic stewardship pro-grams: a two-year review, OscarGuzman,KateShea,JessicaSun,KarenMcConnell

4-111 Impact of student pharmacists on outcomes of an antimicrobial stewardship program in a commu-nity teaching hospital, DavidHa,MariaSaleh,Yi-ChihChiu,JacquelineVo,DanielGluckstein

4-112 Effect of food on the pharmacokinetics of unboosted and boosted tenofovir alafenamide, CamtuHo,JosephCustodio,YongwuShao,XuelianWei,BrianKearney

Leadership4-113 Stepping into the future: innovative and

advanced roles for pharmacy technicians, AnnetteDavis,DenisePropes,ChadiAbbas

Infectious Diseases4-091 Evaluation of incidence and severity of linezolid

induced thrombocytopenia at a tertiary hospital facility, Qatar: retrospective cohort study, EyadAlmadhoun,HassanMitwally,WalidMekkawi

4-092 Evaluation of the epidemiology and treatment of healthcare-associated infections in a community teaching hospital, AndrewAziz,RaniMadduri,AshmiPhilips,MiniVarghese

4-093 Impact of pharmacist-facilitated restriction of daptomycin in an inpatient community hospital, SaraBadaglialacqua,MikeMesdaghi

4-094 Impact of pharmacist antimicrobial stewardship interventions on clostridium difficile infection rates in a large health system, SarahBeaty-Vandemark,JarrodBrubaker,DanLaferriere,ThomasFrench

4-095 Taking an antibiotic time-out: impact of a seven-day automatic stop order on duration of antibiot-ics, StephenBienemann,PatriciaSaunders-Hao,JashvantPoeran,MadhuMazumdar,GopiPatel

4-096 Evaluating compliance with antibiotic guidelines for skin and soft tissue infections in the emer-gency department, JaredBorlagdan,AmyChang,CarolChenoweth,TejalGandhi,JerodNagel

4-097 Using a readiness checklist and ranking grid to prioritize antimicrobial stewardship initiatives, JustinClark

4-098 Pharmaceutical care in hepatitis C outpatients: detecting and solving drug interactions, RobertoCollado-Borrell,AlvaroGiménez-Manzorro,AlmudenaRibed-Sánchez,AnaHerranz-Alonso,MaríaSanjurjo-Sáez

4-99 Implementation of a pharmacist-driven hepatitis C management program, NicoleCroyden,RaniP.Madduri,JosephGugliotta,AshmiA.Philips,NavinPhilips

4-100 A small community hospital experience with fecal microbiota transplantation for clostridium difficile treatment, MichaelDimont,MinaRaju,BorisReznik,KristyFitzgerald,JohnChoi

4-101 Clinical outcomes of laboratory-confirmed influ-enza among hospitalized adults, RyanDull,SarahAdie,LindaK.Ohri,ChristopherDestache

4-102 Extended versus intermittent infusion of piper-acillin/tazobactam in critically ill patients: a pro-spective clinical trial, SheungYinFan,HoiPingShum,WingYeeCheng,YatHeiChan,McShirleyS.Y.Leung


Pain Management4-126 Self-management of pain among pharmacy stu-

dents, DavidAxon,CarlosHernandez,MarionSlack

4-127 Impact of liposomal bupivacaine in total hip and knee arthroplasties, MarshaCrader,WillieCapers

4-128 Assessing the role of intravenous lidocaine infu-sions for chronic pain in an ambulatory pain man-agement clinic, OmarEltair,JenniferH.Elfman,JosephCivello,MichelleMatthews

Pediatrics4-129 Heparin-induced thrombocytopenia in pediatric

patients: reconciling the 4Ts, HEP score, heparin-platelet factor 4 antibody, and serotonin release assay, TaraBergland,JamieSmelser,JaniceStaber

4-130 Importance of pharmacist participation in patients with infantile hemangioma treated with propranolol, SaulCastaneda,HermilaGonzalez,HermelindaDelaCruz,JoseLuisSanchez

4-131 A multifacility health system’s experience in enhancing patient safety through optimization of computerized provider order entry (CPOE) for pediatric populations: failure mode effect analy-sis (FMEA) to identify opportunities, JenniferHarris,KaraMurray,CarenFancher,ConnieL.Saltsman,KarlaM.Miller

4-132 Process improvement in filling pediatric prescrip-tions requiring powdering, SuejeanKim,MinjiGoo,MyungsookMin,JeongmeeKim,YoungmeeLee

Pharmacokinetics4-133 Evaluating the use of vancomycin in hemodialysis

patients at a community hospital, MelanieFlinn,JacquelinePitts,ChristineDinh

4-134 Evaluation of blood drug concentration and intra-cellular IFN-γ and IL-2 expression as surrogate markers for acute rejection and opportunistic infection following kidney transplantation, TakuyaIwamoto,KoheiNishikawa,YoshikiSugimura,MasahiroOkuda

4-135 Evaluation of pharmacokinetic calculators to esti-mate vancomycin dosing in Hawaii’s Asian popu-lation, MichelleKim,RoyGoo,PatrickChan

4-136 Estimation of the initial dose setting of vancomy-cin therapy in subjects with microalbuminuria, HiroshiKimura,AkihiroTanaka,ShinichiWatanabe,MamoruTanaka,HiroakiAraki

Oncology4-114 Actual body-weight chemotherapy dosing for

obese patients: moving away from dose limiting regimens, AghavnyBebirian,ZavenNorigian

4-115 Head-to-head evaluation of closed-system trans-fer devices in a health-system oncology clinic, JayBrown,RolandaDavis-Lowery,BrianWallace

4-116 Evaluation of the use of rivaroxaban in cancer patients, AngelaDeBerardine,KendraYum,GinaCaliendo,JoanneMeyer

4-117 Real value of monitoring liver function tests in patients with localized breast cancer receiving AC protocol followed by weekly paclitaxel, RaulDiez-Fernandez,AlbertoOnteniente-Gonzalez,LauraLopez-Esteban,SantosEnrech-Frances,TeresaMolina-Garcia

4-118 Impact on pharmaceutical costs from a bone-modifying agent criteria for oncology patients at a community outpatient infusion center, BrendaEgan,NishaPherwani

4-119 Optimizing the care of head and neck cancer patients in a community ambulatory care center: a multidisciplinary approach, LisaFarah,AmandaL.Myers,GeorgeE.Brown,RachaelM.Lerman,MehranSaboori

4-120 Plasma levels of trastuzumab in gastric cancer: case report, JonathanGarcia,FernandoGutierrezNicolas,GloriaJuliaNazcoCasariego,GuillermoGonzálezdelaFuente,MariaMicaelaViñaRomero

4-121 Polymorphisms in drug transporter genes and risk of relapse among stage II or III colorectal can-cer patients treated with capecitabine, XandraGarcia-Gonzalez,MariaIGarcia-Garcia,AnaHerranz-Alonso,MariaSanjurjo,LuisALopez-Fernandez

4-122 Toxicity 5-fluorouracil associated mutation 1896T>C in the dihydropyrimidine dehydroge-nase (DPYD) enzyme: a case report, GuillermoGonzalezdelaFuente,FernandoGutierrez,ItamarGonzalez,GloriaJuliaNazco,RuthRamos

4-123 Study of health outcomes in pancreatic cancer: preliminary results, GuillermoGonzalezdelaFuente,FernandoGutierrez,JonathanGonzalez,SaraGarcia,GloriaJuliaNazco

4-124 Impact of pharmacist discharge interventions on medication-related readmissions among oncol-ogy patients, LelaHall,AnayMoscu,CathleenCharles,MoeShwin,MariaFigueroa

4-125 Evaluation of a double-check system in the cre-ation and validation of chemotherapy protocols in a clinical trials unit, MCarmenHerreroDomínguez-Berrueta,PaulaArrabalDurán,MaríaNorbertaSánchezFresneda,AnaHerranzAlonso,MaríaSanjurjoSáez


Poster Presentations4-148 Evaluation of hospital readmission in smokers

and nonsmokers via Humedica real-world data, ScottGlosner,TimMullenix,KellyZou,ChristineBaker,MargaretMcDonald

4-149 Effect of pharmacist interventions on drug cost savings in a collaborative, unit-based practice model, RebeccaGreene,AndrewZullo,ChristineBerard-Collins

4-150 Involvement of clinical pharmacist at the migrant health clinic at Odense University Hospital, MirzaGunic

4-151 Impact of antimicrobial stewardship program implementation on antibiotic expenditures, bac-terial resistance, and Clostridium difficile inci-dence at a suburban community hospital, EugeneKolomiyets,IhabIbrahim,TamarBerger,HowardL.Sussman

Preceptor Skills4-152 National survey of postgraduate year 2 (PGY2)

critical care preceptor professional development engagement, AnnBiesboer,JoelFeih

4-153 A longitudinal project designed to enhance stu-dent understanding of how a clinical skill set can be transferred to a real pharmaceutical industry activity, ColinGillis,KatherineCarey,AakashDheri,EkaterinaEfimova,BhumiPatel

4-154 Helping IPPE students become practice-ready pharmacists, MichaelKendrach,PeterJ.Hughes

Quality Assurance/Medication Safety4-155 Evaluating medication reconciliation in hospitals:

the process of selecting, assessing, and applying assessment tool, MohammedAljamal

4-156 Impact of computerized prescriber order entry on the reduction of occurrences associated with override medications at an academic teaching hospital, VarintornAramvareekul,GeoffreyCox,HaseenaHakeem

4-157 In-house microbial air and surface sampling: les-sons learned, DeniseArena

4-158 Assessment of usage and effectiveness of an updated health-system adult DKA (diabetic keto-acidosis) order set, RosarioAvelino,CaraL.Phillips,DeepakTaneja,BridgetMattson,MarjorieL.Oliver

4-159 Design and implementation of a system to main-tain stock of critical medications, MichaelBarberio

4-160 Combating the opioid abuse epidemic: what can a hospital pharmacy do to help?, LisaBlock,NancyRampe,BrianLatham,BrendaHoang,MargaretSant

Pharmacy Law/Regulatory/Accreditation4-137 Use of advanced pharmacy practice experience

(APPE) evaluations to demonstrate achievement of student learning outcomes, MichelleCaetano,AjinkyaM.Pawar,NormaJ.Owens

4-138 Establishing a statewide sterile compounding alli-ance for review and implementation of sterile compounding regulations related to hospital practice, JacquelineCostantino,ShannonBaker,LisaTortora,JenniferH.Beaugh,ElaineWojcik

4-139 South Dakota practice advancement initiative hospital self assessment comparison to the nation, TaddHellwig,JohnKappes,TarrynJansen

Practice Research/Outcomes Research/Pharmacoeconomics4-140 Information required in research reports for

inclusion in meta-analysis: cohort studies for evaluating the impact of pharmacist care on dia-betes outcomes, NimerAlsaid,AbdulaaliAlmutairi,MaryamFazel,JeannieLee,MarionSlack

4-141 Information required in research reports for inclusion in meta-analysis: cohort studies of pharmacy-supported transition of care and 30-day readmission rates, DavidAxon,LiliZhou,ChinmayeeKatragadda,AmandaHarrington,MarionSlack

4-142 Outcomes of an economic model comparing human regular U-500 insulin 20-mL vials and 3-mL pens in United States hospitals, WendyBibeau,AprilTaylor,StevenBabineaux,KariKelton,SinemPerk

4-143 Cost savings associated with utilization of donated medication program in a hospital outpatient pharmacy setting, HillaryBlackburn,AnitaStanford,DavidNeu,JordanHolland,AustinWeaver

4-144 Influence of cisplatin on DNA extraction for later genomic characterization, VerónicaCasañas-Sánchez,RuthRamos-Díaz,AlejandraRodríguezCapote,GloriaJuliaNazcoCasariego,FernandoGutiérrezNicolás

4-145 Utilization of just-in-time methodology to improve pharmacy operations, MelissaDiamond,JerryD.Smith,ThanhNguyen

4-146 Innovative residency readiness elective: student perceptions regarding usefulness and applicabil-ity of course, KathyEroschenko,CatherineOlipant,TomWadsworth,GlendaCarr

4-147 Time to reach coverage gap and catastrophic cov-erage: a Medicare Part D claims analysis among beneficiaries with chronic obstructive pulmonary disease (COPD), VaidyanathanGanapathy,LinXie,YuexiWang,QisuZhang,OnurBaser


TUESDAY, DECEMBER 6Categories:AdministrativePractice/FinancialManagement

/HumanResources,AmbulatoryCare,Automation/Informatics,Cardiology/Anticoagulation,ClinicalServicesManagement,CriticalCare,Drug-UseEvaluation/DrugInformation,EmergencyMedicine/EmergencyDepartment/EmergencyPreparedness,GeneralClinicalPractice,Geriatrics,IVTherapy/InfusionDevices/HomeCare,InfectiousDiseases,Leadership,Oncology,PainManagement,Pediatrics,Pharmacokinetics,PharmacyLaw/Regulatory/Accreditation,PracticeResearch/OutcomesResearch/Pharmacoeconomics,PreceptorSkills,QualityAssurance/MedicationSafety,SmallandRuralPharmacyPractice

Administrative Practice/Financial Management /Human Resources6-001 Development and implementation of systemwide

staff education modules for medications with risk evaluation and mitigation strategy (REMS) pro-grams, StephanieGregg,GinaCaliendo

6-002 Evaluation of student knowledge following an elective in preparation for pursuing postgraduate residency training, DraytonHammond,JordanM.Rowe,TessaL.Wiley,JacobPainter

6-003 Development, progression, and successes of a comprehensive pharmacy technician career lad-der, JulieLanza,JeanBeach

6-004 Onboarding talimogene laherparepvec at a large academic teaching hospital, ZavenNorigian

6-005 Distribution and inventory management of high-cost medications at a large academic medical center, RobynPisacane,AdrienneDonaldson,MarjorieLazarre,ChristineHong,MollyLeber

6-006 Pharmacy residency program director maternity leave impact on current residents, LisaRichter,LisaNagel

6-007 Implementation of dedicated pharmacy educa-tion and research managers in a large integrated health system, ElizabethSebranekEvans,RichardH.Ensign,SabrinaW.Cole

6-008 Maintaining formulary standardization across multiple technological systems in a multisite healthcare network, ShannonSmallwood

6-009 Establishing pharmacist workflow metrics to guide staffing patterns in an outpatient oncology pharmacy satellite, AndrewSzkiladz,JonathanAngus,MarkHeelon,ErinTaylor

4-161 Assessing the public’s understanding of the regulation of dietary supplements, BrittanyCarroll,JessicaMorrison,TaylorBoyer,LauraPerry

4-162 Aligning education and research with service delivery providing real-time CPD, MaireadCasserly,CiaranMeegan,JenniferBrown,LauraMcCabe,MariosaKieran

4-163 Adult crash carts: process changes improve staff productivity, GayleCotchen,RosellaHoffmann

4-164 Development of a neonatal IV dilution chart to increase standardization and ensure consistent preparation of neonatal sterile products, HollyCreveling,DeniseArena,RenaLithotomos,MargaretStephan

4-165 A retrospective evaluation of the use of continu-ous insulin infusion in a community hospital, MarthaEspinoza-Friedman,MeganZaleski,CarmenVillabona

4-166 Tracking and trending anesthesia controlled substance discrepancies using an electronic database, RebecaGansari,JulieGolembiewski,AdamBursua,RichardBanchs

4-167 Impact of pharmacy-driven metabolic monitoring of patients on antipsychotics, EmilyGray,TeresaCooper

4-168 Evaluating medication use in the operating room, CourtneyHebert,CindyHolcombe

Small and Rural Pharmacy Practice4-169 Impact of the implementation of computerized

prescriber order entry and automated dispensing cabinets on a medication-error analysis program, JamesWilliamson,GingerBain

Emergency Medicine/Emergency Department/Emergency Preparedness4-170 Surge capacity: design and implementation of

a scalable response plan for crisis situations, MichaelBarberio,AngelaMcIntosh

4-171 Impact of emergency department pharmacist on appropriate antimicrobial therapy for community-acquired and healthcare-associated pneumonia, BrettFaine,JennaDietrich,LauraMeadow,KarisaHarland,NicholasMohr

4-172 Factors associated with availability of anticoagu-lation reversal agents in rural and community emergency departments: a mixed methods study, BrettFaine,JulieAmendola,JordanHoman,AzeemuddinAhmed,NicholasMohr


Poster Presentations6-022 Impact of clinical pharmacists’ interventions on

the management of mineral and bone disorder in chronic hemodialysis patients, MohammadZaitoun,SaraHazem,KhaledAlAl-Sheikh,AdelAbouAli

Automation/Informatics6-023 Implementation of clinical decision support (CDS)

within computerized prescriber order entry (CPOE) system guiding intravenous immunoglob-ulin (IVIG) orders and product selection at a large health system, JosephMoss,BridgetGegorski

6-024 Royal Victoria Regional Health Centre pharmacy evaluation of plastic vials in a robotic intravenous admixture machine, PaulMoyer,SeanHopkins,DawnHallyburton

6-025 Optimizing efficiency with automated dispensing cabinets (ADCs), GavinO’Brien,BrendanM.Kuchenbecker,NicholasJ.Nobles,LauraA.Caracci,ThomasP.Lombardi

6-026 Environmental contamination of 5-fluorouracil during mixing by the robot, YoshiyukiSano,TomokoMorita,YasuhikoIchida,ShinichiroSaito,MasakazuYamaguchi

6-027 Creation and implementation of an electronic pharmacy processing system for research medi-cations, MargaretStephan,DavidMangan,StephenMaynard,DavidGrosso,LoisHurst

6-028 Technology-induced prescription errors associ-ated with computerized provider order entry software, ManuelVélez-Díaz-Pallarés,MaríaMuñozGarcía,AnaM.ÁlvarezDíaz,TeresaBermejoVicedo

6-029 Adaptation of a hybrid computer prescriber order entry (CPOE) system in an oncology centre of a multi-site tertiary care teaching hospital, AnjieYang,KarenOng,WallaceLam,CelinaDara,JinHuh

Cardiology/Anticoagulation6-030 Pharmacist-managed glycemic control after car-

diothoracic surgery, BradHein,TylerDickerson

6-031 How clinical pharmacists improve outcomes in heart failure patients being treated with intrave-nous (IV) loop diuretic therapy, AshleyHinton,KathleenDuke

6-032 Assessment of an intravenous chlorothiazide restriction protocol on prescribing practices and outcomes in acute decompensated heart failure, AlexanderKantorovich,MichaelaSmith,BrittniBotchway-Bradley,GeorgeGavrilos,RollaSweis

6-033 Impact of direct oral anticoagulants on anti-factor Xa levels utilized for monitoring heparin: an unanticipated drug-laboratory interaction, KellyMacedo,PeterJ.Tatarian,KennethR.Eugenio

Ambulatory Care6-010 Implementation of a new multidisciplinary clo-

zapine clinic with finger capillary blood sampling capabilities, JonathanLeung,EmilyK.Johnson,BrianPalmer

6-011 Design and implementation of comprehensive, team-based care in a federally qualified health center to improve diabetes and depression out-comes, BrodyMaack,MykellBarnacle,AmyWerremeyer,MarkStrand,SarahSchmidt

6-012 Adherence, quality of life and patient satisfaction with dalfampridine in clinical practice, MaríaBelénMarzal-Alfaro,MaríaLuisaMartinBarbero,AnadeLorenzo-Pinto,AnaHerranz-Alonso,MaríaSanjurjo-Saez

6-013 Impact of a pharmacist-run telemedicine clinic on medication adherence rates in the incarcerated hepatitis C population, DianaMei,AlishaPatel,LeoPratt,LillianBellfi,JulianaChan

6-014 Applying lean methodology to improve hepatitis C care within the Veterans Health Administration, JennyMullakary,AshleySmith,WhitneyRockefeller,WilliamLukesh

6-015 Impact of an interprofessional diabetes specialty clinic for uninsured patients, ScottBrauer,KathleenPackard,KathyHoebelheinrich,EmilyMannschreck,KrisSaunders

6-016 Management of adverse effects from pegylated interferon plus ribavirin in incarcerated patients infected with hepatitis C in a pharmacist-run tele-medicine clinic, AlishaPatel,DianaMei,LeoPratt,LillianBellfi,JulianaChan

6-017 Impact of supporting pharmacists in the primary care network, JarredPrudencio,StephanieRoberts,StephanieMarin

6-018 Pharmacological and nonpharmacological therapy among bariatric surgery patients, JihanSafwan,FarajK.Saade,MarwanG.Akel,MichelleCherfan,KatiaIskandar

6-019 Two-year retrospective review of outpatient clinical pharmacy interventions in patients with hyper-tension at an academic medical center, MariaThurston,CaitlinJenkins

6-020 Evaluating medication adherence in patients who receive financial assistance for prescriptions, LinneaTokushige,AnnRyanHaddad,JessicaSkradski

6-021 Time in therapeutic range for a rural pharmacist-run anticoagulation clinic, DominiqueWerge,DeAnnaManarang,JacobSchwarz,MichaelNguyen


6-047 Outcomes of a prescription bedside delivery pro-gram on hospital readmission in a community teaching hospital, TylerTomasek,DanielLewis,JasonF.Milner

6-048 Novel approach to pharmacist participation on daily patient rounds, JanemarieViscardi,ChristineChun

6-049 Pharmacy-clinical nutrition collaboration on oral nutritional supplement education in an ambula-tory care services countywide health system, JerryWong,LeisaBryant,SarahBodine,GoldinaErowele,JacquelineMilton-Brown

6-050 Implementation of a pharmacist-driven transi-tional care process targeting patients at risk for readmission based on an internally developed readmission risk assessment (RRA) tool, KevinYeh,AlyssaSterling,KananShah

Critical Care6-051 Assessment of rectal quetiapine utilization in

critical care settings, SarahNelson,JonathanG.Leung,BrianneM.Ritchie,WilliamBobo,MariaLapid

6-052 Rebound elevation of international normalized ratio 48 hours after administration of four factor prothrombin complex concentrate, MelissaRaich,FrankRigelsky

6-053 Impact of pharmacy-led education and interven-tion in management of ICU delirium, SarahVolgas,TonyaRobertson,HyeJinGrant,CoreyHayes,RobertFurrey

Drug-Use Evaluation/Drug Information6-054 Dimethyl fumarate: adherence, effectiveness,

and safety, MariaFortes,JoseDeMiguel,LeticiaHerrero,LuciaVillamayor,CarmenFreire

6-055 Appropriate prescribing of methylnaltrexone bro-mide at a community hospital: a medication-use evaluation, BradHein,AndreaBergen

6-056 Evaluation of use of dipeptidyl peptidase-4 inhib-itors in an academic teaching hospital in Japan, MakikoIwasawa,KoichiroAtsuda

6-057 Reformulation of formulary process, structure, and policy in a large health system, IndraniKar,JosephT.Moss,JasonE.Glowczewski,ShawnM.Osborne

6-058 Incidence and severity of adverse events associ-ated with mammalian target of rapamycin inhibi-tors in Korean major center, YoungaeKim,Kwang-WoongLee,HyeyoungKim,Nam-JoonYi,Kyung-SukSuh

6-034 Dosing heparin utilizing adjusted body weight in obese patients for the treatment of venous thromboembolism, DerekNadeau,SarahM.Green,EmilyK.Dornblaser

6-035 Impact of health literacy level on time in thera-peutic range in patients on chronic anticoagula-tion managed through a telephone-based service, AnneOttney,EmmaHolmi

6-036 Evaluation of a comprehensive pharmacist educa-tion consult service for patients on oral anticoag-ulants, FrankRigelsky

6-037 Assessing the appropriateness of venous throm-boembolism (VTE) prophylaxis in the internal medicine and cardiology services in a Lebanese hospital, MarwanSheikh-Taha,RImMoukhadder,NarikZadikian

6-038 Enoxaparin treatment dose and bleeding: a focus on obesity and moderate renal impairment, JamieSmelser,AlexMersch

6-039 4-Factor prothrombin complex concentrates (Kcentra) for reversal of warfarin-related antico-agulation in patients with intracranial hemor-rhage: changing processes to expedite INR reversal, JamieSmelser,BrettFaine

6-040 Making the switch from dipyridamole to adenos-ine in pharmacologic cardiac stress testing, JanemarieViscardi,ChristineChun

6-041 Comparison and evaluation of a higher versus lower heparin weight-based dosing protocol for the treatment of deep vein thrombosis and pul-monary embolism, JaclynYodice,ChristinePrice,JovinoHernandez

Clinical Services Management6-042 Implementation of a novel resident-led pharmacy

transitions-of-care service, KatePerica,LisaSlater

6-043 Impact of pharmacist involvement on time to first antibiotic administration for emergency room patients with severe sepsis or septic shock, KerryRinato,AntoinettePretto-Sparkhul,LauraViti,SusanBatcheller,OlusholaAdeleye

6-044 Usefulness of the pharmaceutical care for treat-ment with dementia outpatients, YuhkiSato,AoiYoshiiwa,RyosukeTatsuta,EishiMiyazaki,HirokiItoh

6-045 Successful medication initiative development and implementation in a large health system, KarenSmethers,RoyGuharoy,JeffreySeggerman,DanLeffler,LynnEschenbacher


Poster Presentations General Clinical Practice

6-070 Evaluation of micafungin usage before and after antimicrobial stewardship program (ASP) imple-mentation, MohammedKhedr,LynetteRichards,SamiaFawzi

6-071 Impact of transitions-of-care pharmacy services on Medicare beneficiaries’ 30-day readmission rates, RezartaLako,ArinAffonso,JeffD.Huntress

6-072 Implementing practice guidelines for intradialytic hypotension (IDH) prevention and management at a small long-term acute care hospital (LTACH): one-year follow-up, HelenaLee,VernettaScott,JamesPark,BrianBeckett,ArnoldDallas

6-073 Implementation of a standardized process for pharmacist monitoring of medications with a narrow therapeutic window, AnnLloyd,TeresaCooper,VivianCarson

6-074 Evaluation of the training and implementation of the New Mexico pharmacist-performed tubercu-losis testing program, StefanieLogothetis,MatthewBorrego,AmyBachyrycz,GrahamS.Timmins,BernadetteJakeman

6-075 Current practice patterns in the management of alcohol withdrawal syndrome: a case-based survey study, YoonsunMo,MichaelThomas,NataliaShcherbakova,MeganL.Bankert,RobertH.Halloran

6-076 Determining the appropriateness and safety of discontinuing metformin upon admission in the inpatient noncritically ill setting: a retrospective study, RobynMoodt,MateSoric

6-077 Impact of a pharmacist-directed discharge medi-cation review pilot on the accuracy of medication reconciliation in an acute care community hospi-tal, KhanhNgo,ErikaPatel,CharlesSchlembach,KayeRathmann,RanXu

6-078 Evaluation of the post-acute care transitions (PACT) pharmacists’ role, KaitlinO’Rourke,IlonaGrigoryan

6-079 The impact of pharmaceutical medication review, medication interview before discharge, and follow up on the incidence of patient satisfaction and readmissions: a randomized clinical trial, LeneRavn-Nielsen

6-080 Thromboprophylaxis practice in surgical patients and clinical outcomes: analyze to optimize, AlmudenaRibed,AnaLorenzo-Pinto,EstherDuran-García,AnaHerranz-Alonso,MaríaSanjurjo-Sáez

6-081 Pharmacist-managed penicillin allergy skin test-ing in an inpatient rehabilitation hospital setting, StaciaRumer,ErinMiller

6-059 Real-world impact of prophylactic pegfilgrastim in diffuse large B-cell lymphoma (DLBCL) patients receiving cyclophosphamide, doxorubicin, vincris-tine, and prednisolone (CHOP) with or without rituximab chemotherapy in Korea, Mi-Ri-NaeLee,Hye-WonHan,Jae-YounKim,HyesunGwak

6-060 Medication-use evaluation of anidulafungin in a secondary care hospital, MariaLeon-Martinez,NancyMorales-Berrios,HildaAleman,MIguelColon,PedroJusino

6-061 Characterization of admitting diagnoses in medi-cally hospitalized patients prescribed clozapine: a focus on gastrointestinal and pulmonary events, JonathanLeung,SarahNelson,JasonBarreto,RobertJ.Morgan

6-062 Study of the association of urinary tract infections occurrence and the use of azathioprine in kidney transplant patients, AlineMilane,PascaleSalameh,AntoineBarbari

6-063 Improving adherence to Centers for Disease Control and Prevention (CDC) recommendations for quadrivalent meningococcal (QM) vaccination in anatomical asplenia, NicholasO’Rourke,WhitneyBergquist

6-064 Demonstration of unique and differentiating fea-tures of USL255, (Topiramate) extended-release capsules, through phase 1 studies, AnnaPlasch,KristiK.Spitzmueller,BethanyZ.Dimaculangan,MarkB.Halvorsen

6-065 Efficacy, tolerability, and safety of USL255, (topi-ramate) extended-release capsules, for the treat-ment of refractory partial-onset seizures, KristiSpitzmueller,BethanyZ.Dimaculangan,AnnaM.Plasch,MarkB.Halvorsen

6-066 Intractable agitation due to trazodone in two traumatic brain injury patients undergoing acute inpatient rehabilitation — involvement of CYP2D6 polymorphism as a possible mechanism., NadiaTancredi,RishiShah

6-067 Nutritional strategies in colorectal cancer after major intraabdominal surgery, SilviaVazquez,MaríaFortes,MaríaGarcía,LaraGonzález,CarlosCrespo-Diz

6-068 Trends in erythropoiesis stimulating agents use among patients with nonmyeloid malignancies treated with chemotherapy in a large tertiary care hospital in the United Arab Emirates, LinaWahba,AliaAlawneh,MedhatElsaid,HassanJaafar,MohammedJaloudi

6-069 Identifying and implementing a pharmacist-driven, cost-savings initiative in orthopedic surgery through a community hospital and physician co-manage-ment agreement, JeffreyWilson,MaxwellThomas


6-094 Comparison of timely oseltamivir to delayed therapy in hospitalized patients, SamuelLaFollette,MateSoric

6-095 Impact of an antimicrobial stewardship program (ASP) at a long-term acute care hospital (LTACH): four-year follow-up, QutinaMack,HelenaLee,AshebirWoldeabezgi,BrianBeckett,DianeWhite

6-096 Treatment response rates among cirrhotic hepati-tis C patients under the care of a clinical pharma-cist at an urban academic medical center, MichelleMartin,MyrnaRivas,VictoriaRamos,GraceGo,DarbyRosenfeld

6-097 Randomized, double-blind comparison of tenofo-vir alafenamide (TAF) versus tenofovir disoproxil fumarate (TDF), each co-formulated with elvitegra-vir, cobicistat, and emtricitabine for initial HIV-1 treatment: week 96 results, PatriciaMartin,DavidWohl,ShinichiOka,NathanClumeck,MarshallFordyce

6-098 Switching from boosted atazanavir (ATV) plus emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) to a tenofovir alafenamide (TAF) based single-tablet regimen (STR): week 48 data in viro-logically suppressed adults, PatriciaMartin,BartRijinders,ChristophStephan,MehriMcKellar,ScottMcCallister

6-099 Creation and use of a computerized retrospective algorithm for reportable indication-specific anti-biotic stewardship metrics, GregoryMatsuura,KellyL.Artiga

6-100 Utilization of ceftaroline in a large tertiary care, public, metropolitan hospital with an active anti-biotic stewardship program (ASP), DharaMehta,HaroldHorowitz,BellaKohn,MichaelBlumenfeld

6-101 Tenofovir alafenamide (TAF) compared with teno-fovir disoproxil fumarate (TDF) in patients with HBeAg-negative and HBeAg-positive chronic HBV (CHB): an integrated analysis of safety and effi-cacy from two phase 3 studies, SarjitaNaik,MariaButi,HenryChan,CalvinPan,JohnFlaherty

6-102 Internally developed antifungal use benchmarking at a large academic medical center and integrated health system, AndreaPallotta,ElizabethNeuner,VasiliosAthans,JeffreyChalmers,StevenGordon

6-103 Evaluation of directly observed therapy with three months of once-weekly isoniazid and rifap-entine for latent tuberculosis infection at an out-patient infectious diseases clinic in an academic medical center, AndreaPallotta,CyndeeMiranda,LucileiaTeixeira

6-104 Antifungal prescribing during initial implementa-tion of candidemia early detection and species identification testing with T2Candida panel, FalguniPatel,ElizabethP.Young

6-082 Impact and cost benefit of pharmacy student provided medication reconciliation in community hospital, AlyssaShangraw,OliviaEmerson,PiyushkumarAmin

6-083 The effect of pharmacy counseling on the patient hospital experience, BradleyShinn,StephonPoulton,ThomasFoti

6-084 Impact of multidisciplinary transition-of-care rounds on average length of stay in a community teaching hospital, Lori-BelleSlone,BrittanyRiley,CharbelSalem,HeidiMoore

6-085 Evaluation of effectiveness of pharmacist-driven education on inhaler technique for hospitalized patients at a community teaching medical center, KhushbuThaker,AshmiPhilips,HinalPatel,ThomNguyen,NavinPhilips

6-086 Retrospective analysis assessing the relationship between health literacy and medication adherence, AnthonyZaki,MichaelJ.Gonyeau

Geriatrics6-087 Potentially inappropriate medications in elderly

Japanese patients: effects of pharmacists’ assess-ment and intervention based on screening tool of older persons’ potentially inappropriate prescrip-tions criteria version 2, TakeshiKimura,FumieOgura,TatsuyaNishioka,IkukoYano,MidoriHirai

6-088 Optimizing geriatric pharmacotherapy in a com-munity hospital, UrsulaZienkiewicz,LynetteM.Richards

IV Therapy/Infusion Devices/Home Care6-089 Analysis of alerts and drug library limits in smart

pumps following implementation, KendraDelibert,JedidiahBurroughs

6-090 Utility of smart pump infusion dosing limits to prevent intravenous (IV) medication errors, AntoinetteDuronio

6-091 Evaluating the accuracy and precision of chemo-therapy preparations — single center site analy-sis, StephenEckel,StephanieSalch,AshleyParuscio,LindseyAmerine

Infectious Diseases6-092 Adherence to Infectious Diseases Society of

America guidelines for the treatment of uncom-plicated urinary tract infections in community pharmacies, WissamKabbara,MohamadMeski,WijdanRamadan,PascaleSalameh

6-093 Reducing the inappropriate use of ertapenem for antimicrobial prophylaxis in noncolorectal intraabdominal surgery, KyungKim,JeredM.Arquiette


Poster Presentations Oncology

6-116 It’s not just ACE-Is: angioedema caused by the combination of everolimus and losartan, GaEunJoung,ArsheenaYassin,MinaxiJhawer,JosephCruz,JeffNemeth

6-117 Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post-autologous hematopoietic stem cell transplantation, KarinKoseck,AmirSteinberg,GinaCaliendo,JoanneMeyer,SaraKim

6-118 Development of a novel oxaliplatin desensitiza-tion protocol with smart pump compatibility, NicholasLink,BernadetteA.Clark,MarcEarl

6-119 Benefits of the novel use of a compounded oral suspension in chemotherapy and radiotherapy induced mucositis, MireyaManesSevilla,M.B.Marzal-Alfaro,EvaGonzález-Haba,AnaHerranz,MaríaSanjurjo

6-120 Nw-hydroxy-L-Arginine as a sensitive and stable indicator for determining ethnic and estrogen-receptor-specific breast cancer disease progres-sion, SrinidiMohan,KellyFrazier,CathyNg,NancyMoua,IanGreenstein

6-121 Estimation of optimal monitoring points used for surveying occupational exposure to antineoplastic agents, TomokoMorita,YoshiyukiSano,YasuhikoIchida,ShinichiroSaito,MasakazuYamaguchi

6-122 Tbo-filgrastim-induced marked leukocytois in a community hospital, Kerry-AnnPeters

6-123 Interdisciplinary implementation of tacrolimus intravenous standard concentration, BrandonShank,MelissaDeaver,AlanMyers,BrentAnderegg,MichaelWestmoreland

6-124 Preparing for United States Pharmacopeia (USP) 800 compliance: evaluating the effectiveness of two closed-system transfer devices (CSTDs) on preventing hazardous drug surface contamina-tion, AndrewSzkiladz,ScottGray,ErinTaylor

6-125 Operationalization of a new oncolytic viral ther-apy at a large health system, CherylWood,KarenDonato,IndraniKar

Pain Management6-126 Evaluating intravenous acetaminophen in bariat-

ric surgery patients, MichaelO’Brien,JamieSmelser

6-127 Pharmacist-led management of chronic pain in an outpatient internal medicine clinic, AlexandraPietras,AmyIves,JonathanPuhl,DevChatterji

6-105 Impact of pharmacist-led review and intervention of positive blood culture, RadhaPatel,HelenLee,StevePark

6-106 Raoultella species infection in a body fluid and sputum culture, Kerry-AnnPeters,ScottE.Brown,ScottE.Brown,PoonsriPantutamnitya,HustonR.Powell

6-107 Optimizing antibiotic selection for the treatment of acute bacterial skin and skin structure infec-tions (ABSSSIs), NicholasPiccicacco,LynneKrop,JonathanGrey,KatieMartinkovic,KathleenShannon

6-108 Treatment of acute bacterial skin and skin struc-ture infection (ABSSSI) with single dose dalba-vancin in an outpatient setting, SailajaPuttagunta,UraniaRappo,PedroGonzalez,KarthikAkinapelli,MichaelDunne

6-109 Eradicating community acquired extended spec-trum beta lactamase (ESBL) producing Escherichia coli using fosfomycin, JihanSafwan,FarajK.Saade,MarwanG.Akel,MichelleCherfan,EtwalBouRaad

6-110 Antimicrobial stewardship in the setting of a piperacillin/tazobactam shortage, JustinVandenBerg,JeffreyO’Connell,MakiniAlleyne,OscarGuzman,KatherineM.Shea

6-111 Non-lactose fermenting culture designation before organism identification: predictive value for Pseudomonas and impact on prescribing at a community hospital, NissyVarughese,GemmaDownham,RuthHackney,JosephReilly,ManishTrivedi

6-112 Rate of positive cultures necessitating definitive therapy in patients receiving empiric vancomycin, DustinWaters,JoshCaraccio

6-113 Re-implementation of an antimicrobial steward-ship program results in a first-year savings of about 900,000 dollars, WarrenWood,MatthewChandler,NicoleReynolds,BobbyIzadi,WinnaAsuming

6-114 Effect of drug shortage mitigation strategies on time to ampicillin/sulbactam administration, AndrewZullo,JamesBeaulieu,ChristineM.Berard-Collins

Leadership6-115 Impact of a structured residency preparation

program on match results, VickyShah,ThomasFranko,EricaHoot,NicolePezzino


Practice Research/Outcomes Research/Pharmacoeconomics6-140 Development and implementation of a pharmacist-

directed sports supplementation and nutrition educational outreach program, CodyLovejoy,KarenKier

6-141 Self-management practices in Type 2 diabetic patients: a cross-sectional survey in Alexandria, Egypt, ReemNagib,MahaAbdul-Latif,LailaAboulAtta,MohamedA.Mekkawy,AdelAbou-Ali

6-142 Impact of liposomal bupivacaine on postoperative outcomes in colorectal surgery, CarliNesheiwat,BrandiLaFrance

6-143 A propensity score matched analysis: the associa-tion between prehospital statin use and mortal-ity in patients with diagnosis of acute respiratory failure, ArinzeNkemdirimOkere,ColleenM.Renier

6-144 Minding the gap: perceived factors affecting pri-mary care coordination of adults in 11 countries, JonathanPenm,NeilJ.MacKinnon,StephenM.Strakowski,JunYing,MichelleM.Doty

6-145 Survey of pharmacy leaders on the priorities for the future of the pharmacy profession in Canada, JonathanPenm,NeilJ.MacKinnon,DerekJorgenson,JenniferSmith

6-146 Recombinant human thrombin use in surgery: literature review of impact on clinical outcomes and costs, AnPham,BelindaLovelace,GeorgeWan,MichaelG.Baker

6-147 Impact of medication therapy management (MTM) services in federally qualified health cen-ters (FQHCs) on measures of chronic disease, BriannePorter,JenniferL.Rodis,MagdiAwad,JenniferClark,AlexaSevin

6-148 Impact of a regional interprofessional clinical rea-soning competition on health profession’s stu-dent team interactions, AdrianSchenk,AnnE.Cabri,KatieA.Huyck,KatieA.Packard,YongyueQi

6-149 Time-motion study of preparing three commercial continuous renal replacement therapy (CRRT) solutions, AlexShaw,WeerachaiChaijamorn,JohnS.Clark,BruceA.Mueller

6-150 Hyperkalemia related to treatments in heart failure patients was associated with excess days in hospital, DavidSmith,XiuhaiYang,MicahThorp,NinaOestreicher,EricJohnson

6-151 Elective residency preparation course may increase student ability to acquire PGY1 pharmacy residency, ThomasWadsworth,KathyEroschenko,GlendaCarr,CathyOliphant

Pediatrics6-128 Pharmacist collaborative practice in the manage-

ment of high-risk pediatric asthma, HannaPhan,MarkBrown

6-129 Use of dexamethasone for acute asthma exacer-bation requiring PICU admission, SteveWillis

6-130 Preventing diaper dermatitis in level II nursery — a simple and cost-effective approach, MonaYu,CarlettePatterson,LisaFischer,WildaChungOn

Pharmacokinetics6-131 Recommended vancomycin dosing is insufficient

to maintain adequate serum levels in pediatric patients, TalitaMaloni,CelinaHaga,FábioFerracini,TalitaBelucci,TatianaMarins

6-132 Calculation of vancomycin clearance and area under the curve using nonsteady-state serum concentrations, WilliamMurray,JoshuaW.Murray

6-133 Drug-drug interactions studies between HCV anti-virals sofosbuvir and velpatasvir and HIV antiret-rovirals, SarjitaNaik,KyleHammond,JoeLlewellyn,AnitaMathias,ErikMogalian

6-134 Model-predicted netupitant pharmacokinetic (PK) profiles on repeated dose schedules: accu-mulation and safety considerations for chemo-therapy-induced nausea and vomiting (CINV) prophylaxis in multiday emetogenic chemother-apy, LeeSchwartzberg,SimonaParisi,AlbertoBernareggi

6-135 Development of a novel LC-MS/MS method for determination of denosumab in human serum and its clinical application to cancer patients, HiroakiShida,TakafumiNaitio,KaitoShibata,JunichiKawakami

6-136 Validated LC-MS/MS method for the simultane-ous determination of amlodipine and its major metabolites in human plasma and its clinical application to patients with hypertension., ReinaTaguchi,TakafumiNaito,HikaruSato,JunichiKawakami

Pharmacy Law/Regulatory/Accreditation6-137 Effective and economical drug supply chain secu-

rity act compliance, StevenRobinson,BrianSayre,JamieBaughan,LisaBray

6-138 Safe medication disposal guidance for patients in a hospital and clinic setting: enhancing a state requirement for dispensing, DeborahSadowski

6-139 Assessing the impact of new regulations on phar-macy education and practice in Lebanon, RonyZeenny,SouheilHallit,GeorgesSili,PascaleSalameh


Poster Presentations6-166 Establishment of policies, procedures, and stan-

dard work in the provision of respiratory medica-tions in a small rural hospital, TeresaTronerud,JayneLepage

6-167 Pharmacists in primary care clinic and outpatient pharmacy of an institution collaborate to improve patient care, JudyWong,GretaSweney,DeniseFreund,AndrewFung,TheresaO’Young

6-168 Interrater agreement among healthcare provid-ers in categorizing medication errors using medi-cation-use process nodes, NancyYam,JoonK.Hwang,CharlesE.Daniels,FelixK.Yam

Small and Rural Pharmacy Practice6-169 Impact of a pharmacist on a patient-centered,

interdisciplinary, hospice team within a rural, independent, Planetree community hospital, PatrickDivoky,DebraLehrer

6-170 Puerto Rican rural pharmacists’ knowledge, atti-tudes, and practices related to gender-based vio-lence: development and face validation of a survey, BrendaSoto-Torres,MiguelMarrero-Medina

Emergency Medicine/Emergency Department/Emergency Preparedness6-171 The impact of implementing clinical pharmacy

services in an emergency department, MatthewFord,HamidAhmed

6-172 Implementation of comprehensive pharmacy ser-vices in a community teaching hospital emer-gency department, ChelseaMcSwain

6-173 Impact of an emergency room clinical staff phar-macist in a tertiary hospital in Puerto Rico, LillianaOrtiz-Acevedo

6-174 Pharmacist career ladder, KarenBabb

6-175 MCA: management controlled anesthesia: the growing pains of space planning for an expanding department, JamesBesier,AshleyWester

6-176 Curing the toxic effects of health-system antidote stocking, AngelaColella,EllenPrichard

6-177 Evaluation of community tech-check-tech as a strategy for pharmacy practice advancement, RachaelFleagle,JoeCesarz

Preceptor Skills6-152 Assessment of student perceptions following

incorporation of a recitation period into the phar-macotherapy course series, KristinPeterson,EricWombwell,MaChu

6-153 Student perceptions of the value they bring to rotation practice sites, PhilipRodgers,AdriaFecteau,KimLeadon

6-154 Development of a preceptor scorecard for pre-ceptor reappointment at an academic medical center, JamilaRusseau,LaurenAziz

Quality Assurance/Medication Safety6-155 Educating pharmacists on the use of human per-

formance tools and the importance of error reporting to reduce pediatric medication errors, KristinKlein,JamesD.Newman

6-156 Medication variance reporting in telepharmacy, HongLam,KevinL.Jones

6-157 Telepharmacy: productivity and quality, HongLam,AmberK.Locke,KevinL.Jones

6-158 Accuracy of hospitalized patients’ height and weight documentation and impact on drug dos-ing, RonaldPatrickLandayan,AliceMargulis,NicholasQuinn,AlisonLew,MichaelGonyeau

6-159 Improving barcode overrides in medication administration: a process improvement initiative, JayneLepage,TeresaTronerud

6-160 Influencing patient and provider safety and satis-faction through inclusion of an indication on new prescriptions, KatePerica,AmandaNenaber

6-161 Using a risk-analysis method to evaluate the impact of robotic dispensing on patient safety, CarmenRodriguez-Gonzalez,AnaHerranz-Alonso,VicenteEscudero-Vilaplana,ArantzaAis-Larisgoitia,MariaSanjurjo-Saez

6-162 Medication-use evaluation: exploring the extent of counterfeit medicine in households in Lebanon, LydiaSholy,AngelaMacAdam,PaulGard,SianWilliams

6-163 Nature of counterfeit medicine in Lebanon, LydiaSholy,PaulGard,AngelaMacAdam,SianWilliams,KenRutt

6-164 Enhanced process for withholding anticoagula-tion prior to invasive procedures, JacynthaSterling,MeganHayes

6-165 Pancreatic enzyme tablet protocol for clearing occluded enteral feeding tubes: a retrospective study, JaniceStumpf,CherylL.Bruck,JacentaM.Gabriel,HeenaP.Patel


ACKNOWLEDGMENTS

ASHP Section of Ambulatory Care PractitionersKristina (Kristy) Butler,ChairKelly T. Epplen,ImmediatePastChairLaura M. Traynor,Chair-ElectMollie A. Scott,Director-at-LargeBetsy B. (Mary Elizabeth) Shilliday,Director-at-LargeJessica W. Skelley,Director-at-Large-ElectRanee Runnebaum,BoardLiaisonMelanie Smith,Director

ASHP Section of Clinical Specialists and ScientistsCasey H. White,ChairCurtis Collins,ImmediatePastChairKim W. Benner,Chair-ElectJoel Hennenfent,Director-at-LargeAaron L. Steffenhagen,Director-at-LargeDouglas Slain,Director-at-Large-ElectAmber Lucas,BoardLiaisonVictoria ‘Vicki’ Basalyga,Director

ASHP Section of Inpatient Care PractitionersJennifer Robertson,ChairEmily Alexander,ImmediatePastChairLinda M. Spooner,Chair-ElectJohn Hertig,Director-at-Large

Jacqueline Olin,Director-at-LargePaul E. Milligan,Director-at-Large-ElectTodd Karpinski,BoardLiaisonErika L. Thomas,Director

ASHP Section of Pharmacy Informatics and TechnologySylvia Belford,ChairBrandon Ordway,ImmediatePastChairJoseph J. Lassiter,Chair-ElectMaritza Lew,Director-at-LargeBeth Prier,Director-at-LargeSeth W. Hartman,Director-at-Large-ElectLea S. Eiland,BoardLiaisonAmey Hugg,Director

ASHP Section of Pharmacy Practice ManagersRick Couldry,ChairJames Hoffman,ImmediatePastChairJennifer E. Tryon,Chair-ElectKristine K. Gullickson,Director-at-LargeSamuel Calabrese,Director-at-LargePhillip W. Brummond,Director-at-Large-ElectDonald Letendre,BoardLiaisonDavid Chen,SeniorDirector

ASHP New Practitioners ForumAshley M. Duty,ChairCalvin J. Ice,ViceChairJillian DeGuzman,MemberElizabeth N. Dow,MemberNicholas J. Messinger,MemberTim R. Brown,BoardLiaisonChristina Y. Martin,Director

Lisa M. Gersema,PresidentPaul W. Bush,President-ElectJohn A. Armitstead,ImmediatePastPresidentThomas J. Johnson,TreasurerPaul W. Abramowitz,ChiefExecutiveOfficerTimothy R. BrownLea S. Eiland

Todd A. KarpinskiDonald E. LetendreAmber J. LucasRanee M. RunnebaumJennifer M. SchultzStephen F. Eckel ,Board-ElectLinda S. Tyler,Board-Elect

ASHP Officers and Board of Directors

ASHP Section and Forum Executive Committees


Acknowledgments

ASHP Pharmacy Student ForumJenna L. Fancher,ChairLauren K. Stanz,ViceChairKristy T. Nguyen,MemberAdam T. Smith,MemberKelsey C. Stephens,MemberJennifer M. Schultz,BoardLiaisonDiana L. Dabdub,Director

ASHP Section of Clinical Specialists and ScientistsSarah Bush, ChairAudrey R. Kennedy, Vice-ChairKim Benner, ImmediatePastChairKevin E. AngerNadia AwadMelody L. BergMichael J. CawleyTeresa C. KamGretchen LindseyAnn LloydJoel C. MarrsMarco MartinoKaren J. McConnellPhilippe A. MentlerEve-Michelle SegalJessica StarrJennifer SternbachStephanie WeightmanSuprat Saely WilsonCasey White, ExecutiveCommitteeLiaison

ASHP Section of Ambulatory Care PractitionersNicholas LeonChairKristi Kelley, Vice-ChairEmily M. ArmstrongElaine ChowJennifer N. ClementsSandra CuellarLindsey ElmoreAmber FisherKerry HaneyMelody L. HartzlerCassie HeffernAmy HennemanMichelle HilaireJaime HorneckerDiana IsaacsTracy MartinezDina Hunsinger-NorrisAngela J. OlenikMary H. ParkerHaley M. PhillippeAmber Lanae SmithPamela L. StammJames WangAnne YooJennifer A. Buxton, ExecutiveCommitteeLiaison

ASHP Section of Inpatient Care PractitionersLinda M. Spooner, ChairChristina E. DeRemer, Vice-ChairTerri AlbaranoDelia CariasAmber CastleJonathan C. ChoDarlette G. LukeSandy MoreauSusan SkledarKristin A. Howard, ResidentBenjamin Laliberte, ResidentMeredith A. Collins, StudentJohn Hertig, ExecutiveCommitteeLiaison

ASHP Section of Pharmacy Informatics and TechnologySeth Hartman , ChairDavid Aguero, Vice-ChairLeena AmineJaninah S. BarretoMart T. BaumgartBarry McClainAchsah PhilipEric W. SchrammNancy R. SmestadRobert L. SteinPhillip StewartBarbara Giacomelli, ExecutiveCommitteeLiaison

ASHP Section of Pharmacy Practice ManagersDoina Dumitru, ChairPhilip W. Brummond, Vice-ChairMatthew Eberts,,ImmediatePastChairMichelle L. BorchartAnthony C. ColavecchiaRobb DenggJulia GlowczewskiAngela S. LivingoodJohn D. Pastor IIIEllen PrichardGina SomersRebecca TaylorSam Calabrese, ExecutiveCommitteeLiaisonWilliam M. (Mike) HeathAnthony P. MorrealeHeather OurthJennifer Baker

The ASHP Federal Forum Planning CommitteeWilliam M. (Mike) HeathAnthony P. MorrealeHeather OurthJennifer Baker

2015-2016 ASHP Section Educational Steering Committees


S P E C I A L AC K N O W L E D G M E N TSASHPwouldliketothankthefollowingorganizationsfortheirassistanceinplanningeducationalsessions:

Accreditation Council for Pharmacy Educationl ACPEUpdate2016l ContinuingProfessionalDevelopment(CPD):ACascadeofBenefitsforEmployers

American Association of Colleges of Pharmacyl InterprofessionalEducation:PreparingStudentsforTeam-basedCarel SteppingintoAcademia:FindingtheRightFit

American College of Clinical Pharmacyl BCOPClinicalSessions:LungCancerTherapyandMolecularTargetsl BCOPClinicalSessions:MultipleMyelomaandPediatricCINV

American Institute of the History of Pharmacyl LessonsfromHistory:AdvocatingEffectivelyforPharmacy’sPublicPolicyAgenda

American Pharmacists Associationl #EvidenceBased?ExploringChallengeswiththeQuality,Reporting,andTransparencyofEvidenceinHealthcareResearch

l AntimicrobialStewardshipforAll:WhatYouNeedtoKnowl ControversialHigh-ImpactPublicationsinHypertension:SPRINTingTowardtheGoall PreparingforChange:AntimicrobialStewardshipinAmbulatoryCare

American Society of Transplantation Pharmacy Community of Practicel UpdatesinTransplantation2016

Infectious Diseases Society of Americal SafetyandEfficacyUpdatesintheManagementofInvasiveFungalInfections

Institute for Safe Medication Practicesl AnISMPUpdatefor2017l ImplementingISMP’sTargetedMedicationSafetyBestPracticesl The2016ISMPMedicationSafetyAssessmentandStrategiesforAntithromboticTherapyinHospitals

Pharmacy Technician Certification Boardl PharmacyTechnicians:EssentialPiecesoftheSpecialtyPharmacyPuzzle

Society of Critical Care Medicinel FocusonNeuromuscularBlockingAgents:NewSCCMGuidelines

Society of Infectious Diseases Pharmacistsl AStraightShot:UpdateonAdultVaccinationRecommendations

The Joint Commissionl ReportfromtheField2016:FocusPointsforaSuccessfulJointCommissionSurvey

The Joint Commission Resourcesl TheJointCommissionUpdatefor2017


Acknowledgments

GlenAlbrachtFadiAlkhateebManalAlmutairiMichaelAlwanMaryAmatoScottAndersonPamelaAndrewsVarintornAramvareekulMaryArchambaultRobertaAuliePhilAyersRamadasBalasubramanianSilvanaBalliuJeffreyBarlettaVickiBasalygaEulaBeasleyBradleyBeckEllikaBengtsonBonaBenjaminKimBennerMelodyBergKimberlyBergerSnehalBhattMarianneBilleterDonnaBinghamKimBirtcherBryanBishopMelissaBlairAmyBoldtSaraBorkCherylnBoutanHeidiBraggJanetBramellMichaelBrennerPatrickBridgemanJeffBrittainMitchellBuckleyRonBurnetteAdrianaCabreraSamuelCalabreseKarimCalisShaunaCamachoLeeCarselloAngelaCassanoTheresaCatalano-ChristouOliviaChandlerShirleyChaoJackChenJudyChengChristineClarkJohnClarkNicoleClarkMaryCoberCurtisCollinsJillComeauMichelleCorradoJenniferCostelloJessicaCottreauMaureenCrossman

ErickaCrouseBrianCryderLourdesCuellarWilliamDagerGaryDalinMicheleDanishLisaDealCynthiaDerouinTravisDickBethanyDipaulaErnestDoleAshleyDonatoJulieDopheideMichelleDrzewieckaRabiahDysCristinaElginThomasEllingtonJasonEllisonFrankErnstLynnEschenbacherClaireExausJohnFanikosMeganFarrajKateFarthingJeffreyFishKatieFlowers-ChoateChristineFormeaJillianFosterMichelleFraleyAntheaFrancisElizabethFrancoMaishaFreemanCarlaFryeMelissaGabrielJasonGallagherArpitaGandhiBrettGeigerTraciGeorgeBarbaraGiacomelliRamyGirgisKerryGoldrosenMikiGoldwireLuisGonzalezNancyGrangerShannonGrayJaneGreenTonyaGrossRoyGuharoyMichaelGulsethKarlGumpperLeighGurleyMattHaasMargaretHabermanGenevieveHaleMarkHallDorothy(Sara)HancockEricaHanesworthMichelleHarms

MargaretHegerBradHeinThaddausHellwigChristyHenryMaryHessMeredithHollingerJulieHolstadCharleneHopeLindsayHovestreydtDinaIbrahimCherryJacksonSamanthaJellinek-CohenChelseyJensenMistyJensenPaulJensenRitaJewTaniaJohnJillJohnsonThomasJohnsonMilicaJovicAbbyKahalehAbirKanaanSeemaKapadiaNishaminyuKasbekarJessicaKayBethKeeneyMichaelKendrachWilliamKernanTonyKesselsPatriciaKienlePollyKintzelBonnieKirschenbaumThomasKirschlingMarkKlangAmyKnoblockScottKnoerSusannahKoontzSuzanneKoppJoanneKowiatekJenniferLaiTrishaLaPointeJanelLarewRodnaLarsonBrianLathamCheserLauToddLemkeBonnieLevinJimLilePolinLipnikThomasLittleChrisLoweSherylLoweryKristinLugoKimberlyLuiRaniMadduriSimaMadhiwalaJeannellMansurFancyManton

ShannonManziEricMaroykaChristinaMartinAliMcBrideNishaMehtaRichaMehtaShekharMehtaBetsyMeisbergerChristinaMichalekGaryMilavetzLukeMillerSarahMillerRobertMilnesSandyMoreauAnnaMorinOussaymaMoukhachenRobertMouraJenniferMulhallLeeMurdaughJohnMurphyMichelleMurrayLynseyNeighborsLyndaNguyenKatelynNicholsNatashaNicolBarbaraNussbaumBernieOlinCathyOliphantShawnOsborneZoonParkStevenPassAsadPatanwalaHinaPatelMansiPatelShivaniPatelBriannaPatrickErinPenderDaisyPetersonJenniferPetrieAshmiPhilipsJenniferPhillipsLauraPhillipsMarjoriePhillipsKatePleasantsRyanProutyClaudiaRakhmanJeffreyReitzChristineRichardsonWilliamRickleyCarolRollinsSusanRossilliMargaretRymanGordonSacksDeborahSadowskiSaraSamuelCynthiaSanoskiMichaelScaleseDouglasScheckelhoffAmySchilling

JeanScholtzTerrenceSchwinghammerValerieSheehanBradleyShinnHarminderSikandTedSimperMarkSiskaSusanSkledarDouglasSlainMaureenSmytheJillianSnyderNancySommersClydeSpenceDougSt.JohnPamelaStammLisaStayAaronSteffenhagenMichaelSteinbergSethStrawbridgeMeghanSwarthoutPaulSzumitaAnthonyTardiJanineThenWinnieThiErikaThomasWhitneyThomasAngelaThomasonEricTichyKathrynTinklerCrystalTomJenniferTreviñoDennisTribbleAnneTuckerLindaTylerEuphemiaUhegbuAnnUngermanRayburnVrabelLauraWachterMatthewWanatDavidWarnerKristinWatsonAmandaWeberKathrynWeberMollyWebsterSaraWhiteWhitneyWhiteMichelleWiestKaciWilhelmSheilaWilhelmKristineWillettLonyelWilliamsCrystalWinkSusanWinklerTiffanyWithersJamesonWoodWilliamWullerBarbaraYoungAntoniaZapantisRonyZeenny

Session Proposal, Poster, and Management Case Study Reviewers


ASHP would like to extend a special thanks to the following sponsors:

Sponsors

SponsoringMeetingLanyards

SponsoringHotelKeys

SponsoringASHPTVDailyVideoBroadcast,ColumnWraps,andRechargingStations

Sponsoring3DFloorstickers

SponsoringFloorstickers

SponsoringFloorstickers

SponsoringParkBenches

SponsoringParkBenches

SponsoringExhibitHallBanner

SponsoringMeterBoards

SponsoringMeterBoardsandLobbyBanner

SponsoringLobbyBanners

SponsoringLobbyandExhibitHallBanners,MeterBoards


ASHP STAFF IN ATTENDANCE

Sean Abell, MarketingManager,Membership,MarketingandSalesOffice

Angela Abraham,ProjectManager,OfficeofProfessionalDevelopment

Paul Abramowitz,ChiefExecutiveOfficer,ASHP

Mirela Almonte,AssistantManager,Meetings,ConferenceandConventionDivision

Chris Baker,Director,BusinessIntelligenceandReporting,InformationSystemsTechnology

Sybil Walker Barnes, SocialMediaStrategist,CommunicationsDivision

Victoria Basalyga,Director,SectionofClinicalSpecialistsandScientists,PharmacyPracticeSections

Bona Benjamin,Director,Medication-UseQualityImprovement,CenteronMedicationSafetyandQuality

Kimberlee Berry,SeniorManager,AffiliateRelationsDivision

Colette Bevis,LearningManagementSystemManager,OfficeofProfessionalDevelopment

Beverly Black,Director,AffiliateRelationsDivision

Ruth Bloom,EditorialProjectManager,BooksandeLearn-ingCourses,AcquisitionsandSpecialPublishing

Michelle Bonnarens,SeniorDirector,ProgramDevelopment,OfficeofProfessionalDevelopment

Tyricia Bradley,Manager,EducationalPrograms,EducationalServicesDivision

Carla Brink,Director,ScientificProjects,OfficeofProfessionalDevelopment

Jack Bruggeman,Director,SpecialPublishing

Brendan Burke,Manager,HelpDesk,InformationSystemsTechnology

Fran Byrnes,Director,ConferenceandConventionDivision,OfficeofProfessionalDevelopment

Kim Cackowski,SeniorProjectManager,CertificationDevelopment,OfficeofProfessionalDevelopment

Beth Campbell,AcquisitionsEditor,PublicationsandDrugInformationSystemsOffice

Maria Carias,MembershipProgramManager,MemberRelationsOffice

James Carlson, AccreditationServicesAssociate,AccreditationServicesOffice

Claudia Carson, MeetingsCoordinator,ConferenceandConventionDivision

David Chen,SeniorDirector,SectionofPharmacyPracticeManagers,PharmacyPracticeSections

Daniel Cobaugh,AssistantVicePresidentandEditorinChief,AJHP,PublicationsandDrugInformationSystemsOffice

Jessica Cremer,SeniorManager,MeetingsandLogistics,ConferenceandConventionDivision

Chap Cronquist,Manager,BusinessAnalysisandTraining,InformationSystemsTechnology

Karin Cushman, Director,MeetingsandEducationMarketing,MarketingandSalesOffice

Diana Dabdub,Director,PharmacyStudentForum,MemberRelationsOffice

Brennan Dalecki, AssistantDirector,WebCommunications,OfficeofPolicy,PlanningandCommunications

Anna Legreid Dopp, Director,ClinicalGuidelinesandQualityImprovement,CenteronMedicationSafetyandQuality

Isreal Dyson, EducationProjectAssistant,EducationalServicesDivision

Brian Esuchanko,SeniorManager,EducationalPrograms,EducationalServicesDivision

Dayna Evans,Director,Exhibits&SponsorshipsandAssistantDirector,ConferenceandConventionDivision

Basma Fayyad,ExecutiveManager,ExecutiveOffice

Joseph Feese,Director,CommunicationsDivision

Susan Francis,AccreditationServicesAssociate,AccreditationServicesOffice

Katrin Fulginiti,Director,ResidencyAccreditation,AccreditationServices,AccreditationServicesOffice

Bryce Gaylor,WebDeveloper,InformationSystemsTechnology

Rachel Gellman,MarketingManager,PublishingandDrugInformation,MarketingandSalesOffice

Nicholas Gentile,Director,StateGrassrootsAdvocacyandPoliticalAction,GovernmentRelationsDivision

David Gershman,Director,IndustryRelations,MarketingandSalesOffice

Autumn Gordon, CustomerRelationsAssistant,InformationSystemsTechnoloy

Vanessa Gripper,EducationProjectAssistant,EducationalServicesDivision

Aretha Hankinson,Director,AdvocacyCommunications,CommunicationsDivision

Ken Harding,Manager,Operations,OfficeofProfessionalDevelopment

Andrea Haron,AccreditationServicesAssociate,AccreditationServicesOffice

JoAnn Stacy Harris,Director,EducationalServicesDivision

Guy Hasegawa,SeniorEditor,AJHP

Jill Haug,Director,EducationalStrategyandSpecialProjects,OfficeofProfessionalDevelopment

Bruce Hawkins,EditorialDirector,OfficeofPolicy,Planning,andCommunications

John Heberlein, SeniorVicePresidentandChiefFinancialOfficer,FinanceOffice

Johnna Hershey, Director,PublicationsProductionCenter

Joseph Hill,Director,GovernmentRelationsDivision

Kristi Hofer,Director,ScientificProjects,CertificationDevelopment,OfficeofProfessionalDevelopment

Amey Hugg,Director,SectionofPharmacyInformaticsandTechnology,MemberRelations

Cheryl Imirie,Director,ExecutiveOffice

Chris Jezowski,InstitutionalSalesRepresentative,MarketingandSalesOffice

Lori Justice, AssociateEditor,AJHP

Louise Kelley,Director,Operations

Catherine Klein,Director,EducationDevelopmentandOutcomes,OfficeofProfessionalDevelopment

Lakeisha Knight, CustomerRelationsAnalyst,InformationSystemsTechnology

Chuck Lebioda,Manager,CustomerRelationsManagement,InformationSystemsTechnology

Lisa Lifshin,Director,PharmacyTechnicianAccreditation&ResidencyServices,AccreditationServicesOffice

Mitsi Lizer, AccreditationServicesAssociate,AccreditationServicesOffice

Lisa Lucas,Manager,EducationalPrograms,EducationalServicesDivision


Louise Maitland,Manager,TechnologyCommunications,EducationalServicesDivision

Dean Manke,VicePresident,MarketingandSalesOffice

Randy Manos,Manager,CareerPharm,PublicationsandDrugInformationSystemsOffice

Eric Maroyka, Director,CenteronPharmacyPracticeAdvancement

Christina Martin, Director, NewPractitionersForum,MemberRelationsOffice

Shana Martin,MarketingManager,OfficeofProfessionalDevelopment

Tony Martin,Director,ScientificProjects,OfficeofProfessionalDevelopment

Diane McCleskey,Director,eLearningandLogistics,OfficeofProfessionalDevelopment

Chris McCoy,Manager,NetworkEngineering,ITInfrastructureandDesktopServices

Gerry McEvoy,AssistantVicePresident,AHFSDrugInformation,PublicationsandDrugInformationSystemsOffice

Mary Kate McGinty, AccreditationServicesAssociate,AccreditationServicesOffice

Naomi Michaelis,ProgramManager,GovernmentAffairsDivision

Edward Millikan,Director,ProductDevelopmentandMaintenance,eHealthSolutions;ClinicalInformaticist

Maryam Mohassel,ManagingEditor,AJHP

Shannon Mora,ProjectManager,CertificationDevelopment,OfficeofProfessionalDevelopment

Bruce Nelson,Director,Operations,AccreditationServicesOffice

Sandra Oh Clarke,SeniorDirector,CertificationDevelopment,OfficeofProfessionalDevelopment

Warren Parris,SeniorProjectCoordinator,OfficeoftheGeneralCounsel

Deborah Pasko,Director,MedicationSafety&Quality,CenteronMedicationSafetyandQuality

Giovana Peroni,Manager,MeetingsandTravel,ConferenceandConventionDivision

Jennifer Perrell,ProjectManager,OfficeofProfessionalDevelopment

Brad Pierson,Director,CareerPharm,PublicationsandDrugInformationSystemsOffice

Angela Raval,Director,ScientificProjects,OfficeofProfessionalDevelopment

Verna Reed,Director,CustomerRelations/CustomerService,InformationSystemsTechnology

Andrea Roberson,Director,ProcessandQualityImprovement,AccreditationServicesOffice

Alicia Ross,ProjectManager,SpecialProjects,OfficeofProfessionalDevelopment

Martha Russell,SeniorDirector,ProjectManagement,OfficeofProfessionalDevelopment

Navili Sandoval,StaffAccountant,FinancialManagementDivision

Douglas Scheckelhoff,SeniorVicePresident,OfficeofPracticeAdvancement

Jillanne Schulte, Director,FederalRegulatoryAffairs,GovernmentRelationsDivision

Naomi Schultheis,Director,StandardsDevelopmentandTraining,AccreditationServicesOffice

Jeff Shick,SeniorDirector,eHealthSolutions;ClinicalInformaticist

Kevin Shroyer,AssistantDirector,HumanResourcesDivision

Janet Silvester,VicePresident,AccreditationServices,AccreditationServicesOffice

Gregory Smith,ChiefInformationOfficerandVicePresidentofOperationsandTechnology,OperationsandTechnologyOffice

Leah Smith, AccreditationServicesAssociate,AccreditationServicesOffice

Melanie Smith,Director,SectionofAmbulatoryCarePractitioners,MemberRelations

Irina Stepanova, Director,WebCommunications,OfficeofPolicy,PlanningandCommunications

Akilah Strawder,AccreditationServicesAssociate,AccreditationServicesOffice

Erika Thomas,Director,SectionofInpatientCarePractitioners,PharmacyPracticeSections

Cheryl Thompson,Director,NewsCenter,OfficeofPolicy,Planning,andCommunications

Kasey Thompson,VicePresident,OfficeofPolicy,Planning,andCommunications

Stacey Thompson,ProjectManager,ExecutiveOffice

Paula Tiedemann,GeneralCounsel;VicePresident&ChiefComplianceOfficer,ExecutiveOffice

Christopher Topoleski,Director,FederalLegislativeAffairs,GovernmentRelationsDivision

Kate Traynor,NewsWriter,NewsCenter;AJHP,OfficeofPolicy,Planning,andCommunications

Robert Tremmel, Director,EducationalProgramsI,EducationalServicesDivision

Michelle Tyler,Manager,ExhibitsandAffiliateEvents,ConferenceandConventionDivision

Hannah Vanderpool,VicePresident,MemberRelationsOffice

Cynthia Von Heeringen,Director,EducationalProgramsII,EducationalServicesDivision

Terry Wang,SoftwareEngineer,eHealthSolutions,PublicationsandDrugInformationSystemsOffice

David Warner,Director,CenteronPharmacyPracticeAdvancement,PracticeAdvancementOffice

Julie Webb,SeniorVicePresident,OfficeofProfessionalDevelopment

Tyffani Wingfield,DirectorofMemberEngagement,MemberRelationsOffice

David Witmer,SeniorVicePresident,ExecutiveOffice

Carol Wolfe,SeniorVicePresident,PublicationsandDrugInformationSystemsOffice

Tracy Yaklyvich, AssistantController,FinancialManagementDivision

Vickie Yarborough,ProjectManager,OfficeofProfessionalDevelopment

Cheri Zollicoffer,EducationProjectAssistant,EducationalServicesDivision

Dana Zook,AssistantDirector,ProgramDevelopment,OfficeofProfessionalDevelopment

ASHP Research and Education FoundationStephen Allen,ChiefExecutiveOfficer,ASHPResearchandEducationFoundation

Stephanie Brown,DirectorofPrograms,ASHPResearchandEducationFoundation

Bethany Coulter,DirectorofStrategicCommunicationsandDonorRelations,ASHPResearchandEducationFoundation

Barbara Nussbaum,VicePresident,ASHPResearchandEducationFoundation

Ericka Ochoa, DevelopmentManager,ASHPResearchandEducationFoundation


PRESENTER DISCLOSURES

ASHPrequiresallpresenters,ProgramChairs,andplanningcommitteememberstodiscloserelevantfinancialrelation-ships.Anyconflictsofinterestareresolvedpriortoanindi-vidual’sparticipationisconfirmed.Thefollowingpresentershaveindicatedtheyhaveadisclosure;allotherpresentershavenothingtodisclose.

Martin AllainNationalAssociationofBoardsofPharmacy:Employee

Jason AtlasApexus:Employee

Phil AyersASPEN:BoardMember/AdvisoryPanel;BBraun:Consultant;Baxter:Consultant;FreseniusKabi:Consultant;Janssen:Consultant

Nina BembenSynergyPharmaceuticals(Spouse/Partner):Stockholder/OwnershipInterest

Christopher BlandALKAbello:Consultant,Grant/ResearchSupport;Merck:Speaker’sBureau

Todd CanadaFreseniusKabi:BoardMember/AdvisoryPanel,Consultant,Speaker’sBureau

Angela CassanoPTCB:Consultant

Karrie DerenskiBaxter:Speaker’sBureau

Robert DiDomenicoAmgen:HonorariumfordrugmonographappearinginPharmacyPracticeNews,OtherFinancialorMaterialSupport;OtsukaAmericaPharmaceuticals,Inc.:BoardMember/AdvisoryPanel

Matthew FrickerBoehringer-Ingelheim:Grant/ResearchSupport;CSLBehring:Grant/ResearchSupport;Pfizer:Grant/ResearchSupport

Jeffrey FudinAstraZeneca:Consultant,Speaker’sBureau;Clarity:Consultant;DepoMed:Consultant,Speaker’sBureau;Endo:Consultant,Speaker’sBureau;Kaléo:Consultant,Speaker’sBureau;Kashiv:Consultant;MillenniumHealth,LLC:Speaker’sBureau;Remitigate,LLC-Stockholder/OwnershipInterest;Scilex-Consultant

Michael GulsethBMS:Consultant,Speaker’sBureau;BoehringerIngelheim:Consultant;Janssen:Speaker’sBureau;Pfizer:Speaker’sBureau

Melody HartzlerAstraZeneca:Speaker’sBureau;Janssen:Speaker’sBureau

Christopher HatwigApexus:Employee

Julie KelseyPfizer:Stockholder/OwnershipInterest

Patricia KienleCardinalHealth:Employee,Stockholder/OwnershipInterest(excludingdiversifiedmutualfunds);CriticalPoint:Speaker’sBureau;USP:BoardMember/AdvisoryPanel,Speaker’sBureau

Michael KraftRockwellMedical:Consultant

Edward LiEliLillyandPfizer:BoardMember/AdvisoryBoard,Pfizer:SpeakersBureau

Steven LucioVizient:Employee

Melissa MadiganNationalAssociationofBoardsofPharmacy:Employee

Jeannell MansurJointCommissionResources:Employee

Ali McBrideHospira:BoardMember/AdvisoryPanel;Sandoz:BoardMember/AdvisoryPanel,Grant/ResearchSupport

Christopher McCoyAllergan:BoardMember/AdvisoryPanel;TheMedicinesCompany:BoardMember/AdvisoryPanel;TheravanceBiopharma:BoardMember/AdvisoryPanel;Zavante:Grant/ResearchSupport

Manjunath (Amit) PaiAstellasPharma,Inc.:Consultant;MelintaTherapeutics:Consultant;TheravanceBiopharma:BoardMember/AdvisoryPanel

Julie PawolaEpic(Spouse/Partner):Employee

Beth RobertsHoganLovellsUSLLP:Employee

Susan SametCardinalHealth:Employee

Marc ScheetzMerck:Grant/ResearchSupport;Premier:Speaker’sBureau

Kayla StoverAstellasPharma,Inc.:Grant/ResearchSupport

Kathleen SwansonTriCoreReferenceLaboratories:Employee

John ValgusAmgen:BoardMember/AdvisoryPanel;Sandoz:BoardMember/AdvisoryPanel;Teva:BoardMember/AdvisoryPanel

Benjamin Van TassellNovartis:Grant/ResearchSupport

Jeremy VandiverDiagnosticaStago:OtherFinancialorMaterialSupport

James WagnerEaglesonInstitute:Speaker’sBureau

Christine WalkoBMS:HonorariumforICLIOMelanomaSubcommittee;Merck:HonorariumforICLIOMelanomaSubcommittee


PRESENTER INDEX

A

Abazia,Daniel 103Accursi,MalloryL. 92Achey,ThomasS. 82Acquisto,NicoleM. 46, 68,88Adams,B.Jane 70Adams,JenniferL. 46Adejuwon,Adesola 83Advani,Ashish 62Aguero,David 97,101AlexanderJr.,Earnest 79Aljedai,Ahmed 72Allain,Martin 74Altman,RussB. 34,95Alwan,Laura 88Amato,MaryG. 83Ambrose,Jordan 81Anderson,SarahL. 48Anger,KevinE. 71,83,97Anguiano,RebekahH.100Antonopoulos,Tony 96Armitstead,JohnA. 66Astrup,Greta 93Atlas,Jason 70Atwater,Sandy 103Aungst,TimothyD. 102Awad,NadiaI.. 85,102Ayers,Phil 99

B

Badamas,Rilwan 97Baker,WilliamL. 47,88Barstow,LindaH. 93Bashqoy,Ferras 89Bates,Jill 86Batterman,Gina 78Baumgartner,Jennifer 66Beatty,Amy 84Beck,AmandaM. 63Belford,Sylvia 97Belisle,CarynD. 92Bemben,NinaM. 90Benefield,Emily 76Benner,KimW. 88

Bennett,Corbin 70Bennwitz,Kristina 75Berg,MelodyL. 90,91Bergman,ScottJ. 104Bergsbaken,Jason 71Betz,Christopher 103Bhatt,Snehal 103,105Bilhimer,Matt 93Birney,Patrick 63Bishop,BryanM. 95Bland,ChristopherM.100Bleske,Barry 89Bloom,Ruth 63Bloss,Michelle 88Bonnarens,JosephK. 45Bork,SaraJ.D. 70Bowman,Caitlin 88Boyle,JaclynA. 96Bridgeman,Patrick 71,93Brierton,Dennis 66Brine,PatrickL. 69Briscoe-Dwyer,Leigh 66Bruggeman,JackR. 63Brummond,Philip 80Brunetti,Luigi 99BrylesPhillips,Beth 43Buck,BrianDale 97Buckley,Mitchell 79Burton,Stephanie 88Bush,Sarah 85,88

C

Calabrese,Samuel 92Campbell,Beth 63Campbell,RobertC. 85Canada,ToddW. 99Canaday,BruceR. 87Cannon,Kristin 62Cano,Steven 73Carroll,Donald 83Carter,Tracy 48Cassano,AngelaT. 78Cawley,MichaelJ. 98Cesarz,Joe 78Chan,AmyY. 62Chan,RaymondC. 98Chantal,David 82

Chisholm,Julia 63Chiu,KimberlyW. 83Chrymko,Margaret 43Clark,JohnS. 64Clifford,Kalin 74Cobaugh,DanielJ. 47Cober,MaryPetrea 47Cohen,Howard 69Cohen,Michael 94Colavecchia,AnthonyCarmine 92Conley,ChristianS. 80Coralic,Zlatan 46Cowan,DebraL. 54Cranyon,Ryan 78Cross,Brian 48Cuellar,Sandra 68,69Cunningham,Kevin 100

D

Dager,William 72Davis,GeorgeA. 90Davis,Joshua 97Davis,StephenJ. 70Deal,Lisa 96Degnan,Dan 70Dejos,MichaelC. 71DeMuth,JamesE. 43Denaburg,Michael 80Derenski,Karrie 47DiDomenico,RobertJ. 47DiPiro,JosephT. 45Dodd,MelanieA. 47Dodd,Monique 73Dole,ErnestJ. 69,73,77Donaldson,JenniferA. 95Donihi,AmyC. 48Dowling,Thomas 86Draper,HeatherM. 70,75Dubrovskaya,Yanina 95Dugan,CaseyR. 89Dumitru,Doina 81,92Dunne,JessieL. 105Durham,Spencer 78Dzierba,AmyL. 83

E

Eberts,Matthew 64Eckel,Stephen 92Eldridge,SandraL. 76Elson,E.Claire 76Emanuel,John 84English,II,DaleE. 103Enright,SharonMurphy 73,96EnsignII,RichardH. 62Erstad,BrianL. 96,104Eschenbacher,Lynn81,96Ezekiel,TanyaO. 97

F

Fanikos,John 72Farmer,EricK. 91Fedorova,Margarita 67Feinberg,EricaA. 98Ferris,David 101Fink,Robert 80Finks,ShannonW. 45Flannery,AlexanderH.104Fortier,Christopher 80Foster,Jillian 45,54Fox,Erin 66Foy,Maria 77,103Frantzen,Leah 89Fraser,Gilles 79,97Fredrickson,MaryE. 69FrickerJr.,MatthewP. 67Fritsch,MichelleA. 47Fudin,Jeffrey 69


Presenter IndexG

Gentile,Nicholas 81Ghamrawi,Riane 94Giacomelli,BarbaraL. 63, 82Gibson,GabrielleA. 101Gilmore,JamesF. 88Glowczewski,Jason 100Glowczewski,Julia 83Goldrosen,KerryA. 89Gonzales,AdrianJ. 97Grace,EdwardE. 92,100Granko,RobertP. 105Gray,AlistairH. 72Griffin,Brooke 85,104Griffith,NieshaL. 83Grindrod,Kelly 102Groppi,Julie 78Grosdidier,Jamie 85Guharoy,Roy 84Gulseth,Michael 67,72Gumpper,KarlF. 97

H

Ha,David 99Haines,SeenaL. 94Halfpap,Joseph 46Hammerquist,Rhonda 67Hamner,JenniferR. 89Hanf-Kristufek,LaurylR.91Harris,Jennifer 98Hartzler,Melody 105Hatwig,ChristopherA. 70Havriliak,Renee 69Hayes,BryanD.46,93,102Hays,Amanda 90Heath,Mike 65Heavner,MojdehS. 46Heindel,GregoryA. 62Hellwig,Tadd 88,92Helmons,PieterJ. 77Helsel,Heather 81Hennenfent,JoelA.48,97Higby,Gregory 86Hilaire,MichelleL. 45,48, 68,78Hill,Jerame 82,89Hill,Joseph 81Hodges,Angela 75Hoesly,Megan 64Hoffman,JamesM. 79Homsted,Felicity 87Hoover,Matthew 82Horn,Donna 85

Hornecker,JaimeR. 48Huang,Yimei 72Hudson-Disalle,Sarah 83

I

Isaacs,Diana 69

J

Jain,Ruchi 71Jameson,John 86Jean,GaryW. 79Jen,Christi 46Jenkins,MatthewT. 103Jennings,Douglas 74Jensen,Brenda 66Jensen,ChelseyJ. 76John,Bob 76Johnson,AshleyN. 86,87Johnson,Chad 70Johnson,PeterN. 76Johnson,Thomas 66Jones,BruceM. 97Jones,ChristopherM.. 65Jordin,Robert 72

K

Kalichira,Asha 98Kanouse,EricJ. 93Kar,Indrani 71Karcsh,Andrew 64Karel,LaurenI. 62Karr,Samantha 105Kasbekar,Nishaminy 96Kastango,EricS. 87Kelley,KristiW. 105Kelsey,JulieJ. 85Kempke,AnnaP. 102Kennedy,Audrey 76,87Kent,Stan 80Kernan,William 81Kienle,PatriciaC. 72,87Kilber,Emily 93Killingsworth,Tricia 82King,PhilipK. 81Kirschenbaum,Bonnie 93Knoer,ScottJ. 80,87Koch,AdaZ. 89Koehl,Jenny 93Koehl,Kathy 96Kong,BenL. 87Kraft,Michael 99Kraft,Shawna 102Krzan,KaraD. 79Kumor,LisaM. 100Kuper,Kristi 99

L

Laible,BradR. 84,85Laroco,Laurimay 46Latham,Brian 82,105Le,Brian 98Leal,Sandra 85Leber,Molly 84Lee,Helena 81Lee,LorraineA. 69Lenz,JanelleR. 71Leonhart,KayM. 69Lewis,MichelleA. 67Li,Edward 46,80Li,MaryL. 66Lingenfelter,ErinM. 88Link,NicholasA. 67Lirette,Stephen 103Little,JeffD. 66Lodise,Thomas 94Loeb,Al 73Lucio,Steven 84Luong,DonnaD. 96Lyden,Abbie 101

M

MacLaughlin,EricJ. 80Madigan,MelissaA. 74Mahomed,ShuaibH. 72Mahoney,Monica 102Malinowski,Scott 98Malone,PatrickM. 62Mansur,Jeannell 54,100Manzi,Shannon 87Markham,Ryan 98Maroyka,EricM. 72Marrs,JoelC. 45,68,80, 90Martin,Colleen 93Marx,David 105Matthews,Michele73,104Mattox,Kimberly 43McBride,Ali 75McConnell,KarenJ.45,88McCoy,Christopher 102McKelvey,Jeremiah 65McPherson,Christopher 71McPherson,MaryLynnL.91Mehta,Dhara 98Meisel,Steven 103Melody,Nichole 88Mendez-Rico,Elena 62Mentler,Philippe 74,98

Merandi,Jenna 79Meyer,BrianM. 86Michalek,Christina 67,94Miller,Douglas 98Miller,WilliamA. 43Milligan,Paul 70Misher,Anne 85MobleySmith,Miriam 78Moffett,BradyS. 76Mone,MichaelA. 68Monroe,P.Sayer 71Moore,LeAnne 94Morton,Carrie 81Moser,Lynette 89MossJr.,JosephT. 98Mourad,Hesham 97Mueller,BruceA. 45Mueller,ScottW. 71Murdaugh,LeeB. 72Myers,Brad 63

N

Naseman,Ryan 105Nathan,Aaron 83Nazario,Mitchell 65Nazir,Jawad 85Nelson,ScottD. 104Newman,Sarah 89Nguyen,LindaP. 63Nichols,KristenR. 82Nicol,Natasha 79Niemczyk,Ashley 93Noh,LydiaE. 75Novak,KimberlyJ. 88

O

O’Neal,BrianC. 82Oelschlaeger,LaDonnaM. 75Olin,JacquelineL. 48Onatade,Raliat 72Ordway,Brandon 89Ortmann,MelindaJ. 85Osborne,Shawn 100Owen,EmilyJ. 101


P

PageII,RobertL. 90Pai,Manjunath(Amit) 94Painter,NathanA. 75Paley,Daniel 93Pappas,Ashley 62Pasko,DeborahA. 64Pass,Steven 43Patanwala,AsadE. 68Patel,Hina 93Patel,Kashyap 64Patel,Sheetal 101Pavich,Emily 93Pawola,Julie 61,89Peaty,Nate 101Pedersen,CraigA. 91Pedley,Krista 70Penk,MaryJo 69Petrich,John 70Petroff,Barbara 78Phelps,Pamela 80Popish,SarahJ. 47Pote,Lindsey 84Powell,MichaelF. 96Prichard,Ellen 62Purohit,Ashley 61,73

Q

Quesenberry,Alexander 54

R

Reardon,David 78,83Rebo,Elizabeth 71Reece,Kelley 71Reitz,ShirleyJ. 77Rhodes,NathanielJ. 74Rich,DarrylS. 94,103Richards,Hal 97Richardson,JenniferL. 91Rickles,NateM. 69Rigelsky,FrankS. 67Ritchie,EvelynB. 65Roberson,AndreaG. 43Roberts,AaronJ. 72Roberts,Beth 93Robertson,Jennifer 70Rochon,Jeff 77RodriguezGonzalez,CarmenGuadalupe 72Rollins,CarolJ. 78,82,91Rosovsky,RachelP. 90

Rostas,Sara 71Rubio,Teresa 71Russ,AlissaL. 104Rybak,MichaelJ. 94Ryle,KarenM. 85

S

Sacks,Gordon 99SafwanSaade,JihanH. 72Samet,Susan 89,90Sammons,ArpitaT. 64Sarashinsky,Megan 47Saseen,Joseph 80Scheckelhoff,Douglas 91Scheetz,MarcH. 70,94Schiff,Gordon 83Schilling,Amy 99Schneider,PhilipJ. 91Schondelmeyer,StephenW. 86Schroeder,Michael 89Schulte,Jillanne 81Scipione,MarcoR. 95Scott,ChristopherM. 43Scott,MollieA. 47Scoville,Bridget 45Sebaaly,Jamie 48SebranekEvans,Elizabeth 62Segal,Eve 75Sera,Leah 90Shah,BhavikM. 88Shah,Pinaki 62Shah-Mohammadi,Ali-Reza 71Shane,Rita 67,75Shank,Brandon 88Sheehan,AmyHeck 62Shilliday,Betsy 78Shrader,Sarah 68Siegfried,Justin 95Sims,Sharanie 94Skiermont,Kyle 69Slabach,Brock 54Sleeper,RebeccaB. 99Sloan,ColganT. 93Slocum,GilesW. 93Smith,AmberLanae 89Smith,Janessa 84

Smith,Jennifer 90Soric,MateM. 63Spencer,Dustin 88Spooner,LindaM. 48,54Srinivasan,Arjun 63Stamatakis,Mary 98Stanley,Todd 69Starr,Jessica 74,88Sternbach,Jennifer 101Stevenson,JamesG. 46Stewart,KyanaD. 76,82, 87Stilgenbauer,Mike 68Stover,KaylaR. 104Stubbings,JoAnn 100Subramaniam,Vaiyapuri 66Swanson,Kathleen 73Swarthout,MeghanD. 73Szumita,PaulM.. 97

T

Tata,AshaL. 86Taylor,RebeccaA. 68TemplemanJr.,BillA. 71Thackray,JenniferL. 86Thompson,Kasey 81Thornby,Krisy-Ann 87Ticehurst,ErinH. 84Tichy,EricM. 46Tisdale,JamesE. 92,98Topoleski,Christopher 81Tran,Hai 76Trinkley,KatyE. 92Tucker,Anne 47Turner,Suzanne 66Tyler,Linda 66

U

Uselton,JohnP. 72

V

Valgus,John 75VanTassell,Benjamin 89VanAmburgh,JennyA. 94Vandiver,JeremyW.58,71Verdell,AmberJ. 91Vermeulen,Lee 33,72Vest,KathleenM. 104Villanueva-Quirino,JuanE. 82Vlasimsky,TaraBehring64Vlasses,Peter 68Vo,Teresa 87

W

Wade,Elizabeth 71Wagner,JamesT. 87Walker,KathrynA. 91Walko,ChristineM. 79Warner,DavidJ. 43Weightman,Stephanie 76Welch,Sarah 101WetherillIV,SamuelR. 82White,SaraJ. 73,96Wickesberg,ChristopherJ. 64Wilets,Kathy 66Williams,Cynthia 80,96, 101Williams,MontgomeryF.99Wilson,Courtenay 104Wilson,SupratSaely.45,98Wirick,NathanP. 67Witt,Daniel 92Wollitz,AmandaD. 71Wong,Adrian 98Woolf,Roger 77,87

Y

Youmbi,KarenV. 67,81

Z

Zellmer,WilliamA. 79,80, 86Zillich,Alan 45Zilz,DavidA. 80Zschoche,Juliana 93


SHUTTLE SERVICE SCHEDULE

ASHP Official HotelsHotel Route Boarding

Aria 3 TourBusLobby

The Cosmopolitan 4 RightofMainEntrance

Delano Walk WalktoMandalayBayConventionCenter

Four Seasons Walk WalktoMandalayBayConventionCenter

Luxor Walk WalktoMandalayBayConventionCenter

Mandalay Bay Walk WalktoMandalayBayConventionCenter

MGM Grand 1 SouthConferenceCenterEntrance

Monte Carlo 2 TourBusArea

New York-New York 2 MainEntrance

Signature at MGM Grand 1 MGMGrandSouthConferenceCenterEntrance

a Shuttles Operate Saturday, December 3 - Thursday, December 8

Shuttle Service to and from Mandalay Bay Convention CenterEstimated Wait Time: 15 to 20 Minutes

ServiceBegins LastBusDeparts LastBusDeparts Hotel Hotel Convention Center

SATURDAY 6:30a.m. 5:00p.m. 6:00p.m.

SUNDAY 6:30a.m. 5:00p.m. 6:00p.m.

MONDAY 6:30a.m. 5:00p.m. 6:00p.m.

TUESDAY 7:00a.m. 5:00p.m. 6:00p.m.

WEDNESDAY 7:00a.m. 4:30p.m. 5:30p.m.

THURSDAY 8:00a.m. 2:30p.m. 3:30p.m.

7:00 p.m.–10:30 p.m.Shuttleserviceto/fromofficialASHPHotels,exceptthose

withinwalkingdistanceoftheMandalayBayConventionCenter.

Wheelchairaccessibletransportationisavailableduringhoursofoperation.Calltollfree866-439-8563toschedule(allow30minutes).

Shuttlesmanaged&operatedbyTransportation Management Services

Theshuttlescheduleissubjecttochangebasedonusage,traffic,andweatherconditions.PleasecheckASHPLIVEappandtheMidyear News & Viewsdailyforupdatestotheschedule.

Wednesday Evening Event

at Mandalay Bay


LAS

VEG

AS B

OU

LEVA

RD

LAS

VEG

AS B

OU

LEVA

RD

RUSSELL ROAD

MANDALAY BAY ROAD

RENO AVENUE RENO AVENUE

KOVA

L LA

NE

KO

VAL

LAN

E

TROPICANA AVENUE TROPICANA AVENUE

PARK AVENUE

HARMON AVENUE HARMON AVENUE

GAS

GAS

GAS

AUDR

IE S

TREE

T

AUDR

IE S

TREE

T

FRAN

K SI

NAT

RA D

RIVE

FR

ANK

SIN

ATRA

DRI

VE

FRAN

K SI

NAT

RA D

RIVE

MCCARRAN INTERNATIONAL

AIRPORT

THE COSMOPOLITAN

ARIA

MONTE CARLO

NEW YORK NEW YORK

MGM GRAND

MGM ARENA

LUXOR

MANDALAY BAY

NORTH CONV

CENTER

SOUTH CONV

CENTER

EVENTS CENTER

DELANO LAS VEGAS

MANDALAY BAY HOTEL

FOUR SEASONS

MARQUEE BALLROOM

POOL CONF.CENTER

THESIGNATUREAT MGM GRAND

Indicates the shuttle bus drop-off/pickup locations. Refer to the ASHP LIVE app for details on boarding locations.

AYES

TRUE

Use these pages during sessions with color-card audience participation.

GREEN

FUN FACT

The famous Las Vegas Strip is not located within

the city limits of Las Vegas. The strip

actually comes under the jurisdiction of

Clark County.

BNO

FALSE

FUN FACT

Over 22,000 conventions

are held in Las Vegas every year.

RED

CUse these pages during sessions with color-card audience participation.

YELLOW

FUN FACT

Legalization of gambling in 1931 encouraged other

parts of the country to request the recall of Nevada’s statehood.

Today there are forms of legalized gambling in

48 of the 50 states.

DFUN FACTWith its millions of lights, Las Vegas is considered the brightest spot on Earth.

BLUE


NOTES

Documents

Onsite Program Book - ASHP MediaWelcome to Las Vegas! It is great to be back in this city of boundless energy and excitement for the largest gathering of pharmacists in the world